
<html lang="en"     class="pb-page"  data-request-id="c5308578-60b6-4dc8-a3fb-bd3c2cf26675"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm500261q;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations" /></meta><meta name="dc.Creator" content="Ted W.  Johnson" /></meta><meta name="dc.Creator" content="Paul F.  Richardson" /></meta><meta name="dc.Creator" content="Simon  Bailey" /></meta><meta name="dc.Creator" content="Alexei  Brooun" /></meta><meta name="dc.Creator" content="Benjamin J.  Burke" /></meta><meta name="dc.Creator" content="Michael R.  Collins" /></meta><meta name="dc.Creator" content="J. Jean  Cui" /></meta><meta name="dc.Creator" content="Judith G.  Deal" /></meta><meta name="dc.Creator" content="Ya-Li  Deng" /></meta><meta name="dc.Creator" content="Dac  Dinh" /></meta><meta name="dc.Creator" content="Lars D.  Engstrom" /></meta><meta name="dc.Creator" content="Mingying  He" /></meta><meta name="dc.Creator" content="Jacqui  Hoffman" /></meta><meta name="dc.Creator" content="Robert L.  Hoffman" /></meta><meta name="dc.Creator" content="Qinhua  Huang" /></meta><meta name="dc.Creator" content="Robert S.  Kania" /></meta><meta name="dc.Creator" content="John C.  Kath" /></meta><meta name="dc.Creator" content="Hieu  Lam" /></meta><meta name="dc.Creator" content="Justine L.  Lam" /></meta><meta name="dc.Creator" content="Phuong T.  Le" /></meta><meta name="dc.Creator" content="Laura  Lingardo" /></meta><meta name="dc.Creator" content="Wei  Liu" /></meta><meta name="dc.Creator" content="Michele  McTigue" /></meta><meta name="dc.Creator" content="Cynthia L.  Palmer" /></meta><meta name="dc.Creator" content="Neal W.  Sach" /></meta><meta name="dc.Creator" content="Tod  Smeal" /></meta><meta name="dc.Creator" content="Graham L.  Smith" /></meta><meta name="dc.Creator" content="Albert E.  Stewart" /></meta><meta name="dc.Creator" content="Sergei  Timofeevski" /></meta><meta name="dc.Creator" content="Huichun  Zhu" /></meta><meta name="dc.Creator" content="Jinjiang  Zhu" /></meta><meta name="dc.Creator" content="Helen Y.  Zou" /></meta><meta name="dc.Creator" content="Martin P.  Edwards" /></meta><meta name="dc.Description" content="Although crizotinib demonstrates robust efficacy in anaplastic lymphoma kinase (ALK)-positive non-small-cell lung carcinoma patients, progression during treatment eventually develops. Resistant pat..." /></meta><meta name="Description" content="Although crizotinib demonstrates robust efficacy in anaplastic lymphoma kinase (ALK)-positive non-small-cell lung carcinoma patients, progression during treatment eventually develops. Resistant pat..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 3, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500261q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500261q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500261q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500261q" /></link>
        
    
    

<title>Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500261q" /></meta><meta property="og:title" content="Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0018.jpeg" /></meta><meta property="og:description" content="Although crizotinib demonstrates robust efficacy in anaplastic lymphoma kinase (ALK)-positive non-small-cell lung carcinoma patients, progression during treatment eventually develops. Resistant patient samples revealed a variety of point mutations in the kinase domain of ALK, including the L1196M gatekeeper mutation. In addition, some patients progress due to cancer metastasis in the brain. Using structure-based drug design, lipophilic efficiency, and physical-property-based optimization, highly potent macrocyclic ALK inhibitors were prepared with good absorption, distribution, metabolism, and excretion (ADME), low propensity for p-glycoprotein 1-mediated efflux, and good passive permeability. These structurally unusual macrocyclic inhibitors were potent against wild-type ALK and clinically reported ALK kinase domain mutations. Significant synthetic challenges were overcome, utilizing novel transformations to enable the use of these macrocycles in drug discovery paradigms. This work led to the discovery of 8k (PF-06463922), combining broad-spectrum potency, central nervous system ADME, and a high degree of kinase selectivity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500261q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500261q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500261q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500261q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500261q&amp;href=/doi/10.1021/jm500261q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4720-4744</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5002524" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500279x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of (10<i>R</i>)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-<i>2H</i>-8,4-(metheno)pyrazolo[4,3-<i>h</i>][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ted+W.++Johnson">Ted W. Johnson</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+F.++Richardson">Paul F. Richardson</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Bailey">Simon Bailey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexei++Brooun">Alexei Brooun</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+J.++Burke">Benjamin J. Burke</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+R.++Collins">Michael R. Collins</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Jean++Cui">J. Jean Cui</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judith+G.++Deal">Judith G. Deal</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ya-Li++Deng">Ya-Li Deng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dac++Dinh">Dac Dinh</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lars+D.++Engstrom">Lars D. Engstrom</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mingying++He">Mingying He</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacqui++Hoffman">Jacqui Hoffman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+L.++Hoffman">Robert L. Hoffman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qinhua++Huang">Qinhua Huang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+S.++Kania">Robert S. Kania</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+C.++Kath">John C. Kath</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hieu++Lam">Hieu Lam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Justine+L.++Lam">Justine L. Lam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Phuong+T.++Le">Phuong T. Le</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Lingardo">Laura Lingardo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Liu">Wei Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michele++McTigue">Michele McTigue</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cynthia+L.++Palmer">Cynthia L. Palmer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neal+W.++Sach">Neal W. Sach</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tod++Smeal">Tod Smeal</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Graham+L.++Smith">Graham L. Smith</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Albert+E.++Stewart">Albert E. Stewart</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sergei++Timofeevski">Sergei Timofeevski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huichun++Zhu">Huichun Zhu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinjiang++Zhu">Jinjiang Zhu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helen+Y.++Zou">Helen Y. Zou</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+P.++Edwards">Martin P. Edwards</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#502435347e277e3a3f383e233f3e102036392a35227e333f3d"><span class="__cf_email__" data-cfemail="255140410b520b4f4a4d4b564a4b6555434c5f40570b464a48">[email protected]</span></a>. Phone: (858) 526-4683.</div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#6919081c05470f471b000a01081b0d1a060729190f00130c1b470a0604"><span class="__cf_email__" data-cfemail="b0c0d1c5dc9ed69ec2d9d3d8d1c2d4c3dfdef0c0d6d9cad5c29ed3dfdd">[email protected]</span></a>. Phone: (858) 526-4290.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500261q&amp;href=/doi/10.1021%2Fjm500261q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4720–4744</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 13, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 February 2014</li><li><span class="item_label"><b>Published</b> online</span>3 June 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 June 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500261q" title="DOI URL">https://doi.org/10.1021/jm500261q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4720%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTed%2BW.%2BJohnson%252C%2BPaul%2BF.%2BRichardson%252C%2BSimon%2BBailey%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D11%26contentID%3Djm500261q%26title%3DDiscovery%2Bof%2B%252810R%2529-7-Amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528metheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2B%2528PF-06463922%2529%252C%2Ba%2BMacrocyclic%2BInhibitor%2Bof%2BAnaplastic%2BLymphoma%2BKinase%2B%2528ALK%2529%2Band%2Bc-ros%2BOncogene%2B1%2B%2528ROS1%2529%2Bwith%2BPreclinical%2BBrain%2BExposure%2Band%2BBroad-Spectrum%2BPotency%2Bagainst%2BALK-Resistant%2BMutations%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4744%26publicationDate%3DJune%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500261q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">12479</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">265</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500261q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ted&quot;,&quot;last_name&quot;:&quot;W. Johnson&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;F. Richardson&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Bailey&quot;},{&quot;first_name&quot;:&quot;Alexei&quot;,&quot;last_name&quot;:&quot;Brooun&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;J. Burke&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;R. Collins&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Jean Cui&quot;},{&quot;first_name&quot;:&quot;Judith&quot;,&quot;last_name&quot;:&quot;G. Deal&quot;},{&quot;first_name&quot;:&quot;Ya-Li&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Dac&quot;,&quot;last_name&quot;:&quot;Dinh&quot;},{&quot;first_name&quot;:&quot;Lars&quot;,&quot;last_name&quot;:&quot;D. Engstrom&quot;},{&quot;first_name&quot;:&quot;Mingying&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Jacqui&quot;,&quot;last_name&quot;:&quot;Hoffman&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;L. Hoffman&quot;},{&quot;first_name&quot;:&quot;Qinhua&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;S. Kania&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;C. Kath&quot;},{&quot;first_name&quot;:&quot;Hieu&quot;,&quot;last_name&quot;:&quot;Lam&quot;},{&quot;first_name&quot;:&quot;Justine&quot;,&quot;last_name&quot;:&quot;L. Lam&quot;},{&quot;first_name&quot;:&quot;Phuong&quot;,&quot;last_name&quot;:&quot;T. Le&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Lingardo&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;McTigue&quot;},{&quot;first_name&quot;:&quot;Cynthia&quot;,&quot;last_name&quot;:&quot;L. Palmer&quot;},{&quot;first_name&quot;:&quot;Neal&quot;,&quot;last_name&quot;:&quot;W. Sach&quot;},{&quot;first_name&quot;:&quot;Tod&quot;,&quot;last_name&quot;:&quot;Smeal&quot;},{&quot;first_name&quot;:&quot;Graham&quot;,&quot;last_name&quot;:&quot;L. Smith&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;E. Stewart&quot;},{&quot;first_name&quot;:&quot;Sergei&quot;,&quot;last_name&quot;:&quot;Timofeevski&quot;},{&quot;first_name&quot;:&quot;Huichun&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Jinjiang&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Helen&quot;,&quot;last_name&quot;:&quot;Y. Zou&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;P. Edwards&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;4720-4744&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500261q&quot;},&quot;abstract&quot;:&quot;Although crizotinib demonstrates robust efficacy in anaplastic lymphoma kinase (ALK)-positive non-small-cell lung carcinoma patients, progression during treatment eventually develops. Resistant patient samples revealed a variety of point mutations in the kinase domain of ALK, including the L1196M gatekeeper mutation. In addition, some patients progress due to cancer metastasis in the brain. Using structure-based drug design, lipophilic efficiency, and physical-property-based optimization, highly potent macrocyclic ALK inhibitors were prepared with good absorption, distribution, metabolism, and excretion (ADME), low propensity for p-glycoprotein 1-mediated efflux, and good passive permeability. These structurally unusual macrocyclic inhibitors were potent against wild-type ALK and clinically reported ALK kinase domain mutations. Significant synthetic challenges were overcome, utilizing novel transformations to enable the use of these macrocycles in drug discovery paradigms. This work led to the discovery of 8k&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500261q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500261q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500261q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500261q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500261q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500261q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500261q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500261q&amp;href=/doi/10.1021/jm500261q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500261q" /></input><a href="/doi/pdf/10.1021/jm500261q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26pmid%3D24819116%26genre%3Darticle%26aulast%3DJohnson%26date%3D2014%26atitle%3DDiscovery%2Bof%2B%252810R%2529-7-Amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528metheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2B%2528PF-06463922%2529%252C%2Ba%2BMacrocyclic%2BInhibitor%2Bof%2BAnaplastic%2BLymphoma%2BKinase%2B%2528ALK%2529%2Band%2Bc-ros%2BOncogene%2B1%2B%2528ROS1%2529%2Bwith%2BPreclinical%2BBrain%2BExposure%2Band%2BBroad-Spectrum%2BPotency%2Bagainst%2BALK-Resistant%2BMutations%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D11%26spage%3D4720%26epage%3D4744%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291163" title="Macrocycles">Macrocycles</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jmcmar.2014.57.issue-11/production/jmcmar.2014.57.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Although crizotinib demonstrates robust efficacy in anaplastic lymphoma kinase (ALK)-positive non-small-cell lung carcinoma patients, progression during treatment eventually develops. Resistant patient samples revealed a variety of point mutations in the kinase domain of ALK, including the L1196M gatekeeper mutation. In addition, some patients progress due to cancer metastasis in the brain. Using structure-based drug design, lipophilic efficiency, and physical-property-based optimization, highly potent macrocyclic ALK inhibitors were prepared with good absorption, distribution, metabolism, and excretion (ADME), low propensity for p-glycoprotein 1-mediated efflux, and good passive permeability. These structurally unusual macrocyclic inhibitors were potent against wild-type ALK and clinically reported ALK kinase domain mutations. Significant synthetic challenges were overcome, utilizing novel transformations to enable the use of these macrocycles in drug discovery paradigms. This work led to the discovery of <b>8k</b> (PF-06463922), combining broad-spectrum potency, central nervous system ADME, and a high degree of kinase selectivity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Anaplastic lymphoma kinase (ALK) is a member of the insulin receptor (IR) subfamily of receptor tyrosine kinases. It is primarily expressed in adult brain tissue and plays an important role in the development and function of the nervous system.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> ALK knockout mice live a full life span without obvious abnormalities, but are described as having an “antidepressive” phenotype.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The ALK name was derived from the discovery of the driving role this kinase plays in anaplastic large-cell lymphoma (ALCL), a subtype of non-Hodgkin lymphoma, in which the t(2;5)(p32;q35) chromosomal translocation involving the <i>ALK</i> gene was first described.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The finding that this translocation results in the fusion of nucleophosmin (NPM) to a truncated form of ALK led to the first suggestion that this fusion could result in a constitutively active cytoplasmic tyrosine kinase that could be acting as an oncogenic driver.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Subsequently, other ALK-fusion proteins have been identified in diffuse large-B-cell lymphoma (DLBCL),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> inflammatory myofibroblastic tumors (IMTs),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and non-small-cell lung carcinoma (NSCLC).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Over the past 20 years, more than a dozen fusion partners for ALK have been identified in a variety of cancer types (typically rare childhood cancers). Like NPM, the fusion partners replace the ALK protein domains responsible for ligand binding and crossing the membrane with a domain that results in constitutive dimerization/oligomerization activation of ALK tyrosine kinase in the cytoplasm. However, it was the discovery of a fusion of echinoderm microtubule-associated protein-like 4 with ALK (EML4–ALK) in 3–7% of NSCLC patients that enabled the rapid clinical development and validation of ALK inhibitors as a viable, new cancer therapy.<a onclick="showRef(event, 'cit7c cit7d'); return false;" href="javascript:void(0);" class="ref cit7c cit7d">(7c, 7d)</a> In addition to chromosomal translocations leading to fusion proteins, amplification of <i>ALK</i> and activating point mutations in full-length protein have been described in neuroblastoma,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> inflammatory breast cancer,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and ovarian cancer<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> patients. Similar to <i>ALK</i>, c-ros oncogene 1 (<i>ROS1</i>) chromosomal translocations define a unique, albeit smaller, subset of non-small-cell lung cancers.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Compound <b>1</b> (PF-02341066, crizotinib),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> a MET, ALK, and ROS1 kinase inhibitor at clinically relevant drug exposures, was in early clinical trials when the EML4–ALK translocation was identified.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The marked efficacies from two clinical trials led to U.S. Food and Drug Administration (FDA) approval in 2011 based on an objective response rate of approximately 60% and progression-free survival (PFS) times of approximately 10 months.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Xalkori was the first ALK inhibitor approved by the U.S. FDA as a first-line treatment for ALK-positive lung cancer patients.</div><div class="NLM_p">Although compound <b>1</b> demonstrates initial robust efficacy in ALK-positive tumors, patients eventually develop resistance. Emerging data from the analysis of patient tumor tissue collected after progression suggest that resistance develops through point mutations in the <i>ALK</i> gene, which may be as frequent as that seen in the EGFR setting (gatekeeper mutation frequency over 40%).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Additionally, a common site of metastases in NSCLC patients is in the brain, where the current standard of care (SOC) and recent experimental agents have only limited effectiveness, thus identifying an area of unmet medical need. A sample taken at steady state from a single patient at the recommended 250 mg twice daily (bid) dose of compound <b>1</b> showed a CSF to free plasma ratio of 0.03.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The high level of asymmetric distribution indicates poor blood–brain barrier penetration of the drug.</div><div class="NLM_p">Approximately 200 000 brain metastases (BMs) are diagnosed annually in the United States, accounting for 20% of cancer mortality. Across tumor types, lung cancers and breast cancers constitute the majority of brain metastases, with the next most prevalent being melanoma.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Among the cohort of lung cancer patients with brain metastases, 10–25% of patients exhibit brain metastases at diagnosis, another 40–50% during the course of disease, and more at autopsy.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Overall, patients presenting metastatic brain cancer have a poor prognosis with a median survival of 2.5 months,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> which may be due partly to the poor blood–brain barrier (BBB) permeability of the drugs developed for treating systemic disease. Treatment of peripheral disease with CNS-excluded drugs may extend progression-free survival times, but could enhance the proportion of patient mortality due to uncontrolled brain metastases.</div><div class="NLM_p">Recently, several inhibitors of ALK have become a new and promising class of therapeutics for treatment-naive and relapsed ALK-positive NSCLC patients, highlighted by AP26113 (Ariad, undisclosed structure exemplified as <b>2</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><b>3</b> (CH5424802, Roche/Chugai),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a><b>4</b> (ASP3026, Astellas),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and <b>5</b> (LDK378, Novartis)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The clinical impact on metastasis in the brain and relation to preclinical CNS exposure or brain tumor models are not well-established for these compounds.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of ALK inhibitors marketed or currently in the clinic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> In Vitro Resistance</h3><div class="NLM_p last">Compound <b>1</b> phospho-ALK IC<sub>50</sub> values in NIH-3T3 cell lines engineered with mutations reported from the clinic have been previously described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The mutant cell IC<sub>50</sub> data for compound <b>1</b> ranged from 165 to 3039 nM, which represented a 2–38-fold shift relative to the wt potency (pALK cell IC<sub>50</sub> = 80 nM) in the same engineered line.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Objectives</h3><div class="NLM_p">The goal of this next-generation ALK inhibitor program was to develop a small-molecule inhibitor that combined CNS exposure with broad-spectrum ALK potency. A compound with these properties has potential utility in the treatment of patients who exhibit tumor progression, overcoming both resistance mutations and brain metastases.</div><div class="NLM_p last">By avoiding transporter-mediated efflux at the BBB and tumor cell surface, the increased CNS availability of this next-generation inhibitor could provide significant efficacy benefits. The benefits include higher free brain and tumor intracellular concentrations for better target modulation, critical for patients who relapse due to brain metastases or overexpression of efflux transporters in tumor cells. To mitigate cell toxicity associated with off-target activities and improve therapeutic indices, a high degree of kinase selectivity was required to avoid potential liabilities associated with the inhibition of closely related kinases.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Critical Parameters To Meet the Objectives: LipE and MW</h3><div class="NLM_p">Ligand interactions with most proteins are substantially influenced by lipophilicity.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> To monitor the progress of optimization, lipophilic efficiency (LipE = p<i>K</i><sub>i</sub> (or pIC<sub>50</sub>) – log <i>D</i>) was used as a numerical index of binding effectiveness per unit lipophilicity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Drug design aimed at improving LipE results in parallel optimization for desirable ADME and greater likelihood of safe drug profiles by increasing the ratio of potency to lipophilicity. Since log <i>D</i> within a series also tends to correlate with oxidative clearance,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> increasing LipE will raise the chance for a lower dose through improvements in IC<sub>50</sub> and clearance, assuming the introduction of structural features does not impart greater metabolic liabilities.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p last">Since molecular weight is inversely correlated with permeability within a series,<a onclick="showRef(event, 'ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref29">(27, 29)</a> reducing the ligand size was crucial to provide the smallest, most potent inhibitors with the greatest chance of possessing desired druglike properties, including CNS exposure.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Acyclic Aminopyridine/Aminopyrazine ALK Inhibitors</h3><div class="NLM_p">Optimization to address emerging resistance to compound <b>1</b> was previously described.<a onclick="showRef(event, 'cit24a ref30'); return false;" href="javascript:void(0);" class="ref cit24a ref30">(24a, 30)</a> Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> highlights some key compounds from the first- and second-generation ALK inhibitor programs. Compound <b>1</b> lacks sufficient potency against resistant clinical mutants and shows high P-glycoprotein 1 (Pgp) efflux as measured by the MDR BA/AB ratio (>2.5), consistent with CNS exclusion.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Structure-based, property-based, and efficiency-focused drug design efforts culminated in broadly potent, permeable, and metabolically stable second-generation ALK inhibitors, highlighted by compound <b>6a</b> (PF-06439015).<a onclick="showRef(event, 'cit24a'); return false;" href="javascript:void(0);" class="ref cit24a">(24a)</a> This compound improved wild-type and gatekeeper (L1196M) mutant potencies by 105- and 128-fold relative to compound <b>1</b> and showed robust in vivo efficacy in the same gatekeeper mutant cell line. While significant improvements in potency were achieved, the overall higher lipophilicity required introduction of polar groups to lower the lipophilicity of the whole molecule for acceptable LipE and good metabolic stability. This added polarity and molecular weight resulted in high efflux potential and very low rat CSF drug levels. Other analogues were pursued that lacked excess hydrogen bond donors and polarity. Compounds <b>6b</b> and <b>6c</b> both had improved in vitro clearance and permeability relative to compound <b>1</b>. The MDR efflux ratios for both compounds are less than or equal to 2.5 and consistent with good predicted brain availability in humans. Unfortunately, both wild-type ALK and ALK-L1196M cellular IC<sub>50</sub> values suffered. Compound <b>6d</b> also displayed a desirable, low MDR efflux ratio, but lacked the required potency and in vitro clearance.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potency and ADME of Compound <b>1</b> and Other Key Acyclic Leads</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0014.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">log <i>D</i> was measured at pH 7.4.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">LipE = −[log(pALK-L1196M cell IC<sub>50</sub>)] – log <i>D</i>.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Cl<sub>int,app</sub> refers to the total intrinsic clearance obtained from scaling in vitro half-lives in human liver microsomes.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">MDCK-MDR1 BA/AB efflux at 2 μM substrate concentration and pH 7.4.</p></div></div><div></div></div><div class="NLM_p">The amide substituents on the phenyl ring of compounds <b>6e</b>, <b>6f</b>, and <b>6h</b> were designed to lower lipophilicity and improve efficiency. Indeed, the amide group in <b>6e</b> and <b>6f</b> lowered the lipophilicity significantly relative to the triazole <b>6d</b>. Insights into the impact of the amide on potency and efficiency were gained by highlighting matched molecular pairs. The secondary amide <b>6e</b> showed roughly a 10-fold reduction in cellular potencies against both wild-type and mutant ALK and a slight improvement in LipE compared to the aminopyridine 1,2,3-triazole <b>6d</b>. Addition of a methyl group provided the tertiary amide analogue <b>6f</b>, which lost more than 100-fold potency relative to the triazole analogue <b>6d</b>, presumably due to steric clash of the pyrazole and <i>N</i>,<i>N</i>-dimethyl amide in the preferred bound conformation The aminopyrazine matched molecular pair demonstrated a similar trend. <i>N</i>-Methyl amide <b>6h</b> showed a 6-fold loss in mutant cell potency but a modest gain in LipE relative to the triazole analogue <b>6g</b>. Although acyclic phenyl sulfone analogue <b>6i</b> came the closest to meeting our laboratory objectives, it lacked the required potency and selectivity (data not shown).</div><div class="NLM_p">These acyclic compounds represented the difficulty in overlapping potency (L1196M IC<sub>50</sub> < 25 nM) and low MDR BA/AB ratios (<2.5) to afford the highest probability of reaching efficacious exposures in the CNS. To overlap the required properties, new design efforts targeted neutral inhibitors with improved lipophilic efficiency that fell within property space commensurate with low efflux. This strategy required a novel approach, which is the focus of this paper.</div><div class="NLM_p">Acyclic ligands bound to the ALK kinase domain provided key structural information which revealed protein ligand interactions and facilitated the design of ligands with improved binding affinity and efficiency. Methyl ether <b>6b</b> was one of the earliest cocrystal structures obtained in the wild-type kinase domain of ALK (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, left panel). The aminopyridine core interacted with the hinge portion of the protein via an acceptor–donor motif. The benzylic fragment adopted a conformation with the benzylic hydrogen coplanar to the methoxy substituent that minimized A-1,3 strain. Both the benzylic methyl and fluorophenyl filled the lipophilic pockets. In addition, the aryl fluoride polarized the <i>ortho</i> aryl C–H groups, which provided close contact and electrostatic complementarity with backbone carbonyls at Gly1269 and Arg1253. The orientation of the triazole ring was at a 30° torsion with a close contact to the C–H of the Gly1202 residue, approximating a C–H donor−π interaction. Finally, the Leu1256 residue beneath the ligand filled the hydrophobic pocket created by the U-shaped structure of the inhibitor.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Left panel: compound <b>6b</b> cocrystal structure in the ALK kinase domain (purple, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CNH">4CNH</a>) highlighting the type I U-shaped binding conformation and proximity of the methoxyfluorophenyl headgroup and triazole tail group. Right panel: ALK cocrystal of <b>6h</b> (cyan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMO">4CMO</a>) overlaid with <b>6i</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMT">4CMT</a>) showing the triazole, amide, and G-loop conformations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cocrystal structure of the ALK kinase domain with amide <b>6h</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, right panel, cyan structure) revealed that the amide N–H formed a hydrogen bond to water and the carbonyl group of the secondary amide interacted with the carbonyl group of His1124 via a water molecule. The amide carbonyl did not seem optimal for interaction with structural waters to Lys1150, which would have required a more perpendicular dihedral angle. Overlay of <b>6h</b> with <b>6i</b> (a similar analogue having the 2-triazol-2-yl headgroup, green structure) illustrated the orientation of the amide away from the surface of the triazole group (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, right panel). The dihedral angle of the amide (CCCO) was 45°, while the angle for the triazole (CCNN) was 64°, representing an approximate 20° rotation difference. Consequently, the methyl group did not point to the desired direction for a stronger hydrophobic interaction with Leu1122, Gly1123, and Val1130 in the G-loop. Overall, the G-loop backbone was displaced away from the <i>N</i>-methyl amide <b>6h</b> relative to triazole <b>6i</b>.</div><div class="NLM_p last">Structural data in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> showcased specific interactions driving binding, but also presented opportunities to enhance lipophilic efficiency. The bound structures of these U-shaped binders underscored the proximity of the substituted fluorophenyl headgroup to the heteroaromatic tail, which was directly linked to the aminopyridine or aminopyrazine hinge-binding motif. Two general designs were pursued to provide novel macrocyclic<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a> templates and a means to control conformations for further optimization. Specifically, macrocycles were formed by linking the two groups from the triazole 4-carbon to the methoxy carbon of <b>6b</b> or the pyrazole carbon and amide nitrogen of <b>6e</b> and <b>6f</b>. These templates were expected to reinforce the binding conformation and provide additional protein ligand interactions in the linker region. Additionally, they significantly reduced the number of rotatable bonds and were more compact with increased buried surface area than acyclic analogues, which we postulated would provide permeability advantages. Furthermore, we envisioned that designing macrocycle-based inhibitors driven by LipE and MW optimization would provide the highest probability to achieve desirable CNS ADME properties without sacrificing potency.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Macrocyclic ALK Inhibitors</h3><div class="NLM_p">To evaluate the macrocycle design concept, a variety of 12–14-membered ether-linked macrocycles were prepared on the basis of the cocrystal structure analysis of acyclic methyl ether <b>6b</b>, and the data are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. According to matched molecular pairs, the smaller ring sizes consistently provided the most lipophilic efficient macrocycles. For example, cyclic ethers <b>7a</b>, <b>7c</b>, and <b>7e</b> had higher LipE than their corresponding larger ring matched molecular pairs <b>7b</b>, <b>7d</b>, and <b>7f</b>. The 12-membered macrocycle <b>7e</b> displayed the highest LipE (4.4) with picomolar binding affinities and good cellular potencies (ALK IC<sub>50</sub> = 1.0 nM; ALK-L1196M IC<sub>50</sub> = 20 nM). Although some of the more efficient analogues provided improved potency and lipophilic efficiency relative to the acyclic analogue <b>6b</b>, the macrocyclic ethers were generally too lipophilic and still lacked the required efficiency for more facile overlap of potency, ADME, and CNS availability.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potency and Efficiency of the Ether-Linked Macrocycles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">log <i>D</i> was measured at pH 7.4.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">LipE = −[log(pALK-L1196M cell IC<sub>50</sub>)] – log <i>D</i>.</p></div></div><div></div></div><div class="NLM_p">The second template followed a design strategy to harness the increased LipE of the 12-membered ether macrocycles while lowering lipophilicity with a lactam linker. Modeling (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) suggested a single carbon atom linking the amide with the proximal pyrazole moiety, leading to a proposed 12-membered lactam that would have minimal binding strain (see the section “<a class="ref internalNav" href="#sec5_57" aria-label="Modeling Methods">Modeling Methods</a>”). In addition, the <i>N</i>-methyl group may provide close contact with Leu1122, Gly1123, and Val1130 of the G-loop, and the lactam carbonyl oxygen may act through a structural water to stabilize Lys1150 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Importantly, the amide macrocycles would significantly lower lipophilicity, placing them in optimal log <i>D</i> space (2−3).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Left panel: acyclic amide <b>6h</b> cocrystal structure in ALK (cyan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMO">4CMO</a>) overlaid with modeled macrocycle <b>8a</b> (purple) in ALK (see the section “<a class="ref internalNav" href="#sec5_57" aria-label="Modeling Methods">Modeling Methods</a>”). Right panel: <b>8a</b> cocrystal structure in ALK kinase domain (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMU">4CMU</a>) overlaid with the modeled ligand (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A set of amide-linked macrocycles was prepared to test the hypothesis. The cocrystal structure of the ALK kinase domain with the cyclic amide <b>8a</b> supported the design hypothesis and molecular modeling, superimposing well with the original docking result (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, right panel). As expected, the <i>N</i>-methyl group in <b>8a</b> was pulled tighter toward the G-loop by 1.2 Å from the open amide position and therefore had a closer contact with the carbonyl group of Leu1122 (3.4 Å) and nearby side chains of Leu1122 (4.1 Å), Gly1123 (4.7 Å), and Val1130 (4.7 Å). The amide carbonyl of macrocycle <b>8a</b> formed a water bridge with Lys1150 and a second water bridge to His1124. It was expected that interaction of the lactam carbonyl oxygen with waters in the bound state may effectively lower binding desolvation penalties.</div><div class="NLM_p">Improvement in key parameters was realized upon cyclization to the amide macrocyle <b>8a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) from acyclic analogues <b>6d</b>–<b>f</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>8a</b> improved cellular potencies against ALK and ALK-L1196M by 10-fold relative to compound <b>6d</b> and also lowered lipophilicity by 1 unit, without additional molecular weight. As a result, macrocycle <b>8a</b> had more than 2 units higher LipE. Relative to <b>6e</b>, compound <b>8a</b> improved cellular potency against the gatekeeper mutant protein by 119-fold while maintaining log <i>D</i>, which also translated to a 2 unit increase in LipE. Improvements in potency and efficiency were even more pronounced relative to those of the closest matched pair <b>6f</b>. A reduction of the in vitro clearance from 56 mL/min/kg (high) to the lower limit of detection for this assay demonstrated the inherent metabolic stability of the cyclic structure. Finally, the permeability of <b>8a</b>, measured by Pgp efflux potential, was superior to the acyclic analogue <b>6f</b>. Overall, there was a dramatic and compelling improvement in overall properties for <b>8a</b> relative to <b>6f</b>. These results clearly positioned the macrocyclic amides as an attractive series for the generation of ALK inhibitors capable of brain penetration. The higher LipE and lower MW allowed navigation to desired CNS ADME space without sacrificing potency and safety.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Impact of Macrocyclization, Benzylic Methyl, Aminopyrazine vs Pyridine, and Different Tail Groups on Potency and Efficiency</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0016.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">log <i>D</i> was measured at pH 7.4.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">LipE = −[log(pALK-L1196M cell IC<sub>50</sub>)] – log <i>D</i>.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Cl<sub>int,app</sub> refers to the total intrinsic clearance obtained from scaling in vitro half-lives in human liver microsomes.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">MDCK-MDR1 BA/AB efflux at 2 μM substrate concentration and pH 7.4.</p></div></div><div></div></div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> highlights important ALK protein sensitivities to subtle structural changes within the amide macrocycle series. The stereochemical sensitivity was determined by the eutomer/distomer ratio. Both <b>8a</b> and <b>8d</b> improved potency relative to their enantiomeric pairs <b>8b</b> and <b>8e</b> by 210- and 610-fold, respectively, on the basis of gatekeeper mutant biochemical potencies. The desmethyl analogue <b>8c</b> lost potency and LipE relative to the more potent methyl analogue <b>8a</b>. Three matched molecular pairs highlighted the tolerance of the aminopyrazine core. Several examples (<b>8a/8d</b>, <b>8f/8g</b>, and <b>8h/8i</b>) showed an improvement in potency for the aminopyrazine analogues, but the LipE improvement was attenuated as this change was accompanied by an increase, rather than a decrease, in lipophilicity. The additional buried nitrogen atom was not well-solvated and also decreased the basicity of the aminopyrazine. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> also highlights the tolerability of both substituted five- and six-membered aromatics adjacent to the aminopyridine or aminopyrazine cores. The (methylsulfonyl)benzene substituent on the aminopyrazine inhibitor <b>8i</b> was one of the most lipophilic efficient analogues (L1196M cell IC<sub>50</sub> LipE = 6.5). A comparison of sulfones <b>8h</b> and <b>8i</b> with the dimethylpyrazoles <b>8a</b> and <b>8d</b> revealed that both inhibitors possess almost identical potencies. The increased LipE of the sulfone is partly due to the polarity of the sulfone exposed to solvent, which maintained potency and lowered log <i>D</i> without incurring additional desolvation penalties.</div><div class="NLM_p last">In addition to providing potent inhibtors of ALK within the desired range of log <i>D</i> (2–3), the amide macrocycles generally diplayed low clearance and low MDR BA/AB efflux ratios. With the initial encouraging results, lead optimization on the macrocyclic amide 2-aminopyridine/pyrazine series was carried out to achieve the best overall balance of potency, CNS availability, ADME, <i>and</i> selectivity in a <i>single</i> compound.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Designing for Selectivity</h3><div class="NLM_p">There are 27 residues in the ATP-binding pocket of ALK, and to gain selectivity against other kinases, residues were targeted that differed from those of ALK. The ALK Leu1198 residue is conserved in 26% of the kinome at this position and is most often Phe or Tyr in other kinases (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). This smaller Leu residue is potentially an avenue to gain selectivity against a majority of kinases (60%) by building into this pocket to bump into the larger Phe and Tyr residues.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Left panel: <b>8a</b>- and ALK-bound structure (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMU">4CMU</a>) and TrkB (purple, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AT3">4AT3</a>) with selectivity residues highlighted. Right panel: ligands from ALK cocrystal structures aligned with TrkB, demonstrating the potential for clash between the ligand and Tyr635 [<b>8a</b> (Me, green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMU">4CMU</a>), <b>8j</b> (cyPr, yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTC">4CTC</a>), <b>8k</b> (CN, cyan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CLI">4CLI</a>), <b>8m</b> (orange, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTB">4CTB</a>)]. Distances shown are between the <b>8a</b> methyl carbon (shown as a ball) and TrkB Tyr635. PDB atom names for the terminal atoms are shown on Tyr635 (OH, CZ, CE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a surrogate for kinases containing a Phe/Tyr residue at the position corresponding to ALK Leu1198, TrkB (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AT3">4AT3</a>)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and ALK proteins were aligned by superposition on the basis of a set of residues in the active site. Several macrocyclic amides were prepared, and ALK cocrystal X-ray structures were solved for <b>8a</b>, <b>8j</b>, <b>8k</b>, and <b>8m</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The closest distance between ALK cocrystallized compounds and the Tyr635 atoms of TrkB was measured. Sub van der Waals distances reflect the need for protein or ligand movement to accommodate the ALK compounds in kinases with Phe/Tyr residues at this selectivity position.</div><div class="NLM_p">Substituents at the <i>ortho</i> position of the pyrazole in ALK structures can approach atoms in the TrkB Tyr635 residue at distances below the sum of van der Waals radii for the pair of atoms. The methyl on the pyrazole group of <b>8a</b> in the ALK structure begins to reach the contact distance to TrkB Tyr635 since it is 3.2–4.1 Å away from the three terminal atoms of the Tyr (terminal OH group (OH), terminal carbon (CZ), and adjacent carbon (CE); see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, right panel) in the aligned TrkB structure. The cyclopropyl group on <b>8j</b> had similar distances ranging from 3.2 to 3.7 Å away. The cyano group on <b>8k</b> pointed toward the terminal carbon (CZ) of Tyr635 and was 2.1–3.1 Å from the three terminal Tyr atoms. The carbon of the cyano group in <b>8m</b> would approximate the position of the terminal methyl of <b>8l</b>, which is estimated to be 2.0–2.3 Å from Tyr635. The nitrile of compound <b>8m</b> was measured to be 1.0–1.8 Å from the terminal two atoms, indicating a greater potential clash than with smaller substituents. Furthermore, the macrocycle restricts rotation and the groups are unable to rotate away from the Tyr/Phe residues as might be hypothesized with acyclic compounds.</div><div class="NLM_p">Macrocyclic amides <b>8a</b> and <b>8j</b>–<b>m</b> were tested against TrkB (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Both the pyrazoles substituted at C3 with methyl and cyclopropyl (<b>8a</b> and <b>8j</b>, respectively) retained picomolar enzymatic potencies against TrkB and provided little to no selectivity on the basis of the ALK-L1196M <i>K</i><sub>i</sub> (approximately 2-fold). However, the cyanopyrazole <b>8k</b> and the methyl-substituted imidazopyrimidine <b>8l</b> displayed significantly attenuated potency in TrkB and provided reasonable selectivity ratios (approximately 40-fold). Finally, the cyanoimidazopyridine <b>8m</b> afforded the most robust selectivity ratio (93-fold). These selectivity data were consistent with our previous modeling analysis.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Potency, ADME, and Selectivity of Macrocyclic Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0017.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">log <i>D</i> was measured at pH 7.4.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Cl<sub>int,app</sub> refers to the total intrinsic clearance obtained from scaling in vitro half-lives in human liver microsomes.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">MDCK-MDR1 BA/AB efflux at 2 μM substrate concentration and pH 7.4.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">RRCK-BCRP BA/AB is 37/28 (1.3), determined at 2 μM substrate concentration and pH 7.4.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">TrkB <i>K</i><sub>i</sub> and ratio relative to ALK-L1196M <i>K</i><sub>i</sub>.</p></div></div><div></div></div><div class="NLM_p last">The pyrazole cyano moiety in <b>8k</b> was efficient for obtaining selectivity because the cyano contains only one more heavy atom than the unselective methyl analogue <b>8a</b> and gains >35-fold selectivity, similar to the bulkier methyl-substituted imidazopyrimidine <b>8l</b>. It is hypothesized that the nitrile makes an unfavorable contact with the CE atom of the Tyr635 in TrkB, closer to the midpoint of the side chain rather than at the terminus (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, right panel). Unfavorable desolvation penalties or electrostatics due to the proximity of the electron-rich nitrile nitrogen atom and tyrosine may further enhance selectivity.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Designing for CNS Availability</h3><div class="NLM_p">Previous publications highlighted the importance of minimizing efflux in Pgp-overexpressing cell lines (MDCK-MDR1) to maximize both CSF to free plasma ratios and free brain to free plasma ratios.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Compounds that exhibited MDR BA/AB efflux ratios (ERs) of less than 2.5 did not demonstrate significant BBB efflux in vivo and have higher probability for achieving pharmacologically relevant brain to plasma ratios. To elucidate the physicochemical properties that provide low MDR efflux, we performed an analysis of the Pfizer MDR data set that contains greater than 115 000 compounds evaluated in the same MDR permeability model.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> A combination of experimental HPLC-based and shake-flask methods were used to measure log <i>D</i>. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> depicts a subset of these data that focus within a range of molecular weight and lipophilicity values to encompass the majority of the inhibitors in our ALK program. Often authors discuss the influence of a single physicochemical descriptor in the analysis of efflux and permeability. However, similar to the CNS MPO<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> algorithm, the dependence of a given ADME property is multidimensional, and it is more appropriate to consider several factors simultaneously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of log <i>D</i>, HBD count, and MW on the MDR BA/AB ratio (blue, <2.5; red, >2.5). The percentage of each sector shown and total count per bin are highlighted in the center of the pie.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Along with plotting binned values for molecular weight on the <i>y</i>-axis and lipophilicity on the <i>x</i>-axis, we also examined further segmentation by hydrogen bond donor (HBD) count (not pH-corrected). The independent influence of molecular weight, lipophilicity, and HBD count was clearly demonstrated in the outcome of binned MDR ratio performance, confirming these as first principles. The chance of increased efflux was observed with elevated molecular weight or HBD counts, and the chance of decreased efflux was seen with increased lipophilicity. This type of data visualization also provided the opportunity to readily evaluate the influence of multiple first-principle operators and determine the trade-offs that can be utilized in compound design. For example, the impact of increased HBD count on efflux within defined molecular weight and lipophilicity bins was clearly demonstrated by the comparison of binned efflux ratios. Trade-offs between physicochemical properties were observed as with the comparison of areas A and B (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), where for molecules with two HBD counts similar distributions of binned efflux were observed between groups of compounds with higher molecular weight and log <i>D</i> (A) and lower molecular weight and log <i>D</i> (B). This, and other property-based analyses, reinforced the importance of molecular weight and lipophilicity efficiency indices as a means to drive the design of small-molecule inhibitors within a focused log <i>D</i> range of 2–3 and with minimal introduction of hydrogen bond donors.</div><div class="NLM_p">The selection of the aminopyridine as a kinase hinge-binding motif provides a minimum requirement of two HBDs and a constraint for inhibitor design. As outlined earlier, one of the NH<sub>2</sub> group hydrogen atoms provides a key interaction with the carbonyl of hinge residue Glu1197 within the protein–ligand complex.<a onclick="showRef(event, 'cit24a'); return false;" href="javascript:void(0);" class="ref cit24a">(24a)</a> However, the potential for the second NH<sub>2</sub> hydrogen to participate in an intramolecular hydrogen bond (IMHB) with the adjacent ether oxygen may provide lower MDR ratios than other molecules with two HBDs and similar physicochemical properties.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In this program, it was observed that the presence of even a moderately basic nitrogen when combined with elevated molecular weight and HBD count can increase MDR ratios and limit CNS exposure, as observed with compound <b>1</b>.</div><div class="NLM_p">While the analysis of large data sets against physicochemical properties is a valuable method to assess general probabilistic odds for defined outcomes, it can also furnish comparison sets for new hypothesis generation. The pie charts of Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> illustrate that macrocyclic inhibitors display lower levels of binned MDR efflux when compared to acyclic molecules with similar molecular weight, measured log <i>D</i>, and HBD count. The macrocycles may afford the potential benefits for permeability and efflux by reducing rotatable bonds and achieving a highly compact shape for a given molecular weight. The box and whisker plots of Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> illustrate that, on average, solvent-accessible surface areas (SASAs)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> for macrocyclic molecules are almost 10% smaller than those for non-macrocycles within defined molecular weight ranges. Replacing molecular weight with SASA may provide a more accurate descriptor for molecular size and increase the probabilistic assessment in the future design of macrocyclic inhibitors.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Top panel: comparison of acyclic and macrocyclic compound binned MDR ratios (blue, <2.5; red, >2.5) for compounds within the same MW, log <i>D</i>, and HBD count (2) bins. The percentage of each sector shown and total count per bin are highlighted in the center of the pie. Bottom panel: acyclic and macrocyclic compound SASA differences within the same MW, log <i>D</i>, and HBD count (2) bins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The cohort of potent and low-clearance compounds shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were also tested in vitro for their Pgp-mediated efflux potential. Compounds <b>8a</b>, <b>8l</b>, and <b>8m</b> showed MDR BA/AB ratios significantly above 2.5 and are predicted to be substrates of Pgp with the inability to adequately cross the BBB. Both compounds <b>8j</b> and <b>8k</b> displayed MDR BA/AB ratios of less than 2.5 and are predicted to access the CNS. These data were consistent with the Pfizer comprehensive data set analysis describing the impact of MW (or SASA), log <i>D</i>, and HBD count on binned MDR ratios (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div></div><div id="sec2_7b" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Potency Efficiency of Macrocycles vs. Acyclics</h3><div class="NLM_p">To appreciate the efficiency differences between macrocyclic and acyclic analogues, two plots were constructed. The LipE plot (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, left panel), with log <i>D</i> on the <i>x</i>-axis and potency on the <i>y</i>-axis, showed that many of the macrocyclic compounds (colored aqua), some that display LipE values of greater than 6, out-performed the acyclics in both potency and LipE. Importantly, many macrocycles were able to access optimal log <i>D</i> space (2–3) coupled with improvements in potency. Evaluation of both LipE and heavy atom count (HACNT) on the same plot (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, right panel) clearly demonstrated that the macrocycles were able to achieve the highest lipophilic efficiency measures in heavy atom count cohorts, indicating the economical use of each atom in exploiting complementarity to the binding pocket of the kinase with minimal ligand strain. Consequently, property overlap was made more facile.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Left panel: LipE plot comparing macrocyclic (aqua) and acyclic (light gray) analogues. Right panel: LipE vs HACNT plot with macrocyclic and acyclic analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Potency, Selectivity, and PK of <b>8k</b> (PF-06463922)</h3><div class="NLM_p">On the basis of outstanding potency, low in vitro clearance, good selectivity, and low efflux potential, macrocycle <b>8k</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) emerged as a candidate for further profiling. As revealed in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <b>8k</b> demonstrated significantly improved cell activity against ALK and a large set of ALK clinical mutations compared to compound <b>1</b>. In the engineered NIH-3T3 ALK wild-type phosphorylation assay, the potency of <b>8k</b> was improved 62-fold (from 80 nM IC<sub>50</sub> vs wt ALK for compound <b>1</b> to 1.3 nM for <b>8k</b>). In addition, it was potent against all available clinical ALK mutants, showing a 40–825-fold potency improvement compared to compound <b>1</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. pALK Inhibition (IC<sub>50</sub>) Values for Compounds <b>1</b> and <b>8k</b> against ALK and Clinical Mutants of ALK</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="9" align="center">pALK IC<sub>50</sub> (nM) in 3T3-EML4-ALK engineered cell lines</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd no.</th><th class="colsep0 rowsep0" align="center">ALK</th><th class="colsep0 rowsep0" align="center">F1174L</th><th class="colsep0 rowsep0" align="center">C1156Y</th><th class="colsep0 rowsep0" align="center">G1269A</th><th class="colsep0 rowsep0" align="center">S1206Y</th><th class="colsep0 rowsep0" align="center">L1196M</th><th class="colsep0 rowsep0" align="center">L1152R</th><th class="colsep0 rowsep0" align="center">G1202R</th><th class="colsep0 rowsep0" align="center">1151Tins</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">165</td><td class="colsep0 rowsep0" align="left">478</td><td class="colsep0 rowsep0" align="left">605</td><td class="colsep0 rowsep0" align="left">626</td><td class="colsep0 rowsep0" align="left">843</td><td class="colsep0 rowsep0" align="left">1026</td><td class="colsep0 rowsep0" align="left">1148</td><td class="colsep0 rowsep0" align="left">3039</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8k</b></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">38</td></tr></tbody></table></div></div><div class="NLM_p">To investigate kinase selectivity of <b>8k</b> relative to its target kinases ALK and ROS1, it was evaluated in biochemical kinase screening assays against a panel of 206 recombinant kinases. In these preliminary biochemical kinase selectivity screens, only 10 off-target kinases were identified that exhibited enzyme-based activity and showed selectivity margins of less than 100-fold compared to the ALK-L1196M gatekeeper mutant (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Enzyme-Based Selectivity of <b>8k</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> or <i>K</i><sub>i</sub>,<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>(nM)</th><th class="colsep0 rowsep0" align="center">fold shift vs ALK-L1196M</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ROS1</td><td class="colsep0 rowsep0" align="left"><0.02<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK</td><td class="colsep0 rowsep0" align="left"><0.07<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK-L1196M</td><td class="colsep0 rowsep0" align="left">0.7<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LTK (TYK1)</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FER</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FES (FPS)</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">8.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTK2B (FAK2)</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNK2 (ACK)</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTK2 (FAK)</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NTRK2 (TRKB)</td><td class="colsep0 rowsep0" align="left">23<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NTRK1 (TRKA)</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NTRK3 (TRKC)</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FRK (PTK5)</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">76</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values by Invitrogen Z’-LYTE assays using <i>K</i><sub>M</sub> levels of ATP, unless specified otherwise.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last"><i>K</i><sub>i</sub> by off-chip mobility shift assays conducted in-house.</p></div></div></div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> summarizes rat pharmacokinetic data. Compound <b>8k</b> displayed low plasma clearance, a moderate volume of distribution, a reasonable half-life, and a bioavailability of 100%. This very good preclinical PK and low protein binding provided high free plasma exposures. In addition, CNS penetration of <b>8k</b> was evaluated in rats. After a single 10 mg/kg oral dose, samples of CSF, brain, and plasma were collected at 1, 4, 7, 12, and 24 h with the PK parameters shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. Area under the curve (AUC) ratios of CSF to free plasma (0.31) and free brain to free plasma<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (0.21) suggest <b>8k</b> distributes into the CNS. The rat in vivo data were further supported by in vitro data in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, which indicated a lack of transporter-mediated efflux in both Pgp- and breast cancer resistance protein (BCRP)-overexpressing cell lines.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Preclinical Rat PK of <b>8k</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">free<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a><i>C</i><sub>max</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>inf</sub>/AUC<sub>(0–24)</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">free <i>C</i><sub>av</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>p</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1150</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">15.5</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">1727</td><td class="colsep0 rowsep0" align="char" char=".">1530</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">14933</td><td class="colsep0 rowsep0" align="char" char=".">551</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">The formulation for the iv and po routes was ethanol/PEG200/water (10:40:50) in solution.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Dose: po, 10 mg/kg every day (qd); iv, 1 mg/kg qd.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Rat plasma protein binding fraction unbound of 0.36 (determined at 2.4 μM).</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Preclinical in Vivo CNS Availability Data of <b>8k</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">matrix</th><th class="colsep0 rowsep0" align="center" char=".">AUC (nM·h)</th><th class="colsep0 rowsep0" align="center" char=".">free AUC<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a> (nM·h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">CSF</td><td class="colsep0 rowsep0" align="char" char=".">3475</td><td class="colsep0 rowsep0" align="char" char=".">3475</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="char" char=".">19621</td><td class="colsep0 rowsep0" align="char" char=".">2355<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">30700</td><td class="colsep0 rowsep0" align="char" char=".">11052<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Dose: po, 10 mg/kg.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">The free brain AUC was calculated using a brain <i>f</i><sub>u</sub> of 0.12.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">The free plasma AUC was calculated using a plasma protein binding (PPB) <i>f</i><sub>u</sub> of 0.36.</p></div></div></div><div class="NLM_p last">In vivo efficacy data on <b>8k</b> were generated in a variety of wild-type and resistant ALK and ROS1 engineered cell lines and were disclosed previously.<a onclick="showRef(event, 'cit24b cit24c cit24d'); return false;" href="javascript:void(0);" class="ref cit24b cit24c cit24d">(24b-24d)</a> Additionally, a detailed pharmacology paper is currently in preparation.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ring closure presents a unique synthetic challenge in devising routes to access macrocycles.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Eight- to eleven-membered rings are typically the most challenging to prepare with a modest increase in intramolecular rate of ring closure for rings with ≥12 members. As well as ring size, other factors influence the intramolecular ring closure, such as the strain present in preferred precyclization conformations<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and the reaction conditions employed. Given the structural diversity and highly engineered nature of the macrocyclic inhibitors described herein, a range of ring closure methods were evaluated for each series to ensure efficient access to the desired target.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Ether-Linked Macrocycles</h3><div class="NLM_p">The route to compounds <b>7a</b> and <b>7b</b> is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> (described herein for <b>7a</b>, <i>n</i> = 0). The starting materials (<b>9</b>, <b>10</b>) were prepared from 5-fluoro-2-hydroxybenzoic acid via a three-step esterification, alkylation, and reduction sequence. Treatment of the alkyne <b>9</b> with ethyl diazoacetate in a sealed tube afforded the pyrazole <b>11</b> as a 4:1 mixture of regioisomers favoring the desired C3 ethyl ester.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The ester was converted to the nitrile through a two-step amidation–dehydration process to afford compound <b>13</b>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Iodination of the 4-position of the pyrazole proceeded cleanly to give alcohol <b>15</b> followed by a Mitsunobu reaction<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> with the Boc-protected 2-amino-3-hydroxy-5-iodopyridine (<b>17</b>) to provide <b>18</b>. The ring closure was achieved by a one-pot Suzuki coupling,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> with the boronate being generated in situ using bispinacolatodiboron (B<sub>2</sub>pin<sub>2</sub>) to give the intermediate-protected macrocycle (not shown). Removal of the Boc group under standard acid-mediated conditions<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> afforded the desired macrocycle <b>7a</b>. Compound <b>7b</b> was prepared via an identical sequence starting with the alkyne <b>10</b>.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Ether-Linked Macrocycles <b>7a</b> and <b>7b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (yields for <i>n</i> = 0): (a) 1.1 equiv of ethyl diazoacetate, 100 °C, sealed tube, 18 h, 49%; (b) NH<sub>4</sub>OH, MeOH, 60 °C, 12 h; (c) 4 equiv of TFAA, pyridine, 0 °C, 1 h, 81% over two steps; (d) 0.70 equiv of I<sub>2</sub>, 0.70 equiv of CAN, MeCN, 60 °C, 2 h, 66%; (e) 1.25 equiv of Ph<sub>3</sub>P, 1.25 equiv of DIAD, 1 equiv of Boc-2-amino-3-hydroxy-5-iodopyridine (<b>17</b>), THF, 1 h, 16%; (f) 5 equiv of B<sub>2</sub>pin<sub>2</sub>, 5 equiv of CsF, 6 mol % Pd(amphos)Cl<sub>2</sub>, MeOH, H<sub>2</sub>O, 60 °C, 1 h; (g) 25 equiv of HCl (4 M in dioxane), CH<sub>2</sub>Cl<sub>2</sub>, 12 h, rt, 29% over two steps.</p></p></figure><div class="NLM_p">Compounds <b>7c</b> and <b>7d</b> were synthesized in an alternative manner, with the ring closure being achieved through ether bond formation as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> (described herein for <b>7c</b>, <i>n</i> = 1). The pyrazole <b>20</b> was obtained from Suzuki coupling of the 5-substituted boronic acid of methylpyrazole with Boc-protected 2-amino-3-hydroxy-5-bromopyridine, followed by regioselective iodination at the 4-position of the pyrazole. The iodide <b>20</b> was coupled with the alkyne <b>21</b> under standard Sonagashira conditions<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> with concomitant cyclization between the Boc moiety and the adjacent alcohol to afford the cyclic carbamate <b>22</b>. Hydrogenation of <b>22</b> to give <b>24</b> followed by hydrolysis provided <b>26</b>. Activation of <b>26</b> gave mesylate <b>28</b>, which was then cyclized via a mesyl-transfer<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> process to afford the desired macrocycle <b>7c</b>. Compound <b>7d</b> was prepared via an identical sequence starting with the alkyne <b>9</b>.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Ether-Linked Macrocycles <b>7c and 7d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (yields for <i>n</i> = 1): (a) 1 equiv of Ph<sub>3</sub>P, 20 mol % CuI, 20 mol % PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, piperidine, 90 °C, 5 h; (b) 10 wt % Pd(OH)<sub>2</sub> (20% on carbon), EtOH, 50 °C, 4 bar of H<sub>2</sub>, 18 h; (c) 15% aq NaOH, EtOH, 85 °C, 12 h, 34% over three steps; (d) 10 equiv of pyridine, 1 equiv of MsCl, cat DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 1 h; (e) 1 equiv of NaH (60 wt %), DMF, 50 °C, 2 h, 37% over two steps.</p></p></figure><div class="NLM_p">The methyl-substituted macrocycles <b>7e</b> and <b>7f</b> incorporated a similar strategy shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> but utilized a direct arylation<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> ring-closing process (described herein for <b>7e</b>, <i>n</i> = 1). Initial [3 + 2] condensation of the alkyne <b>30</b> with ethyl diazoacetate formed the pyrazole <b>32</b>,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> followed by methylation and ester group elaboration through an amidation–dehydration sequence<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> that resulted in the nitrile group in <b>36</b>. Reduction and activation of the alcohol followed by reaction with 2-amino-3-hydroxy-5-bromopyridine allowed access to the cyclization precursor <b>40</b>. Direct arylation was achieved under Pd-catalyzed conditions to give <b>42</b> as a mixture of enantiomers, which were separated by chiral SFC to afford <b>7e</b>. Compound <b>7f</b> was prepared via an identical sequence starting with the alkyne <b>31</b>.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Ether-Linked Macrocycles <b>7e</b> and <b>7f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (yields for <i>n</i> = 1): (a) 1.1 equiv of ethyl diazoacetate, sealed tube, 100 °C, 18 h, 76%; (b) 1.2 equiv of Me<sub>2</sub>SO<sub>4</sub>, toluene, 80 °C, 12 h, 46%; (c) NH<sub>4</sub>OH, MeOH, 60 °C, 18 h, 74%; (d) 2 equiv of TFAA, 4 equiv of pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h, 94%; (e) 1.1 equiv of NaBH<sub>4</sub>, MeOH, 0 °C, 1 h; (f) 1.1 equiv of MsCl, 1.5 equiv of TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h, 94% over two steps; (g) 1.2 equiv of 2-amino-3-hydroxy-5-bromopyridine, 2 equiv of Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 40 h, 18%; (h) 20 mol % cataCXium A, 20 mol % Pd(OAc)<sub>2</sub>, 5 equiv of KOAc, <i>t</i>-AmOH, 140 °C, 2 h, 24%; (i) chiral SFC, Whelk-O1 (<i>R</i>,<i>R</i>) 30% MeOH at 120 bar, 4 mL/min.</p></p></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Amide-Linked Macrocycles</h3><div class="NLM_p">The approach to the amide-based macrocycles featuring the aminopyridine hinge-binding motif (<b>8a</b>–<b>c</b>, <b>8f</b>, <b>8h</b>, <b>8j</b>–<b>l</b>) is shown for <b>8k</b> and illustrated in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. A Suzuki coupling between <b>44</b> and the heteroaryl halide <b>45</b> provided <b>46</b>. Subsequent studies on this coupling reaction indicated that optimal yields were obtained by carrying out the borylation and coupling as separate processes using different palladium–ligand combinations. Ester hydrolysis gave <b>47</b>, which underwent acid-mediated Boc deprotection to provide the macrocycle precursor <b>48</b>. The ring closure to form <b>8k</b> was achieved by a HATU-mediated macrolactamization reaction in DMF.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In general, high dilution conditions were employed, with the slow addition of a solution of the hydrochloride salt of <b>48</b> and base in DMF being added to a solution of HATU in the same solvent at 0 °C. The reaction was observed to be complete by the end of the addition, and yields ranged from 2% to 45% across the analogues prepared, with higher yields being obtained for compounds featuring the chiral benzylic methyl.</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyridine Amide Macrocycle <b>8k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 20 mol % CataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 1.24 equiv of <b>45</b>, 1.5 equiv of B<sub>2</sub>pin<sub>2</sub>, 5 equiv of CsF, MeOH, H<sub>2</sub>O, 60 °C, 3 h, 43%; (b) NaOH, MeOH, H<sub>2</sub>O, 40 °C, 3.5 h, 87%; (c) 4 M HCl in dioxane, MeOH, 40 °C, 2.5 h, 87%; (d) for compound <b>8k</b>, 1.4 equiv of HATU, 10 equiv of DIPEA, DMF, 0 °C, 30 min, slow reverse addition, 29%. Macrocycles <b>8a</b>–<b>c</b>, <b>8f</b>, <b>8h</b>, <b>8j</b>, and <b>8l</b> were prepared in an analogous manner.</p></p></figure><div class="NLM_p">The importance of the conformation of the precursor to cyclization in the overall success of the macrocyclization is illustrated in the case of <b>8a</b> and <b>8c</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The presence of the chiral methyl in compound <b>8a</b> provided a 10-fold improvement in the yield of the cyclization (22% vs 2%), and this is observed as a trend throughout the series. Preliminary conformational studies on these two molecules indicate that the benzylic chiral center methyl substituent enables a preferred conformation by A-1,3 strain,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> which allows the acid and amine termini of the molecule to be in close proximity for cyclization to take place. Interestingly, <b>8c</b> exists as a pair of atropisomers<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> in this case, which can be separated by chiral SFC. The atropisomerism is observed by <sup>1</sup>H NMR, but after SFC separation the distinct atropisomers convert back to an equilibrium 50:50 mixture upon standing for several weeks at room temperature.</div><div class="NLM_p">An alternative approach was developed to the amide macrocycles featuring the aminopyrazine hinge-binding motif (<b>8d</b>, <b>8e</b>, <b>8g</b>, <b>8i</b>, <b>8m)</b>. For these molecules, the critical ring closure step is achieved through formation of the aryl–aryl bond as shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a> via either an intramolecular Suzuki coupling<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> or a direct arylation-type process.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Selective aminocarbonylation<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> of <i>rac</i>-<b>49</b> with pyrazole <b>50</b> afforded amide <b>52</b>. Ring closure via an in situ Suzuki coupling approach led to the racemic product, which after chiral separation gave compounds <b>8d</b> and <b>8e</b>. A similar aminocarbonylation of <b>49</b> with <b>51</b> gave intermediate amide <b>53</b>, which was subjected to a direct arylation-type process to afford <b>8g</b>. From reaction screening studies, it was determined that cataCXium A was crucial to enable this reaction to take place in DMF. Subsequent optimization indicated that solvent played a crucial role and that use of <i>t</i>-AmOH<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> with the reaction performed in a pressure vessel avoided the need for high dilution conditions. The yields within the program varied depending on the substrate employed, with the best yields being observed with substrates possessing an adjacent C3 substituent capable of directing C–H activation.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Carbonylation of the iodide <b>49</b> in the presence of methanol followed by hydrolysis provided the intermediate <b>54</b>. Condensation of <b>54</b> with <b>55</b> under standard amide coupling conditions provided amide <b>56</b>, which was converted to compound <b>8m</b> by a direct arylation process. In a similar manner, condensation of <b>54</b> with <b>57</b> provided amide <b>58</b>, which was converted to compound <b>8i</b> by an in situ Suzuki coupling.</div><figure id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Pyrazine Amide Macrocycles <b>8d</b>, <b>8e</b>, <b>8g</b>, <b>8i</b>, and <b>8m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for synthesis of <b>52</b>, 1.25 equiv of 50, 10 mol % Pd(P<sup><i>t</i></sup>Bu<sub>3</sub>)<sub>2</sub>, 5 equiv of DIPEA, toluene, 85 °C, 4 bar of CO, 18 h, 21%; (b) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 5 equiv of B<sub>2</sub>pin<sub>2</sub>, 5 equiv of CsF, MeOH, H<sub>2</sub>O, 90 °C, 6 h, 11%; (c) chiral SFC, Chiralcel OD-H 25% MeOH at 140 bar, 3 mL/min; (d) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 5 equiv of KOAc, 0.25 equiv of PivOH, DMF, 150 °C, 1 h, 8%; (e) 5 mol % Pd(OAc)<sub>2</sub>, 10 mol % DPE-Phos, 5 equiv of DIPEA, MeOH, 50 °C, 4 bar of CO, 3 h, 77%; (f) 5 equiv of NaOH, MeOH/THF/H<sub>2</sub>O (5:2:1), rt, 15 h, 89%; (g) 1.1 equiv of <b>55</b>, 1.5 equiv of EDCI, 1.5 equiv of HOBt, 5 equiv of DIPEA, DMF, −30 °C to rt, 15 h, 46%; (h) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 10 mol % <i>t</i>-AmOH, 5 equiv of KOAc, DMA, 110 °C, 12 h, 12%; (i) 1.1 equiv of <b>57</b>, 1.1 equiv of HATU, 4 equiv of DIPEA, DMF, rt, 12 h, 94%; (j) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 3 equiv of B<sub>2</sub>pin<sub>2</sub>, 5 equiv of K<sub>2</sub>CO<sub>3</sub>, THF, 80 °C, 6 h, 8%.</p></p></figure><div class="NLM_p">This methodology has also been extended to the analogous pyridine-based macrocycles (such as <b>8k</b>) though judicious protection of the aminopyridine is required to effect the directed arylation as shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. The iodide <b>59</b> can be accessed in three steps from readily available starting materials. Aminocarbonylation in the presence of <b>60</b>, under conditions similar to those employed for the transformation of <b>49</b> to <b>53</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>), allowed access to <b>61</b>. Bromination using a slight excess of NBS at −10 °C formed the desired cyclization precursor <b>62</b> in a regioselective fashion. Attempts to directly cyclize <b>62</b> led to only minor amounts of the desired product <b>8k</b>, with the major product resulting from deshalogenation. To overcome this unproductive reaction pathway, the aminopyridine was protected as the bis-acetamide derivative. Heating <b>62</b> with acetic anhydride as the solvent allowed <b>63</b> to be obtained after solvent evaporation and azeotropic distillation with toluene. The optimal conditions for the direct arylation described previously utilized <i>t</i>-AmOH as the solvent (0.1 M concentration), with no additive being required.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The reaction went to completion in a sealed vessel on heating overnight with a mixture of <b>8k</b>, and the corresponding mono- and bis-protected derivatives of the desired product were obtained. The crude mixture of products was subjected to exhaustive acid-mediated deprotection to provide <b>8k</b> in a 42% yield over two steps.</div><figure id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>8k</b> by Directed Arylation<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 5 mol % Pd(P<sup><i>t</i></sup>Bu<sub>3</sub>)<sub>2</sub>, 3 equiv of DIPEA, 1.1 equiv of <b>60</b>, toluene, 80 °C, 4 bar of CO, 18 h, 70%; (b) 1.1 equiv of NBS, THF, −10 °C, 2 h, 86%; (c) acetic anhydride, 100 °C, 8 h, quantitative; (d) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 5 equiv of KOAc, <i>t</i>-AmOH, 130 °C, 14 h; (e) 10 equiv of 4 N HCl in dioxane, MeOH, 60 °C, 14 h, 42% over two steps.</p></p></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The challenges associated with overlapping potency against resistant mutants of ALK and CNS exposure in kinase inhibitor chemical space required a special approach. Utilizing structure-based drug design, a unique macrocyclic template was discovered, leading to the development of amido-linked 12-membered macrocycles possessing significantly increased lipophilic efficiencies relative to those of acyclic analogues. This increase in efficiency was the foundation for overlapping broad-spectrum potency and desirable ADME, including CNS availability. Diverse synthetic approaches were adopted to access the novel macrocycles, and reactivity trends emerged which guided efforts toward optimal methods to close the ring. In addition, we believe this to be the first report of a macrocyclic ring closure achieved by a palladium-catalyzed direct arylation. This work culminated in <b>8k</b>, a novel macrocyclic ALK inhibitor with excellent potency, selectivity, ADME, and CNS availability. Compound <b>8k</b> is currently in phase 1/2 clinical trials (<a href="http://clinicaltrials.gov/ct2/show/NCT01970865" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01970865</a>).</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Starting materials and other reagents were purchased from commercial suppliers and were used without further purification unless otherwise indicated. Compound <b>6a (</b>PF-06439015) is now commercially available from Sigma-Aldrich. The syntheses of <b>6a</b>, <b>6b</b>, <b>6c</b>, <b>6d</b>, <b>6g</b>, and <b>6i</b> have been reported in the literature.<a onclick="showRef(event, 'cit24a ref30'); return false;" href="javascript:void(0);" class="ref cit24a ref30">(24a, 30)</a> The syntheses of <b>6e</b>, <b>6f</b>, and <b>6h</b> and the intermediates utilized here (<b>9</b>, <b>10</b>, <b>17</b>, <b>20</b>, <b>21</b>, <b>30</b>, <b>31</b>, <b>44</b>, <b>45</b>, <b>49</b>–<b>51</b>, <b>55</b>, <b>57</b>, <b>59</b>, <b>60</b>, <b>69</b>–<b>75</b>) are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. All reactions were performed under a positive pressure of nitrogen or argon or with a drying tube at ambient temperature (unless otherwise stated) in anhydrous solvents (unless otherwise indicated). Analytical thin-layer chromatography was performed on glass-backed silica gel 60_F 254 plates (Analtech (0.25 mm)) and eluted with the appropriate solvent ratios (v/v). The reactions were assayed by high-performance liquid chromatography (HPLC) or thin-layer chromatography (TLC) and terminated as judged by the consumption of starting material. The TLC plates were visualized by UV, phosphomolybdic acid stain, or iodine stain. Microwave-assisted reactions were run in a Biotage initiator. <sup>1</sup>H NMR spectra were recorded on a Bruker instrument operating at 400 MHz unless otherwise indicated. <sup>1</sup>H NMR spectra are obtained as DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> solutions as indicated (reported in parts per million) using chloroform as the reference standard (7.25 ppm) or DMSO-<i>d</i><sub>6</sub> (2.50 ppm). Other NMR solvents were used as needed. When peak multiplicities are reported, the following abbreviations are used: s = singlet, d = doublet, t = triplet, m = multiplet, br = broad, dd = doublet of doublets, dt = doublet of triplets. Coupling constants, when given, are reported in hertz. The mass spectra were obtained using liquid chromatography–mass spectrometry (LC–MS) on an Agilent instrument using atmospheric pressure chemical ionization (APCI) or electrospray ionization (ESI). High-resolution mass measurements were carried out on an Agilent TOF 6200 series with ESI. All test compounds showed >95% purity as determined by combustion analysis or by HPLC. HPLC conditions were as follows: XBridge C18 column at 80 °C, 4.6 mm × 150 mm, 5 μm, 5–95% MeOH/H<sub>2</sub>O buffered with 0.2% formic acid/0.4% ammonium formate, 3 min run, flow rate 1.2 mL/min, UV detection (λ = 254, 224 nm). Combustion analyses were performed by Atlantic Microlab, Inc. (Norcross, GA).</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Ethyl 3-{2-[4-Fluoro-2-(hydroxymethyl)phenoxy]ethyl}-1<i>H</i>-pyrazole-5-carboxylate (<b>11</b>)</h3><div class="NLM_p last">Ethyl diazoacetate (1.18 mL, 11.1 mmol) and <b>9</b> (2 g, 10.3 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) were heated at 100 °C in a sealed tube for 18 h. The crude product was purified by flash chromatography on silica gel eluting with EtOAc/heptanes (0–80%) to give <b>11</b> (1.56 g, 49% yield) as a cream solid, with a second fraction being eluted as a yellow gum (451 mg) containing 40% of the desired regioisomer: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.29 (br s, 1 H), 7.13 (dd, <i>J</i> = 9.4, 2.6 Hz, 1 H), 7.06–6.89 (m, 2 H), 6.63 (br s, 1 H), 5.34–4.95 (m, 1 H), 4.40 (s, 2 H), 4.25 (d, <i>J</i> = 6.6 Hz, 2 H), 4.22–4.13 (m, 2 H), 3.07 (br s, 2 H), 1.28 (t, <i>J</i> = 7.0 Hz, 3 H).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Ethyl 3-{3-[4-Fluoro-2-(hydroxymethyl)phenoxy]propyl}-1<i>H</i>-pyrazole-5-carboxylate (<b>12</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>11</b> was used to prepare compound <b>12</b> as a 4:1 regioisomeric mixture of pyrazoles from compound <b>10</b> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), which was used without further purification.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-{3-[4-Fluoro-2-(hydroxymethyl)phenoxy]ethyl}-1<i>H</i>-pyrazole-5-carbonitrile (<b>13</b>)</h3><div class="NLM_p last">In a sealed tube, a solution of <b>11</b> (1.55 g, 5.0 mmol) in MeOH (20 mL) was heated at 60 °C for 1 h. Aqueous 33% ammonium hydroxide (10 mL) was added, and the solution was heated at 60 °C overnight. The reaction mixture was concentrated and cooled to 0 °C, and the solids were collected by vacuum filtration to give the intermediate primary amide (933 mg, 67% yield). To a cooled (0 °C) mixture of the intermediate primary amide (930 mg, 3.33 mmol) in pyridine (16.6 mL) was added TFAA (1.87 mL, 13.3 mmol) in a dropwise manner. After 1 h at 0 °C the solution was diluted with EtOAc (100 mL), washed with saturated NaHCO<sub>3</sub> (2 × 25 mL), 1 N HCl (2 × 25 mL), and brine (25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting solid was slurried in 50% EtOAc/heptanes and filtered to afford <b>13</b> (703 mg, 81% yield) as a cream solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.77 (br s, 1 H), 7.13 (dd, <i>J</i> = 9.6, 3.0 Hz, 1 H), 7.05–6.91 (m, 2 H), 6.82 (s, 1 H), 4.37 (s, 2 H), 4.19 (t, <i>J</i> = 6.3 Hz, 2 H), 3.10 (t, <i>J</i> = 6.2 Hz, 2 H).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3-{3-[4-Fluoro-2-(hydroxymethyl)phenoxy]propyl}-1<i>H</i>-pyrazole-5-carbonitrile (<b>14</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>13</b> was used to prepare compound <b>14</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.71 (br s, 1 H), 7.14 (dd, <i>J</i> = 9.4, 3.1 Hz, 1 H), 7.03–6.94 (m, 1 H), 6.94–6.88 (m, 1 H), 6.76 (s, 1 H), 4.48 (s, 2 H), 3.96 (t, <i>J</i> = 6.0 Hz, 2 H), 2.82 (t, <i>J</i> = 7.7 Hz, 2 H), 2.12–1.96 (m, 2 H).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-{3-[4-Fluoro-2-(hydroxymethyl)phenoxy]ethyl}-4-iodo-1<i>H</i>-pyrazole-5-carbonitrile (<b>15</b>)</h3><div class="NLM_p last">To a solution of <b>13</b> (650 mg, 2.5 mmol) and cerium ammonium nitrate (954 mg, 1.74 mmol) in MeCN (25 mL) was added a solution of iodine (442 mg, 1.74 mmol) in MeCN (5 mL). The reaction was heated at 60 °C and stirred for 2 h. The reaction mixture was diluted with EtOAc (100 mL), washed with saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (2 × 25 mL), and brine (25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The resulting solids were triturated with 30% EtOAc/heptanes to afford <b>15</b> (632 mg, 66% yield) as a cream solid, which contained ∼5% of the aldehyde: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.13 (dd, <i>J</i> = 9.4, 3.2 Hz, 1 H), 7.05–6.91 (m, 2 H), 4.34 (s, 2 H), 4.20 (t, <i>J</i> = 6.2 Hz, 2 H), 3.10 (t, <i>J</i> = 6.2 Hz, 2 H).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-{3-[4-Fluoro-2-(hydroxymethyl)phenoxy]propyl}-4-iodo-1<i>H</i>-pyrazole-5-carbonitrile (<b>16</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>15</b> was used to prepare compound <b>16</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.15 (dd, <i>J</i> = 9.4, 3.1 Hz, 1 H), 7.02–6.94 (m, 1 H), 6.91–6.87 (m, 1 H), 4.50 (s, 2 H), 3.94 (t, <i>J</i> = 5.9 Hz, 2 H), 2.81 (t, <i>J</i> = 7.6 Hz, 2 H), 2.08–1.99 (m, 2 H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>tert</i>-Butyl [3-({2-[3-(5-Cyano-4-iodo-1<i>H</i>-pyrazol-3-yl)ethoxy]-5-fluorobenzyl}oxy)-5-iodopyridin-2-yl]carbamate (<b>18</b>)</h3><div class="NLM_p last">To a solution of <b>15</b> (625 mg, 1.65 mmol), <i>tert</i>-butyl (3-hydroxy-5-iodopyridin-2-yl)carbamate (<b>17</b>) (624 mg, 1.86 mmol), and triphenylphosphine (635 mg, 2.42 mmol) in THF (6.7 mL; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) was added DIAD (494 μL, 2.42 mmol) dropwise over 1 h. Once the reaction was complete by LC–MS, the solution was concentrated and purified by flash chromatography eluting with EtOAc/heptanes (0–50%). The fractions containing the desired product were concentrated, and the solids were triturated with Et<sub>2</sub>O to give <b>18</b> (181 mg, 16% yield) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.23 (br s, 1 H), 9.03 (s, 1 H), 8.17 (d, <i>J</i> = 1.8 Hz, 1 H), 7.74 (d, <i>J</i> = 1.8 Hz, 1 H), 7.33 (dd, <i>J</i> = 9.3, 3.0 Hz, 1 H), 7.19–6.96 (m, 2 H), 5.00 (s, 2 H), 4.25 (t, <i>J</i> = 6.3 Hz, 2 H), 3.16 (t, <i>J</i> = 6.2 Hz, 2 H), 1.41 (s, 9 H).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>tert</i>-Butyl [3-({2-[3-(5-Cyano-4-iodo-1<i>H</i>-pyrazol-3-yl)propoxy]-5-fluorobenzyl}oxy)-5-iodopyridin-2-yl]carbamate (<b>19</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>18</b> was used to prepare compound <b>19</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.14 (br s, 1 H), 9.00 (s, 1 H), 8.15 (d, <i>J</i> = 1.5 Hz, 1 H), 7.80 (d, <i>J</i> = 1.5 Hz, 1 H), 7.35 (dd, <i>J</i> = 9.2, 3.2 Hz, 1 H), 7.13 (td, <i>J</i> = 8.8, 3.2 Hz, 1 H), 7.02 (dd, <i>J</i> = 9.2, 4.4 Hz, 1 H), 5.12 (s, 2 H), 4.02 (t, <i>J</i> = 5.7 Hz, 2 H), 2.85 (t, <i>J</i> = 7.4 Hz, 2 H), 2.15–1.99 (m, 2 H), 1.40 (s, 9 H).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 7-Amino-12-fluoro-16,17-dihydro-1<i>H</i>,10<i>H</i>-8,4-(metheno)pyrazolo-[3,4-<i>d</i>][1,11,8]benzodioxazacyclotetradecine-3-carbonitrile (<b>7a</b>)</h3><div class="NLM_p last">To a sealed vial were added <b>18</b> (175 mg, 0.25 mmol), B<sub>2</sub>pin<sub>2</sub> (315 mg, 1.24 mmol), and CsF (188 mg, 1.24 mmol) in MeOH (12 mL) and water (1.2 mL), and the mixture was bubbled with nitrogen. A solution of bis{di-<i>tert</i>-butyl[4-(dimethylamino)phenyl]phosphine}dichloropalladium(II) (26 mg, 0.037 mmol) in toluene (0.8 mL) was added. The mixture was heated at 60 °C for 1 h, then diluted with EtOAc (100 mL), washed with brine (2 × 25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL), and HCl was added (4 N in dioxane, 2 mL, 4.2 mmol). After being stirred at room temperature overnight, the reaction was concentrated and purified by flash chromatography on silica gel eluting with 7 N NH<sub>3</sub>–MeOH/CH<sub>2</sub>Cl<sub>2</sub> (0–10%). The fractions containing the desired product were concentrated, and the resultant solids were triturated with Et<sub>2</sub>O to give <b>7a</b> (25 mg, 29% yield) as a yellow solid: LC–MS (ESI) <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.46 (s, 1 H), 7.86 (d, <i>J</i> = 1.8 Hz, 1 H), 7.67 (d, <i>J</i> = 1.8 Hz, 1 H), 7.37 (dd, <i>J</i> = 9.1, 3.0 Hz, 1 H), 7.19–7.02 (m, 2 H), 5.54 (br s, 2 H), 5.19 (br s, 2 H), 4.51 (br s, 2 H), 3.17–3.06 (m, 2 H).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 7-Amino-12-fluoro-1,16,17,18-tetrahydro-10<i>H</i>-8,4-(metheno)pyrazolo[3,4-<i>e</i>][1,12,9]benzodioxazacyclopentadecine-3-carbonitrile (<b>7b</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>7a</b> was used to prepare compound <b>7b</b> from <b>19</b>: LC–MS (APCI) <i>m</i>/<i>z</i> 366 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.88 (br s, 1 H), 7.75 (d, <i>J</i> = 1.8 Hz, 1 H), 7.38 (d, <i>J</i> = 2.0 Hz, 1 H), 7.30 (dd, <i>J</i> = 8.9, 2.4 Hz, 1 H), 7.16–7.04 (m, 2 H), 5.90 (s, 2 H), 5.21 (br s, 2 H), 4.55–3.55 (m, 2 H), 3.03 (br s, 2 H), 2.23 (br s, 2 H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 6-(4-{4-[4-Fluoro-2-(hydroxymethyl)phenoxy]prop-1-yn-1-yl}-1-methyl-1<i>H</i>-pyrazol-5-yl)[1,3]oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>22</b>)</h3><div class="NLM_p last">A mixture of <b>20</b> (270 mg, 0.65 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), <b>21</b> (176 mg, 0.97 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), cuprous iodide (6 mg, 0.032 mmol), triphenylphosphine (17 mg, 0.065 mmol), and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (23 mg, 0.032 mmol) in piperidine (4.3 mL) was bubbled with nitrogen and then heated in an oil bath to 90 °C. After 5 h, the reaction was allowed to cool and diluted with EtOAc (100 mL). The solution was washed with saturated aqueous NH<sub>4</sub>Cl (2 × 50 mL) and brine (25 mL), and the organics were dried over MgSO<sub>4</sub>. The solution was filtered and concentrated and the residue subjected to column chromatography over silica gel (0–5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford <b>22</b> as a gummy solid contaminated with excess piperidine. This material was used without further purification in the following step.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 6-(4-{4-[4-Fluoro-2-(hydroxymethyl)phenoxy]but-1-yn-1-yl}-1-methyl-1<i>H</i>-pyrazol-5-yl)[1,3]oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>23</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>22</b> was used to prepare compound <b>23</b> from <b>9</b> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>): LC–MS (APCI), <i>m</i>/<i>z</i> 409 [M + H] <sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.22 (s, 1 H), 8.06 (d, <i>J</i> = 2.01 Hz, 1 H), 7.64 (s, 1 H) 7.45 (d, <i>J</i> = 1.76 Hz, 1 H), 7.13 (dd, <i>J</i> = 9.32, 2.77 Hz, 1 H), 7.01–6.92 (m, 2 H), 5.13 (br s, 1 H), 4.48 (d, <i>J</i> = 2.27 Hz, 2 H), 4.06 (t, <i>J</i> = 6.67 Hz, 2 H), 3.82 (s, 3 H), 2.78 (t, <i>J</i> = 6.55 Hz, 2 H).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 6-(4-{3-[4-Fluoro-2-(hydroxymethyl)phenoxy]propyl}-1-methyl-1<i>H</i>-pyrazol-5-yl)[1,3]oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>24</b>)</h3><div class="NLM_p last">Compound <b>22</b> (256 mg, 0.65 mmol) was dissolved in ethanol (50 mL), and palladium hydroxide (50 mg, 20% on carbon) was added. The mixture was flushed with nitrogen, followed by being pressurized under 3–4 bar of hydrogen gas. The reaction was agitated and heated at 50 °C for 18 h. The reaction vessel was allowed to cool, and LC–MS indicated that the major product was the desired <b>24</b> accompanied by minor amounts of the ethyl carbamate. The reaction was filtered through a Celite cartridge to remove the catalyst and washed with MeOH. The filtrate was concentrated to afford crude <b>24</b>, which was used without further purification.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 6-(4-{3-[4-Fluoro-2-(hydroxymethyl)phenoxy]butyl}-1-methyl-1<i>H</i>-pyrazol-5-yl)[1,3]oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>25</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>24</b> was used to prepare compound <b>25</b>, which was used without further purification.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-Amino-5-(4-{4-[4-fluoro-2-(hydroxymethyl)phenoxy]propyl}-1-methyl-1<i>H</i>-pyrazol-5-yl)pyridin-3-ol (<b>26</b>)</h3><div class="NLM_p last">Compound <b>24</b> was dissolved in ethanol (5 mL), and 15% aqueous NaOH (5 mL) was added. The reaction was heated at 85 °C for 12 h and allowed to cool. The mixture was neutralized with 1 N aqueous HCl and extracted with EtOAc (3 × 100 mL). The organics were dried over MgSO<sub>4</sub>, concentrated, and purified by column chromatography over silica gel (0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford <b>26</b> (82 mg, 34% yield over three steps) as a colorless solid: LC–MS (APCI) <i>m</i>/<i>z</i> 372.2 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.72 (br s, 1 H), 7.41 (s, 1 H), 7.33 (s, 1 H), 7.12 (dd, <i>J</i> = 9.6, 3.0 Hz, 1 H), 7.00–6.89 (m, 1 H), 6.83 (dd, <i>J</i> = 9.1, 4.5 Hz, 1 H), 6.80 (d, <i>J</i> = 1.5 Hz, 1 H), 5.75 (s, 2 H), 5.11 (br s, 1 H), 4.43 (br s, 2 H), 3.87 (t, <i>J</i> = 6.2 Hz, 2 H), 3.64 (s, 3 H), 2.49–2.42 (m, 2 H), 1.85 (q, <i>J</i> = 6.9 Hz, 2 H).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Amino-5-(4-{4-[4-fluoro-2-(hydroxymethyl)phenoxy]butyl}-1-methyl-1<i>H</i>-pyrazol-5-yl)pyridin-3-ol (<b>27</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>26</b> was used to prepare compound <b>27</b>: LC–MS (APCI) <i>m</i>/<i>z</i> 387 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.72 (br s, 1 H), 7.41 (d, <i>J</i> = 1.76 Hz, 1 H), 7.33 (s, 1 H), 7.12 (dd, <i>J</i> = 9.44, 3.15 Hz, 1 H), 7.02–6.91 (m, 1 H), 6.85 (dd, <i>J</i> = 8.81, 4.53 Hz, 1 H), 6.79 (d, <i>J</i> = 2.01 Hz, 1 H), 5.75 (s, 2 H), 5.13 (br s,1 H), 4.45 (s, 2 H), 3.87 (t, <i>J</i> = 6.04 Hz, 2 H), 3.64 (s, 3 H), 2.35 (t, <i>J</i> = 7.30 Hz, 2 H), 1.74–1.47 (m, 4 H).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-Amino-5-(4-{4-[4-fluoro-2-(hydroxymethyl)phenoxy]propyl}-1-methyl-1<i>H</i>-pyrazol-5-yl)pyridin-3-yl Methanesulfonate (<b>28</b>)</h3><div class="NLM_p last">To a cooled (0 °C) solution of <b>26</b> (80 mg, 0.22 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.4 mL) were added pyridine (200 μL, 2.5 mmol) and a catalytic amount of DMAP (2–3 mg), followed by a solution of MsCl (17 μL, 0.22 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL). The reaction was allowed to slowly warm to room temperature. After 2 h, the reaction was diluted with EtOAc (10 mL) and washed with saturated aqueous NH<sub>4</sub>Cl (5 mL) and brine (5 mL). The organics were dried (MgSO<sub>4</sub>), filtered, and concentrated. After being dried overnight under high vacuum, <b>28</b> (96 mg) was isolated as a slightly yellow gum, which was used without purification in the cyclization step.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-Amino-5-(4-{4-[4-fluoro-2-(hydroxymethyl)phenoxy]butyl}-1-methyl-1<i>H</i>-pyrazol-5-yl)pyridin-3-yl Methanesulfonate (<b>29</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>28</b> was used to prepare compound <b>29</b>, which was used without purification in the cyclization step.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 12-Fluoro-3-methyl-3,16,17,18-tetrahydro-10<i>H</i>8,4-(metheno)pyrazolo[4,3-<i>e</i>][1,12,9]benzodioxazacyclopentadecin7-amine (<b>7c</b>)</h3><div class="NLM_p last">To a solution of <b>28</b> (96 mg, 0.21 mmol) in DMF (4.1 mL) was added NaH (9.1 mg, 60% dispersion in mineral oil, 0.23 mmol). The reaction was heated at 50 °C for 30 min. The reaction was diluted with EtOAc (10 mL), washed with a saturated aqueous NH<sub>4</sub>Cl/water mixture (1:1, 5 mL) and brine (5 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The residue was purified by column chromatography over silica gel (0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford <b>7c</b> (27 mg, 37% yield over two steps) as a cream solid: LC–MS (APCI) <i>m</i>/<i>z</i> 355 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.65 (d, <i>J</i> = 1.5 Hz, 1 H), 7.38 (s, 1 H), 7.36–7.25 (m, 2 H), 7.16–6.99 (m, 2 H), 5.68 (br s, 2 H), 5.22 (s, 2 H), 4.14–3.97 (m, 2 H), 3.78 (s, 3 H), 2.65 (t, <i>J</i> = 6.8 Hz, 2 H), 2.20–2.04 (m, 2 H).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 12-Fluoro-3-methyl-16,17,18,19-tetrahydro-3<i>H</i>,10<i>H</i>8,4(metheno)pyrazolo[4,3-<i>f</i>][1,13,10]benzodioxazacyclohexadecin-7amine (<b>7d</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>7c</b> was used to prepare compound <b>7d</b> from <b>29</b>: LC–MS (APCI) <i>m</i>/<i>z</i> 369 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, 80 °C, DMSO-<i>d</i><sub>6</sub>) δ 7.57–7.50 (m, 2 H), 7.33–7.29 (m, 2 H), 7.09–7.00 (m, 1 H), 7.00–6.92 (m, 1 H), 5.77 (br s, 2 H), 5.28 (s, 2 H), 4.02 (t, <i>J</i> = 5.54 Hz, 2 H), 3.69 (s, 3 H), 2.34–2.18 (m, 2 H), 1.89–1.71 (m, 4 H).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Ethyl 3-[2-(2-Acetyl-4-fluorophenoxy)ethyl]-1<i>H</i>-pyrazole-5-carboxylate (<b>32</b>)</h3><div class="NLM_p last">1-[2-(But-3-yn-1-yloxy)-5-fluorophenyl]ethanone (<b>30</b>) (1.43 g, 6.94 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and ethyl diazoacetate (0.87 g, 7.63 mmol) were combined in a sealed tube and heated at 100 °C for 36 h. The reaction was allowed to cool and the mixture purified by column chromatography on silica gel (0–50% EtOAc/heptanes) to afford <b>32</b> (2.22 g, 76% yield) as an amber gum: LC–MS (APCI) <i>m</i>/<i>z</i> 321.1 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.43 (br s, 1 H), 7.45–7.36 (m, 1 H), 7.32 (dd, <i>J</i> = 9.1, 3.3 Hz, 1 H), 7.24 (dd, <i>J</i> = 9.2, 4.4 Hz, 1 H), 6.69 (s, 1 H), 4.38 (t, <i>J</i> = 6.5 Hz, 2 H), 4.30–4.17 (m, 2 H), 3.15 (t, <i>J</i> = 6.4 Hz, 2 H), 2.38 (s, 3 H), 1.32–1.23 (m, 5 H).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Ethyl 3-[2-(2-Acetyl-4-fluorophenoxy)propyl]-1<i>H</i>-pyrazole-5-carboxylate (<b>33</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>32</b> was used to prepare compound <b>33</b> from <b>31</b> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>): LC–MS (APCI) <i>m</i>/<i>z</i> 335.1 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.23 (br s, 1 H), 7.43–7.28 (m, 2 H), 7.17 (dd, <i>J</i> = 8.8, 4.3 Hz, 1 H), 6.55 (s, 1 H), 4.34–4.17 (m, 2 H), 4.16–4.04 (m, 2 H), 2.82 (t, <i>J</i> = 7.6 Hz, 2 H), 2.58 (s, 3 H), 2.12 (t, <i>J</i> = 7.2 Hz, 2 H), 1.33–1.21 (m, 3 H).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Ethyl 3-[2-(2-Acetyl-4-fluorophenoxy)ethyl]-1-methyl-1<i>H</i>-pyrazole-5-carboxylate (<b>34</b>)</h3><div class="NLM_p last">Dimethyl sulfate (1.35 mL, 14.2 mmol) was added in a dropwise manner to a solution of <b>32</b> (3.8 g, 11.9 mmol) in toluene (47.5 mL). Upon completion of addition, the reaction was heated at 80 °C for 12 h. The reaction was allowed to cool, concentrated in vacuo, and purified by column chromatography on silica gel (0–25% EtOAc/heptanes) to afford <b>34</b> (1.83 g, 46% yield) as a colorless gum, which solidified on standing: LC–MS (APCI) <i>m</i>/<i>z</i> 335.1 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.40–7.35 (m, 1 H), 7.30 (dd, <i>J</i> = 9.2, 3.4 Hz, 1 H), 7.23 (dd, <i>J</i> = 9.1, 4.3 Hz, 1 H), 6.81 (s, 1 H), 4.36 (t, <i>J</i> = 6.5 Hz, 2 H), 4.28 (q, <i>J</i> = 8 Hz, 2 H), 4.02 (s, 3 H), 3.06 (t, <i>J</i> = 6.4 Hz, 2 H), 2.41 (s, 3 H), 1.29 (t, <i>J</i> = 8 Hz, 3 H).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Ethyl 3-[2-(2-Acetyl-4-fluorophenoxy)propyl]-1-methyl-1<i>H</i>-pyrazole-5-carboxylate (<b>35</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>34</b> was used to prepare compound <b>35</b>: LC–MS (APCI) <i>m</i>/<i>z</i> 349.1 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.42–7.30 (m, 2 H), 7.22–7.12 (m, 1 H), 6.71 (s, 1H), 4.27 (q, <i>J</i> = 7.1 Hz, 2 H), 4.11 (t, <i>J</i> = 6.3 Hz, 2 H), 4.01 (s, 3 H), 2.73 (t, <i>J</i> = 7.6 Hz, 2 H), 2.56 (s, 3 H), 2.17–2.03 (m, 2 H), 1.29 (t, <i>J</i> = 7.1 Hz, 3 H).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-[2-(2-Acetyl-4-fluorophenoxy)ethyl]-1-methyl-1<i>H</i>-pyrazole-5-carbonitrile (<b>36</b>)</h3><div class="NLM_p last">A solution of <b>34</b> (2.65 g, 7.93 mmol) in MeOH (20 mL) was heated in a sealed tube for 1 h at 60 °C before being allowed to cool. Aqueous 33% ammonium hydroxide (10 mL, 260 mmol) was added, and the tube was resealed and heated for 18 h at 60 °C. The reaction was cooled and concentrated in vacuo. The residue was slurried in water, and the solids were collected by filtration to afford the primary amide (1.79 g) as a colorless solid. The amide (1.74 g, 5.7 mmol) was taken up in CH<sub>2</sub>Cl<sub>2</sub> (38 mL), pyridine (1.84 mL, 22.8 mmol) was added, and the mixture was cooled to 0 °C using an ice–water bath. TFAA (1.60 mL, 11.4 mmol) was added in a dropwise manner, leading to the formation of a clear solution. The reaction was stirred for 1 h before being diluted with EtOAc (100 mL). The organic solution was washed with 1 M aqueous Na<sub>2</sub>CO<sub>3</sub> (2 × 25 mL), brine (25 mL), 1 M HCl (2 × 25 mL), and brine (25 mL), dried over MgSO<sub>4</sub>, and concentrated to afford <b>36</b> (1.54 g, 70% yield over two steps) as a yellow solid: LC–MS (APCI) <i>m</i>/<i>z</i> 288.2 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.41–7.36 (m, 1 H), 7.32 (dd, <i>J</i> = 9.1, 3.3 Hz, 1 H), 7.22 (dd, <i>J</i> = 9.1, 4.3 Hz, 1 H), 7.07 (s, 1 H), 4.36 (t, <i>J</i> = 6.3 Hz, 2 H), 3.95 (s, 3 H), 3.11 (t, <i>J</i> = 6.3 Hz, 2 H), 2.41 (s, 3 H).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3-[2-(2-Acetyl-4-fluorophenoxy)propyl]-1-methyl-1<i>H</i>-pyrazole-5-carbonitrile (<b>37</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>36</b> was used to prepare compound <b>37</b>: LC–MS (APCI) <i>m</i>/<i>z</i> 302.1 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.42–7.30 (m, 2 H), 7.18 (dd, <i>J</i> = 9.1, 4.3 Hz, 1 H), 6.99 (s, 1 H), 4.12 (t, <i>J</i> = 6.3 Hz, 2 H), 3.94 (s, 3 H), 2.77 (t, <i>J</i> = 7.6 Hz, 2 H), 2.56 (s, 3 H), 2.16–2.00 (m, 2 H).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-{2-[2-(5-Cyano-1-methyl-1<i>H</i>-pyrazol-3-yl)ethoxy]-5-fluorophenyl}ethyl Methanesulfonate (<b>38</b>)</h3><div class="NLM_p last">Sodium borohydride (223 mg, 5.9 mmol) was added to a solution of <b>36</b> (1.54 g, 5.36 mmol) in MeOH (26.8 mL) cooled to 0 °C. After being stirred for 2 h, the reaction was diluted with EtOAc (25 mL). The organic solution was washed with water (10 mL) and brine (10 mL) and dried over MgSO<sub>4</sub>. The reaction was concentrated in vacuo and the residue purified by column chromatography over silica gel (eluting with 0–60% EtOAc/heptanes) to afford the intermediate alcohol (1.48 g) as a viscous gum. The alcohol (400 mg, 1.38 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (6.92 mL), and TEA (289 μL, 2.08 mmol) was added. The mixture was cooled to 0 °C using an ice–water bath, and MsCl (118 μL, 1.52 mmol) was added in a dropwise manner. After 1 h, LC–MS indicated that the starting material had been consumed. The reaction was diluted with EtOAc (15 mL), washed with water (5 mL) and brine (5 mL), and dried over MgSO<sub>4</sub>. The reaction was filtered and concentrated in vacuo to afford <b>38</b> (508 mg, 94% yield over two steps) as a viscous gum, which was used without further purification: LC–MS (APCI) <i>m</i>/<i>z</i> 272.1 [M – OSO<sub>2</sub>Me]<sup>+</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-{2-[2-(5-Cyano-1-methyl-1<i>H</i>-pyrazol-3-yl)propoxy]-5-fluorophenyl}ethyl Methanesulfonate <b>(39)</b></h3><div class="NLM_p last">The procedure used to prepare compound <b>38</b> was used to prepare compound <b>39</b>: LC–MS (APCI) <i>m</i>/<i>z</i> 286.1 [M – OSO<sub>2</sub>Me]<sup>+</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 3-[2-(2-{1-[(2-Amino-5-bromopyridin-3-yl)oxy]ethyl}-4-fluorophenoxy)ethyl]-1-methyl-1<i>H</i>-pyrazole-5-carbonitrile (<b>40</b>)</h3><div class="NLM_p last">2-Amino-3-hydroxy-5-bromopyridine (313 mg, 1.66 mmol), <b>38</b> (507 mg, 1.38 mmol), and cesium carbonate (899 mg, 2.76 mmol) were combined in DMF (6.9 mL), and the reaction mixture was heated at 80 °C for 40 h. The reaction was allowed to cool, diluted with EtOAc (15 mL), washed with water (10 mL) and brine (5 mL), and dried over MgSO<sub>4</sub>. The reaction was filtered and concentrated in vacuo and the residue purified by column chromatography over silica gel (0–50% EtOAc/heptanes) to afford <b>40</b> (115 mg, 18% yield) as a brown solid, which was used without further purification: LC–MS (APCI) <i>m</i>/<i>z</i> 460.2/462.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 3-[2-(2-{1-[(2-Amino-5-bromopyridin-3-yl)oxy]propyl}-4-fluorophenoxy)ethyl]-1-methyl-1<i>H</i>-pyrazole-5-carbonitrile (<b>41</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>40</b> was used to prepare compound <b>41</b>: LC–MS (APCI) <i>m</i>/<i>z</i> 474.1/476.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (10<i>R</i>)-7-Amino-12-fluoro-2,10-dimethyl-16,17-dihydro-2<i>H</i>,10<i>H</i>-8,4-(metheno)pyrazolo[3,4-<i>d</i>][1,11,8]benzodioxazacyclotetradecine-3-carbonitrile (<b>7e</b>)</h3><div class="NLM_p last">Potassium acetate (123 mg, 1.25 mmol), <b>40</b> (115 mg, 0.25 mmol), cataCXium A (18.5 mg, 0.05 mmol), Pd(OAc)<sub>2</sub> (5.6 mg, 0.025 mmol), and <i>tert</i>-amyl alcohol (5 mL) were combined in a microwave vial. Nitrogen was bubbled through the solution for 10 min, and then the vial was sealed and heated in the microwave for 1 h at 140 °C. Additional portions of both cataCXium A (18.5 mg, 0.05 mmol) and Pd(OAc)<sub>2</sub> (5.6 mg, 0.025 mmol) were added, and the vial was resealed and heated in the microwave at 140 °C for 1 h. LC–MS indicated the starting material had been consumed. The reaction was diluted with EtOAc (20 mL) and the organic phase washed with water (10 mL) and brine (10 mL) before being dried over MgSO<sub>4</sub>. The solution was filtered and concentrated in vacuo. with the residue being purified by column chromatography over silica gel (0–100% EtOAc/heptanes) to afford <b>42</b> (23 mg, 24% yield) as a white solid: LC-MS <i>m</i>/<i>z</i> 460.2 [M + H]<sup>+</sup>. Chiral separation was carried out by SFC using a Whelk-O1 (<i>R,R</i>) 5 μm column (4.6 × 100 mm) eluting with 30% MeOH at 120 bar with a flow rate of 4 mL/min. <b>7e</b> was obtained as peak 1 (<i>t</i><sub>R</sub> = 1.36 min): [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +22.1 (<i>c</i> = 0.1, CHCl<sub>3</sub>); LC–MS (APCI) <i>m</i>/<i>z</i> 380.1 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, 80 °C, DMSO-<i>d</i><sub>6</sub>) δ 7.82 (d, <i>J</i> = 1.8 Hz, 1 H), 7.65 (s, 1 H), 7.43 (dd, <i>J</i> = 9.7, 3.1 Hz, 1 H), 7.10–6.95 (m, 2 H), 6.01–5.86 (m,1 H), 5.62 (s, 2 H), 4.62–4.47 (m, 1 H), 3.97 (s, 3 H), 3.34–3.18 (m, <i>J</i> = 16.1 Hz, 1 H), 2.98 (br s, 2 H), 1.69 (d, <i>J</i> = 6.5 Hz, 3 H). The inactive enantiomer was obtained as peak 2 (<i>t</i><sub>R</sub> = 1.60 min)</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (10<i>R</i>)-7-Amino-12-fluoro-2,10-dimethyl-16,17-dihydro-2<i>H</i>,10<i>H</i>-8,4-(metheno)pyrazolo[3,4-<i>d</i>][1,11,8]benzodioxazacyclotetradecine-3-carbonitrile (<b>7f</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>42</b> was used to prepare compound <b>43</b>. Chiral separation of <b>43</b> was carried out by SFC using a Chiralcel OD-H 5 μm column (4.6 × 100 mm) eluting with 30% MeOH at 120 bar with a flow rate of 4 mL/min. <b>7f</b> was obtained as peak 2 (<i>t</i><sub>R</sub> = 1.27 min): [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −18.76 (<i>c</i> = 0.1, MeOH); LC–MS (APCI) <i>m</i>/<i>z</i> 394.2 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, 80 °C, DMSO-<i>d</i><sub>6</sub>) δ 7.82 (d, <i>J</i> = 1.8 Hz, 1 H), 7.65 (s, 1 H), 7.43 (dd, <i>J</i> = 9.6, 3.0 Hz, 1 H), 7.11–6.94 (m, 2 H), 6.01–5.88 (m, 1 H), 5.62 (s, 2 H), 4.61–4.48 (m, 1 H), 3.98 (s, 3 H), 3.26 (br s, 2 H), 2.71 (s, 2 H), 1.69 (d, <i>J</i> = 6.3 Hz, 3 H). The inactive enantiomer was obtained as peak 1 (<i>t</i><sub>R</sub> = 1.11 min).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Methyl 2-[(1<i>R</i>)-1-{[2-Amino-5-(3-{[(<i>tert</i>-butoxycarbonyl)methylamino]methyl}-5-cyano-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl]-4-fluorobenzoate (<b>46</b>)</h3><div class="NLM_p last">Pd(OAc)<sub>2</sub> (53 mg, 0.24 mmol) and cataCXium A (180 mg, 0.5 mmol) were mixed together in toluene (1.5 mL, degassed), and the resulting solution was added via pipette to a stirred solution of <b>44</b> (0.9 g, 2.4 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), <b>45</b> (1.0 g, 3.0 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), B<sub>2</sub>pin<sub>2</sub> (0.9 g, 3.6 mmol), and CsF (1.9 g, 12.6 mmol) in MeOH/H<sub>2</sub>O (9:1, 12 mL, degassed) at 60 °C. The resulting mixture was then stirred at reflux for 3 h. Further portions of Pd(OAc)<sub>2</sub> (26 mg, 0.12 mmol) and cataCXium A (90 mg, 0.25 mmol) in toluene (1.5 mL, degassed) were added, and the yellow reaction mixture was stirred at 60 °C overnight. After being cooled to room temperature, the mixture was diluted with EtOAc (150 mL) and filtered through Celite. The filtrate was washed with water (100 mL) and then brine (100 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated. The residue was purified by flash chromatography over silica gel, which was eluted with 50% EtOAc/cyclohexane, and gave <b>46</b> (570 mg, 43% yield) as a yellow oil: TLC <i>R<sub>f</sub></i> = 0.40 (50% EtOAc/cyclohexane); LC–MS (ESI) <i>m</i>/<i>z</i> 539 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03 (m, 1 H), 7.65 (s, 1 H), 7.27 (dd, <i>J</i> = 9.9, 2.7 Hz, 1 H), 7.01 (m, 1 H), 6.68 (m, 1 H), 6.40 (m, 1 H), 4.90 (br s, 2 H), 4.30–4.20 (m, 2 H), 3.96 (s, 3 H), 3.94 (s, 3 H), 2.85–2.55 (m, 3 H), 1.68 (d, <i>J</i> = 6.6 Hz, 3 H), 1.24 (s, 9 H).</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-[(1<i>R</i>)-1-{[2-Amino-5-(3-{[(<i>tert</i>-butoxycarbonyl)methylamino]methyl}-5-cyano-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl]-4-fluorobenzoic Acid <b>(47)</b></h3><div class="NLM_p last">To a solution of <b>46</b> (69% purity, 0.95 g, assumed 1.05 mmol) in MeOH (20 mL) was added a solution NaOH (1.0 g, 25 mmol) in water (2 mL). The mixture was stirred at 40 °C for 3.5 h. The reaction was diluted with water (80 mL), concentrated by 20 mL to remove MeOH on the rotovap, and washed with TBME (100 mL). The aqueous layer was then acidified carefully with 1 M aq HCl to approximately pH 2 (pH paper). Sodium chloride (15 g) was added to the mixture, and the mixture was extracted with EtOAc (100 mL). The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give <b>47</b> (480 mg, 87% yield) as a pale yellow solid: LC–MS (ESI) <i>m</i>/<i>z</i> 525 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.05 (m, 1 H), 7.45 (s, 1 H), 7.37 (dd, <i>J</i> = 10.4, 2.8 Hz, 1 H), 7.10 (dt, <i>J</i> = 8.5, 2.4 Hz, 1 H), 6.60–6.50 (m, 2 H), 4.30–4.05 (m, 2 H), 3.99 (s, 3 H), 2.80–2.60 (m, 3 H), 1.72 (d, <i>J</i> = 6.5 Hz, 3 H).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2-{(1<i>R</i>)-1-[(2-Amino-5-{5-cyano-1-methyl-3-[(methylamino)methyl]-1<i>H</i>-pyrazol-4-yl}pyridin-3-yl)oxy]ethyl}-4-fluorobenzoic Acid (<b>48</b>)</h3><div class="NLM_p last">A solution of HCl in dioxane (4 M, 6.0 mL) was added to a solution of <b>47</b> (480 mg, 0.91 mmol) in MeOH (6 mL), and the reaction was stirred at 40 °C for 2.5 h. The reaction mixture was then concentrated to dryness under reduced pressure. The residue was taken up in MeOH (50 mL), MeCN (100 mL) was added, and the mixture was then again evaporated to dryness to give <b>48</b> (400 mg, 87% yield) as an off-white solid: LC–MS (ESI) <i>m</i>/<i>z</i> 425 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.07 (dd, <i>J</i> = 8.9. 5.9 Hz, 1 H), 7.51 (d, <i>J</i> = 1.7 Hz, 1 H), 7.42 (dd, <i>J</i> = 9.8, 2.6 Hz, 1 H), 7.23 (d, <i>J</i> = 1.6 Hz, 1 H), 7.16 (dt, <i>J</i> = 8.5, 2.7 Hz, 1 H), 6.73 (dd, <i>J</i> = 11.9, 6.9 Hz, 1 H), 4.22 (d, <i>J</i> = 14.7 Hz, 1 H), 4.14 (d, <i>J</i> = 14.7 Hz, 1 H), 4.07 (s, 3 H), 2.75 (s, 3 H), 1.75 (d, <i>J</i> = 5.5 Hz, 3 H).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (10<i>R</i>)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2<i>H</i>-8,4-(metheno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile (<b>8k</b>)</h3><div class="NLM_p last">A solution of <b>48</b> (400 mg, assumed 0.91 mmol) as the HCl salt and DIPEA (1.17 g, 9.1 mmol) in DMF (5.0 mL) and THF (0.5 mL) was added dropwise to a solution of HATU (482 mg, 1.27 mmol) in DMF (10.0 mL) at 0 °C over 30 min. After complete addition, the mixture was stirred at 0 °C for a further 30 min. Water (70 mL) was added, and the mixture was extracted into EtOAc (2 × 60 mL). The combined organics were washed with saturated aqueous NaHCO<sub>3</sub> (2 × 100 mL) and brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by column chromatography over silica gel, which was eluted with 70% EtOAc/cyclohexane, giving 205 mg of a pale yellow residue (semi-solid). The solids were dissolved in TBME (7 mL), and cyclohexane (20 mL) was added slowly with good stirring to precipitate the product. After being stirred for 30 min, the mixture was filtered, and <b>8k</b> (110 mg, 29% yield) was collected as a white solid: TLC <i>R<sub>f</sub></i> = 0.40 (70% EtOAc in cyclohexane); LC–MS (ESI), <i>m</i>/<i>z</i> 407.1 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.83 (d, <i>J</i> = 2.0 Hz, 1 H), 7.30 (dd, <i>J</i> = 9.6, 2.4 Hz, 1 H), 7.21 (dd, <i>J</i> = 8.4, 5.6 Hz, 1 H), 6.99 (dt, <i>J</i> = 8.0, 2.8 Hz, 1 H), 6.86 (d, <i>J</i> = 1.2 Hz, 1 H), 5.75–5.71 (m, 1 H), 4.84 (s, 2 H), 4.45 (d, <i>J</i> = 14.4 Hz, 1 H), 4.35 (d, <i>J</i> = 14.4 Hz, 1 H), 4.07 (s, 3 H), 3.13 (s, 3 H), 1.79 (d, <i>J</i> = 6.4 Hz, 3 H).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 7-Amino-12-fluoro-1,3,10,16-tetramethyl-16,17-dihydro-1<i>H</i>-8,4-(metheno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecin-15(10<i>H</i>)-one (<b>8a</b> and <b>8b</b>)</h3><div class="NLM_p last">Compounds <b>8a</b> and <b>8b</b> were prepared similarly to <b>8k</b> using <i>rac</i>-<b>44</b> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and <i>tert</i>-butyl [(4-bromo-1,3-dimethyl-1<i>H</i>-pyrazol-5-yl)methyl]methylcarbamate (<b>70</b>) (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) as the reagents in the initial coupling step. Chiral separation was performed on the final compounds using a Chiralcel OD-3 3 μm column (4.6 × 100 mm) eluting with 30% MeOH at 120 bar with a flow rate of 5 mL/min. Data for compound <b>8a</b>, peak 1 (<i>t</i><sub>R</sub> = 0.75 min): LC–MS (ESI) <i>m</i>/<i>z</i> 397.0 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.62 (dd, <i>J</i> = 10.3, 2.5 Hz, 1 H), 7.43–7.33 (m, 2 H), 7.23–7.15 (m, 1 H), 6.76 (d, <i>J</i> = 1.5 Hz, 1 H), 5.81 (s, 2 H), 5.60 (br s, 1 H), 4.62 (d, <i>J</i> = 15.1 Hz, 1 H), 4.08 (d, <i>J</i> = 15.1 Hz, 1 H), 3.88 (s, 3 H), 2.99 (s, 3 H), 2.21 (s, 3 H), 1.65 (d, <i>J</i> = 6.0 Hz, 3 H). Data for compound <b>8b</b>, peak 2 (<i>t</i><sub>R</sub> = 1.3 min): LC–MS (ESI) <i>m</i>/<i>z</i> 397.0 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.65–7.57 (m, 1 H), 7.44–7.33 (m, 2 H), 7.23–7.12 (m, 1 H), 6.76 (s, 1 H), 5.80 (s, 2 H), 5.61 (br s, 1 H), 4.62 (d, <i>J</i> = 15.4 Hz, 1 H), 4.09 (d, <i>J</i> = 15.1 Hz, 1 H), 3.88 (s, 3 H), 2.99 (s, 3 H), 2.21 (s, 3 H), 1.66 (d, <i>J</i> = 6.0 Hz, 3 H).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 7-Amino-12-fluoro-1,3,16-trimethyl-16,17-dihydro-1<i>H</i>-8,4-(metheno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecin-15(10<i>H</i>)-one (<b>8c</b>)</h3><div class="NLM_p last">Compound <b>8c</b> was prepared similarly to <b>8k</b> using methyl 2-{[(2-amino-5-bromopyridin-3-yl)oxy]methyl}-4-fluorobenzoate (<b>71</b>) (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and <b>70</b> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) as the reagents in the initial coupling step: LC–MS (ESI) <i>m</i>/<i>z</i> 382 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.56 (dd, <i>J</i> = 9.6, 2.4 Hz, 1 H), 7.44–7.38 (m, 2 H), 7.22 (td, <i>J</i> = 8.4, 2.8 Hz, 1 H), 6.73 (d, <i>J</i> = 1.6 Hz, 1 H), 5.82 (br s, 2 H), 5.30 (d, <i>J</i> = 13.6 Hz, 1 H), 5.17 (d, <i>J</i> = 13.6 Hz, 1 H), 4.65 (d, <i>J</i> = 15.2 Hz, 1 H), 4.20 (d, <i>J</i> = 15.2 Hz, 1 H), 3.89 (s, 3 H), 2.97 (s, 3 H), 2.54 (s, 1 H), 2.22 (s, 3 H).</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (5<i>R</i>)-7-Amino-12-fluoro-3-methoxy-1,10,16-trimethyl-16,17-dihydro-1<i>H</i>-8,4-(metheno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecin-15(10<i>H</i>)-one (<b>8f</b>)</h3><div class="NLM_p last">Compound <b>8f</b> was prepared similarly to <b>8k</b> using <b>44</b> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and <i>tert</i>-butyl [(4-bromo-3-methoxy-1-methyl-1<i>H</i>-pyrazol-5-yl)methyl]methylcarbamate (<b>72</b>) (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) as the reagents in the initial coupling step: LC–MS (ESI) <i>m</i>/<i>z</i> 412 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.62 (d, <i>J</i> = 1.6 Hz, 1 H), 7.50 (dd, <i>J</i> = 6.4, 2.6 Hz, 1 H), 7.43 (dd, <i>J</i> = 5.6, 3.2 Hz, 1 H), 7.16–7.11 (m, 1 H), 6.90 (d, <i>J</i> = 1.2 Hz, 1 H), 5.64–5.60 (m, 1 H), 4.84 (d, <i>J</i> = 15.2 Hz, 1 H), 4.37 (d, <i>J</i> = 15.6 Hz, 1 H), 3.92 (d, <i>J</i> = 9.2 Hz, 6 H), 3.17 (s, 3 H), 1.78 (d, <i>J</i> = 6 Hz, 3 H).</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (5<i>R</i>)-8-Amino-3-fluoro-5,17-dimethyl-13-(methylsulfonyl)-16,17-dihydro-7,11-(metheno)dibenzo[<i>g</i>,<i>l</i>][1,4,10]oxadiazacyclotetradecin-18(5<i>H</i>)-one (<b>8h</b>)</h3><div class="NLM_p last">Compound <b>8h</b> was prepared similarly to <b>8k</b> using <b>44</b> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and <i>tert</i>-butyl [2-bromo-4-(methylsulfonyl)benzyl]methylcarbamate (<b>73</b>) (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) as the reagents in the initial coupling step: LC–MS (ESI) <i>m</i>/<i>z</i> 456 [M + H]<sup>+</sup>; [α]<sub class="stack">D</sub><sup class="stack">22</sup> = +52.5 (<i>c</i> = 0.52, MeOH); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.92–7.84 (m, 3 H), 7.69 (dd, <i>J</i> = 10.4, 2.8 Hz, 1 H), 7.51 (d, <i>J</i> = 2.0 Hz, 1 H), 7.36 (dd, <i>J</i> = 8.8, 6.0 Hz, 1 H), 7.14 (dt, <i>J</i> = 8.4, 2.4 Hz, 1 H), 7.09 (d, <i>J</i> = 2.0 Hz, 1 H), 6.13 (s, 2H), 5.71–5.67 (m, 1 H), 4.45 (d, <i>J</i> = 13.2 Hz, 1 H), 4.22 (d, <i>J</i> = 13.2 Hz, 1 H), 3.29 (s, 3 H), 3.01 (s, 3 H), 1.69 (d, <i>J</i> = 6.4 Hz, 3 H).</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (5<i>R</i>)-7-Amino-3-cyclopropyl-12-fluoro-1,10,16-trimethyl-16,17-dihydro-1<i>H</i>-8,4-(metheno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecin-15(10<i>H</i>)-one (<b>8j</b>)</h3><div class="NLM_p last">Compound <b>8j</b> was prepared similarly to <b>8k</b> using <b>44</b> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and <i>tert</i>-butyl [(4-bromo-3-cyclopropyl-1-methyl-1<i>H</i>-pyrazol-5-yl)methyl]methylcarbamate (<b>74</b>) (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) as the reagents in the initial coupling step: LC–MS (ESI) <i>m</i>/<i>z</i> 422 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.76–7.75 (m, 1 H), 7.25 (dd, <i>J</i> = 7.2, 2.8 Hz, 1 H), 7.10 (dd, <i>J</i> = 5.6, 2.8 Hz, 1 H), 6.93–6.90 (m, 1 H), 6.80 (br s, 1 H), 5.69 (s, 1 H), 4.54 (s, 2 H), 4.40 (d, <i>J</i> = 15.2 Hz, 1 H), 4.22 (d, <i>J</i> = 15.2 Hz, 1 H), 3.85 (s, 3 H), 3.06 (s, 3 H), 1.85 (m, 1 H), 1.70 (d, <i>J</i> = 6.4 Hz, 3 H), 1.02–1.01 (m, 1 H), 0.95–0.93 (m, 1 H), 0.81–0.79 (m, 1 H), 0.63 (m, 1 H).</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (5<i>R</i>)-8-Amino-3-fluoro-5,14,19-trimethyl-18,19-dihydro-7,11-(metheno)pyrimido[2′,1′:2,3]imidazo[4,5-<i>h</i>][2,5,11]benzoxadiazacyclotetradecin-20(5<i>H</i>)-one (<b>8l</b>)</h3><div class="NLM_p">Compound <b>8l</b> was prepared similarly to <b>8k</b> with the modification that the initial Suzuki coupling was performed utilizing the pre-formed protected boronate <b>69</b> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), as described below.</div><div class="NLM_p">Nitrogen was bubbled through a suspension of <b>69</b> (489 mg, 0.56 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), <i>tert</i>-butyl [(3-bromo-6-methylimidazo[1,2-<i>a</i>]pyrimidin-2-yl)methyl]methylcarbamate (<b>75</b>) (197 mg, 0.57 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), and CsF (253 mg, 1.66 mmol) in toluene (3.7 mL) for a period of 10 min. To the mixture was added PdCl<sub>2</sub>·dppf (45.7 mg, 0.06 mmol), and the reaction was heated at reflux for 14 h. The reaction was allowed to cool and diluted with EtOAc (20 mL). The organic phase was washed with water (2 × 5 mL) and brine (5 mL) and dried over MgSO<sub>4</sub>. The solution was filtered and concentrated and the residue purified by column chromatography on silica gel eluting with 0–100% EtOAc/heptanes to afford methyl 2-[(1<i>R</i>)-1-({3-[bis(<i>tert</i>-butoxycarbonyl)amino]-6-(2-{[(<i>tert</i>-butoxycarbonyl)methylamino]methyl}-6-cyanoimidazo[1,2-<i>a</i>]pyridin-3-yl)pyrazin-2-yl}oxy)ethyl]-4-fluorobenzoate (288 mg, 66% yield) as a viscous oil: LC–MS (APCI) <i>m</i>/<i>z</i> 765.3 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (s, 1 H), 8.20 (s, 2 H), 7.97 (dd, <i>J</i> = 8.7, 6.2 Hz, 1 H), 7.44–7.33 (m, 2 H), 7.28–7.21 (m, 1 H), 6.41–6.30 (m, 1 H), 4.45–4.25 (m, 2 H), 3.82 (s, 3 H), 2.74 (s, 3 H), 2.28 (s, 3 H), 1.61 (d, <i>J</i> = 6.3 Hz, 3 H), 1.47 (s, 18 H), 1.30 (br s, 9 H).</div><div class="NLM_p last">The ester hydrolysis, exhaustive Boc deprotection, and HATU-mediated macrolactamization were performed similarly to those for <b>8k</b> to afford <b>8l</b> as a colorless solid: LC–MS (APCI) <i>m</i>/<i>z</i> 433 [M + H]<sup>+</sup>; [α]<sub class="stack">D</sub><sup class="stack">22</sup> = −199.2 (<i>c</i> = 0.57, MeOH); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (dd, <i>J</i> = 2.1, 1.2 Hz, 1 H), 8.45 (d, <i>J</i> = 2.2 Hz, 1 H), 7.82 (d, <i>J</i> = 1.7 Hz, 1 H), 7.66 (dd, <i>J</i> = 10.3, 2.6 Hz, 1 H), 7.47 (dd, <i>J</i> = 8.5, 5.8 Hz, 1 H), 7.17 (dt, <i>J</i> = 8.4, 2.7 Hz, 1 H), 6.88 (d, <i>J</i> = 1.6 Hz, 1 H), 6.22 (s, 2 H), 5.73–5.63 (m, 1 H), 4.50 (d, <i>J</i> = 13.9 Hz, 1 H), 4.31 (d, <i>J</i> = 13.8 Hz, 1 H), 3.06 (s, 3 H), 2.31 (s, 3 H), 1.69 (d, <i>J</i> = 6.2 Hz, 3 H).</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 2-{1-[(3-Amino-6-bromopyrazin-2-yl)oxy]ethyl}-<i>N</i>-[(4-bromo-1,3-dimethyl-1<i>H</i>-pyrazol-5-yl)methyl]-4-fluoro-<i>N</i>-methylbenzamide (<b>52</b>)</h3><div class="NLM_p last">To a solution of <i>rac</i>-<b>49</b> (266 mg, 0.607 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), 1-(4-bromo-1,3-dimethyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-methylmethanamine (<b>50</b>) (166 mg, 0.759 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), and DIPEA (211 μL, 1.21 mmol) in toluene (60 mL) was added Pd(P<sup><i>t</i></sup>Bu<sub>3</sub>)<sub>2</sub> (32 mg, 0.06 mmol). The reaction mixture was heated at 100 °C under 4 bar of CO overnight and then concentrated to afford <b>52</b>, which was used without further purification.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 2-{1-[(3-Amino-6-bromopyrazin-2-yl)oxy]ethyl}-<i>N</i>-[(4-bromo-3-methoxy-1-methyl-1<i>H</i>-pyrazol-5-yl)methyl]-4-fluoro-<i>N</i>-methylbenzamide (<b>53</b>)</h3><div class="NLM_p last">The procedure used to prepare compound <b>52</b> was used to prepare compound <b>53</b> (from <b>49</b> and <b>51</b>; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), which was used without further purification: LC–MS (APCI) <i>m</i>/<i>z</i> 493.0/495.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 7-Amino-12-fluoro-1,3,10,16-tetramethyl-16,17-dihydro-1<i>H</i>-8,4-(azeno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecin-15(10<i>H</i>)-one (<b>8d</b> and <b>8e</b>)</h3><div class="NLM_p last">The residue of crude <b>52</b> was taken up in MeOH (12 mL) and water (1.3 mL) and added to a vial containing B<sub>2</sub>pin<sub>2</sub> (771 mg, 3.04 mmol) and CsF (461 mg, 3.04 mmol). The vial was sealed, and the reaction mixture was bubbled with nitrogen before addition of a solution of Pd(OAc)<sub>2</sub> (14 mg, 0.06 mmol) and cataCXium A (45 mg, 0.12 mmol) in toluene (0.5 mL). After the resulting solution was heated for 30 min at 60 °C, the temperature was increased to 90 °C for 6 h. The reaction was allowed to stand at room temperature overnight, and then additional Pd(OAc)<sub>2</sub> (14 mg, 0.06 mmol) and cataCXium A (45 mg, 0.12 mmol) in toluene (0.5 mL) were added. After being heated for 2 h at 100 °C, the reaction mixture was cooled to room temperature and filtered. The mother liquor was diluted with EtOAc (50 mL), washed with water (2 × 20 mL) and brine (10 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude product was purified by flash chromatography eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (0–8%) followed by a second column eluting with EtOAc/heptanes (50–100%) and then MeOH/CH<sub>2</sub>Cl<sub>2</sub> (0–6%) and finally chiral separation by SFC to afford both enantiomers of the title compound. The chiral separation was performed by SFC on a Chiralcel OD-H 5 μm column (4.6 mm × 250 mm), which was eluted with 25% MeOH in CO<sub>2</sub> at 140 bar with a flow rate of 3.0 mL/min. Data for compound <b>8d</b>, peak 1 (<i>t</i><sub>R</sub> = 4.23 min): [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −77.1 (<i>c</i> = 0.23, MeOH); 14 mg, >99% ee, 6% yield; LC–MS (ESI) <i>m</i>/<i>z</i> 397 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.51 (s, 1 H), 7.51–7.46 (m, 1 H), 7.36 (dd, <i>J</i> = 8.3, 5.8 Hz, 1 H), 7.17 (dt, <i>J</i> = 8.6, 2.5 Hz, 1 H), 6.29 (s, 2 H), 5.95–5.84 (m, 1 H), 4.47 (d, <i>J</i> = 14.7 Hz, 1 H), 4.27 (d, <i>J</i> = 14.4 Hz, 1 H), 3.87 (s, 3 H), 2.87 (s, 3 H), 2.26 (s, 3 H), 1.62 (d, <i>J</i> = 6.6 Hz, 3 H). Data for compound <b>8e</b>, peak 2 (<i>t</i><sub>R</sub> = 5.60 min); [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +78.6 (<i>c</i> = 0.24, MeOH); 13 mg, 99% ee, 5% yield; LC–MS (ESI) <i>m</i>/<i>z</i> 397 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.51 (s, 1 H), 7.49 (dd, <i>J</i> = 10.2, 2.7 Hz, 1 H), 7.36 (dd, <i>J</i> = 8.5, 5.7 Hz, 1 H), 7.17 (dt, <i>J</i> = 8.5, 2.5 Hz, 1 H), 6.29 (s, 2 H), 5.95–5.82 (m, 1 H), 4.47 (d, <i>J</i> = 14.7 Hz, 1 H), 4.27 (d, <i>J</i> = 14.4 Hz, 1 H), 3.87 (s, 3 H), 2.87 (s, 3 H), 2.26 (s, 3 H), 1.62 (d, <i>J</i> = 6.6 Hz, 3 H).</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (10<i>R</i>)-7-Amino-12-fluoro-3-methoxy-1,10,16-trimethyl-16,17-dihydro-1<i>H</i>-8,4-(azeno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecin-15(10<i>H</i>)-one (<b>8g</b>)</h3><div class="NLM_p last">KOAc (89.3 mg, 0.91 mmol), pivalic acid (4.6 mg, 0.05 mmol), and <b>53</b> (90 mg, 0.018 mmol) were combined in a microwave vial, and DMF (1.82 mL) was added. Nitrogen was bubbled through the solution, followed by the addition of Pd(OAc)<sub>2</sub> (4 mg, 0.018 mmol) and cataCXium A (13.3 mg, 0.036 mmol). The vial was sealed and heated at 120 °C in the microwave for 1 h. LC–MS indicated no reaction had taken place. Pd(OAc)<sub>2</sub> and cataCXium A were added again, and the vial was resealed and heated in the microwave at 150 °C for 1 h. The solution was diluted with EtOAc (10 mL), washed with water (5 mL) and brine (5 mL), and dried over MgSO<sub>4</sub>. The solution was filtered, concentrated, and purified by reversed-phase HPLC (3-hydroxyphenol column, no additive) to afford <b>8g</b> (5.6 mg, 8% yield) as a colorless solid: LC–MS (APCI) <i>m</i>/<i>z</i> 413.1 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.79 (s, 1 H), 7.44 (dd, <i>J</i> = 10.1, 2.5 Hz, 1 H), 7.38 (dd, <i>J</i> = 8.6, 5.8 Hz, 1 H), 7.23–7.13 (m, 1 H), 6.21 (s, 2 H), 5.83–5.68 (m, 1 H), 4.46 (d, <i>J</i> = 14.4 Hz, 1 H), 4.29 (d, <i>J</i> = 14.4 Hz, 1 H), 3.87 (s, 3 H), 3.81 (s, 3 H), 2.89 (s, 3 H), 1.61 (d, <i>J</i> = 6.5 Hz, 3 H).</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2-{(1<i>R</i>)-1-[(3-Amino-6-bromopyrazin-2-yl)oxy]ethyl}-4-fluorobenzoic Acid (<b>54</b>)</h3><div class="NLM_p">Compound <b>49</b> (1.00 g, 2.28 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) was partially dissolved in MeOH (10 mL), and then DIPEA (2.00 mL, 11.41 mmol), bis-[2-(diphenylphosphino)phenyl]ether (DPE-Phos) (147 mg, 0.274 mmol), and Pd(OAc)<sub>2</sub> (31 mg, 0.137 mmol) were added. The mixture was then heated at 50 °C under 4 bar of CO pressure for 3 h. After being allowed to cool to room temperature, the mixture was filtered through Celite and eluted with EtOAc (80 mL). The filtrate was concentrated to one-third volume (30 mL), then washed with saturated NaHCO<sub>3</sub> solution (2 × 15 mL) and brine (20 mL), dried over MgSO<sub>4</sub>, and concentrated. The crude material was purified by flash chromatography on silica gel (1:2 EtOAc/heptanes) to give methyl 2-{(1<i>R</i>)-1-[(3-amino-6-bromopyrazin-2-yl)oxy]ethyl}-4-fluorobenzoate (0.65 g, 77% yield) as a colorless solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94 (dd, <i>J</i> = 8.7, 5.8 Hz, 1 H), 7.57 (s, 1 H), 7.24 (dd, <i>J</i> = 9.9, 2.7 Hz, 1 H), 7.00 (ddd, <i>J</i> = 8.8, 7.7, 2.7 Hz, 1 H), 6.89 (qd, <i>J</i> = 6.5, 1.4 Hz, 1 H), 4.89 (s, 2 H), 3.95 (s, 3 H), 1.72 (d, <i>J</i> = 6.4 Hz, 3 H).</div><div class="NLM_p last">Methyl 2-{(1<i>R</i>)-1-[(3-amino-6-bromopyrazin-2-yl)oxy]ethyl}-4-fluorobenzoate (0.65 g, 1.76 mmol) was suspended in MeOH (10 mL), and a solution of NaOH (0.35 g, 8.80 mmol) in H<sub>2</sub>O (1 mL) was added. THF (2 mL) was subsequently added to aid solubility and the reaction mixture stirred at room temperature overnight. The reaction was diluted with H<sub>2</sub>O (15 mL) and washed with TBME (2 × 10 mL). The basic aqueous phase was then acidified to pH ≈ 3 with 2 M HCl solution and extracted with EtOAc (3 × 10 mL). The combined organic extracts were dried over MgSO<sub>4</sub> and concentrated to give <b>54</b> (0.56 g, 89% yield) as a colorless solid: LC–MS (ESI) <i>m</i>/<i>z</i> 356.0, 357.9 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.92 (dd, <i>J</i> = 8.7, 6.0 Hz, 1 H), 7.67 (dd, <i>J</i> = 10.5, 2.7 Hz, 1 H), 7.52 (s, 1 H), 7.19 (td, <i>J</i> = 8.4, 2.7 Hz, 1 H), 6.88 (q, <i>J</i> = 6.4 Hz, 1 H), 6.68 (s, 2 H), 1.57 (d, <i>J</i> = 6.3 Hz, 3 H).</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-{(1<i>R</i>)-1-[(3-Amino-6-bromopyrazin-2-yl)oxy]ethyl}-<i>N</i>-[(6-cyanoimidazo[1,2-<i>a</i>]pyridin-2-yl)methyl]-4-fluoro-<i>N</i>-methylbenzamide (<b>56</b>)</h3><div class="NLM_p last">To a mixture of compound <b>54</b> (0.217 g, 0.611 mmol) and 2-[(methylamino)methyl]imidazo[1,2-<i>a</i>]pyridine-6-carbonitrile (<b>55</b>) (0.15 g, 0.673 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) in DMF (20 mL) were added EDCI (0.176 g, 0.916 mmol), HOBt (0.124 g, 0.916 mmol), and DIPEA (0.531 mL, 3.055 mmol) at −35 °C. The resulting mixture was stirred at −30 °C for 30 min and stirred at room temperature overnight. TLC (petroleum ether/EtOAc, 1:1) indicated that the majority of the starting material had been consumed. The mixture was diluted with EtOAc (50 mL) and H<sub>2</sub>O (10 mL). The organic layer was separated, and the aqueous layer was extracted with EtOAc (2 × 20 mL). The organic layers were combined, washed with brine (5 × 10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give the crude product, which was purified by preparative TLC to obtain <b>56</b> (150 mg, 46% yield) as a white solid, which was used without further purification: LC–MS (APCI) <i>m</i>/<i>z</i> 524/526 [M + 1]<sup>+</sup>.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (5<i>R</i>)-8-Amino-3-fluoro-5,19-dimethyl-20-oxo-5,18,19,20-tetrahydro-7,11-(azeno)pyrido[2′,1′:2,3]imidazo[4,5-<i>h</i>][2,5,11]benzoxadiazacyclotetradecine-14-carbonitrile (<b>8m</b>)</h3><div class="NLM_p last">To a mixture of <b>56</b> (0.15 g, 0.29 mmol), cataCXium A (22 mg, 0.058 mmol), <i>t</i>-AmOH (6 mg, 0.06 mmol), and KOAc (140 mg, 1.43 mmol) in freshly distilled DMA (15 mL) was added Pd(OAc)<sub>2</sub> (7 mg, 0.029 mmol) at room temperature under a nitrogen atmosphere. The resulting mixture was sealed and heated at 110 °C for 12 h. LC–MS showed the reaction was complete. The mixture was diluted with EtOAc (50 mL) and then washed with brine (4 × 10 mL). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give the crude product, which was purified by preparative TLC and then repurified by reversed-phase preparative HPLC to obtain <b>8m</b> (15.4 mg, 12% yield) as a yellow solid: LC–MS (APCI) <i>m</i>/<i>z</i> 444.1 [M + H]<sup>+</sup>; [α]<sub class="stack">D</sub><sup class="stack">23</sup> = −177.0 (<i>c</i> = 0.5, MeOH); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.28 (s, 1 H), 8.03 (s, 1 H), 7.79 (d, <i>J</i> = 9.3 Hz, 1 H), 7.61–7.49 (m, 2 H), 7.42 (dd, <i>J</i> = 8.6, 5.8 Hz, 1 H), 7.17 (dt, <i>J</i> = 8.5, 2.6 Hz, 1 H), 6.80 (s, 2 H), 6.10–5.99 (m, 1 H), 4.51–4.32 (m, 2 H), 2.95 (s, 3 H), 1.67 (d, <i>J</i> = 6.5 Hz, 3 H).</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 2-{(1<i>R</i>)-1-[(3-Amino-6-bromopyrazin-2-yl)oxy]ethyl}-<i>N</i>-[2-bromo-4-(methylsulfonyl)benzyl]-4-fluoro-<i>N</i>-methylbenzamide (<b>58</b>)</h3><div class="NLM_p last">To a mixture of compound <b>54</b> (0.300 g, 0.842 mmol) and 1-[2-bromo-4-(methylsulfonyl)phenyl]-<i>N</i>-methylmethanamine (<b>57</b>) (0.291 g, 0.926 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) in DMF (5.61 mL) was added HATU (0.363 g, 0.926 mmol), followed by DIPEA (0.586 mL, 3.37 mmol), at room temperature. The mixture was stirred for 12 h, then diluted with EtOAc (50 mL), and washed with saturated Na<sub>2</sub>CO<sub>3</sub> solution (2 × 20 mL) and brine (20 mL). The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give the crude product, which was purified by column chromatography on silica gel (0–75% EtOAc/heptanes) to afford <b>58</b> (487 mg, 94% yield) as a cream solid, which was used without further purification: LC–MS (APCI) <i>m</i>/<i>z</i> 614.9/616.9/618.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (5<i>R</i>)-8-Amino-3-fluoro-5,17-dimethyl-13-(methylsulfonyl)-16,17-dihydro-7,11-(azeno)dibenzo[<i>g</i>,<i>l</i>][1,4,10]oxadiazacyclotetradecin-18(5<i>H</i>)-one (<b>8i</b>)</h3><div class="NLM_p last">Compound <b>58</b> (485 mg, 0.787 mmol) was taken up in THF (15.7 mL) and added to a vial containing B<sub>2</sub>pin<sub>2</sub> (600 mg, 2.36 mmol) and K<sub>2</sub>CO<sub>3</sub> (544 mg, 3.94 mmol). The vial was sealed, and the reaction mixture was bubbled with nitrogen before addition of Pd(OAc)<sub>2</sub> (17.7 mg, 0.08 mmol) and cataCXium A (58 mg, 0.157 mmol) and heated to 80 °C for 6 h. The reaction was diluted with EtOAc (100 mL), washed with saturated NH<sub>4</sub>Cl solution (40 mL) and brine (40 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude product was purified twice by flash chromatography on silica gel eluting with EtOAc/heptanes (0–100%) to afford <b>8i</b> (28 mg, 8% yield) as a white solid: LC–MS (APCI) <i>m</i>/<i>z</i> 457.1 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.96 (s, 1 H), 7.93–7.81 (m, 2 H), 7.77 (s, 1 H), 7.57 (d, <i>J</i> = 10.6 Hz, 1 H), 7.35 (dd, <i>J</i> = 8.1, 5.8 Hz, 1 H), 7.22–7.10 (m, 1 H), 6.71 (br s, 2 H), 6.05–5.91 (m, <i>J</i> = 6.3 Hz, 1 H), 4.47 (d, <i>J</i> = 12.3 Hz, 1 H), 4.32 (d, <i>J</i> = 12.3 Hz, 1 H), 3.29 (br s, 3 H), 2.87 (s, 3H), 1.66 (d, <i>J</i> = 6.0 Hz, 3 H).</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 2-{(1<i>R</i>)-1-[(2-Aminopyridin-3-yl)oxy]ethyl}-<i>N</i>-[(5-cyano-1-methyl-1<i>H</i>-pyrazol-3-yl)methyl]-4-fluoro-<i>N</i>-methylbenzamide (<b>61</b>)</h3><div class="NLM_p last">To a solution of <b>59</b> (1 g, 2.8 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), <b>60</b> (573 mg, 3.07 mmol; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), and DIPEA (1.94 mL, 11.2 mmol) in toluene (28 mL) was added Pd(P<sup><i>t</i></sup>Bu<sub>3</sub>)<sub>2</sub> (146 mg, 0.28 mmol). The reaction mixture was heated at 85 °C under 4 bar of CO for 18 h and then concentrated. The residue was taken up in EtOAc (50 mL), and the organic layer was washed with water (25 mL) and brine (25 mL) before being dried over MgSO<sub>4</sub>. The solution was filtered and concentrated and the residue purified by column chromatography on silica gel (0–5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford <b>61</b> (1.08 g, 95% yield) as a yellow gummy solid, which was used without further purification (contains ca. 15% <i>tert</i>-butylphosphine oxide by NMR): LC–MS (APCI) <i>m</i>/<i>z</i> 409.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 2-{(1<i>R</i>)-1-[(2-Amino-5-bromopyridin-3-yl)oxy]ethyl}-<i>N</i>-[(5-cyano-1-methyl-1<i>H</i>-pyrazol-3-yl)methyl]-4-fluoro-<i>N</i>-methylbenzamide (<b>62</b>)</h3><div class="NLM_p last">To a −10 °C (ice–salt bath) solution of <b>61</b> (4.6 g, 11 mmol) in THF (115 mL) was added a solution of NBS (2 g, 11 mmol) in THF (35 mL). The reaction was stirred for 1 h, with the reaction temperature being maintained below 0 °C. LC–MS indicated that ∼35% of <b>61</b> remained. Solid NBS (682 mg, 3.83 mmol) was added in a portionwise manner, with the reaction temperature being maintained below 0 °C. After the reaction was stirred for 15 min, LC–MS indicated that the reaction was complete. The reaction was diluted with EtOAc (250 mL), washed with 1 M Na<sub>2</sub>CO<sub>3</sub> (2 × 100 mL) and brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by column chromatography over silica gel (eluting with 25–75% EtOAc/heptanes) to afford <b>62</b> as a slightly yellow solid, which was used without any further purification: LC–MS (APCI) <i>m</i>/<i>z</i> 487.0/489.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 2-[(1<i>R</i>)-1-{[5-Bromo-2-(diacetylamino)pyridin-3-yl]oxy}ethyl]-<i>N</i>-[(5-cyano-1-methyl-1<i>H</i>-pyrazol-3-yl)methyl]-4-fluoro-<i>N</i>-methylbenzamide (<b>63</b>)</h3><div class="NLM_p last">Compound <b>62</b> (6.38 g, 13.1 mmol) was taken up in acetic anhydride (26.2 mL) and heated at 100 °C for 24 h. The reaction was allowed to cool and the solvent evaporated. The residue was azeotroped with toluene (2 × 100 mL) followed by being dried in the vacuum oven to afford <b>63</b> (7.48 g, 100%) as a gummy solid, which was used without any further purification: LC–MS (APCI) <i>m</i>/<i>z</i> 571.0/573.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (10<i>R</i>)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2<i>H</i>-8,4-(metheno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile (<b>8k</b>)</h3><div class="NLM_p last">KOAc (6.43 g, 65.5 mmol) and <b>63</b> (7.48 g, 13.1 mmol) were combined in a 500 mL Parr vessel, and <i>t</i>-AmOH (1.82 mL) was added. Nitrogen was bubbled through the solution, followed by the addition of Pd(OAc)<sub>2</sub> (294 mg, 1.31 mmol) and cataCXium A (968 mg, 2.62 mmol). The vessel was sealed and heated at 130 °C for 14 h. The solution was diluted with EtOAc (500 mL), washed with water (2 × 250 mL) and brine (250 mL), and dried over MgSO<sub>4</sub>. The solution was filtered and concentrated, the residue dissolved in MeOH (100 mL), and HCl (4 M in dioxane, 32.8 mL) added. The reaction was heated at 60 °C for 18 h. The solution was diluted with EtOAc (250 mL), washed with saturated NaHCO<sub>3</sub> solution (3 × 100 mL) and brine (100 mL), and dried over MgSO<sub>4</sub>. The solution was filtered and concentrated and the residue purified by column chromatography over silica gel eluting with 15–100% EtOAc/heptanes to afford 2.3 g of a light foamy solid. This solid was slurried in MeOH/water for 1 h. The solid was isolated by filtration and dried overnight in the vacuum oven to afford <b>8k</b> (2.25 g, 42% yield) as a colorless powder: LC–MS (ESI) <i>m</i>/<i>z</i> 407.1 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.83 (d, <i>J</i> = 2.0 Hz, 1 H), 7.30 (dd, <i>J</i> = 9.6, 2.4 Hz, 1 H), 7.21 (dd, <i>J</i> = 8.4, 5.6 Hz, 1 H), 6.99 (dt, <i>J</i> = 8.0, 2.8 Hz, 1 H), 6.86 (d, <i>J</i> = 1.2 Hz, 1 H), 5.75–5.71 (m, 1 H), 4.84 (s, 2 H), 4.45 (d, <i>J</i> = 14.4 Hz, 1 H), 4.35 (d, <i>J</i> = 14.4 Hz, 1 H), 4.07 (s, 3 H), 3.13 (s, 3 H), 1.79 (d, <i>J</i> = 6.4 Hz, 3 H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.26, 163.09, 149.73, 144.18, 143.45, 138.97, 137.43, 132.13, 128.26, 127.51, 118.42, 115.42, 114.69, 114.55, 112.35, 110.66, 71.64, 47.56, 38.94, 31.66, 22.47; <sup>19</sup>F NMR (377 MHz, DMSO-<i>d</i><sub>6</sub>) δ −110.12 (note that it is negative relative to the reference CFCl<sub>3</sub> at 0 ppm for <sup>19</sup>F); ∼99.5% ee; [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −90.8 (<i>c</i> = 0.58, MeOH). Chiral analysis was done by SFC on a Whelk O-1 (<i>R</i>,<i>R</i>) 5 μm column (4.6 mm × 250 mm), which was eluted with 30% MeOH in CO<sub>2</sub> at 140 bar with a flow rate of 3.0 mL/min. <b>8k</b> was eluted as peak 1 (<i>t</i><sub>R</sub> = 2.99 min). Under these conditions, the enantiomer elutes as peak 2 (<i>t</i><sub>R</sub> = 4.33 min).</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Cocrystal Structures</h3><div class="NLM_p last">The cocrystal structures described for the first time here have been deposited in the Protein Data Bank (wwPDB), and the details of the methods used can be found under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CNH">4CNH</a> (wt ALK + <b>6b</b>, 1.84 Å), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMO">4CMO</a> (wt ALK + <b>6h</b>, 1.83 Å), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMT">4CMT</a> (wt ALK + <b>6i</b>, 1.73 Å), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMU">4CMU</a> (wt ALK + <b>8a</b>, 1.80 Å), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTC">4CTC</a> (wt ALK + <b>8j</b>, 2.14 Å), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CLI">4CLI</a> (wt ALK + <b>8k</b>, 2.05 Å), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CLJ">4CLJ</a> (ALK-L1196M + <b>8k</b>, 1.66 Å), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTB">4CTB</a> (wt ALK + <b>8m</b>, 1.79 Å). Nonphosphorylated human wt and L1196M mutant ALK kinase domain proteins (amino acids 1093–1411) were crystallized by the hanging drop vapor diffusion method at 13 °C by mixing equal volumes of a purified protein (11–15 mg/mL)–inhibitor (0.001 M) complex solution with a crystallization solution containing 0.15 M ammonium sulfate, 9–10.5% (w/v) monomethyl ether poly(ethylene glycol) (MW 5000), and 0.1 M MES buffer in a pH range of 5.3–5.6 for wt ALK or 0.2 M lithium sulfate, 18% (w/v) poly(ethylene glycol) (MW 5000), and 0.1 M Tris at pH 8.5 for ALK-L1196M.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Modeling Methods</h3><div class="NLM_p last">Compound <b>8a</b> was built from the crystal structure of compound <b>6h</b> using in-house software. The resulting ligand was minimized in the rigid protein structure of cocrystal <b>6h</b> using the OPLS2001 force field.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The strain calculations were based on three calculations. First, restrained minimization was performed for the given conformation where torsion angles were fixed with a force constant of 500 kJ/mol while bond lengths and angles were relaxed (energy A). Second, the given conformation was minimized to the nearest local minimum (energy B). Third, the given conformation was subjected to a Monte Carlo conformational search followed by minimization to locate the global energy minima (energy C). The minimization and searches were performed with the BatchMin MCMM search routine using the OPLS2001 force field.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The local strain energy was reported as the difference between energies A and B, and the global strain energy was reported as the difference between energies A and C.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Biochemical Kinase Assays</h3><div class="NLM_p last">Recombinant human wild-type and mutant ALK kinase domain proteins (amino acids 1093–1411) were produced in-house using baculoviral expression, preactivated via autophosphorylation with MgATP, and assayed for kinase activity using a microfluidic mobility shift assay, essentially as previously reported.<a onclick="showRef(event, 'cit24a ref30'); return false;" href="javascript:void(0);" class="ref cit24a ref30">(24a, 30)</a> The reactions contained 1.3 nM wild-type ALK or 0.5 nM mutant ALK (appropriate to produce 15–20% phosphorylation of peptide substrate after 1 h of reaction), 3 μM 5-FAM-KKSRGDYMTMQIG-CONH<sub>2</sub>), 5 mM MgCl<sub>2</sub>, and the <i>K</i><sub>m</sub> level of ATP in 25 mM Hepes, pH 7.1. The inhibitors were shown to be ATP-competitive from kinetic and crystallographic studies. The <i>K</i><sub>i</sub> values were calculated by fitting the conversion (%) to a competitive inhibition equation (GraphPad Prism, GraphPad Software, San Diego, CA). ROS1 enzyme was assayed as described above for ALK, except using 0.25 nM recombinant human ROS1 catalytic domain (amino acids 1883–2347) (Invitrogen Inc., Carlsbad, CA). Kinase inhibitor selectivity was evaluated using a 206-kinase Invitrogen panel.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Kinase Selectivity Enzyme Assays</h3><div class="NLM_p last">The experiments were conducted at Invitrogen Inc. at their Madison, WI, facility. Most of the kinase panel assays were the fluorescence resonance energy transfer (FRET)-based Z’-LYTE assays that employ a fluorescence-based, coupled-enzyme format, taking advantage of the differential sensitivity of phosphorylated and nonphosphorylated peptides to proteolytic cleavage. Other assays were the time-resolved  fluorescence resonance energy transfer (TR-FRET)-based Adapta assay format that employs an Alexa Fluor 647-labeled ADP tracer and Eu-labeled anti-ADP antibody. The assays of the above two formats were normally conducted with ATP near the <i>K</i><sub>M,app</sub>. Another assay format used was the TR-FRET-based LanthaScreen binding assay utilizing an Alexa Fluor tracer and Eu-labeled antitag antibody that binds to the respective affinity tag of the target kinase. Details of these assay procedures are described on the vendor’s Web site (<a href="https://www.lifetechnologies.com/us/en/home/brands/invitrogen.html" class="extLink">https://www.lifetechnologies.com/us/en/home/brands/invitrogen.html</a>).</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Cell-Based Phospho-ALK ELISA Assay</h3><div class="NLM_p last">Cells were seeded at 20 000 cells/well in a 96-well plate in growth media with 0.5% serum and incubated overnight. Compounds were diluted in media without serum, added to the cells, incubated for 1 h, and then removed by aspirating the media by vacuum suction. Cell lysates were generated, and the phospho-ALK (Tyr1604) levels were determined by using the PathScan Phospho-ALK (Tyr1604) Chemiluminescent Sandwich ELISA Kit (Cell Signaling, catalog no. 7020) or PathScan Total ALK Chemiluminescent Sandwich ELISA Kit (Cell Signaling, catalog no. 7084) as described in the manufacturer’s protocol. The IC<sub>50</sub> values were calculated by concentration–response curve fitting utilizing a four-parameter analytical method.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91"><a href="/doi/suppl/10.1021/jm500261q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">X-ray data and 207-member panel kinase selectivity data for compound <b>8k</b> and experimental data for compounds <b>6e</b>, <b>6f</b>, <b>6h</b>, <b>9</b>, <b>10</b>, <b>17</b>, <b>20</b>, <b>21</b>, <b>30</b>, <b>31</b>, <b>44</b>, <b>45</b>, <b>49</b>–<b>51</b>, <b>55</b>, <b>57</b>, <b>59</b>, <b>60</b>, and <b>69</b>–<b>75</b> not explicitly shown in the schemes. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500261q/suppl_file/jm500261q_si_001.pdf">jm500261q_si_001.pdf (800.32 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500261q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61537" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61537" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ted W. Johnson</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4b3f2e2f653c65212423253824250b3b2d22312e3965282426"><span class="__cf_email__" data-cfemail="f3879697dd84dd999c9b9d809c9db383959a899681dd909c9e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul F. Richardson</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#25554450490b430b574c464d445741564a4b6555434c5f40570b464a48"><span class="__cf_email__" data-cfemail="5e2e3f2b327038702c373d363f2c3a2d31301e2e3837243b2c703d3133">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Bailey</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexei Brooun</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin J. Burke</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael R. Collins</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Jean Cui</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judith G. Deal</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ya-Li Deng</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dac Dinh</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lars D. Engstrom</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingying He</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqui Hoffman</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert L. Hoffman</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qinhua Huang</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert S. Kania</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John C. Kath</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hieu Lam</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justine L. Lam</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phuong T. Le</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Lingardo</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Liu</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele McTigue</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cynthia L. Palmer</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neal W. Sach</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tod Smeal</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graham L. Smith</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert E. Stewart</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sergei Timofeevski</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huichun Zhu</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinjiang Zhu</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helen Y. Zou</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin P. Edwards</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3156e6670-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20018" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20018" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Kevin N. Dack, Patrick S. Johnson, Nick Puhalo, and Andrew S. Cook for helpful discussion and synthesis of compounds <b>6b</b> and <b>6c</b>, Klaus Dress for data management and visualization, Curtis Moore (University of California, San Diego) and Alex Yanovsky for the small-molecule X-ray of <b>8k</b>, and Jeff Elleraas and Loanne Chung for purification work.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i93" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i93"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i94" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i94"> Abbreviations</h2><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">ATP-binding cassette</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">ALCL</td><td class="NLM_def"><p class="first last">anaplastic large-cell lymphoma</p></td></tr><tr><td class="NLM_term">ALK</td><td class="NLM_def"><p class="first last">anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">BM</td><td class="NLM_def"><p class="first last">brain metastasis</p></td></tr><tr><td class="NLM_term">CAN</td><td class="NLM_def"><p class="first last">ceric ammonium nitrate</p></td></tr><tr><td class="NLM_term">c-MET</td><td class="NLM_def"><p class="first last">mesenchymal epithelial transition factor</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>eff</sub></td><td class="NLM_def"><p class="first last">efficacious concentration</p></td></tr><tr><td class="NLM_term">Cl<sub>u</sub></td><td class="NLM_def"><p class="first last">unbound clearance</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>tox</sub></td><td class="NLM_def"><p class="first last">toxic concentration</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i><i>N</i>,<i>N</i></i>-diisopropylethylamine (Hunig’s base)</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large-B-cell lymphoma</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">EML4</td><td class="NLM_def"><p class="first last">echinoderm microtubule-associated protein-like 4</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability (%)</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">G-loop</td><td class="NLM_def"><p class="first last">glycine loop</p></td></tr><tr><td class="NLM_term">HACNT</td><td class="NLM_def"><p class="first last">heavy atom count</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen bond donor</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% inhibitory concentration</p></td></tr><tr><td class="NLM_term">IMHB</td><td class="NLM_def"><p class="first last">intramolecular hydrogen bond</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">log <i>D</i></td><td class="NLM_def"><p class="first last">octanol/buffer (pH 7.4) distribution coefficient</p></td></tr><tr><td class="NLM_term">IMT</td><td class="NLM_def"><p class="first last">inflammatory myofibroblastic tumor</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">insulin receptor</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multiple-drug resistance</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiple-parameter optimization</p></td></tr><tr><td class="NLM_term">MsCl</td><td class="NLM_def"><p class="first last">methanesulfonyl chloride</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">NPM</td><td class="NLM_def"><p class="first last">nucleophosmin</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung carcinoma</p></td></tr><tr><td class="NLM_term">pALK</td><td class="NLM_def"><p class="first last">phospho-ALK</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein 1</p></td></tr><tr><td class="NLM_term">PFS</td><td class="NLM_def"><p class="first last">progression-free survival</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">ROS1</td><td class="NLM_def"><p class="first last">c-ros oncogene 1</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">SASA</td><td class="NLM_def"><p class="first last">solvent-accessible surface area</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">SOC</td><td class="NLM_def"><p class="first last">standard of care</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoroacetic anhydride</p></td></tr><tr><td class="NLM_term">wt</td><td class="NLM_def"><p class="first last">wild type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 60 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. P.</span><span> </span><span class="NLM_article-title">ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin’s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">2175</span><span class="NLM_x">–</span> <span class="NLM_lpage">2188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=2175-2188&issue=18&author=S.+W.+Morrisauthor=C.+Naeveauthor=P.+Mathewauthor=P.+L.+Jamesauthor=M.+N.+Kirsteinauthor=X.+Cuiauthor=D.+P.+Witte&title=ALK%2C+the+chromosome+2+gene+locus+altered+by+the+t%282%3B5%29+in+non-Hodgkin%E2%80%99s+lymphoma%2C+encodes+a+novel+neural+receptor+tyrosine+kinase+that+is+highly+related+to+leukocyte+tyrosine+kinase+%28LTK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DNaeve%26aufirst%3DC.%26aulast%3DMathew%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DP.%2BL.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWitte%26aufirst%3DD.%2BP.%26atitle%3DALK%252C%2520the%2520chromosome%25202%2520gene%2520locus%2520altered%2520by%2520the%2520t%25282%253B5%2529%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%252C%2520encodes%2520a%2520novel%2520neural%2520receptor%2520tyrosine%2520kinase%2520that%2520is%2520highly%2520related%2520to%2520leukocyte%2520tyrosine%2520kinase%2520%2528LTK%2529%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26issue%3D18%26spage%3D2175%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bilsland, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeldon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Znamenskiy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnert, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heavens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiting, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Sanjuan, I.</span><span> </span><span class="NLM_article-title">Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=685-700&issue=3&author=J.+G.+Bilslandauthor=A.+Wheeldonauthor=A.+Meadauthor=P.+Znamenskiyauthor=S.+Almondauthor=K.+A.+Watersauthor=M.+Thakurauthor=V.+Beaumontauthor=T.+P.+Bonnertauthor=R.+Heavensauthor=P.+Whitingauthor=G.+McAllisterauthor=I.+Munoz-Sanjuan&title=Behavioral+and+neurochemical+alterations+in+mice+deficient+in+anaplastic+lymphoma+kinase+suggest+therapeutic+potential+for+psychiatric+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilsland%26aufirst%3DJ.%2BG.%26aulast%3DWheeldon%26aufirst%3DA.%26aulast%3DMead%26aufirst%3DA.%26aulast%3DZnamenskiy%26aufirst%3DP.%26aulast%3DAlmond%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DK.%2BA.%26aulast%3DThakur%26aufirst%3DM.%26aulast%3DBeaumont%26aufirst%3DV.%26aulast%3DBonnert%26aufirst%3DT.%2BP.%26aulast%3DHeavens%26aufirst%3DR.%26aulast%3DWhiting%26aufirst%3DP.%26aulast%3DMcAllister%26aufirst%3DG.%26aulast%3DMunoz-Sanjuan%26aufirst%3DI.%26atitle%3DBehavioral%2520and%2520neurochemical%2520alterations%2520in%2520mice%2520deficient%2520in%2520anaplastic%2520lymphoma%2520kinase%2520suggest%2520therapeutic%2520potential%2520for%2520psychiatric%2520indications%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26issue%3D3%26spage%3D685%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Le Beau, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doane, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardiman, J. W.</span><span> </span><span class="NLM_article-title">The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1989&pages=866-870&issue=12&author=M.+M.+Le+Beauauthor=M.+A.+Bitterauthor=R.+A.+Larsonauthor=L.+A.+Doaneauthor=E.+D.+Ellisauthor=W.+A.+Franklinauthor=C.+M.+Rubinauthor=M.+E.+Kadinauthor=J.+W.+Vardiman&title=The+t%282%3B5%29%28p23%3Bq35%29%3A+A+recurring+chromosomal+abnormality+in+Ki-1-positive+anaplastic+large+cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DBitter%26aufirst%3DM.%2BA.%26aulast%3DLarson%26aufirst%3DR.%2BA.%26aulast%3DDoane%26aufirst%3DL.%2BA.%26aulast%3DEllis%26aufirst%3DE.%2BD.%26aulast%3DFranklin%26aufirst%3DW.%2BA.%26aulast%3DRubin%26aufirst%3DC.%2BM.%26aulast%3DKadin%26aufirst%3DM.%2BE.%26aulast%3DVardiman%26aufirst%3DJ.%2BW.%26atitle%3DThe%2520t%25282%253B5%2529%2528p23%253Bq35%2529%253A%2520A%2520recurring%2520chromosomal%2520abnormality%2520in%2520Ki-1-positive%2520anaplastic%2520large%2520cell%2520lymphoma%26jtitle%3DLeukemia%26date%3D1989%26volume%3D3%26issue%3D12%26spage%3D866%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x"> (</span><span class="NLM_issue">5151</span><span class="NLM_x">) </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&issue=5151&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+kinase+gene%2C+ALK%2C+to+a+nucleolar+protein+gene%2C+NPM%2C+in+non-Hodgkin%E2%80%99s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520kinase%2520gene%252C%2520ALK%252C%2520to%2520a%2520nucleolar%2520protein%2520gene%252C%2520NPM%252C%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26issue%3D5151%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, D. R.</span><span> </span><span class="NLM_article-title">ALK-positive large B-cell lymphoma: Report of a case</span> <span class="citation_source-journal">Zhonghua Bing Li Xue Za Zhi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fns1Kiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=561-562&issue=8&author=H.+Yuauthor=J.+X.+Huangauthor=C.+F.+Wangauthor=D.+R.+Shi&title=ALK-positive+large+B-cell+lymphoma%3A+Report+of+a+case"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">ALK-positive large B-cell lymphoma: report of a case</span></div><div class="casAuthors">Yu Hong; Huang Jun-xing; Wang Chao-fu; Shi Da-ren</div><div class="citationInfo"><span class="NLM_cas:title">Zhonghua bing li xue za zhi Chinese journal of pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-2</span>
        ISSN:<span class="NLM_cas:issn">0529-5807</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8MWU7G799eXwOGIfWJ7-GfW6udTcc2eYiBQK1O13rqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fns1Kiuw%253D%253D&md5=cab1bf32f1eb07c3ea8b4ec0661f8061</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%2BX.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DShi%26aufirst%3DD.%2BR.%26atitle%3DALK-positive%2520large%2520B-cell%2520lymphoma%253A%2520Report%2520of%2520a%2520case%26jtitle%3DZhonghua%2520Bing%2520Li%2520Xue%2520Za%2520Zhi%26date%3D2011%26volume%3D40%26issue%3D8%26spage%3D561%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Griffin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlman, E. J.</span><span> </span><span class="NLM_article-title">Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2776</span><span class="NLM_x">–</span> <span class="NLM_lpage">2780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2776-2780&issue=12&author=C.+A.+Griffinauthor=A.+L.+Hawkinsauthor=C.+Dvorakauthor=C.+Henkleauthor=T.+Ellinghamauthor=E.+J.+Perlman&title=Recurrent+involvement+of+2p23+in+inflammatory+myofibroblastic+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DC.%2BA.%26aulast%3DHawkins%26aufirst%3DA.%2BL.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DHenkle%26aufirst%3DC.%26aulast%3DEllingham%26aufirst%3DT.%26aulast%3DPerlman%26aufirst%3DE.%2BJ.%26atitle%3DRecurrent%2520involvement%2520of%25202p23%2520in%2520inflammatory%2520myofibroblastic%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D12%26spage%3D2776%26epage%3D2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2349</span><span class="NLM_x">–</span> <span class="NLM_lpage">2355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1111%2Fj.1349-7006.2008.00972.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=2349-2355&issue=12&author=H.+Mano&title=Non-solid+oncogenes+in+solid+tumors%3A+EML4-ALK+fusion+genes+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer</span></div><div class="casAuthors">Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2349-2355</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  It is generally accepted that recurrent chromosome translocations play a major role in the mol. pathogenesis of hematol. malignancies but not of solid tumors.  However, chromosome translocations involving the e26 transformation-specific sequence transcription factor loci have been demonstrated recently in many prostate cancer cases.  Furthermore, through a functional screening with retroviral cDNA expression libraries, we have discovered the fusion-type protein tyrosine kinase echinoderm microtubule-assocd. protein like-4 (EML4)-anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) specimens.  A recurrent chromosome translocation, inv(2)(p21p23), in NSCLC generates fused mRNA encoding the amino-terminal half of EML4 ligated to the intracellular region of the receptor-type protein tyrosine kinase ALK.  EML4-ALK oligomerizes constitutively in cells through the coiled coil domain within the EML4 region, and becomes activated to exert a marked oncogenicity both in vitro and in vivo.  Break and fusion points within the EML4 locus may diverge in NSCLC cells to generate various isoforms of EML4-ALK, which may constitute -5% of NSCLC cases, at least in the Asian ethnic group.  In the present review I summarize how detection of EML4-ALK cDNA may become a sensitive diagnostic means for NSCLC cases that are pos. for the fusion gene, and discuss whether suppression of ALK enzymic activity could be an effective treatment strategy against this intractable disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxSS7U51wKbVg90H21EOLACvtfcHk0lgYQ7k3elrlIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D&md5=84386550daedbd29b3a34b11a4774684</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00972.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00972.x%26sid%3Dliteratum%253Aachs%26aulast%3DMano%26aufirst%3DH.%26atitle%3DNon-solid%2520oncogenes%2520in%2520solid%2520tumors%253A%2520EML4-ALK%2520fusion%2520genes%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26issue%3D12%26spage%3D2349%26epage%3D2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span> </span><span class="NLM_article-title">Targeting anaplastic lymphoma kinase in lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1158%2F1078-0432.CCR-10-1591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21288922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2081-2086&issue=8&author=A.+T.+Shawauthor=B.+Solomon&title=Targeting+anaplastic+lymphoma+kinase+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Anaplastic Lymphoma Kinase in Lung Cancer</span></div><div class="casAuthors">Shaw, Alice T.; Solomon, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2081-2086</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Several decades of cancer research have revealed a pivotal role for tyrosine kinases as key regulators of signaling pathways, controlling cell growth and differentiation.  Deregulation of tyrosine kinase-mediated signaling occurs frequently in cancer and is believed to drive the initiation and progression of disease.  Chromosomal rearrangements involving the tyrosine kinase anaplastic lymphoma kinase (ALK) occur in a variety of human malignancies including non-small cell lung cancer (NSCLC), anaplastic large cell lymphomas, and inflammatory myofibroblastic tumors.  The aberrant activation of ALK signaling leads to "oncogene addiction" and marked sensitivity to ALK inhibitors such as crizotinib (PF-02341066).  This review focuses on ALK rearrangements in NSCLC, starting with the discovery of the EML4-ALK fusion oncogene, and culminating in the recent validation of ALK as a therapeutic target in patients with ALK-rearranged NSCLC.  Current efforts seek to expand the role of ALK kinase inhibition in lung and other cancers and to address the mol. basis for the development of resistance.  Clin Cancer Res; 17(8); 2081-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCqEzvXv0qJrVg90H21EOLACvtfcHk0lgYQ7k3elrlIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCgs7k%253D&md5=6d0f5e1174ba934f00c10a877a3b17e1</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-1591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-1591%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DSolomon%26aufirst%3DB.%26atitle%3DTargeting%2520anaplastic%2520lymphoma%2520kinase%2520in%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D8%26spage%3D2081%26epage%3D2086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x"> (</span><span class="NLM_issue">7153</span><span class="NLM_x">) </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1038%2Fnature05945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=17625570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&issue=7153&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+transforming+EML4-ALK+fusion+gene+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span></div><div class="casAuthors">Soda, Manabu; Choi, Young Lim; Enomoto, Munehiro; Takada, Shuji; Yamashita, Yoshihiro; Ishikawa, Shunpei; Fujiwara, Shin-ichiro; Watanabe, Hideki; Kurashina, Kentaro; Hatanaka, Hisashi; Bando, Masashi; Ohno, Shoji; Ishikawa, Yuichi; Aburatani, Hiroyuki; Niki, Toshiro; Sohara, Yasunori; Sugiyama, Yukihiko; Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue">7153</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Improvement in the clin. outcome of lung cancer is likely to be achieved by identification of the mol. events that underlie its pathogenesis.  Here we show that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-assocd. protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells.  Mouse 3T3 fibroblasts forced to express this human fusion tyrosine kinase generated transformed foci in culture and s.c. tumors in nude mice.  The EML4-ALK fusion transcript was detected in 6.7% (5 out of 75) of NSCLC patients examd.; these individuals were distinct from those harboring mutations in the epidermal growth factor receptor gene.  Our data demonstrate that a subset of NSCLC patients may express a transforming fusion kinase that is a promising candidate for a therapeutic target as well as for a diagnostic mol. marker in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomhAXuLtrJ6rVg90H21EOLACvtfcHk0liHAc2mb7Wwvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D&md5=7f567e80814b9ccc87e5bceeebb467a7</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1038%2Fnature05945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05945%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520transforming%2520EML4-ALK%2520fusion%2520gene%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26issue%3D7153%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span> </span><span class="NLM_article-title">Anaplastic lymphoma kinase inhibitors for the treatment of ALK-positive cancers</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2FB978-0-12-396492-2.00019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eju7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=281-293&author=K.+Kinoshitaauthor=N.+Oikawaauthor=T.+Tsukuda&title=Anaplastic+lymphoma+kinase+inhibitors+for+the+treatment+of+ALK-positive+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase inhibitors for the treatment of ALK-positive cancers</span></div><div class="casAuthors">Kinoshita, Kazutomo; Oikawa, Nobuhiro; Tsukuda, Takuo</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">281-293</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review on the development of anaplastic lymphoma kinase (ALK) inhibitors which is the most highly competitive drug targets in oncol. research.  A no. of research groups have identified promising drugs, where Pfizer succeeded in launching a potent ALK inhibitor, crizotinib, for treatment of EML4-ALK-pos. NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX549XOu0aZrVg90H21EOLACvtfcHk0liHAc2mb7Wwvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eju7vE&md5=2fb9597a39e7dd478a4ef41be4df7be6</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00019-9%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DOikawa%26aufirst%3DN.%26aulast%3DTsukuda%26aufirst%3DT.%26atitle%3DAnaplastic%2520lymphoma%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520ALK-positive%2520cancers%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D281%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Azarova, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span> </span><span class="NLM_article-title">Emerging importance of ALK in neuroblastoma</span> <span class="citation_source-journal">Semin. Cancer. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2Fj.semcancer.2011.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSktLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=267-275&issue=4&author=A.+M.+Azarovaauthor=G.+Gautamauthor=R.+E.+George&title=Emerging+importance+of+ALK+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging importance of ALK in neuroblastoma</span></div><div class="casAuthors">Azarova, Anna M.; Gautam, Gargi; George, Rani E.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-275</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since the original descriptions of gain-of function mutations in anaplastic lymphoma kinase (ALK), interest in the role of this receptor tyrosine kinase in neuroblastoma development and as a potential therapeutic target has escalated.  As a group, the activating point mutations in full-length ALK, found in approx. 8% of all neuroblastoma tumors, are distributed evenly across different clin. stages.  However, the most frequent somatic mutation, F1174L, is assocd. with amplification of the MYCN oncogene.  This combination of features appears to confer a worse prognosis than MYCN amplification alone, suggesting a cooperative effect on neuroblastoma formation by these two proteins.  Indeed, F1174L has shown more potent transforming activity in vivo than the second most common activating mutation, R1275Q, and is responsible for innate and acquired resistance to crizotinib, a clin. relevant ALK inhibitor that will soon be com. available.  These advances cast ALK as a bona fide oncoprotein in neuroblastoma and emphasize the need to understand ALK-mediated signaling in this tumor.  This review addresses many of the current issues surrounding the role of ALK in normal development and neuroblastoma pathogenesis, and discusses the prospects for clin. effective targeted treatments based on ALK inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpqmFzh9Q3frVg90H21EOLACvtfcHk0liHAc2mb7Wwvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSktLzN&md5=e07445aecd9829c465f1f4023124521f</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2011.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2011.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DAzarova%26aufirst%3DA.%2BM.%26aulast%3DGautam%26aufirst%3DG.%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26atitle%3DEmerging%2520importance%2520of%2520ALK%2520in%2520neuroblastoma%26jtitle%3DSemin.%2520Cancer.%2520Biol.%26date%3D2011%26volume%3D21%26issue%3D4%26spage%3D267%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Caren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinsson, T.</span><span> </span><span class="NLM_article-title">High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2008&pages=153-159&issue=2&author=H.+Carenauthor=F.+Abelauthor=P.+Kognerauthor=T.+Martinsson&title=High+incidence+of+DNA+mutations+and+gene+amplifications+of+the+ALK+gene+in+advanced+sporadic+neuroblastoma+tumours"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaren%26aufirst%3DH.%26aulast%3DAbel%26aufirst%3DF.%26aulast%3DKogner%26aufirst%3DP.%26aulast%3DMartinsson%26aufirst%3DT.%26atitle%3DHigh%2520incidence%2520of%2520DNA%2520mutations%2520and%2520gene%2520amplifications%2520of%2520the%2520ALK%2520gene%2520in%2520advanced%2520sporadic%2520neuroblastoma%2520tumours%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D416%26issue%3D2%26spage%3D153%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, S.</span><span> </span><span class="NLM_article-title">Oncogenic mutations of ALK kinase in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7215</span><span class="NLM_x">) </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1038%2Fnature07399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=18923524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GgurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=971-974&issue=7215&author=Y.+Chenauthor=J.+Takitaauthor=Y.+L.+Choiauthor=M.+Katoauthor=M.+Ohiraauthor=M.+Sanadaauthor=L.+Wangauthor=M.+Sodaauthor=A.+Kikuchiauthor=T.+Igarashiauthor=A.+Nakagawaraauthor=Y.+Hayashiauthor=H.+Manoauthor=S.+Ogawa&title=Oncogenic+mutations+of+ALK+kinase+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic mutations of ALK kinase in neuroblastoma</span></div><div class="casAuthors">Chen, Yuyan; Takita, Junko; Choi, Young Lim; Kato, Motohiro; Ohira, Miki; Sanada, Masashi; Wang, Lili; Soda, Manabu; Kikuchi, Akira; Igarashi, Takashi; Nakagawara, Akira; Hayashi, Yasuhide; Mano, Hiroyuki; Ogawa, Seishi</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7215</span>),
    <span class="NLM_cas:pages">971-974</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroblastoma in advanced stages is one of the most intractable pediatric cancers, even with recent therapeutic advances.  Neuroblastoma harbors a variety of genetic changes, including a high frequency of MYCN amplification, loss of heterozygosity at 1p36 and 11q, and gain of genetic material from 17q, all of which have been implicated in the pathogenesis of neuroblastoma.  However, the scarcity of reliable mol. targets has hampered the development of effective therapeutic agents targeting neuroblastoma.  Here we show that the anaplastic lymphoma kinase (ALK), originally identified as a fusion kinase in a subtype of non-Hodgkin's lymphoma (NPM-ALK) and more recently in adenocarcinoma of lung (EML4-ALK), is also a frequent target of genetic alteration in advanced neuroblastoma.  According to our genome-wide scans of genetic lesions in 215 primary neuroblastoma samples using high-d. single-nucleotide polymorphism genotyping microarrays, the ALK locus, centromeric to the MYCN locus, was identified as a recurrent target of copy no. gain and gene amplification.  Furthermore, DNA sequencing of ALK revealed eight novel missense mutations in 13 out of 215 (6.1%) fresh tumors and 8 out of 24 (33%) neuroblastoma-derived cell lines.  All but one mutation in the primary samples (12 out of 13) were found in stages 3-4 of the disease and were harbored in the kinase domain.  The mutated kinases were autophosphorylated and displayed increased kinase activity compared with the wild-type kinase.  They were able to transform NIH3T3 fibroblasts as shown by their colony formation ability in soft agar and their capacity to form tumors in nude mice.  Furthermore, we demonstrate that downregulation of ALK through RNA interference suppresses proliferation of neuroblastoma cells harbouring mutated ALK.  We anticipate that our findings will provide new insights into the pathogenesis of advanced neuroblastoma and that ALK-specific kinase inhibitors might improve its clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot7m1PigjoirVg90H21EOLACvtfcHk0lidw-ElP5Tdfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GgurjN&md5=145b8ecbf3e27342d55be53c98ceed24</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1038%2Fnature07399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07399%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTakita%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DOhira%26aufirst%3DM.%26aulast%3DSanada%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DKikuchi%26aufirst%3DA.%26aulast%3DIgarashi%26aufirst%3DT.%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DS.%26atitle%3DOncogenic%2520mutations%2520of%2520ALK%2520kinase%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7215%26spage%3D971%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrady, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Activating mutations in ALK provide a therapeutic target in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7215</span><span class="NLM_x">) </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=975-978&issue=7215&author=R.+E.+Georgeauthor=T.+Sandaauthor=M.+Hannaauthor=S.+Frohlingauthor=W.+Lutherauthor=J.+Zhangauthor=Y.+Ahnauthor=W.+Zhouauthor=W.+B.+Londonauthor=P.+McGradyauthor=L.+Xueauthor=S.+Zozulyaauthor=V.+E.+Gregorauthor=T.+R.+Webbauthor=N.+S.+Grayauthor=D.+G.+Gillilandauthor=L.+Dillerauthor=H.+Greulichauthor=S.+W.+Morrisauthor=M.+Meyersonauthor=A.+T.+Look&title=Activating+mutations+in+ALK+provide+a+therapeutic+target+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DSanda%26aufirst%3DT.%26aulast%3DHanna%26aufirst%3DM.%26aulast%3DFrohling%26aufirst%3DS.%26aulast%3DLuther%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DMcGrady%26aufirst%3DP.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZozulya%26aufirst%3DS.%26aulast%3DGregor%26aufirst%3DV.%2BE.%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DDiller%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DActivating%2520mutations%2520in%2520ALK%2520provide%2520a%2520therapeutic%2520target%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7215%26spage%3D975%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Janoueix-Lerosey, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lequin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugieres, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Pontual, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combaret, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puisieux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleiermacher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valteau-Couanet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frebourg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyonnet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amiel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delattre, O.</span><span> </span><span class="NLM_article-title">Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7215</span><span class="NLM_x">) </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=967-970&issue=7215&author=I.+Janoueix-Leroseyauthor=D.+Lequinauthor=L.+Brugieresauthor=A.+Ribeiroauthor=L.+de+Pontualauthor=V.+Combaretauthor=V.+Raynalauthor=A.+Puisieuxauthor=G.+Schleiermacherauthor=G.+Pierronauthor=D.+Valteau-Couanetauthor=T.+Frebourgauthor=J.+Michonauthor=S.+Lyonnetauthor=J.+Amielauthor=O.+Delattre&title=Somatic+and+germline+activating+mutations+of+the+ALK+kinase+receptor+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanoueix-Lerosey%26aufirst%3DI.%26aulast%3DLequin%26aufirst%3DD.%26aulast%3DBrugieres%26aufirst%3DL.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3Dde%2BPontual%26aufirst%3DL.%26aulast%3DCombaret%26aufirst%3DV.%26aulast%3DRaynal%26aufirst%3DV.%26aulast%3DPuisieux%26aufirst%3DA.%26aulast%3DSchleiermacher%26aufirst%3DG.%26aulast%3DPierron%26aufirst%3DG.%26aulast%3DValteau-Couanet%26aufirst%3DD.%26aulast%3DFrebourg%26aufirst%3DT.%26aulast%3DMichon%26aufirst%3DJ.%26aulast%3DLyonnet%26aufirst%3DS.%26aulast%3DAmiel%26aufirst%3DJ.%26aulast%3DDelattre%26aufirst%3DO.%26atitle%3DSomatic%2520and%2520germline%2520activating%2520mutations%2520of%2520the%2520ALK%2520kinase%2520receptor%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7215%26spage%3D967%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Mosse, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudenslager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquaglia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laureys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speleman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schork, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span> </span><span class="NLM_article-title">Identification of ALK as a major familial neuroblastoma predisposition gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7215</span><span class="NLM_x">) </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=930-935&issue=7215&author=Y.+P.+Mosseauthor=M.+Laudenslagerauthor=L.+Longoauthor=K.+A.+Coleauthor=A.+Woodauthor=E.+F.+Attiyehauthor=M.+J.+Laquagliaauthor=R.+Sennettauthor=J.+E.+Lynchauthor=P.+Perriauthor=G.+Laureysauthor=F.+Spelemanauthor=C.+Kimauthor=C.+Houauthor=H.+Hakonarsonauthor=A.+Torkamaniauthor=N.+J.+Schorkauthor=G.+M.+Brodeurauthor=G.+P.+Toniniauthor=E.+Rappaportauthor=M.+Devotoauthor=J.+M.+Maris&title=Identification+of+ALK+as+a+major+familial+neuroblastoma+predisposition+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMosse%26aufirst%3DY.%2BP.%26aulast%3DLaudenslager%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DLaquaglia%26aufirst%3DM.%2BJ.%26aulast%3DSennett%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BE.%26aulast%3DPerri%26aufirst%3DP.%26aulast%3DLaureys%26aufirst%3DG.%26aulast%3DSpeleman%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DTonini%26aufirst%3DG.%2BP.%26aulast%3DRappaport%26aufirst%3DE.%26aulast%3DDevoto%26aufirst%3DM.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520ALK%2520as%2520a%2520major%2520familial%2520neuroblastoma%2520predisposition%2520gene%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7215%26spage%3D930%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tuma, R. S.</span><span> </span><span class="NLM_article-title">ALK gene amplified in most inflammatory breast cancers</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1093%2Fjnci%2Fdjr553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=22215853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2012&pages=87-88&issue=2&author=R.+S.+Tuma&title=ALK+gene+amplified+in+most+inflammatory+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">ALK Gene Amplified in Most Inflammatory Breast Cancers</span></div><div class="casAuthors">Tuma, Rabiya S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-88</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Inflammatory breast cancer (IBC) is a rare form of the disease that differs substantially from non-inflammatory breast cancer in presentation and response to therapy. Despite those differences, researchers have uncovered few mol. characteristics that distinguish IBC from non-inflammatory breast cancer, and IBC treatment generally relies on std. breast cancer regimens.  Recently, it has been reported that ALK gene amplification is a common feature of IBC tumors and that small-mol. ALK inhibitors are effective in mouse xenograft models.  Current developments on this recent report are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB9yX6fegRi7Vg90H21EOLACvtfcHk0lgBjHhLzf108w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWhsb0%253D&md5=46e7633055aadc3aacfc6bac9b4cb591</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjr553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjr553%26sid%3Dliteratum%253Aachs%26aulast%3DTuma%26aufirst%3DR.%2BS.%26atitle%3DALK%2520gene%2520amplified%2520in%2520most%2520inflammatory%2520breast%2520cancers%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2012%26volume%3D104%26issue%3D2%26spage%3D87%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beausoleil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innocenti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comb, M. J.</span><span> </span><span class="NLM_article-title">Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3312</span><span class="NLM_x">–</span> <span class="NLM_lpage">3323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=3312-3323&issue=13&author=H.+Renauthor=Z.+P.+Tanauthor=X.+Zhuauthor=K.+Crosbyauthor=H.+Haackauthor=J.+M.+Renauthor=S.+Beausoleilauthor=A.+Moritzauthor=G.+Innocentiauthor=J.+Rushauthor=Y.+Zhangauthor=X.+M.+Zhouauthor=T.+L.+Guauthor=Y.+F.+Yangauthor=M.+J.+Comb&title=Identification+of+anaplastic+lymphoma+kinase+as+a+potential+therapeutic+target+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DZ.%2BP.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCrosby%26aufirst%3DK.%26aulast%3DHaack%26aufirst%3DH.%26aulast%3DRen%26aufirst%3DJ.%2BM.%26aulast%3DBeausoleil%26aufirst%3DS.%26aulast%3DMoritz%26aufirst%3DA.%26aulast%3DInnocenti%26aufirst%3DG.%26aulast%3DRush%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%2BM.%26aulast%3DGu%26aufirst%3DT.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BF.%26aulast%3DComb%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%2520anaplastic%2520lymphoma%2520kinase%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26issue%3D13%26spage%3D3312%26epage%3D3323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bergethon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovly, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massion, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siwak-Tapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino-Kenudson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span> </span><span class="NLM_article-title">ROS1 rearrangements define a unique molecular class of lung cancers</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1200%2FJCO.2011.35.6345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC38XntV2lsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=863-870&issue=8&author=K.+Bergethonauthor=A.+T.+Shawauthor=S.+H.+Ouauthor=R.+Katayamaauthor=C.+M.+Lovlyauthor=N.+T.+McDonaldauthor=P.+P.+Massionauthor=C.+Siwak-Tappauthor=A.+Gonzalezauthor=R.+Fangauthor=E.+J.+Markauthor=J.+M.+Battenauthor=H.+Chenauthor=K.+D.+Wilnerauthor=E.+L.+Kwakauthor=J.+W.+Clarkauthor=D.+P.+Carboneauthor=H.+Jiauthor=J.+A.+Engelmanauthor=M.+Mino-Kenudsonauthor=W.+Paoauthor=A.+J.+Iafrate&title=ROS1+rearrangements+define+a+unique+molecular+class+of+lung+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">ROS1 rearrangements define a unique molecular class of lung cancers</span></div><div class="casAuthors">Bergethon, Kristin; Shaw, Alice T.; Ou, Sai-Hong Ignatius; Katayama, Ryohei; Lovly, Christine M.; McDonald, Nerina T.; Massion, Pierre P.; Siwak-Tapp, Christina; Gonzalez, Adriana; Fang, Rong; Mark, Eugene J.; Batten, Julie M.; Chen, Haiquan; Wilner, Keith D.; Kwak, Eunice L.; Clark, Jeffrey W.; Carbone, David P.; Ji, Hongbin; Engelman, Jeffrey A.; Mino-Kenudson, Mari; Pao, William; Iafrate, A. John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">863-870</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Chromosomal rearrangements involving the ROS1 receptor tyrosine kinase gene have recently been described in a subset of non-small-cell lung cancers (NSCLCs).  Because little is known about these tumors, we examd. the clin. characteristics and treatment outcomes of patients with NSCLC with ROS1 rearrangement.  Patients and Methods Using a ROS1 fluorescent in situ hybridization (FISH) assay, we screened 1,073 patients with NSCLC and correlated ROS1 rearrangement status with clin. characteristics, overall survival, and when available, ALK rearrangement status.  In vitro studies assessed the responsiveness of cells with ROS1 rearrangement to the tyrosine kinase inhibitor crizotinib.  The clin. response of one patient with ROS1-rearranged NSCLC to crizotinib was investigated as part of an expanded phase I cohort.  Results Of 1.073 tumors screened, 18 (1.7%) were ROS1 rearranged by FISH, and 31 (2.9%) were ALK rearranged.  Compared with the ROS1-neg. group, patients with ROS1 rearrangements were significantly younger and more likely to be never-smokers (each P < .001).  All of the ROS1-pos. tumors were adenocarcinomas, with a tendency toward higher grade.  ROS1-pos. and -neg. groups showed no difference in overall survival.  The HCC78 ROS1-rearranged NSCLC cell line and 293 cells transfected with CD74-ROS1 showed evidence of sensitivity to crizotinib.  The patient treated with crizotinib showed tumor shrinkage, with a near complete response.  Conclusion ROS1 rearrangement defines a mol. subset of NSCLC with distinct clin. characteristics that are similar to those obsd. in patients with ALK-rearranged NSCLC.  Crizotinib shows in vitro activity and early evidence of clin. activity in ROS1-rearranged NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovHC_E3hvZw7Vg90H21EOLACvtfcHk0ljMkpTMMxiDtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntV2lsbg%253D&md5=2540d37c3135597601ed2c15386b9f13</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.35.6345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.35.6345%26sid%3Dliteratum%253Aachs%26aulast%3DBergethon%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DLovly%26aufirst%3DC.%2BM.%26aulast%3DMcDonald%26aufirst%3DN.%2BT.%26aulast%3DMassion%26aufirst%3DP.%2BP.%26aulast%3DSiwak-Tapp%26aufirst%3DC.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DR.%26aulast%3DMark%26aufirst%3DE.%2BJ.%26aulast%3DBatten%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DCarbone%26aufirst%3DD.%2BP.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DMino-Kenudson%26aufirst%3DM.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26atitle%3DROS1%2520rearrangements%2520define%2520a%2520unique%2520molecular%2520class%2520of%2520lung%2520cancers%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D30%26issue%3D8%26spage%3D863%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gainor, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span> </span><span class="NLM_article-title">Novel targets in non-small cell lung cancer: ROS1 and RET fusions</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=865-875&issue=7&author=J.+F.+Gainorauthor=A.+T.+Shaw&title=Novel+targets+in+non-small+cell+lung+cancer%3A+ROS1+and+RET+fusions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGainor%26aufirst%3DJ.%2BF.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DNovel%2520targets%2520in%2520non-small%2520cell%2520lung%2520cancer%253A%2520ROS1%2520and%2520RET%2520fusions%26jtitle%3DOncologist%26date%3D2013%26volume%3D18%26issue%3D7%26spage%3D865%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&issue=18&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.+P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal-epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Cui, J. Jean; Tran-Dube, Michelle; Shen, Hong; Nambu, Mitchell; Kung, Pei-Pei; Pairish, Mason; Jia, Lei; Meng, Jerry; Funk, Lee; Botrous, Iriny; McTigue, Michele; Grodsky, Neil; Ryan, Kevin; Padrique, Ellen; Alton, Gordon; Timofeevski, Sergei; Yamazaki, Shinji; Li, Qiuhua; Zou, Helen; Christensen, James; Mroczkowski, Barbara; Bender, Steve; Kania, Robert S.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6342-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the crit. roles of aberrant signaling in cancer, both c-MET and ALK receptor tyrosine kinases are attractive oncol. targets for therapeutic intervention.  The cocrystal structure of 3 (PHA-665752), bound to c-MET kinase domain, revealed a novel ATP site environment, which served as the target to guide parallel, multiattribute drug design.  A novel 2-amino-5-aryl-3-benzyloxypyridine series was created to more effectively make the key interactions achieved with 3.  In the novel series, the 2-aminopyridine core allowed a 3-benzyloxy group to reach into the same pocket as the 2,6-dichlorophenyl group of 3 via a more direct vector and thus with a better ligand efficiency (LE).  Further optimization of the lead series generated the clin. candidate crizotinib (PF-02341066), which demonstrated potent in vitro and in vivo c-MET kinase and ALK inhibition, effective tumor growth inhibition, and good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHs_cKJ-U3t7Vg90H21EOLACvtfcHk0ljMkpTMMxiDtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN&md5=dbab4c1b3e7c76180dbad04be2b6a474</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Case history: Xalkori<sup>TM</sup> (Crizotinib), a potent and selective dual inhibitor of mesenchymal epithelial transition (MET) and anaplastic lymphoma kinase (ALK) for cancer treatment</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=421-434&author=J.+J.+Cuiauthor=M.+McTigueauthor=R.+Kaniaauthor=M.+Edwards&title=Case+history%3A+XalkoriTM+%28Crizotinib%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal+epithelial+transition+%28MET%29+and+anaplastic+lymphoma+kinase+%28ALK%29+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DKania%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DCase%2520history%253A%2520XalkoriTM%2520%2528Crizotinib%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal%2520epithelial%2520transition%2520%2528MET%2529%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520for%2520cancer%2520treatment%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D421%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span> </span><span class="NLM_article-title">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">12, Part 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3314</span><span class="NLM_x">–</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1158%2F1535-7163.MCT-07-0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3314-3322&issue=12%2C+Part+1&author=J.+G.+Christensenauthor=H.+Y.+Zouauthor=M.+E.+Arangoauthor=Q.+Liauthor=J.+H.+Leeauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=G.+R.+Altonauthor=B.+Mroczkowskiauthor=G.+Los&title=Cytoreductive+antitumor+activity+of+PF-2341066%2C+a+novel+inhibitor+of+anaplastic+lymphoma+kinase+and+c-Met%2C+in+experimental+models+of+anaplastic+large-cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span></div><div class="casAuthors">Christensen, James G.; Zou, Helen Y.; Arango, Maria E.; Li, Qiuhua; Lee, Joseph H.; McDonnell, Scott R.; Yamazaki, Shinji; Alton, Gordon R.; Mroczkowski, Barbara; Los, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3314-3322</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL).  PF-2341066 was recently identified as a p.o. bioavailable, small-mol. inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK fusion protein.  PF-2341066 also potently inhibited NPM-ALK phosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value, 24 nmol/L).  In biochem. and cellular screens, PF-2341066 was shown to be selective for c-Met and ALK at pharmacol. relevant concns. across a panel of >120 diverse kinases.  PF-2341066 potently inhibited cell proliferation, which was assocd. with G1-S-phase cell cycle arrest and induction of apoptosis in ALK-pos. ALCL cells (IC50 values, ∼30 nmol/L) but not ALK-neg. lymphoma cells.  The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase-mediated nick-end labeling and Annexin V staining (IC50 values, 25-50 nmol/L).  P.o. administration of PF-2341066 to severe combined immunodeficient-Beige mice bearing Karpas299 ALCL tumor xenografts resulted in dose-dependent antitumor efficacy with complete regression of all tumors at the 100 mg/kg/d dose within 15 days of initial compd. administration.  A strong correlation was obsd. between antitumor response and inhibition of NPM-ALK phosphorylation and induction of apoptosis in tumor tissue.  In addn., inhibition of key NPM-ALK signaling mediators, including phospholipase C-γ, signal transducers and activators of transcription 3, extracellular signal-regulated kinases, and Akt by PF-2341066 were obsd. at concns. or dose levels, which correlated with inhibition of NPM-ALK phosphorylation and function.  Collectively, these data illustrate the potential clin. utility of inhibitors of NPM-ALK in treatment of patients with ALK-pos. ALCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptqY0tUwGnurVg90H21EOLACvtfcHk0liqi4P7GvYEcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL&md5=04fbbaf43ca527408bde8cabcd38e1fd</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0365%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DLos%26aufirst%3DG.%26atitle%3DCytoreductive%2520antitumor%2520activity%2520of%2520PF-2341066%252C%2520a%2520novel%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520and%2520c-Met%252C%2520in%2520experimental%2520models%2520of%2520anaplastic%2520large-cell%2520lymphoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D12%252C%2520Part%25201%26spage%3D3314%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&issue=9&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.+P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D9%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camidge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezube, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidias, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino-Kenudson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shreeve, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratain, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span> </span><span class="NLM_article-title">Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1056%2FNEJMoa1006448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=20979469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1693-703&issue=18&author=E.+L.+Kwakauthor=Y.+J.+Bangauthor=D.+R.+Camidgeauthor=A.+T.+Shawauthor=B.+Solomonauthor=R.+G.+Makiauthor=S.+H.+Ouauthor=B.+J.+Dezubeauthor=P.+A.+Janneauthor=D.+B.+Costaauthor=M.+Varella-Garciaauthor=W.+H.+Kimauthor=T.+J.+Lynchauthor=P.+Fidiasauthor=H.+Stubbsauthor=J.+A.+Engelmanauthor=L.+V.+Sequistauthor=W.+Tanauthor=L.+Gandhiauthor=M.+Mino-Kenudsonauthor=G.+C.+Weiauthor=S.+M.+Shreeveauthor=M.+J.+Ratainauthor=J.+Settlemanauthor=J.+G.+Christensenauthor=D.+A.+Haberauthor=K.+Wilnerauthor=R.+Salgiaauthor=G.+I.+Shapiroauthor=J.+W.+Clarkauthor=A.+J.+Iafrate&title=Anaplastic+lymphoma+kinase+inhibition+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer</span></div><div class="casAuthors">Kwak, Eunice L.; Bang, Yung-Jue; Camidge, Ross; Shaw, Alice T.; Solomon, Benjamin; Maki, Robert G.; Ou, Sai-Hong I.; Dezube, Bruce J.; Janne, Pasi A.; Costa, Daniel B.; Varella-Garcia, Marileila; Kim, Woo-Ho; Lynch, Thomas J.; Fidias, Panos; Stubbs, Hannah; Engelman, Jeffrey A.; Sequist, Lecia V.; Tan, WeiWei; Gandhi, Leena; Mino-Kenudson, Mari; Wei, Greg C.; Shreeve, Martin; Ratain, Mark J.; Settleman, Jeffrey; Christensen, James G.; Haber, Daniel A.; Wilner, Keith; Salgia, Ravi; Shapiro, Geoffrey I.; Clark, Jeffrey W.; Iafrate, A. John</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1693-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of such tumors.  The authors explored the therapeutic efficacy of inhibiting ALK in such tumors in an early-phase clin. trial of crizotinib (PF-02341066), an orally available small-mol. inhibitor of the ALK tyrosine kinase.  METHODS: After screening tumor samples from approx. 1500 patients with non-small-cell lung cancer for the presence of ALK rearrangements, the authors identified 82 patients with advanced ALK-pos. disease who were eligible for the clin. trial.  Most of the patients had received previous treatment.  These patients were enrolled in an expanded cohort study instituted after phase 1 dose escalation had established a recommended crizotinib dose of 250 mg twice daily in 28-day cycles.  Patients were assessed for adverse events and response to therapy.  RESULTS: Patients with ALK rearrangements tended to be younger than those without the rearrangements, and most of the patients had little or no exposure to tobacco and had adenocarcinomas.  At a mean treatment duration of 6.4 mo, the overall response rate was 57% (47 of 82 patients, with 46 confirmed partial responses and 1 confirmed complete response); 27 patients (33%) had stable disease.  A total of 63 of 82 patients (77%) were continuing to receive crizotinib at the time of data cutoff, and the estd. probability of 6-mo progression-free survival was 72%, with no median for the study reached.  The drug resulted in grade 1 or 2 (mild) gastrointestinal side effects.  CONCLUSIONS: The inhibition of ALK in lung tumors with the ALK rearrangement resulted in tumor shrinkage or stable disease in most patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDt_eL7Lyo7Vg90H21EOLACvtfcHk0ljXDiJoLwFW4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FO&md5=47440b9c944100295cca0f1859138d6b</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1006448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1006448%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DSolomon%26aufirst%3DB.%26aulast%3DMaki%26aufirst%3DR.%2BG.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DDezube%26aufirst%3DB.%2BJ.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DW.%2BH.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DFidias%26aufirst%3DP.%26aulast%3DStubbs%26aufirst%3DH.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DGandhi%26aufirst%3DL.%26aulast%3DMino-Kenudson%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DG.%2BC.%26aulast%3DShreeve%26aufirst%3DS.%2BM.%26aulast%3DRatain%26aufirst%3DM.%2BJ.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DWilner%26aufirst%3DK.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26atitle%3DAnaplastic%2520lymphoma%2520kinase%2520inhibition%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26issue%3D18%26spage%3D1693%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeap, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riely, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butaney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebele, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulig, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selaru, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camidge, D. R.</span><span> </span><span class="NLM_article-title">Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: A retrospective analysis</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2FS1470-2045%2811%2970232-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1KmtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=1004-1012&issue=11&author=A.+T.+Shawauthor=B.+Y.+Yeapauthor=B.+J.+Solomonauthor=G.+J.+Rielyauthor=J.+Gainorauthor=J.+A.+Engelmanauthor=G.+I.+Shapiroauthor=D.+B.+Costaauthor=S.+H.+Ouauthor=M.+Butaneyauthor=R.+Salgiaauthor=R.+G.+Makiauthor=M.+Varella-Garciaauthor=R.+C.+Doebeleauthor=Y.+J.+Bangauthor=K.+Kuligauthor=P.+Selaruauthor=Y.+Tangauthor=K.+D.+Wilnerauthor=E.+L.+Kwakauthor=J.+W.+Clarkauthor=A.+J.+Iafrateauthor=D.+R.+Camidge&title=Effect+of+crizotinib+on+overall+survival+in+patients+with+advanced+non-small-cell+lung+cancer+harbouring+ALK+gene+rearrangement%3A+A+retrospective+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis</span></div><div class="casAuthors">Shaw, Alice T.; Yeap, Beow Y.; Solomon, Benjamin J.; Riely, Gregory J.; Gainor, Justin; Engelman, Jeffrey A.; Shapiro, Geoffrey I.; Costa, Daniel B.; Ou, Sai-Hong I.; Butaney, Mohit; Salgia, Ravi; Maki, Robert G.; Varella-Garcia, Marileila; Doebele, Robert C.; Bang, Yung-Jue; Kulig, Kimary; Selaru, Paulina; Tang, Yiyun; Wilner, Keith D.; Kwak, Eunice L.; Clark, Jeffrey W.; Iafrate, A. John; Camidge, D. Ross</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1004-1012</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">ALK gene rearrangement defines a new mol. subtype of non-small-cell lung cancer (NSCLC).  In a recent phase 1 clin. trial, the ALK tyrosine-kinase inhibitor (TKI) crizotinib showed marked antitumor activity in patients with advanced, ALK-pos. NSCLC.  To assess whether crizotinib affects overall survival in these patients, we did a retrospective study comparing survival outcomes in crizotinib-treated patients in the trial and crizotinib-naive controls screened during the same time period.  We examd. overall survival in patients with advanced, ALK-pos. NSCLC who enrolled in the phase 1 clin. trial of crizotinib, focusing on the cohort of 82 patients who had enrolled through Feb 10, 2010.  For comparators, we identified 36 ALK-pos. patients from trial sites who were not given crizotinib (ALK-pos. controls), 67 patients without ALK rearrangement but pos. for EGFR mutation, and 253 wild-type patients lacking either ALK rearrangement or EGFR mutation.  To assess differences in overall survival, we assessed subsets of clin. comparable ALK-pos. and ALK-neg. patients.  Among 82 ALK-pos. patients who were given crizotinib, median overall survival from initiation of crizotinib has not been reached (95% CI 17 mo to not reached); 1-yr overall survival was 74% (95% CI 63-82), and 2-yr overall survival was 54% (40-66).  Overall survival did not differ based on age, sex, smoking history, or ethnic origin.  Survival in 30 ALK-pos. patients who were given crizotinib in the second-line or third-line setting was significantly longer than in 23 ALK-pos. controls given any second-line therapy (median overall survival not reached [95% CI 14 mo to not reached] vs 6 mo [4-17], 1-yr overall survival 70% [95% CI 50-83] vs 44% [23-64], and 2-yr overall survival 55% [33-72] vs 12% [2-30]; hazard ratio 0.36, 95% CI 0.17-0.75; p = 0.004).  Survival in 56 crizotinib-treated, ALK-pos. patients was similar to that in 63 ALK-neg., EGFR-pos. patients given EGFR TKI therapy (median overall survival not reached [95% CI 17 mo to not reached] vs 24 mo [15-34], 1-yr overall survival 71% [95% CI 58-81] vs 74% [61-83], and 2-yr overall survival 57% [40-71] vs 52% [38-65]; p = 0.786), whereas survival in 36 crizotinib-naive, ALK-pos. controls was similar to that in 253 wild-type controls (median overall survival 20 mo [95% CI 13-26] vs 15 mo [13-17]; p = 0.244).  In patients with advanced, ALK-pos. NSCLC, crizotinib therapy is assocd. with improved survival compared with that of crizotinib-naive controls.  ALK rearrangement is not a favorable prognostic factor in advanced NSCLC.  Funding: Pfizer Inc, V Foundation for Cancer Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMS7fRYJSyrrVg90H21EOLACvtfcHk0ljXDiJoLwFW4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1KmtrzL&md5=5482da97726293764c9fe42419d187cb</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2811%2970232-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252811%252970232-7%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DYeap%26aufirst%3DB.%2BY.%26aulast%3DSolomon%26aufirst%3DB.%2BJ.%26aulast%3DRiely%26aufirst%3DG.%2BJ.%26aulast%3DGainor%26aufirst%3DJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DButaney%26aufirst%3DM.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DMaki%26aufirst%3DR.%2BG.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26aulast%3DKulig%26aufirst%3DK.%26aulast%3DSelaru%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26atitle%3DEffect%2520of%2520crizotinib%2520on%2520overall%2520survival%2520in%2520patients%2520with%2520advanced%2520non-small-cell%2520lung%2520cancer%2520harbouring%2520ALK%2520gene%2520rearrangement%253A%2520A%2520retrospective%2520analysis%26jtitle%3DLancet%2520Oncol.%26date%3D2011%26volume%3D12%26issue%3D11%26spage%3D1004%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielecki, J.</span><span> </span><span class="NLM_article-title">Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1038%2Fnrc2947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWlsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=760-774&issue=11&author=W.+Paoauthor=J.+Chmielecki&title=Rational%2C+biologically+based+treatment+of+EGFR-mutant+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer</span></div><div class="casAuthors">Pao, William; Chmielecki, Juliann</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">760-774</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) was first recognized in 2004 as a distinct, clin. relevant mol. subset of lung cancer.  The disease has been the subject of intensive research at both the basic scientific and clin. levels, becoming a paradigm for how to understand and treat oncogene-driven carcinomas.  Although patients with EGFR-mutant tumors have increased sensitivity to tyrosine kinase inhibitors (TKIs), primary and acquired resistance to these agents remains a major clin. problem.  This Review summarizes recent developments aimed at treating and ultimately curing the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_b4ITVJ2ZnrVg90H21EOLACvtfcHk0ljXDiJoLwFW4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWlsrrN&md5=448b40d66a0a5f171106baa1dc709c29</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc2947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2947%26sid%3Dliteratum%253Aachs%26aulast%3DPao%26aufirst%3DW.%26aulast%3DChmielecki%26aufirst%3DJ.%26atitle%3DRational%252C%2520biologically%2520based%2520treatment%2520of%2520EGFR-mutant%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26issue%3D11%26spage%3D760%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandya, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span> </span><span class="NLM_article-title">CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">e443</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=e443-445&issue=15&author=D.+B.+Costaauthor=S.+Kobayashiauthor=S.+S.+Pandyaauthor=W.+L.+Yeoauthor=Z.+Shenauthor=W.+Tanauthor=K.+D.+Wilner&title=CSF+concentration+of+the+anaplastic+lymphoma+kinase+inhibitor+crizotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DPandya%26aufirst%3DS.%2BS.%26aulast%3DYeo%26aufirst%3DW.%2BL.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26atitle%3DCSF%2520concentration%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520inhibitor%2520crizotinib%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26issue%3D15%26spage%3De443%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camphausen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span> </span><span class="NLM_article-title">Brain metastases as preventive and therapeutic targets</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1038%2Fnrc3053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21472002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVCrtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=352-363&issue=5&author=P.+S.+Steegauthor=K.+A.+Camphausenauthor=Q.+R.+Smith&title=Brain+metastases+as+preventive+and+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Brain metastases as preventive and therapeutic targets</span></div><div class="casAuthors">Steeg, Patricia S.; Camphausen, Kevin A.; Smith, Quentin R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">352-363</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The incidence of metastasis to the brain is apparently rising in cancer patients and threatens to limit the gains that have been made by new systemic treatments.  The brain is considered a 'sanctuary site' as the blood-tumor barrier limits the ability of drugs to enter and kill tumor cells.  Translational research examg. metastasis to the brain needs to be multi-disciplinary, marrying advanced chem., blood-brain barrier pharmacokinetics, neurocognitive testing and radiation biol. with metastasis biol., to develop and implement new clin. trial designs.  Advances in the chemoprevention of brain metastases, the validation of tumor radiation sensitizers and the amelioration of cognitive deficits caused by whole-brain radiation therapy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM3sRu7fNrQrVg90H21EOLACvtfcHk0lgjlTH65sv5MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVCrtro%253D&md5=b45316ddf5f3ce9a04076157365831b7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrc3053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3053%26sid%3Dliteratum%253Aachs%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DCamphausen%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26atitle%3DBrain%2520metastases%2520as%2520preventive%2520and%2520therapeutic%2520targets%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D5%26spage%3D352%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Yamanaka, R.</span><span> </span><span class="NLM_article-title">Management of refractory or relapsed primary central nervous system lymphoma (review)</span> <span class="citation_source-journal">Mol. Med. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.3892%2Fmmr_00000186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12qsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=879-885&issue=6&author=R.+Yamanaka&title=Management+of+refractory+or+relapsed+primary+central+nervous+system+lymphoma+%28review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Management of refractory or relapsed primary central nervous system lymphoma (review)</span></div><div class="casAuthors">Yamanaka, Ryuya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">879-885</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Primary central nervous system lymphoma (PCNSL) is a non-Hodgkin's lymphoma arising in the central nervous system.  Combined methotrexate-based chemoradiotherapy is the std. treatment for PCNSL, resulting in a median overall survival of 25-51 mo.  Failure of first-line treatment has been reported in most patients with PCNSL.  Salvage therapy improves outcome; however, since many different treatments have been applied, conclusions cannot be drawn regarding an optimal treatment schedule.  This review analyzes the efficacy of different salvage therapies that have been reported in the literature.  These well-designed, randomized trials may help elucidate issues such as the best chemotherapy regimen for second-line treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC3vHGX62hWrVg90H21EOLACvtfcHk0lgjlTH65sv5MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12qsr%252FE&md5=44fc965a86a713a7b52028195b1c8dab</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3892%2Fmmr_00000186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr_00000186%26sid%3Dliteratum%253Aachs%26aulast%3DYamanaka%26aufirst%3DR.%26atitle%3DManagement%2520of%2520refractory%2520or%2520relapsed%2520primary%2520central%2520nervous%2520system%2520lymphoma%2520%2528review%2529%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2009%26volume%3D2%26issue%3D6%26spage%3D879%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Nguyen, T. D.; DeAngelis, L. M.</span><span> </span><span class="NLM_article-title">Brain metastases</span>.  <span class="citation_source-journal">Neurol. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span>),  <span class="NLM_fpage">x</span><span class="NLM_x">–</span> <span class="NLM_lpage">xi</span>,  <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1192</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=x+1173-xi+1192&issue=4&author=T.+D.+Nguyen&author=L.+M.+DeAngelis&title=Brain+metastases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BD.%26atitle%3DBrain%2520metastases%26jtitle%3DNeurol.%2520Clin.%26date%3D2007%26volume%3D25%26issue%3D4%26spage%3Dx%26epage%3Dxi%26spage%3D1173%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Katayama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifshits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span> </span><span class="NLM_article-title">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7535-7540&issue=18&author=R.+Katayamaauthor=T.+M.+Khanauthor=C.+Benesauthor=E.+Lifshitsauthor=H.+Ebiauthor=V.+M.+Riveraauthor=W.+C.+Shakespeareauthor=A.+J.+Iafrateauthor=J.+A.+Engelmanauthor=A.+T.+Shaw&title=Therapeutic+strategies+to+overcome+crizotinib+resistance+in+non-small+cell+lung+cancers+harboring+the+fusion+oncogene+EML4-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DEbi%26aufirst%3DH.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520strategies%2520to%2520overcome%2520crizotinib%2520resistance%2520in%2520non-small%2520cell%2520lung%2520cancers%2520harboring%2520the%2520fusion%2520oncogene%2520EML4-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26issue%3D18%26spage%3D7535%26epage%3D7540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohwada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span> </span><span class="NLM_article-title">9-substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles as highly selective and potent anaplastic lymphoma kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6286</span><span class="NLM_x">–</span> <span class="NLM_lpage">6294</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200652u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6286-6294&issue=18&author=K.+Kinoshitaauthor=T.+Kobayashiauthor=K.+Asohauthor=N.+Furuichiauthor=T.+Itoauthor=H.+Kawadaauthor=S.+Haraauthor=J.+Ohwadaauthor=K.+Hattoriauthor=T.+Miyagiauthor=W.+S.+Hongauthor=M.+J.+Parkauthor=K.+Takanashiauthor=T.+Tsukaguchiauthor=H.+Sakamotoauthor=T.+Tsukudaauthor=N.+Oikawa&title=9-substituted+6%2C6-dimethyl-11-oxo-6%2C11-dihydro-5H-benzo%5Bb%5Dcarbazoles+as+highly+selective+and+potent+anaplastic+lymphoma+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm200652u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200652u%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DOhwada%26aufirst%3DJ.%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DW.%2BS.%26aulast%3DPark%26aufirst%3DM.%2BJ.%26aulast%3DTakanashi%26aufirst%3DK.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DOikawa%26aufirst%3DN.%26atitle%3D9-substituted%25206%252C6-dimethyl-11-oxo-6%252C11-dihydro-5H-benzo%255Bb%255Dcarbazoles%2520as%2520highly%2520selective%2520and%2520potent%2520anaplastic%2520lymphoma%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6286%26epage%3D6294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span> </span><span class="NLM_article-title">Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3788</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3788-93&issue=12&author=K.+Kinoshitaauthor=Y.+Onoauthor=T.+Emuraauthor=K.+Asohauthor=N.+Furuichiauthor=T.+Itoauthor=H.+Kawadaauthor=S.+Tanakaauthor=K.+Morikamiauthor=T.+Tsukaguchiauthor=H.+Sakamotoauthor=T.+Tsukudaauthor=N.+Oikawa&title=Discovery+of+novel+tetracyclic+compounds+as+anaplastic+lymphoma+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DEmura%26aufirst%3DT.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DOikawa%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520novel%2520tetracyclic%2520compounds%2520as%2520anaplastic%2520lymphoma%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D12%26spage%3D3788%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span> </span><span class="NLM_article-title">CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=679-690&issue=5&author=H.+Sakamotoauthor=T.+Tsukaguchiauthor=S.+Hiroshimaauthor=T.+Kodamaauthor=T.+Kobayashiauthor=T.+A.+Fukamiauthor=N.+Oikawaauthor=T.+Tsukudaauthor=N.+Ishiiauthor=Y.+Aoki&title=CH5424802%2C+a+selective+ALK+inhibitor+capable+of+blocking+the+resistant+gatekeeper+mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DHiroshima%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%2BA.%26aulast%3DOikawa%26aufirst%3DN.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DY.%26atitle%3DCH5424802%252C%2520a%2520selective%2520ALK%2520inhibitor%2520capable%2520of%2520blocking%2520the%2520resistant%2520gatekeeper%2520mutant%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26issue%3D5%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kuromitsu, S.; Mori, M.; Shimada, I.; Kondoh, Y.; Shindoh, N.; Soga, T.; Furutani, T.; Konagai, S.; Sakagami, H.; Nakata, M.; Ueno, Y.; Saito, R.; Sasamata, M.; Kudou, M.</span><span> </span><span class="NLM_article-title">Anti-tumor activity of ASP3026. A novel and selective ALK inhibitor of anaplastic lymphoma kinase (ALK)</span>.  <span class="citation_source-book">Annual Meeting of the American Assocation for Cancer Research (AACR)</span>, Orlando, FL, April 2–6, 2011; <span class="NLM_publisher-name">AACR</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Kuromitsu&author=M.+Mori&author=I.+Shimada&author=Y.+Kondoh&author=N.+Shindoh&author=T.+Soga&author=T.+Furutani&author=S.+Konagai&author=H.+Sakagami&author=M.+Nakata&author=Y.+Ueno&author=R.+Saito&author=M.+Sasamata&author=M.+Kudou&title=Annual+Meeting+of+the+American+Assocation+for+Cancer+Research+%28AACR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKuromitsu%26aufirst%3DS.%26atitle%3DAnti-tumor%2520activity%2520of%2520ASP3026.%2520A%2520novel%2520and%2520selective%2520ALK%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26btitle%3DAnnual%2520Meeting%2520of%2520the%2520American%2520Assocation%2520for%2520Cancer%2520Research%2520%2528AACR%2529%26pub%3DAACR%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&issue=1&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26issue%3D1%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Marsilje, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkisova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pferdekamper, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groessl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phimister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aycinena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursulaya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanewsky, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michellys, P. Y.</span><span> </span><span class="NLM_article-title">Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">5675</span><span class="NLM_x">–</span> <span class="NLM_lpage">5690</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400402q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5675-5690&issue=14&author=T.+H.+Marsiljeauthor=W.+Peiauthor=B.+Chenauthor=W.+Luauthor=T.+Unoauthor=Y.+Jinauthor=T.+Jiangauthor=S.+Kimauthor=N.+Liauthor=M.+Warmuthauthor=Y.+Sarkisovaauthor=F.+Sunauthor=A.+Steffyauthor=A.+C.+Pferdekamperauthor=A.+G.+Liauthor=S.+B.+Josephauthor=Y.+Kimauthor=B.+Liuauthor=T.+Tuntlandauthor=X.+Cuiauthor=N.+S.+Grayauthor=R.+Steensmaauthor=Y.+Wanauthor=J.+Jiangauthor=G.+Chopiukauthor=J.+Liauthor=W.+P.+Gordonauthor=W.+Richmondauthor=K.+Johnsonauthor=J.+Changauthor=T.+Groesslauthor=Y.+Q.+Heauthor=A.+Phimisterauthor=A.+Aycinenaauthor=C.+C.+Leeauthor=B.+Bursulayaauthor=D.+S.+Karanewskyauthor=H.+M.+Seidelauthor=J.+L.+Harrisauthor=P.+Y.+Michellys&title=Synthesis%2C+structure-activity+relationships%2C+and+in+vivo+efficacy+of+the+novel+potent+and+selective+anaplastic+lymphoma+kinase+%28ALK%29+inhibitor+5-chloro-N2-%282-isopropoxy-5-methyl-4-%28piperidin-4-yl%29phenyl%29-N4-%282-%28isopropylsulfonyl%29phenyl%29pyrimidine-2%2C4-diamine+%28LDK378%29+currently+in+phase+1+and+phase+2+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm400402q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400402q%26sid%3Dliteratum%253Aachs%26aulast%3DMarsilje%26aufirst%3DT.%2BH.%26aulast%3DPei%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DUno%26aufirst%3DT.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DSarkisova%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DPferdekamper%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DA.%2BG.%26aulast%3DJoseph%26aufirst%3DS.%2BB.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DW.%2BP.%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DHe%26aufirst%3DY.%2BQ.%26aulast%3DPhimister%26aufirst%3DA.%26aulast%3DAycinena%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DMichellys%26aufirst%3DP.%2BY.%26atitle%3DSynthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520in%2520vivo%2520efficacy%2520of%2520the%2520novel%2520potent%2520and%2520selective%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520inhibitor%25205-chloro-N2-%25282-isopropoxy-5-methyl-4-%2528piperidin-4-yl%2529phenyl%2529-N4-%25282-%2528isopropylsulfonyl%2529phenyl%2529pyrimidine-2%252C4-diamine%2520%2528LDK378%2529%2520currently%2520in%2520phase%25201%2520and%2520phase%25202%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D14%26spage%3D5675%26epage%3D5690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunker, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dack, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsaparikos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1170</span><span class="NLM_x">–</span> <span class="NLM_lpage">1187</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401805h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1170-1187&issue=4&author=Q.+Huangauthor=T.+W.+Johnsonauthor=S.+Baileyauthor=A.+Broounauthor=K.+D.+Bunkerauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=A.+S.+Cookauthor=J.+J.+Cuiauthor=K.+D.+Dackauthor=J.+G.+Dealauthor=Y.-L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=P.+S.+Johnsonauthor=R.+S.+Kaniaauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=Q.+Liauthor=L.+Lingardoauthor=W.+Liuauthor=M.+W.+Luauthor=M.+McTigueauthor=C.+L.+Palmerauthor=P.+F.+Richardsonauthor=N.+W.+Sachauthor=H.+Shenauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=K.+Tsaparikosauthor=H.+Wangauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Design+of+potent+and+selective+inhibitors+to+overcome+clinical+anaplastic+lymphoma+kinase+mutations+resistant+to+crizotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm401805h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401805h%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBunker%26aufirst%3DK.%2BD.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDack%26aufirst%3DK.%2BD.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DJohnson%26aufirst%3DP.%2BS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DM.%2BW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DTsaparikos%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDesign%2520of%2520potent%2520and%2520selective%2520inhibitors%2520to%2520overcome%2520clinical%2520anaplastic%2520lymphoma%2520kinase%2520mutations%2520resistant%2520to%2520crizotinib%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D4%26spage%3D1170%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Johnson, T. W.; Bailey, S.; Burke, B. J.; Collins, M. R.; Cui, J. J.; Deal, J.; Deng, Y.; Edwards, M. P.; He, M.; Hoffman, J.; Hoffman, R. L.; Huang, Q.; Kania, R. S.; Le, P.; McTigue, M.; Palmer, C. L.; Richardson, P. F.; Sach, N. W.; Smith, G. L.; Engstrom, L.; Hu, W.; Lam, H.; Lam, J. L.; Smeal, S.; Zou, H. Y.</span><span> </span><span class="NLM_article-title">Is CNS availability for oncology a no-brainer? Discovery of PF-06463922, a novel small molecule inhibitor of ALK/ROS1 with preclinical brain availability and broad spectrum potency against ALK-resistant mutations</span>.  <span class="citation_source-journal">Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics</span>, Boston, MA, Oct 19–23, 2013; <span class="NLM_publisher-name">American Association for Cancer Research (AACR)</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, 2013;  <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">11, Suppl.</span>), Abstract PR10.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&issue=11%2C+Suppl.&author=T.+W.+Johnson&author=S.+Bailey&author=B.+J.+Burke&author=M.+R.+Collins&author=J.+J.+Cui&author=J.+Deal&author=Y.+Deng&author=M.+P.+Edwards&author=M.+He&author=J.+Hoffman&author=R.+L.+Hoffman&author=Q.+Huang&author=R.+S.+Kania&author=P.+Le&author=M.+McTigue&author=C.+L.+Palmer&author=P.+F.+Richardson&author=N.+W.+Sach&author=G.+L.+Smith&author=L.+Engstrom&author=W.+Hu&author=H.+Lam&author=J.+L.+Lam&author=S.+Smeal&author=H.+Y.+Zou&title=Is+CNS+availability+for+oncology+a+no-brainer%3F+Discovery+of+PF-06463922%2C+a+novel+small+molecule+inhibitor+of+ALK%2FROS1+with+preclinical+brain+availability+and+broad+spectrum+potency+against+ALK-resistant+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26atitle%3DIs%2520CNS%2520availability%2520for%2520oncology%2520a%2520no-brainer%253F%2520Discovery%2520of%2520PF-06463922%252C%2520a%2520novel%2520small%2520molecule%2520inhibitor%2520of%2520ALK%252FROS1%2520with%2520preclinical%2520brain%2520availability%2520and%2520broad%2520spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DProceedings%2520of%2520the%2520AACR-NCI-EORTC%2520International%2520Conference%253A%2520Molecular%2520Targets%2520and%2520Cancer%2520Therapeutics%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%2520%2528AACR%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26issue%3D11%252C%2520Suppl" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zou, H. Y.; Engstrom, L. R.; Li, Q.; West-Lu, M.; Tang, R. W.; Wang, H.; Tsaparikos, K.; Timofeevski, S.; Lam, J.; Yamazaki, S.; Hu, W.; Gukasyan, H.; Lee, N.; Johnson, T. W.; Fantin, V.; Smeal, T.</span><span> </span><span class="NLM_article-title">PF-06463922, a novel ROS1/ALK inhibitor, demonstrates sub-nanomolar potency against oncogenic ROS1 fusions and capable of blocking the resistant ROS1-G2032R mutant in preclinical tumor models</span>.  <span class="citation_source-journal">Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics</span>, Boston, MA, Oct 19–23, 2013; <span class="NLM_publisher-name">American Association for Cancer Research (AACR)</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, 2013;  <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">11, Suppl.</span>), Abstract A277.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&issue=11%2C+Suppl.&author=H.+Y.+Zou&author=L.+R.+Engstrom&author=Q.+Li&author=M.+West-Lu&author=R.+W.+Tang&author=H.+Wang&author=K.+Tsaparikos&author=S.+Timofeevski&author=J.+Lam&author=S.+Yamazaki&author=W.+Hu&author=H.+Gukasyan&author=N.+Lee&author=T.+W.+Johnson&author=V.+Fantin&author=T.+Smeal&title=PF-06463922%2C+a+novel+ROS1%2FALK+inhibitor%2C+demonstrates+sub-nanomolar+potency+against+oncogenic+ROS1+fusions+and+capable+of+blocking+the+resistant+ROS1-G2032R+mutant+in+preclinical+tumor+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26atitle%3DPF-06463922%252C%2520a%2520novel%2520ROS1%252FALK%2520inhibitor%252C%2520demonstrates%2520sub-nanomolar%2520potency%2520against%2520oncogenic%2520ROS1%2520fusions%2520and%2520capable%2520of%2520blocking%2520the%2520resistant%2520ROS1-G2032R%2520mutant%2520in%2520preclinical%2520tumor%2520models%26jtitle%3DProceedings%2520of%2520the%2520AACR-NCI-EORTC%2520International%2520Conference%253A%2520Molecular%2520Targets%2520and%2520Cancer%2520Therapeutics%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%2520%2528AACR%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26issue%3D11%252C%2520Suppl" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zou, H. Y.; Engstrom, L. R.; Li, Q.; Lu, M. W.; Tang, R. W.; Wang, H.; Tsaparikos, K.; Wang, J.; Timofeevski, S.; Dinh, D. M.; Lam, H.; Lam, J.; Yamazaki, S.; Hu, W.; Affolter, T.; Lappin, P. B.; Gukasyan, H.; Lee, N.; Tursi, J. M.; Johnson, T. W.; Fantin, V.; Smeal, T.</span><span> </span><span class="NLM_article-title">PF-06463922, a novel brain-penetrating small molecule inhibitor of ALK/ROS1 with potent activity against a broad spectrum of ALK resistant mutations in preclinical models in vitro and in vivo</span>.  <span class="citation_source-journal">Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics</span>; Boston, MA, Oct 19–23, 2013; <span class="NLM_publisher-name">American Association for Cancer Research (AACR)</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, 2013;  <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">11, Suppl.</span>), Abstract C253.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&issue=11%2C+Suppl.&author=H.+Y.+Zou&author=L.+R.+Engstrom&author=Q.+Li&author=M.+W.+Lu&author=R.+W.+Tang&author=H.+Wang&author=K.+Tsaparikos&author=J.+Wang&author=S.+Timofeevski&author=D.+M.+Dinh&author=H.+Lam&author=J.+Lam&author=S.+Yamazaki&author=W.+Hu&author=T.+Affolter&author=P.+B.+Lappin&author=H.+Gukasyan&author=N.+Lee&author=J.+M.+Tursi&author=T.+W.+Johnson&author=V.+Fantin&author=T.+Smeal&title=PF-06463922%2C+a+novel+brain-penetrating+small+molecule+inhibitor+of+ALK%2FROS1+with+potent+activity+against+a+broad+spectrum+of+ALK+resistant+mutations+in+preclinical+models+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26atitle%3DPF-06463922%252C%2520a%2520novel%2520brain-penetrating%2520small%2520molecule%2520inhibitor%2520of%2520ALK%252FROS1%2520with%2520potent%2520activity%2520against%2520a%2520broad%2520spectrum%2520of%2520ALK%2520resistant%2520mutations%2520in%2520preclinical%2520models%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DProceedings%2520of%2520the%2520AACR-NCI-EORTC%2520International%2520Conference%253A%2520Molecular%2520Targets%2520and%2520Cancer%2520Therapeutics%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%2520%2528AACR%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26issue%3D11%252C%2520Suppl" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span> </span><span class="NLM_article-title">Role of physicochemical properties and lipophilic ligand efficiency (LipE or LLE) in addressing drug safety risks</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=381-391&author=M.+P.+Edwardsauthor=D.+A.+Price&title=Role+of+physicochemical+properties+and+lipophilic+ligand+efficiency+%28LipE+or+LLE%29+in+addressing+drug+safety+risks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520physicochemical%2520properties%2520and%2520lipophilic%2520ligand%2520efficiency%2520%2528LipE%2520or%2520LLE%2529%2520in%2520addressing%2520drug%2520safety%2520risks%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D381%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Freeman-Cook, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span> </span><span class="NLM_article-title">Lipophilic efficiency: The most important efficiency metric in medicinal chemistry</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.4155%2Ffmc.12.208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=23360135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=113-115&issue=2&author=K.+D.+Freeman-Cookauthor=R.+L.+Hoffmanauthor=T.+W.+Johnson&title=Lipophilic+efficiency%3A+The+most+important+efficiency+metric+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span></div><div class="casAuthors">Freeman-Cook, Kevin D.; Hoffman, Robert L.; Johnson, Ted W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-115</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review is given on the crit. role of lipophilicity in drug discovery and optimization of general absorption, distribution, metab. and excretion properties, toxicol. profiles and ultimately pharmacol. response.  Math. equations are presented concerning the impact of lipophilicity on the dose and the calcn. of the lipophilic ligand efficiency (LipE).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhEHH7Hf1qbVg90H21EOLACvtfcHk0li7X3jr4krKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D&md5=36170decfa1f1e3ef09ecf772322a210</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.208%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26atitle%3DLipophilic%2520efficiency%253A%2520The%2520most%2520important%2520efficiency%2520metric%2520in%2520medicinal%2520chemistry%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26issue%3D2%26spage%3D113%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&issue=15&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0ljiypkntg62Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D15%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the golden triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&issue=19&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+golden+triangle+to+optimize+clearance+and+oral+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520golden%2520triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5560%26epage%3D5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">Dose is proportional to (<i>C</i><sub>eff</sub>Cl<sub>u</sub>)/<i>F</i>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&issue=4&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0ljiypkntg62Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Bunnage, M. E.; Cook, A. S.; Cui, J. J.; Dack, K. N.; Deal, J. G.; Gu, D.; He, M.; Johnson, P. S.; Johnson, T. W.; Le, P. T.; Palmer, C. L.; Shen, H.</span><span> </span><span class="NLM_article-title">Heterocyclic derivatives for the treatment of diseases</span>. WO 2011/138751 A2,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+E.+Bunnage&author=A.+S.+Cook&author=J.+J.+Cui&author=K.+N.+Dack&author=J.+G.+Deal&author=D.+Gu&author=M.+He&author=P.+S.+Johnson&author=T.+W.+Johnson&author=P.+T.+Le&author=C.+L.+Palmer&author=H.+Shen&title=Heterocyclic+derivatives+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26atitle%3DHeterocyclic%2520derivatives%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&issue=2&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0ljiypkntg62Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26issue%3D2%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">Macrocycles in drug discovery have been defined as a ring system consisting of 12 or more atoms.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrett, N. K.</span><span> </span><span class="NLM_article-title">The exploration of macrocycles for drug discovery--an underexploited structural class</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=608-624&issue=7&author=E.+M.+Driggersauthor=S.+P.+Haleauthor=J.+Leeauthor=N.+K.+Terrett&title=The+exploration+of+macrocycles+for+drug+discovery%2D%2Dan+underexploited+structural+class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DHale%26aufirst%3DS.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26atitle%3DThe%2520exploration%2520of%2520macrocycles%2520for%2520drug%2520discovery--an%2520underexploited%2520structural%2520class%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26issue%3D7%26spage%3D608%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Giordanetto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlberg, J.</span><span> </span><span class="NLM_article-title">Macrocyclic drugs and clinical candidates: What can medicinal chemists learn from their properties?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400887j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=278-295&issue=2&author=F.+Giordanettoauthor=J.+Kihlberg&title=Macrocyclic+drugs+and+clinical+candidates%3A+What+can+medicinal+chemists+learn+from+their+properties%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fjm400887j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400887j%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520drugs%2520and%2520clinical%2520candidates%253A%2520What%2520can%2520medicinal%2520chemists%2520learn%2520from%2520their%2520properties%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D2%26spage%3D278%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Marsault, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span> </span><span class="NLM_article-title">Macrocycles are great cycles: Applications, opportunities, and challenges of synthetic macrocycles in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&issue=7&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+are+great+cycles%3A+Applications%2C+opportunities%2C+and+challenges+of+synthetic+macrocycles+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0lgdhUR8S5oc1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520are%2520great%2520cycles%253A%2520Applications%252C%2520opportunities%252C%2520and%2520challenges%2520of%2520synthetic%2520macrocycles%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D7%26spage%3D1961%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span> </span><span class="NLM_article-title">Synthetic macrocycles in small-molecule drug discovery</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2FB978-0-12-417150-3.00023-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=371-386&author=S.+Vendevilleauthor=M.+D.+Cummings&title=Synthetic+macrocycles+in+small-molecule+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33dR"><div class="casContent"><span class="casTitleNuber">33d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic macrocycles in small-molecule drug discovery</span></div><div class="casAuthors">Vendeville, Sandrine; Cummings, Maxwell D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">371-386</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Macrocycles, mols. contg. 12-membered or larger rings, are receiving increased attention in small-mol. drug discovery.  In this review the authors briefly describe a few representative examples of recent studies in which macrocyclization has had significant impact on pharmacokinetics and pharmacodynamics and/or potency and/or target selectivity.  The authors conclude with a few relevant issues and several studies aimed at broader understanding in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpY7yB6XMf4rVg90H21EOLACvtfcHk0lgdhUR8S5oc1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu7%252FL&md5=a47d81142ee71f98d34c9ebeaa9868b0</span></div><a href="/servlet/linkout?suffix=cit33d&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417150-3.00023-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-417150-3.00023-5%26sid%3Dliteratum%253Aachs%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26atitle%3DSynthetic%2520macrocycles%2520in%2520small-molecule%2520drug%2520discovery%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D371%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Breslin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoshe, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knecht, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">Design, synthesis, and anaplastic lymphoma kinase (ALK) inhibitory activity for a novel series of 2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=449-464&issue=1&author=H.+J.+Breslinauthor=B.+M.+Laneauthor=G.+R.+Ottauthor=A.+K.+Ghosheauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=M.+Chengauthor=W.+Wanauthor=R.+C.+Haltiwangerauthor=K.+J.+Wells-Knechtauthor=B.+D.+Dorsey&title=Design%2C+synthesis%2C+and+anaplastic+lymphoma+kinase+%28ALK%29+inhibitory+activity+for+a+novel+series+of+2%2C4%2C8%2C22-tetraazatetracyclo%5B14.3.1.13%2C7.19%2C13%5Ddocosa-1%2820%29%2C3%2822%29%2C4%2C6%2C9%2821%29%2C10%2C12%2C16%2C18-nonaene+macrocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreslin%26aufirst%3DH.%2BJ.%26aulast%3DLane%26aufirst%3DB.%2BM.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DGhoshe%26aufirst%3DA.%2BK.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DWells-Knecht%26aufirst%3DK.%2BJ.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520inhibitory%2520activity%2520for%2520a%2520novel%2520series%2520of%25202%252C4%252C8%252C22-tetraazatetracyclo%255B14.3.1.13%252C7.19%252C13%255Ddocosa-1%252820%2529%252C3%252822%2529%252C4%252C6%252C9%252821%2529%252C10%252C12%252C16%252C18-nonaene%2520macrocycles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D55%26issue%3D1%26spage%3D449%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladysheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crenne, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span> </span><span class="NLM_article-title">The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2012&pages=439-453&issue=3&author=T.+Bertrandauthor=M.+Kotheauthor=J.+Liuauthor=A.+Dupuyauthor=A.+Rakauthor=P.+F.+Berneauthor=S.+Davisauthor=T.+Gladyshevaauthor=C.+Valtreauthor=J.+Y.+Crenneauthor=M.+Mathieu&title=The+crystal+structures+of+TrkA+and+TrkB+suggest+key+regions+for+achieving+selective+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDupuy%26aufirst%3DA.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DBerne%26aufirst%3DP.%2BF.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DGladysheva%26aufirst%3DT.%26aulast%3DValtre%26aufirst%3DC.%26aulast%3DCrenne%26aufirst%3DJ.%2BY.%26aulast%3DMathieu%26aufirst%3DM.%26atitle%3DThe%2520crystal%2520structures%2520of%2520TrkA%2520and%2520TrkB%2520suggest%2520key%2520regions%2520for%2520achieving%2520selective%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D423%26issue%3D3%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleasby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span> </span><span class="NLM_article-title">Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=687-693&issue=9&author=H.+Heauthor=K.+A.+Lyonsauthor=X.+Shenauthor=Z.+Yaoauthor=K.+Bleasbyauthor=G.+Chanauthor=M.+Hafeyauthor=X.+Liauthor=S.+Xuauthor=G.+M.+Salituroauthor=L.+H.+Cohenauthor=W.+Tang&title=Utility+of+unbound+plasma+drug+levels+and+P-glycoprotein+transport+data+in+prediction+of+central+nervous+system+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DBleasby%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DHafey%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DCohen%26aufirst%3DL.%2BH.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DUtility%2520of%2520unbound%2520plasma%2520drug%2520levels%2520and%2520P-glycoprotein%2520transport%2520data%2520in%2520prediction%2520of%2520central%2520nervous%2520system%2520exposure%26jtitle%3DXenobiotica%26date%3D2009%26volume%3D39%26issue%3D9%26spage%3D687%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kodaira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusuhara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushiki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuse, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1124%2Fjpet.111.180398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21934030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=935-944&issue=3&author=H.+Kodairaauthor=H.+Kusuharaauthor=T.+Fujitaauthor=J.+Ushikiauthor=E.+Fuseauthor=Y.+Sugiyama&title=Quantitative+evaluation+of+the+impact+of+active+efflux+by+p-glycoprotein+and+breast+cancer+resistance+protein+at+the+blood-brain+barrier+on+the+predictability+of+the+unbound+concentrations+of+drugs+in+the+brain+using+cerebrospinal+fluid+concentration+as+a+surrogate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of the impact of active efflux by P-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate</span></div><div class="casAuthors">Kodaira, Hiroshi; Kusuhara, Hiroyuki; Fujita, Takuya; Ushiki, Junko; Fuse, Eiichi; Sugiyama, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">935-944</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study investigated the impact of the active efflux mediated by P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp) at the blood-brain barrier (BBB) on the predictability of the unbound brain concn. (Cu,brain) by the concn. in the cerebrospinal fluid (CSF) (Cu,CSF) in rats.  Cu,brain is obtained as the product of the total brain concn. and unbound fraction in the brain (fu,brain) detd. in vitro in brain slices.  Twenty-five compds., including P-gp and/or Bcrp substrates, were given a const. i.v. infusion, and their plasma, brain, and CSF concns. were detd.  P-gp and/or Bcrp substrates, such as verapamil, loperamide, flavopiridol, genistein, quinidine, dantrolene, daidzein, cimetidine, and pefloxacin, showed a higher CSF-to-brain unbound concn. ratio (Kp,uu,CSF/brain) compared with non-P-gp and non-Bcrp substrates.  Kp,uu,CSF/brain values of P-gp-specific (quinidine and verapamil) and Bcrp-specific (daidzein and genistein) substrates were significantly decreased in Mdr1a/1b(-/-) and Bcrp(-/-) mice, resp.  Furthermore, consistent with the contribution of P-gp and Bcrp to the net efflux at the BBB, Kp,uu,CSF/brain values of the common substrates (flavopiridol and erlotinib) were markedly decreased in Mdr1a/1b(-/-)/Bcrp(-/-) mice, but only moderately or weakly in Mdr1a/1b(-/-) mice and negligibly in Bcrp(-/-) mice.  In conclusion, predictability of Cu,brain by Cu,CSF decreases along with the net transport activities by P-gp and Bcrp at the BBB.  Cu,CSF of non-P-gp and non-Bcrp substrates can be a reliable surrogate of Cu,brain for lipophilic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6e2OeGRsyrVg90H21EOLACvtfcHk0lhkUbr1OwMu0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSksbo%253D&md5=36a778b164943b101534146120fc6cdf</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.180398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.180398%26sid%3Dliteratum%253Aachs%26aulast%3DKodaira%26aufirst%3DH.%26aulast%3DKusuhara%26aufirst%3DH.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DUshiki%26aufirst%3DJ.%26aulast%3DFuse%26aufirst%3DE.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DQuantitative%2520evaluation%2520of%2520the%2520impact%2520of%2520active%2520efflux%2520by%2520p-glycoprotein%2520and%2520breast%2520cancer%2520resistance%2520protein%2520at%2520the%2520blood-brain%2520barrier%2520on%2520the%2520predictability%2520of%2520the%2520unbound%2520concentrations%2520of%2520drugs%2520in%2520the%2520brain%2520using%2520cerebrospinal%2520fluid%2520concentration%2520as%2520a%2520surrogate%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26issue%3D3%26spage%3D935%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ohe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanatani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, Y.</span><span> </span><span class="NLM_article-title">Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid/plasma concentration ratio</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1251-1254&issue=10&author=T.+Oheauthor=M.+Satoauthor=S.+Tanakaauthor=N.+Fujinoauthor=M.+Hataauthor=Y.+Shibataauthor=A.+Kanataniauthor=T.+Fukamiauthor=M.+Yamazakiauthor=M.+Chibaauthor=Y.+Ishii&title=Effect+of+P-glycoprotein-mediated+efflux+on+cerebrospinal+fluid%2Fplasma+concentration+ratio"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DFujino%26aufirst%3DN.%26aulast%3DHata%26aufirst%3DM.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DKanatani%26aufirst%3DA.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DY.%26atitle%3DEffect%2520of%2520P-glycoprotein-mediated%2520efflux%2520on%2520cerebrospinal%2520fluid%252Fplasma%2520concentration%2520ratio%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26issue%3D10%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Redzic, Z.</span><span> </span><span class="NLM_article-title">Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: Similarities and differences</span> <span class="citation_source-journal">Fluids Barriers CNS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35d&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1186%2F2045-8118-8-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35d&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21349151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35d&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A280%3ADC%252BC3M3itFSktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=3&issue=1&author=Z.+Redzic&title=Molecular+biology+of+the+blood-brain+and+the+blood-cerebrospinal+fluid+barriers%3A+Similarities+and+differences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35dR"><div class="casContent"><span class="casTitleNuber">35d</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences</span></div><div class="casAuthors">Redzic Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Fluids and barriers of the CNS</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Efficient processing of information by the central nervous system (CNS) represents an important evolutionary advantage.  Thus, homeostatic mechanisms have developed that provide appropriate circumstances for neuronal signaling, including a highly controlled and stable microenvironment.  To provide such a milieu for neurons, extracellular fluids of the CNS are separated from the changeable environment of blood at three major interfaces: at the brain capillaries by the blood-brain barrier (BBB), which is localized at the level of the endothelial cells and separates brain interstitial fluid (ISF) from blood; at the epithelial layer of four choroid plexuses, the blood-cerebrospinal fluid (CSF) barrier (BCSFB), which separates CSF from the CP ISF, and at the arachnoid barrier.  The two barriers that represent the largest interface between blood and brain extracellular fluids, the BBB and the BCSFB, prevent the free paracellular diffusion of polar molecules by complex morphological features, including tight junctions (TJs) that interconnect the endothelial and epithelial cells, respectively.  The first part of this review focuses on the molecular biology of TJs and adherens junctions in the brain capillary endothelial cells and in the CP epithelial cells.  However, normal function of the CNS depends on a constant supply of essential molecules, like glucose and amino acids from the blood, exchange of electrolytes between brain extracellular fluids and blood, as well as on efficient removal of metabolic waste products and excess neurotransmitters from the brain ISF.  Therefore, a number of specific transport proteins are expressed in brain capillary endothelial cells and CP epithelial cells that provide transport of nutrients and ions into the CNS and removal of waste products and ions from the CSF.  The second part of this review concentrates on the molecular biology of various solute carrier (SLC) transport proteins at those two barriers and underlines differences in their expression between the two barriers.  Also, many blood-borne molecules and xenobiotics can diffuse into brain ISF and then into neuronal membranes due to their physicochemical properties.  Entry of these compounds could be detrimental for neural transmission and signalling.  Thus, BBB and BCSFB express transport proteins that actively restrict entry of lipophilic and amphipathic substances from blood and/or remove those molecules from the brain extracellular fluids.  The third part of this review concentrates on the molecular biology of ATP-binding cassette (ABC)-transporters and those SLC transporters that are involved in efflux transport of xenobiotics, their expression at the BBB and BCSFB and differences in expression in the two major blood-brain interfaces.  In addition, transport and diffusion of ions by the BBB and CP epithelium are involved in the formation of fluid, the ISF and CSF, respectively, so the last part of this review discusses molecular biology of ion transporters/exchangers and ion channels in the brain endothelial and CP epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuad1QAAjeCTDnmmyUf5qOfW6udTcc2eZUdQcqSP05Xbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3itFSktw%253D%253D&md5=4385fc4ed4dec5b9bc4eb50b07d06121</span></div><a href="/servlet/linkout?suffix=cit35d&amp;dbid=16384&amp;doi=10.1186%2F2045-8118-8-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2045-8118-8-3%26sid%3Dliteratum%253Aachs%26aulast%3DRedzic%26aufirst%3DZ.%26atitle%3DMolecular%2520biology%2520of%2520the%2520blood-brain%2520and%2520the%2520blood-cerebrospinal%2520fluid%2520barriers%253A%2520Similarities%2520and%2520differences%26jtitle%3DFluids%2520Barriers%2520CNS%26date%3D2011%26volume%3D8%26issue%3D1%26spage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="note"><p class="first last">Compounds with low intrinsic permeability (MDR BA < 2.5) were removed from the data set to eliminate low MDR BA/AB false positives.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&issue=6&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lheFq4ru9NRiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26issue%3D6%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&issue=6&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D6%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">Solvent-accessible surface area values were calculated using the Pipeline Pilot 8.5 “3D Coords” and “Surface Area and Volume 3D” protocols.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span> </span><span class="NLM_article-title">Species independence in brain tissue binding using brain homogenates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&issue=7&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+independence+in+brain+tissue+binding+using+brain+homogenates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0lheFq4ru9NRiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520independence%2520in%2520brain%2520tissue%2520binding%2520using%2520brain%2520homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26issue%3D7%26spage%3D1270%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Illuminati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandolini, L.</span><span> </span><span class="NLM_article-title">Ring closure reactions of bifunctional chain molecules</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar00064a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1981&pages=95-102&issue=4&author=G.+Illuminatiauthor=L.+Mandolini&title=Ring+closure+reactions+of+bifunctional+chain+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1021%2Far00064a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far00064a001%26sid%3Dliteratum%253Aachs%26aulast%3DIlluminati%26aufirst%3DG.%26aulast%3DMandolini%26aufirst%3DL.%26atitle%3DRing%2520closure%2520reactions%2520of%2520bifunctional%2520chain%2520molecules%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1981%26volume%3D14%26issue%3D4%26spage%3D95%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wessjohann, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruitjer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Rivera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, W.</span><span> </span><span class="NLM_article-title">What can a chemist learn from nature’s macrocycles?—A brief, conceptual view</span> <span class="citation_source-journal">Mol. Divers.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=171-186&author=L.+A.+Wessjohannauthor=E.+Ruitjerauthor=D.+Garcia-Riveraauthor=W.+Brandt&title=What+can+a+chemist+learn+from+nature%E2%80%99s+macrocycles%3F%E2%80%94A+brief%2C+conceptual+view"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWessjohann%26aufirst%3DL.%2BA.%26aulast%3DRuitjer%26aufirst%3DE.%26aulast%3DGarcia-Rivera%26aufirst%3DD.%26aulast%3DBrandt%26aufirst%3DW.%26atitle%3DWhat%2520can%2520a%2520chemist%2520learn%2520from%2520nature%25E2%2580%2599s%2520macrocycles%253F%25E2%2580%2594A%2520brief%252C%2520conceptual%2520view%26jtitle%3DMol.%2520Divers.%26date%3D2005%26volume%3D9%26spage%3D171%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Blankenstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span> </span><span class="NLM_article-title">Conformation-directed macrocyclization reactions</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1949</span><span class="NLM_x">–</span> <span class="NLM_lpage">1964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1002%2Fejoc.200400751" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1949-1964&author=J.+Blankensteinauthor=J.+Zhu&title=Conformation-directed+macrocyclization+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200400751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200400751%26sid%3Dliteratum%253Aachs%26aulast%3DBlankenstein%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DConformation-directed%2520macrocyclization%2520reactions%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2005%26volume%3D10%26spage%3D1949%26epage%3D1964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Cheung, K. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynisson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span> </span><span class="NLM_article-title">A facile synthesis of pyrazoles with multi-point structural diversity by 1,3-dipolar cycloaddition</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">5915</span><span class="NLM_x">–</span> <span class="NLM_lpage">5918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=5915-5918&issue=45&author=K.+M.+J.+Cheungauthor=J.+Reynissonauthor=E.+McDonald&title=A+facile+synthesis+of+pyrazoles+with+multi-point+structural+diversity+by+1%2C3-dipolar+cycloaddition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DK.%2BM.%2BJ.%26aulast%3DReynisson%26aufirst%3DJ.%26aulast%3DMcDonald%26aufirst%3DE.%26atitle%3DA%2520facile%2520synthesis%2520of%2520pyrazoles%2520with%2520multi-point%2520structural%2520diversity%2520by%25201%252C3-dipolar%2520cycloaddition%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26issue%3D45%26spage%3D5915%26epage%3D5918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casini, G.</span><span> </span><span class="NLM_article-title">A convenient synthesis of nitriles from primary amides under mild conditions</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">1813</span><span class="NLM_x">–</span> <span class="NLM_lpage">1815</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1977&pages=1813-1815&issue=21&author=F.+Campagnaauthor=A.+Carottiauthor=G.+Casini&title=A+convenient+synthesis+of+nitriles+from+primary+amides+under+mild+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DCasini%26aufirst%3DG.%26atitle%3DA%2520convenient%2520synthesis%2520of%2520nitriles%2520from%2520primary%2520amides%2520under%2520mild%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D1977%26volume%3D18%26issue%3D21%26spage%3D1813%26epage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Swamy, K. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, N. N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaraman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, K. V. P. P.</span><span> </span><span class="NLM_article-title">Mitsunobu and related reactions: Advances and applications</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2651</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr800278z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2551-2651&issue=6&author=K.+C.+K.+Swamyauthor=N.+N.+B.+Kumarauthor=E.+Balaramanauthor=K.+V.+P.+P.+Kumar&title=Mitsunobu+and+related+reactions%3A+Advances+and+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fcr800278z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr800278z%26sid%3Dliteratum%253Aachs%26aulast%3DSwamy%26aufirst%3DK.%2BC.%2BK.%26aulast%3DKumar%26aufirst%3DN.%2BN.%2BB.%26aulast%3DBalaraman%26aufirst%3DE.%26aulast%3DKumar%26aufirst%3DK.%2BV.%2BP.%2BP.%26atitle%3DMitsunobu%2520and%2520related%2520reactions%253A%2520Advances%2520and%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26issue%3D6%26spage%3D2551%26epage%3D2651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Merkul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, T. J. J.</span><span> </span><span class="NLM_article-title">Rapid synthesis of bis(hetero)aryls by one-pot Masuda borylation-Suzuki coupling sequence, and its application to concise total syntheses of meridianins A and G</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3139</span><span class="NLM_x">–</span> <span class="NLM_lpage">3141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=3139-3141&author=E.+Merkulauthor=E.+Sch%C3%A4ferauthor=T.+J.+J.+M%C3%BCller&title=Rapid+synthesis+of+bis%28hetero%29aryls+by+one-pot+Masuda+borylation-Suzuki+coupling+sequence%2C+and+its+application+to+concise+total+syntheses+of+meridianins+A+and+G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerkul%26aufirst%3DE.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BJ.%2BJ.%26atitle%3DRapid%2520synthesis%2520of%2520bis%2528hetero%2529aryls%2520by%2520one-pot%2520Masuda%2520borylation-Suzuki%2520coupling%2520sequence%252C%2520and%2520its%2520application%2520to%2520concise%2520total%2520syntheses%2520of%2520meridianins%2520A%2520and%2520G%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D3139%26epage%3D3141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Han, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group using HCl/dioxane (4M)</span> <span class="citation_source-journal">J. Pept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1034%2Fj.1399-3011.2001.00935.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=11606219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFSgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=338-341&issue=4&author=G.+Hanauthor=M.+Tamakiauthor=V.+J.+Hruby&title=Fast%2C+efficient+and+selective+deprotection+of+the+tert-butoxycarbonyl+%28Boc%29+group+using+HCl%2Fdioxane+%284M%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group using HCl/dioxane (4 M)</span></div><div class="casAuthors">Han, G.; Tamaki, M.; Hruby, V. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">338-341</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group of various amino acids and peptides was achieved by using hydrogen chloride (4 M) in anhyd. dioxane soln. for 30 min at room temp.  In the cases studied by the authors, this protocol provided superior selectivity to deprotect Nα-Boc groups in the presence of tert-Bu esters and tert-Bu ethers, including thio-tert-Bu ethers, but not phenolic tert-Bu ethers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyRVdQlr-XZLVg90H21EOLACvtfcHk0ljrcpYrQhR26g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFSgtr4%253D&md5=0b64fab0273836aa86c15009fe795326</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-3011.2001.00935.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-3011.2001.00935.x%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DG.%26aulast%3DTamaki%26aufirst%3DM.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DFast%252C%2520efficient%2520and%2520selective%2520deprotection%2520of%2520the%2520tert-butoxycarbonyl%2520%2528Boc%2529%2520group%2520using%2520HCl%252Fdioxane%2520%25284M%2529%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2001%26volume%3D58%26issue%3D4%26spage%3D338%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Chinchilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, C.</span><span> </span><span class="NLM_article-title">Recent advances in Sonagashira reactions</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">5084</span><span class="NLM_x">–</span> <span class="NLM_lpage">5121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=5084-5121&author=R.+Chinchillaauthor=C.+N%C3%A1jera&title=Recent+advances+in+Sonagashira+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DR.%26aulast%3DN%25C3%25A1jera%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520Sonagashira%2520reactions%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D5084%26epage%3D5121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cripps, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. C.</span><span> </span><span class="NLM_article-title">Synthesis of aryl ethers via a sulfonyl transfer reaction</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">3886</span><span class="NLM_x">–</span> <span class="NLM_lpage">3889</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol301615z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=3886-3889&issue=15&author=N.+W.+Sachauthor=D.+T.+Richterauthor=S.+Crippsauthor=M.+Tran-Dubeauthor=H.+Zhuauthor=B.+Huangauthor=J.+Cuiauthor=S.+C.+Sutton&title=Synthesis+of+aryl+ethers+via+a+sulfonyl+transfer+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol301615z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol301615z%26sid%3Dliteratum%253Aachs%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DRichter%26aufirst%3DD.%2BT.%26aulast%3DCripps%26aufirst%3DS.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%2BC.%26atitle%3DSynthesis%2520of%2520aryl%2520ethers%2520via%2520a%2520sulfonyl%2520transfer%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26issue%3D15%26spage%3D3886%26epage%3D3889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Ackermann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapdi, A. R.</span><span> </span><span class="NLM_article-title">Transition metal-catalyzed direct arylation of (hetero)arenes by C-H bond cleavage</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">52</span><span class="NLM_x">) </span> <span class="NLM_fpage">9792</span><span class="NLM_x">–</span> <span class="NLM_lpage">9826</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=9792-9826&issue=52&author=L.+Ackermannauthor=R.+Vicenteauthor=A.+R.+Kapdi&title=Transition+metal-catalyzed+direct+arylation+of+%28hetero%29arenes+by+C-H+bond+cleavage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAckermann%26aufirst%3DL.%26aulast%3DVicente%26aufirst%3DR.%26aulast%3DKapdi%26aufirst%3DA.%2BR.%26atitle%3DTransition%2520metal-catalyzed%2520direct%2520arylation%2520of%2520%2528hetero%2529arenes%2520by%2520C-H%2520bond%2520cleavage%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D52%26spage%3D9792%26epage%3D9826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Kaur, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heapy, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brimble, M. A.</span><span> </span><span class="NLM_article-title">Synthesis of the all-L cyclopentapeptides versicoloritides A, B, and C</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2284</span><span class="NLM_x">–</span> <span class="NLM_lpage">2288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=2284-2288&author=H.+Kaurauthor=A.+M.+Heapyauthor=M.+A.+Brimble&title=Synthesis+of+the+all-L+cyclopentapeptides+versicoloritides+A%2C+B%2C+and+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DH.%26aulast%3DHeapy%26aufirst%3DA.%2BM.%26aulast%3DBrimble%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%2520of%2520the%2520all-L%2520cyclopentapeptides%2520versicoloritides%2520A%252C%2520B%252C%2520and%2520C%26jtitle%3DSynlett%26date%3D2012%26volume%3D23%26spage%3D2284%26epage%3D2288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Hoffmann, R. W.</span><span> </span><span class="NLM_article-title">Allylic 1,3-strain as a controlling factor in stereoselective transformations</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1860</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00098a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1989&pages=1841-1860&issue=8&author=R.+W.+Hoffmann&title=Allylic+1%2C3-strain+as+a+controlling+factor+in+stereoselective+transformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fcr00098a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00098a009%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DR.%2BW.%26atitle%3DAllylic%25201%252C3-strain%2520as%2520a%2520controlling%2520factor%2520in%2520stereoselective%2520transformations%26jtitle%3DChem.%2520Rev.%26date%3D1989%26volume%3D89%26issue%3D8%26spage%3D1841%26epage%3D1860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fader, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span> </span><span class="NLM_article-title">Revealing atropisomer axial chirality in drug discovery</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=505-513&issue=3&author=S.+R.+LaPlanteauthor=P.+J.+Edwardsauthor=L.+D.+Faderauthor=A.+Jakalianauthor=O.+Hucke&title=Revealing+atropisomer+axial+chirality+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DHucke%26aufirst%3DO.%26atitle%3DRevealing%2520atropisomer%2520axial%2520chirality%2520in%2520drug%2520discovery%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26issue%3D3%26spage%3D505%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit53b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Clayden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span> </span><span class="NLM_article-title">The challenge of atropisomerism in drug discovery</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">6398</span><span class="NLM_x">–</span> <span class="NLM_lpage">6401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6398-6401&issue=35&author=J.+Claydenauthor=W.+J.+Moranauthor=P.+J.+Edwardsauthor=S.+R.+LaPlante&title=The+challenge+of+atropisomerism+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26aulast%3DMoran%26aufirst%3DW.%2BJ.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26atitle%3DThe%2520challenge%2520of%2520atropisomerism%2520in%2520drug%2520discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D35%26spage%3D6398%26epage%3D6401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit53c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Van den Berge, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pospíšil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieu-Van, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robiette, R.</span><span> </span><span class="NLM_article-title">Planar chirality of imidazole-containing macrocycles—Understanding and tuning atropisomerism</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">6649</span><span class="NLM_x">–</span> <span class="NLM_lpage">6655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2011&pages=6649-6655&author=E.+Van+den+Bergeauthor=J.+Posp%C3%AD%C5%A1ilauthor=T.+Trieu-Vanauthor=L.+Collardauthor=R.+Robiette&title=Planar+chirality+of+imidazole-containing+macrocycles%E2%80%94Understanding+and+tuning+atropisomerism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bden%2BBerge%26aufirst%3DE.%26aulast%3DPosp%25C3%25AD%25C5%25A1il%26aufirst%3DJ.%26aulast%3DTrieu-Van%26aufirst%3DT.%26aulast%3DCollard%26aufirst%3DL.%26aulast%3DRobiette%26aufirst%3DR.%26atitle%3DPlanar%2520chirality%2520of%2520imidazole-containing%2520macrocycles%25E2%2580%2594Understanding%2520and%2520tuning%2520atropisomerism%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2011%26volume%3D33%26spage%3D6649%26epage%3D6655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Carbonelle, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span> </span><span class="NLM_article-title">A novel synthesis of biaryl-containing macrocycles by a domino Miyaura arylboronate formation: Intramolecular Suzuki reaction</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">3377</span><span class="NLM_x">–</span> <span class="NLM_lpage">3380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3377-3380&issue=22&author=A.-C.+Carbonelleauthor=J.+Zhu&title=A+novel+synthesis+of+biaryl-containing+macrocycles+by+a+domino+Miyaura+arylboronate+formation%3A+Intramolecular+Suzuki+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarbonelle%26aufirst%3DA.-C.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DA%2520novel%2520synthesis%2520of%2520biaryl-containing%2520macrocycles%2520by%2520a%2520domino%2520Miyaura%2520arylboronate%2520formation%253A%2520Intramolecular%2520Suzuki%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26issue%3D22%26spage%3D3377%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Brennführer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beller, M.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed carbonylation reactions of aryl halides and related compounds</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4114</span><span class="NLM_x">–</span> <span class="NLM_lpage">4133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=4114-4133&issue=23&author=A.+Brennf%C3%BChrerauthor=H.+Neumannauthor=M.+Beller&title=Palladium-catalyzed+carbonylation+reactions+of+aryl+halides+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrennf%25C3%25BChrer%26aufirst%3DA.%26aulast%3DNeumann%26aufirst%3DH.%26aulast%3DBeller%26aufirst%3DM.%26atitle%3DPalladium-catalyzed%2520carbonylation%2520reactions%2520of%2520aryl%2520halides%2520and%2520related%2520compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D23%26spage%3D4114%26epage%3D4133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Bensaid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laidaoui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Abed, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kacimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doucet, H.</span><span> </span><span class="NLM_article-title">Palladium-catalysed direct arylations of heteroaromatics using more eco-compatible solvents pentan-1-ol or 3-methylbutan-1-ol</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1383-1387&issue=12&author=S.+Bensaidauthor=N.+Laidaouiauthor=D.+El+Abedauthor=S.+Kacimiauthor=H.+Doucet&title=Palladium-catalysed+direct+arylations+of+heteroaromatics+using+more+eco-compatible+solvents+pentan-1-ol+or+3-methylbutan-1-ol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBensaid%26aufirst%3DS.%26aulast%3DLaidaoui%26aufirst%3DN.%26aulast%3DEl%2BAbed%26aufirst%3DD.%26aulast%3DKacimi%26aufirst%3DS.%26aulast%3DDoucet%26aufirst%3DH.%26atitle%3DPalladium-catalysed%2520direct%2520arylations%2520of%2520heteroaromatics%2520using%2520more%2520eco-compatible%2520solvents%2520pentan-1-ol%2520or%25203-methylbutan-1-ol%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26issue%3D12%26spage%3D1383%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Du, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed highly selective <i>ortho</i>-halogenation (I, Br, Cl) of arylnitriles via sp<sup>2</sup> C–H bond activation using cyano as directing group</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2786</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo302765g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=2786-2791&issue=6&author=B.+Duauthor=X.+Jiangauthor=P.+Sun&title=Palladium-catalyzed+highly+selective+ortho-halogenation+%28I%2C+Br%2C+Cl%29+of+arylnitriles+via+sp2+C%E2%80%93H+bond+activation+using+cyano+as+directing+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57a&amp;dbid=16384&amp;doi=10.1021%2Fjo302765g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo302765g%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DP.%26atitle%3DPalladium-catalyzed%2520highly%2520selective%2520ortho-halogenation%2520%2528I%252C%2520Br%252C%2520Cl%2529%2520of%2520arylnitriles%2520via%2520sp2%2520C%25E2%2580%2593H%2520bond%2520activation%2520using%2520cyano%2520as%2520directing%2520group%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26issue%3D6%26spage%3D2786%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit57b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span> </span><span class="NLM_article-title">Synthesis of biphenyl-2-carbonitrile derivatives via a palladium-catalyzed sp<sup>2</sup> C–H bond activation using cyano as a directing group</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol103075n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1286-1289&issue=6&author=W.+Liauthor=Z.+Xuauthor=P.+Sunauthor=X.+Jiangauthor=M.+Fang&title=Synthesis+of+biphenyl-2-carbonitrile+derivatives+via+a+palladium-catalyzed+sp2+C%E2%80%93H+bond+activation+using+cyano+as+a+directing+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57b&amp;dbid=16384&amp;doi=10.1021%2Fol103075n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol103075n%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520biphenyl-2-carbonitrile%2520derivatives%2520via%2520a%2520palladium-catalyzed%2520sp2%2520C%25E2%2580%2593H%2520bond%2520activation%2520using%2520cyano%2520as%2520a%2520directing%2520group%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26issue%3D6%26spage%3D1286%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lafrance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagnou, K.</span><span> </span><span class="NLM_article-title">Mild and efficient palladium-catalyzed intramolecular direct arylation reactions</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6015</span><span class="NLM_x">–</span> <span class="NLM_lpage">6020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=6015-6020&issue=26&author=M.+Lafranceauthor=D.+Lapointeauthor=K.+Fagnou&title=Mild+and+efficient+palladium-catalyzed+intramolecular+direct+arylation+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLafrance%26aufirst%3DM.%26aulast%3DLapointe%26aufirst%3DD.%26aulast%3DFagnou%26aufirst%3DK.%26atitle%3DMild%2520and%2520efficient%2520palladium-catalyzed%2520intramolecular%2520direct%2520arylation%2520reactions%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26issue%3D26%26spage%3D6015%26epage%3D6020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit58b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lafrance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagnou, K.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed benzene arylation: Incorporation of catalytic pivalic acid as a proton shuttle and a key element in catalyst design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x"> (</span><span class="NLM_issue">51</span><span class="NLM_x">) </span> <span class="NLM_fpage">16496</span><span class="NLM_x">–</span> <span class="NLM_lpage">16497</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja067144j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=16496-16497&issue=51&author=M.+Lafranceauthor=K.+Fagnou&title=Palladium-catalyzed+benzene+arylation%3A+Incorporation+of+catalytic+pivalic+acid+as+a+proton+shuttle+and+a+key+element+in+catalyst+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58b&amp;dbid=16384&amp;doi=10.1021%2Fja067144j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja067144j%26sid%3Dliteratum%253Aachs%26aulast%3DLafrance%26aufirst%3DM.%26aulast%3DFagnou%26aufirst%3DK.%26atitle%3DPalladium-catalyzed%2520benzene%2520arylation%253A%2520Incorporation%2520of%2520catalytic%2520pivalic%2520acid%2520as%2520a%2520proton%2520shuttle%2520and%2520a%2520key%2520element%2520in%2520catalyst%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26issue%3D51%26spage%3D16496%26epage%3D16497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kaminski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span> </span><span class="NLM_article-title">Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6474</span><span class="NLM_x">–</span> <span class="NLM_lpage">6487</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp003919d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=6474-6487&author=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Evaluation+and+reparametrization+of+the+OPLS-AA+force+field+for+proteins+via+comparison+with+accurate+quantum+chemical+calculations+on+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides</span></div><div class="casAuthors">Kaminski, George A.; Friesner, Richard A.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6474-6487</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present results of improving the OPLS-AA force field for peptides by means of refitting the key Fourier torsional coeffs.  The fitting technique combines using accurate ab initio data as the target, choosing an efficient fitting subspace of the whole potential-energy surface, and detg. wts. for each of the fitting points based on magnitudes of the potential-energy gradient.  The av. energy RMS deviation from the LMP2/cc-pVTZ(-f)//HF/6-31G** data is reduced by ∼40% from 0.81 to 0.47 kcal/mol as a result of the fitting for the electrostatically uncharged dipeptides.  Transferability of the parameters is demonstrated by using the same alanine dipeptide-fitted backbone torsional parameters for all of the other dipeptides (with the appropriate side-chain refitting) and the alanine tetrapeptide.  Parameters of nonbonded interactions have also been refitted for the sulfur-contg. dipeptides (cysteine and methionine), and the validity of the new Coulombic charges and the van der Waals σ's and ε's is proved through reproducing gas-phase energies of complex formation heats of vaporization and densities of pure model liqs.  Moreover, a novel approach to fitting torsional parameters for electrostatically charged mol. systems has been presented and successfully tested on five dipeptides with charged side chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSHwmffIQePbVg90H21EOLACvtfcHk0lgHg9_zLRT71w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D&md5=3ff059626977ee7f6342466f5820f5b7</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjp003919d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp003919d%26sid%3Dliteratum%253Aachs%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DEvaluation%2520and%2520reparametrization%2520of%2520the%2520OPLS-AA%2520force%2520field%2520for%2520proteins%2520via%2520comparison%2520with%2520accurate%2520quantum%2520chemical%2520calculations%2520on%2520peptides%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2001%26volume%3D105%26spage%3D6474%26epage%3D6487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Mohamadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, N. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caufield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Still, W. C.</span><span> </span><span class="NLM_article-title">MacroModel—An integrated software system for modeling organic and bioorganic molecules using molecular mechanics</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=440-467&author=F.+Mohamadiauthor=N.+G.+J.+Richardsauthor=W.+C.+Guidaauthor=R.+Liskampauthor=M.+Liptonauthor=C.+Caufieldauthor=G.+Changauthor=T.+Hendricksonauthor=W.+C.+Still&title=MacroModel%E2%80%94An+integrated+software+system+for+modeling+organic+and+bioorganic+molecules+using+molecular+mechanics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohamadi%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DN.%2BG.%2BJ.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLiskamp%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DM.%26aulast%3DCaufield%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHendrickson%26aufirst%3DT.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DMacroModel%25E2%2580%2594An%2520integrated%2520software%2520system%2520for%2520modeling%2520organic%2520and%2520bioorganic%2520molecules%2520using%2520molecular%2520mechanics%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1990%26volume%3D11%26spage%3D440%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24a','cit24b','cit24c','cit24d'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':[],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':[],'ref33':['cit33a','cit33b','cit33c','cit33d','cit33e'],'ref34':['cit34'],'ref35':['cit35a','cit35b','cit35c','cit35d'],'ref36':[],'ref37':['cit37'],'ref38':['cit38'],'ref39':[],'ref40':['cit40'],'ref41':['cit41a','cit41b'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53a','cit53b','cit53c'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57a','cit57b'],'ref58':['cit58a','cit58b'],'ref59':['cit59'],'ref60':['cit60']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 265 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Shaowen Xie, Yuan Sun, Yulin Liu, Xinnan Li, Xinuo Li, Wenyi Zhong, Feiyan Zhan, Jingjie Zhu, Hong Yao, Dong-Hua Yang, Zhe-Sheng Chen, Jinyi Xu, <span class="NLM_string-name hlFld-ContribAuthor">Shengtao Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9120-9140. <a href="https://doi.org/10.1021/acs.jmedchem.1c00270" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00270%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BAlectinib-Based%252BPROTACs%252Bas%252BNovel%252BPotent%252BDegraders%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DXie%26aufirst%3DShaowen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D11022021%26date%3D28062021%26volume%3D64%26issue%3D13%26spage%3D9120%26epage%3D9140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jennifer Alisa Amrhein, Stefan Knapp, <span class="NLM_string-name hlFld-ContribAuthor">Thomas Hanke</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Opportunities and Challenges for Macrocyclic Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 7991-8009. <a href="https://doi.org/10.1021/acs.jmedchem.1c00217" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00217%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252BOpportunities%252Band%252BChallenges%252Bfor%252BMacrocyclic%252BKinase%252BInhibitors%26aulast%3DAmrhein%26aufirst%3DJennifer%2BAlisa%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04022021%26date%3D02062021%26volume%3D64%26issue%3D12%26spage%3D7991%26epage%3D8009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Richard A. Ward, Stephen Fawell, Nicolas Floc’h, Vikki Flemington, Darren McKerrecher, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and Opportunities in Cancer Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3297-3351. <a href="https://doi.org/10.1021/acs.chemrev.0c00383" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00383%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChallenges%252Band%252BOpportunities%252Bin%252BCancer%252BDrug%252BResistance%26aulast%3DWard%26aufirst%3DRichard%2BA.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D21072020%26volume%3D121%26issue%3D6%26spage%3D3297%26epage%3D3351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paula C. Ortet, Samantha N. Muellers, Lauren A. Viarengo-Baker, Kristina Streu, Blair R. Szymczyna, Aaron B. Beeler, Karen N. Allen, <span class="NLM_string-name hlFld-ContribAuthor">Adrian Whitty</span>. </span><span class="cited-content_cbyCitation_article-title">Recapitulating the Binding Affinity of Nrf2 for KEAP1 in a Cyclic Heptapeptide, Guided by NMR, X-ray Crystallography, and Machine Learning. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (10)
                                     , 3779-3793. <a href="https://doi.org/10.1021/jacs.0c09799" title="DOI URL">https://doi.org/10.1021/jacs.0c09799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c09799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c09799%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DRecapitulating%252Bthe%252BBinding%252BAffinity%252Bof%252BNrf2%252Bfor%252BKEAP1%252Bin%252Ba%252BCyclic%252BHeptapeptide%25252C%252BGuided%252Bby%252BNMR%25252C%252BX-ray%252BCrystallography%25252C%252Band%252BMachine%252BLearning%26aulast%3DOrtet%26aufirst%3DPaula%2BC.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13092020%26date%3D08032021%26volume%3D143%26issue%3D10%26spage%3D3779%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guoyi Yan, Xinxin Zhong, Chunlan Pu, Lin Yue, Huifang Shan, Suke Lan, Meng Zhou, Xueyan Hou, Jie Yang, Deyu Li, Shilong Fan, <span class="NLM_string-name hlFld-ContribAuthor">Rui Li</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent ALKi Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1558-1569. <a href="https://doi.org/10.1021/acs.jmedchem.0c01707" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01707%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BCysteine%252BLocated%252BOutside%252Bthe%252BActive%252BSite%25253A%252BAn%252BEffective%252BStrategy%252Bfor%252BCovalent%252BALKi%252BDesign%26aulast%3DYan%26aufirst%3DGuoyi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29092020%26date%3D20012021%26volume%3D64%26issue%3D3%26spage%3D1558%26epage%3D1569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mehmet Erguven, Tülay Karakulak, M. Kasim Diril, <span class="NLM_string-name hlFld-ContribAuthor">Ezgi Karaca</span>. </span><span class="cited-content_cbyCitation_article-title">How Far Are We from the Rapid Prediction of Drug Resistance Arising Due to Kinase Mutations?. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (2)
                                     , 1254-1265. <a href="https://doi.org/10.1021/acsomega.0c04672" title="DOI URL">https://doi.org/10.1021/acsomega.0c04672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c04672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c04672%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DHow%252BFar%252BAre%252BWe%252Bfrom%252Bthe%252BRapid%252BPrediction%252Bof%252BDrug%252BResistance%252BArising%252BDue%252Bto%252BKinase%252BMutations%25253F%26aulast%3DErguven%26aufirst%3DMehmet%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D23092020%26date%3D11122020%26date%3D04012021%26volume%3D6%26issue%3D2%26spage%3D1254%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ikuo Fujimori, Takeshi Wakabayashi, Morio Murakami, Atsutoshi Okabe, Tsuyoshi Ishii, Aaron McGrath, Hua Zou, Kumar Singh Saikatendu, <span class="NLM_string-name hlFld-ContribAuthor">Hiroshi Imoto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (49)
                                     , 31984-32001. <a href="https://doi.org/10.1021/acsomega.0c04900" title="DOI URL">https://doi.org/10.1021/acsomega.0c04900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c04900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c04900%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDiscovery%252Bof%252BNovel%252Band%252BHighly%252BSelective%252BCyclopropane%252BALK%252BInhibitors%252Bthrough%252Ba%252BFragment-Assisted%25252C%252BStructure-Based%252BDrug%252BDesign%26aulast%3DFujimori%26aufirst%3DIkuo%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07102020%26date%3D13112020%26date%3D30112020%26volume%3D5%26issue%3D49%26spage%3D31984%26epage%3D32001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianyong Chen, Yunlong Zhou, Xuyuan Dong, Liu Liu, Longchuan Bai, Donna McEachern, Sally Przybranowski, Chao-Yie Yang, Jeanne Stuckey, Xiaoqin Li, Bo Wen, Ting Zhao, Siwei Sun, Duxin Sun, Lingling Jiao, Yu Jing, Ming Guo, Dajun Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of CJ-2360 as a Potent and Orally Active Inhibitor of Anaplastic Lymphoma Kinase Capable of Achieving Complete Tumor Regression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13994-14016. <a href="https://doi.org/10.1021/acs.jmedchem.0c01550" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01550%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BCJ-2360%252Bas%252Ba%252BPotent%252Band%252BOrally%252BActive%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252BCapable%252Bof%252BAchieving%252BComplete%252BTumor%252BRegression%26aulast%3DChen%26aufirst%3DJianyong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04092020%26date%3D13112020%26volume%3D63%26issue%3D22%26spage%3D13994%26epage%3D14016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Christopher J. Helal, Jacob C. DeForest, Peter D. Morse, Subham Mahapatra, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Approaches to New Drugs Approved during 2018. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10652-10704. <a href="https://doi.org/10.1021/acs.jmedchem.0c00345" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00345%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252BApproaches%252Bto%252BNew%252BDrugs%252BApproved%252Bduring%252B2018%26aulast%3DFlick%26aufirst%3DAndrew%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26022020%26date%3D22052020%26date%3D27042020%26volume%3D63%26issue%3D19%26spage%3D10652%26epage%3D10704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaoyun Lu, Jeff B. Smaill, <span class="NLM_string-name hlFld-ContribAuthor">Ke Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Strategies for the Development of Kinase Inhibitors Targeting Point Mutations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10726-10741. <a href="https://doi.org/10.1021/acs.jmedchem.0c00507" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00507</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00507%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252BStrategies%252Bfor%252Bthe%252BDevelopment%252Bof%252BKinase%252BInhibitors%252BTargeting%252BPoint%252BMutations%26aulast%3DLu%26aufirst%3DXiaoyun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27032020%26date%3D02062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10726%26epage%3D10741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jonathan A. Spencer, Ian R. Baldwin, Nick Barton, Chun-Wa Chung, Máire A. Convery, Christopher D. Edwards, Craig Jamieson, David N. Mallett, James E. Rowedder, Paul Rowland, Daniel A. Thomas, <span class="NLM_string-name hlFld-ContribAuthor">Charlotte J. Hardy</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Development of a Macrocyclic Series Targeting Phosphoinositide 3-Kinase δ. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (7)
                                     , 1386-1391. <a href="https://doi.org/10.1021/acsmedchemlett.0c00061" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00061%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BDevelopment%252Bof%252Ba%252BMacrocyclic%252BSeries%252BTargeting%252BPhosphoinositide%252B3-Kinase%252B%2525CE%2525B4%26aulast%3DSpencer%26aufirst%3DJonathan%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04022020%26date%3D03062020%26date%3D18062020%26date%3D03062020%26volume%3D11%26issue%3D7%26spage%3D1386%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Deeba Ensan, David Smil, Carlos A. Zepeda-Velázquez, Dimitrios Panagopoulos, Jong Fu Wong, Eleanor P. Williams, Roslin Adamson, Alex N. Bullock, Taira Kiyota, Ahmed Aman, Owen G. Roberts, Aled M. Edwards, Jeff A. O’Meara, Methvin B. Isaac, <span class="NLM_string-name hlFld-ContribAuthor">Rima Al-awar</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4978-4996. <a href="https://doi.org/10.1021/acs.jmedchem.0c00395" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00395%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BALK2%25253A%252BAn%252BOpen%252BScience%252BApproach%252Bto%252BDeveloping%252BTherapeutics%252Bfor%252Bthe%252BTreatment%252Bof%252BDiffuse%252BIntrinsic%252BPontine%252BGlioma%26aulast%3DEnsan%26aufirst%3DDeeba%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06032020%26date%3D05052020%26volume%3D63%26issue%3D9%26spage%3D4978%26epage%3D4996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aimie E. Garces, Mohammed Al-Hayali, Jong Bong Lee, Jiaxin Li, Pavel Gershkovich, Tracey D. Bradshaw, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Stocks</span>. </span><span class="cited-content_cbyCitation_article-title">Codrug Approach for the Potential Treatment of EML4-ALK Positive Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 316-321. <a href="https://doi.org/10.1021/acsmedchemlett.9b00378" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00378%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCodrug%252BApproach%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BEML4-ALK%252BPositive%252BLung%252BCancer%26aulast%3DGarces%26aufirst%3DAimie%2BE.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13082019%26date%3D27092019%26date%3D01102019%26date%3D27092019%26volume%3D11%26issue%3D3%26spage%3D316%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Debasmita Saha, Anupreet Kharbanda, Wei Yan, Naga Rajiv Lakkaniga, Brendan Frett, <span class="NLM_string-name hlFld-ContribAuthor">Hong-Yu Li</span>. </span><span class="cited-content_cbyCitation_article-title">The Exploration of Chirality for Improved Druggability within the Human Kinome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 441-469. <a href="https://doi.org/10.1021/acs.jmedchem.9b00640" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00640%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BExploration%252Bof%252BChirality%252Bfor%252BImproved%252BDruggability%252Bwithin%252Bthe%252BHuman%252BKinome%26aulast%3DSaha%26aufirst%3DDebasmita%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D15042019%26date%3D09102019%26date%3D24092019%26volume%3D63%26issue%3D2%26spage%3D441%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaotian Kong, Peichen Pan, Huiyong Sun, Hongguang Xia, Xuwen Wang, Youyong Li, <span class="NLM_string-name hlFld-ContribAuthor">Tingjun Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 10927-10954. <a href="https://doi.org/10.1021/acs.jmedchem.9b00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252BDiscovery%252BTargeting%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DKong%26aufirst%3DXiaotian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14032019%26date%3D26082019%26date%3D16082019%26volume%3D62%26issue%3D24%26spage%3D10927%26epage%3D10954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cheng Peng, Yoseph Atilaw, Jinan Wang, Zhijian Xu, Vasanthanathan Poongavanam, Jiye Shi, Jan Kihlberg, Weiliang Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Máté Erdélyi</span>. </span><span class="cited-content_cbyCitation_article-title">Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (26)
                                     , 22245-22250. <a href="https://doi.org/10.1021/acsomega.9b03797" title="DOI URL">https://doi.org/10.1021/acsomega.9b03797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b03797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b03797%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DConformation%252Bof%252Bthe%252BMacrocyclic%252BDrug%252BLorlatinib%252Bin%252BPolar%252Band%252BNonpolar%252BEnvironments%25253A%252BA%252BMD%252BSimulation%252Band%252BNMR%252BStudy%26aulast%3DPeng%26aufirst%3DCheng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07112019%26date%3D26112019%26date%3D16122019%26volume%3D4%26issue%3D26%26spage%3D22245%26epage%3D22250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Olga Cruz-López, Carolin Temps, Beatrice Longo, Samuel H. Myers, Francisco Franco-Montalban, <span class="NLM_string-name hlFld-ContribAuthor">Asier Unciti-Broceta</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of a Click-Assembled 18-Atom Macrocycle That Displays Selective AXL Kinase Inhibitory Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (25)
                                     , 21620-21626. <a href="https://doi.org/10.1021/acsomega.9b03525" title="DOI URL">https://doi.org/10.1021/acsomega.9b03525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b03525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b03525%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252Ba%252BClick-Assembled%252B18-Atom%252BMacrocycle%252BThat%252BDisplays%252BSelective%252BAXL%252BKinase%252BInhibitory%252BActivity%26aulast%3DCruz-L%25C3%25B3pez%26aufirst%3DOlga%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22102019%26date%3D14112019%26date%3D03122019%26volume%3D4%26issue%3D25%26spage%3D21620%26epage%3D21626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Harald Engelhardt, Dietrich Böse, Mark Petronczki, Dirk Scharn, Gerd Bader, Anke Baum, Andreas Bergner, Eugene Chong, Sandra Döbel, Georg Egger, Christian Engelhardt, Peter Ettmayer, Julian E. Fuchs, Thomas Gerstberger, Nina Gonnella, Andreas Grimm, Elisabeth Grondal, Nizar Haddad, Barbara Hopfgartner, Roland Kousek, Mariusz Krawiec, Monika Kriz, Lyne Lamarre, Joyce Leung, Moriz Mayer, Nitinchandra D. Patel, Biljana Peric Simov, Jonathan T. Reeves, Renate Schnitzer, Andreas Schrenk, Bernadette Sharps, Flavio Solca, Heinz Stadtmüller, Zhulin Tan, Tobias Wunberg, Andreas Zoephel, <span class="NLM_string-name hlFld-ContribAuthor">Darryl B. McConnell</span>. </span><span class="cited-content_cbyCitation_article-title">Start Selective and Rigidify: The Discovery Path toward a Next Generation of EGFR Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10272-10293. <a href="https://doi.org/10.1021/acs.jmedchem.9b01169" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01169%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStart%252BSelective%252Band%252BRigidify%25253A%252BThe%252BDiscovery%252BPath%252Btoward%252Ba%252BNext%252BGeneration%252Bof%252BEGFR%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DEngelhardt%26aufirst%3DHarald%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14082019%26date%3D13112019%26date%3D05112019%26volume%3D62%26issue%3D22%26spage%3D10272%26epage%3D10293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Solomon
D. Appavoo, Sungjoon Huh, Diego B. Diaz, <span class="NLM_string-name hlFld-ContribAuthor">Andrei K. Yudin</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational Control of Macrocycles by Remote Structural Modification. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (17)
                                     , 9724-9752. <a href="https://doi.org/10.1021/acs.chemrev.8b00742" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00742%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DConformational%252BControl%252Bof%252BMacrocycles%252Bby%252BRemote%252BStructural%252BModification%26aulast%3DAppavoo%26aufirst%3DSolomon%2BD.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D03122018%26date%3D14082019%26volume%3D119%26issue%3D17%26spage%3D9724%26epage%3D9752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maxwell D. Cummings, <span class="NLM_string-name hlFld-ContribAuthor">Sivakumar Sekharan</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 6843-6853. <a href="https://doi.org/10.1021/acs.jmedchem.8b01985" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01985%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BMacrocycle%252BDesign%252Bin%252BSmall-Molecule%252BDrug%252BDiscovery%252Band%252BSimple%252BMetrics%252BTo%252BIdentify%252BOpportunities%252Bfor%252BMacrocyclization%252Bof%252BSmall-Molecule%252BLigands%26aulast%3DCummings%26aufirst%3DMaxwell%2BD.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D18122018%26date%3D22032019%26date%3D12032019%26volume%3D62%26issue%3D15%26spage%3D6843%26epage%3D6853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Makoto Fushimi, Ikuo Fujimori, Takeshi Wakabayashi, Tomoaki Hasui, Youichi Kawakita, Keisuke Imamura, Tomoko Kato, Morio Murakami, Tsuyoshi Ishii, Yorifumi Kikko, Maki Kasahara, Atsushi Nakatani, Yuto Hiura, Maki Miyamoto, Kumar Saikatendu, Hua Zou, Scott Weston Lane, J. David Lawson, <span class="NLM_string-name hlFld-ContribAuthor">Hiroshi Imoto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Selective, and Brain-Penetrant 1H-Pyrazol-5-yl-1H-pyrrolo[2,3-b]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4915-4935. <a href="https://doi.org/10.1021/acs.jmedchem.8b01630" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01630%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain-Penetrant%252B1H-Pyrazol-5-yl-1H-pyrrolo%25255B2%25252C3-b%25255Dpyridines%252Bas%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252BInhibitors%26aulast%3DFushimi%26aufirst%3DMakoto%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21102018%26date%3D03052019%26date%3D22042019%26volume%3D62%26issue%3D10%26spage%3D4915%26epage%3D4935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bryan Li, Ruizhi Li, Peter Dorff, J. Christopher McWilliams, Robert M. Guinn, Steven M. Guinness, Lu Han, Ke Wang, <span class="NLM_string-name hlFld-ContribAuthor">Shu Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Deprotection of N-Boc Groups under Continuous-Flow High-Temperature Conditions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (8)
                                     , 4846-4855. <a href="https://doi.org/10.1021/acs.joc.8b02909" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02909%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDeprotection%252Bof%252BN-Boc%252BGroups%252Bunder%252BContinuous-Flow%252BHigh-Temperature%252BConditions%26aulast%3DLi%26aufirst%3DBryan%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D10122018%26date%3D18012019%26date%3D08012019%26volume%3D84%26issue%3D8%26spage%3D4846%26epage%3D4855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Boshi Huang, Wenmin Chen, Tong Zhao, Zhenyu Li, Xiangyi Jiang, Tiziana Ginex, David Vílchez, Francisco Javier Luque, Dongwei Kang, Ping Gao, Jian Zhang, Ye Tian, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, <span class="NLM_string-name hlFld-ContribAuthor">Xinyong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 2083-2098. <a href="https://doi.org/10.1021/acs.jmedchem.8b01729" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01729%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploiting%252Bthe%252BTolerant%252BRegion%252BI%252Bof%252Bthe%252BNon-Nucleoside%252BReverse%252BTranscriptase%252BInhibitor%252B%252528NNRTI%252529%252BBinding%252BPocket%25253A%252BDiscovery%252Bof%252BPotent%252BDiarylpyrimidine-Typed%252BHIV-1%252BNNRTIs%252Bagainst%252BWild-Type%252Band%252BE138K%252BMutant%252BVirus%252Bwith%252BSignificantly%252BImproved%252BWater%252BSolubility%252Band%252BFavorable%252BSafety%252BProfiles%26aulast%3DHuang%26aufirst%3DBoshi%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D06112018%26date%3D20022019%26date%3D05022019%26volume%3D62%26issue%3D4%26spage%3D2083%26epage%3D2098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Robert    Dugger </span><span class="hlFld-ContribAuthor "> Bryan    Li    </span><span class="hlFld-ContribAuthor "> Paul    Richardson </span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Lorlatinib: A Macrocyclic Inhibitor of EML4-ALK for the Treatment of NSCLC. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 27-59. <a href="https://doi.org/10.1021/bk-2019-1332.ch002" title="DOI URL">https://doi.org/10.1021/bk-2019-1332.ch002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2019-1332.ch002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2019-1332.ch002%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BLorlatinib%25253A%252BA%252BMacrocyclic%252BInhibitor%252Bof%252BEML4-ALK%252Bfor%252Bthe%252BTreatment%252Bof%252BNSCLC%26aulast%3DDugger%26aufirst%3DRobert%26date%3D2019%26date%3D2019%26spage%3D27%26epage%3D59%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B2%26aulast%3DPesti%26aufirst%3DJaan%2BA.%26date%3D2019%26date%3D2019%26volume%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael Siu, Arundhati Sengupta Ghosh, <span class="NLM_string-name hlFld-ContribAuthor">Joseph W. Lewcock</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8078-8087. <a href="https://doi.org/10.1021/acs.jmedchem.8b00370" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00370%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BLeucine%252BZipper%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurodegeneration%26aulast%3DSiu%26aufirst%3DMichael%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08032018%26date%3D04062018%26volume%3D61%26issue%3D18%26spage%3D8078%26epage%3D8087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bryan Li, Richard W. Barnhart, Jacqui E. Hoffman, Asaad Nematalla, Jeffrey Raggon, Paul Richardson, Neal Sach, <span class="NLM_string-name hlFld-ContribAuthor">John Weaver</span>. </span><span class="cited-content_cbyCitation_article-title">Exploratory Process Development of Lorlatinib. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (9)
                                     , 1289-1293. <a href="https://doi.org/10.1021/acs.oprd.8b00210" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00210%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DExploratory%252BProcess%252BDevelopment%252Bof%252BLorlatinib%26aulast%3DLi%26aufirst%3DBryan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26062018%26date%3D14082018%26date%3D01082018%26volume%3D22%26issue%3D9%26spage%3D1289%26epage%3D1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ted W. Johnson, Rebecca A. Gallego, Alexei Brooun, Dan Gehlhaar, <span class="NLM_string-name hlFld-ContribAuthor">Michele McTigue</span>. </span><span class="cited-content_cbyCitation_article-title">Reviving B-Factors: Retrospective Normalized B-Factor Analysis of c-ros Oncogene 1 Receptor Tyrosine Kinase and Anaplastic Lymphoma Kinase L1196M with Crizotinib and Lorlatinib. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (9)
                                     , 878-883. <a href="https://doi.org/10.1021/acsmedchemlett.8b00147" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00147%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DReviving%252BB-Factors%25253A%252BRetrospective%252BNormalized%252BB-Factor%252BAnalysis%252Bof%252Bc-ros%252BOncogene%252B1%252BReceptor%252BTyrosine%252BKinase%252Band%252BAnaplastic%252BLymphoma%252BKinase%252BL1196M%252Bwith%252BCrizotinib%252Band%252BLorlatinib%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28032018%26date%3D18062018%26date%3D28082018%26date%3D18062018%26volume%3D9%26issue%3D9%26spage%3D878%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ted W. Johnson, Ben Bolanos, Alexei Brooun, Rebecca A. Gallego, Dan Gehlhaar, Mehran Jalaie, Michele McTigue, <span class="NLM_string-name hlFld-ContribAuthor">Sergei Timofeevski</span>. </span><span class="cited-content_cbyCitation_article-title">Reviving B-Factors: Activating ALK Mutations Increase Protein Dynamics of the Unphosphorylated Kinase. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (9)
                                     , 872-877. <a href="https://doi.org/10.1021/acsmedchemlett.8b00348" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00348%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DReviving%252BB-Factors%25253A%252BActivating%252BALK%252BMutations%252BIncrease%252BProtein%252BDynamics%252Bof%252Bthe%252BUnphosphorylated%252BKinase%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31072018%26date%3D24082018%26date%3D28082018%26date%3D24082018%26volume%3D9%26issue%3D9%26spage%3D872%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ted W. Johnson, Rebecca A. Gallego, <span class="NLM_string-name hlFld-ContribAuthor">Martin P. Edwards</span>. </span><span class="cited-content_cbyCitation_article-title">Lipophilic Efficiency as an Important Metric in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6401-6420. <a href="https://doi.org/10.1021/acs.jmedchem.8b00077" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00077%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLipophilic%252BEfficiency%252Bas%252Ban%252BImportant%252BMetric%252Bin%252BDrug%252BDesign%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16012018%26date%3D17042018%26date%3D28032018%26volume%3D61%26issue%3D15%26spage%3D6401%26epage%3D6420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Young, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Leeson</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6421-6467. <a href="https://doi.org/10.1021/acs.jmedchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMapping%252Bthe%252BEfficiency%252Band%252BPhysicochemical%252BTrajectories%252Bof%252BSuccessful%252BOptimizations%26aulast%3DYoung%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03022018%26date%3D25042018%26date%3D05042018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhen Chen, Yue Zhang, Jing Nie, <span class="NLM_string-name hlFld-ContribAuthor">Jun-An Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-Metal-Free [3 + 2] Cycloaddition of Nitroolefins and Diazoacetonitrile: A Facile Access to Multisubstituted Cyanopyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (7)
                                     , 2120-2124. <a href="https://doi.org/10.1021/acs.orglett.8b00729" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b00729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b00729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b00729%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTransition-Metal-Free%252B%25255B3%252B%25252B%252B2%25255D%252BCycloaddition%252Bof%252BNitroolefins%252Band%252BDiazoacetonitrile%25253A%252BA%252BFacile%252BAccess%252Bto%252BMultisubstituted%252BCyanopyrazoles%26aulast%3DChen%26aufirst%3DZhen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05032018%26date%3D26032018%26volume%3D20%26issue%3D7%26spage%3D2120%26epage%3D2124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiao Liu, Long Peng, Yifan Zhou, Youzhi Zhang, <span class="NLM_string-name hlFld-ContribAuthor">John Z. H. Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Alanine Scanning with Interaction Entropy for Protein–Ligand Binding Free Energies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2018,</strong> <em>14 </em>
                                    (3)
                                     , 1772-1780. <a href="https://doi.org/10.1021/acs.jctc.7b01295" title="DOI URL">https://doi.org/10.1021/acs.jctc.7b01295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.7b01295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.7b01295%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DComputational%252BAlanine%252BScanning%252Bwith%252BInteraction%252BEntropy%252Bfor%252BProtein%2525E2%252580%252593Ligand%252BBinding%252BFree%252BEnergies%26aulast%3DLiu%26aufirst%3DXiao%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30122017%26date%3D15022018%26date%3D06022018%26volume%3D14%26issue%3D3%26spage%3D1772%26epage%3D1780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinmee  Mah</span>, <span class="hlFld-ContribAuthor ">Jung Hee  Park</span>, <span class="hlFld-ContribAuthor ">Hoi-Yun  Jung</span>, <span class="hlFld-ContribAuthor ">Kukcheol  Ahn</span>, <span class="hlFld-ContribAuthor ">Soyeon  Choi</span>, <span class="hlFld-ContribAuthor ">Hyun Seop  Tae</span>, <span class="hlFld-ContribAuthor ">Kyung Hee  Jung</span>, <span class="hlFld-ContribAuthor ">Jin Kyung  Rho</span>, <span class="hlFld-ContribAuthor ">Jae Cheol  Lee</span>, <span class="hlFld-ContribAuthor ">Soon-Sun  Hong</span>, and <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9205-9221. <a href="https://doi.org/10.1021/acs.jmedchem.7b01039" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01039%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252B4-Phenoxyquinoline%252BBased%252BInhibitors%252Bfor%252BL1196M%252BMutant%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252Bby%252BStructure-Based%252BDesign%26aulast%3DMah%26aufirst%3DShinmee%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17072017%26date%3D09112017%26date%3D22112017%26date%3D01112017%26volume%3D60%26issue%3D22%26spage%3D9205%26epage%3D9221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengquan  Duan</span>, <span class="hlFld-ContribAuthor ">Bryan  Li</span>, <span class="hlFld-ContribAuthor ">Robert W.  Dugger</span>, <span class="hlFld-ContribAuthor ">Brian  Conway</span>, <span class="hlFld-ContribAuthor ">Rajesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Carlos  Martinez</span>, <span class="hlFld-ContribAuthor ">Teresa  Makowski</span>, <span class="hlFld-ContribAuthor ">Robert  Pearson</span>, <span class="hlFld-ContribAuthor ">Mark  Olivier</span>, and <span class="hlFld-ContribAuthor ">Roberto  Colon-Cruz</span>  . </span><span class="cited-content_cbyCitation_article-title">Developing an Asymmetric Transfer Hydrogenation Process for (S)-5-Fluoro-3-methylisobenzofuran-1(3H)-one, a Key Intermediate to Lorlatinib. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2017,</strong> <em>21 </em>
                                    (9)
                                     , 1340-1348. <a href="https://doi.org/10.1021/acs.oprd.7b00187" title="DOI URL">https://doi.org/10.1021/acs.oprd.7b00187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.7b00187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.7b00187%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDeveloping%252Ban%252BAsymmetric%252BTransfer%252BHydrogenation%252BProcess%252Bfor%252B%252528S%252529-5-Fluoro-3-methylisobenzofuran-1%2525283H%252529-one%25252C%252Ba%252BKey%252BIntermediate%252Bto%252BLorlatinib%26aulast%3DDuan%26aufirst%3DShengquan%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D26052017%26date%3D19072017%26date%3D15092017%26date%3D05072017%26volume%3D21%26issue%3D9%26spage%3D1340%26epage%3D1348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Philippe  Krieger</span>, <span class="hlFld-ContribAuthor ">Dominique  Lesuisse</span>, <span class="hlFld-ContribAuthor ">Gino  Ricci</span>, <span class="hlFld-ContribAuthor ">Marc-Antoine  Perrin</span>, <span class="hlFld-ContribAuthor ">Christophe  Meyer</span>, and <span class="hlFld-ContribAuthor ">Janine  Cossy</span>  . </span><span class="cited-content_cbyCitation_article-title">Rhodium(III)-Catalyzed C–H Activation/Heterocyclization as a Macrocyclization Strategy. Synthesis of Macrocyclic Pyridones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (10)
                                     , 2706-2709. <a href="https://doi.org/10.1021/acs.orglett.7b01051" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b01051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b01051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b01051%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRhodium%252528III%252529-Catalyzed%252BC%2525E2%252580%252593H%252BActivation%25252FHeterocyclization%252Bas%252Ba%252BMacrocyclization%252BStrategy.%252BSynthesis%252Bof%252BMacrocyclic%252BPyridones%26aulast%3DKrieger%26aufirst%3DJean-Philippe%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07042017%26date%3D09052017%26date%3D19052017%26volume%3D19%26issue%3D10%26spage%3D2706%26epage%3D2709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanxin  Tian</span>, <span class="hlFld-ContribAuthor ">Yonghuan  Yu</span>, <span class="hlFld-ContribAuthor ">Yudong  Shen</span>, <span class="hlFld-ContribAuthor ">Hua  Wan</span>, <span class="hlFld-ContribAuthor ">Shan  Chang</span>, <span class="hlFld-ContribAuthor ">Tingting  Zhang</span>, <span class="hlFld-ContribAuthor ">Shanhe  Wan</span>, and <span class="hlFld-ContribAuthor ">Jiajie  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Molecular Simulation Studies on the Binding Selectivity of Type-I Inhibitors in the Complexes with ROS1 versus ALK. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (4)
                                     , 977-987. <a href="https://doi.org/10.1021/acs.jcim.7b00019" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DMolecular%252BSimulation%252BStudies%252Bon%252Bthe%252BBinding%252BSelectivity%252Bof%252BType-I%252BInhibitors%252Bin%252Bthe%252BComplexes%252Bwith%252BROS1%252Bversus%252BALK%26aulast%3DTian%26aufirst%3DYuanxin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20012017%26date%3D29032017%26date%3D24042017%26date%3D20032017%26volume%3D57%26issue%3D4%26spage%3D977%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Planken</span>, <span class="hlFld-ContribAuthor ">Douglas C.  Behenna</span>, <span class="hlFld-ContribAuthor ">Sajiv K.  Nair</span>, <span class="hlFld-ContribAuthor ">Theodore O.  Johnson</span>, <span class="hlFld-ContribAuthor ">Asako  Nagata</span>, <span class="hlFld-ContribAuthor ">Chau  Almaden</span>, <span class="hlFld-ContribAuthor ">Simon  Bailey</span>, <span class="hlFld-ContribAuthor ">T. Eric  Ballard</span>, <span class="hlFld-ContribAuthor ">Louise  Bernier</span>, <span class="hlFld-ContribAuthor ">Hengmiao  Cheng</span>, <span class="hlFld-ContribAuthor ">Sujin  Cho-Schultz</span>, <span class="hlFld-ContribAuthor ">Deepak  Dalvie</span>, <span class="hlFld-ContribAuthor ">Judith G.  Deal</span>, <span class="hlFld-ContribAuthor ">Dac M.  Dinh</span>, <span class="hlFld-ContribAuthor ">Martin P.  Edwards</span>, <span class="hlFld-ContribAuthor ">Rose Ann  Ferre</span>, <span class="hlFld-ContribAuthor ">Ketan S.  Gajiwala</span>, <span class="hlFld-ContribAuthor ">Michelle  Hemkens</span>, <span class="hlFld-ContribAuthor ">Robert S.  Kania</span>, <span class="hlFld-ContribAuthor ">John C.  Kath</span>, <span class="hlFld-ContribAuthor ">Jean  Matthews</span>, <span class="hlFld-ContribAuthor ">Brion W.  Murray</span>, <span class="hlFld-ContribAuthor ">Sherry  Niessen</span>, <span class="hlFld-ContribAuthor ">Suvi T. M.  Orr</span>, <span class="hlFld-ContribAuthor ">Mason  Pairish</span>, <span class="hlFld-ContribAuthor ">Neal W.  Sach</span>, <span class="hlFld-ContribAuthor ">Hong  Shen</span>, <span class="hlFld-ContribAuthor ">Manli  Shi</span>, <span class="hlFld-ContribAuthor ">James  Solowiej</span>, <span class="hlFld-ContribAuthor ">Khanh  Tran</span>, <span class="hlFld-ContribAuthor ">Elaine  Tseng</span>, <span class="hlFld-ContribAuthor ">Paolo  Vicini</span>, <span class="hlFld-ContribAuthor ">Yuli  Wang</span>, <span class="hlFld-ContribAuthor ">Scott L.  Weinrich</span>, <span class="hlFld-ContribAuthor ">Ru  Zhou</span>, <span class="hlFld-ContribAuthor ">Michael  Zientek</span>, <span class="hlFld-ContribAuthor ">Longqing  Liu</span>, <span class="hlFld-ContribAuthor ">Yiqin  Luo</span>, <span class="hlFld-ContribAuthor ">Shuibo  Xin</span>, <span class="hlFld-ContribAuthor ">Chengyi  Zhang</span>, and <span class="hlFld-ContribAuthor ">Jennifer  Lafontaine</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 3002-3019. <a href="https://doi.org/10.1021/acs.jmedchem.6b01894" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01894</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01894%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%252528%2525283R%25252C4R%252529-4-Fluoro-1-%2525286-%252528%2525283-methoxy-1-methyl-1H-pyrazol-4-yl%252529amino%252529-9-methyl-9H-purin-2-yl%252529pyrrolidine-3-yl%252529acrylamide%252B%252528PF-06747775%252529%252Bthrough%252BStructure-Based%252BDrug%252BDesign%25253A%252BA%252BHigh%252BAffinity%252BIrreversible%252BInhibitor%252BTargeting%252BOncogenic%252BEGFR%252BMutants%252Bwith%252BSelectivity%252Bover%252BWild-Type%252BEGFR%26aulast%3DPlanken%26aufirst%3DSimon%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11012017%26date%3D29032017%26date%3D13042017%26date%3D13032017%26volume%3D60%26issue%3D7%26spage%3D3002%26epage%3D3019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer E.  Davoren</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Michelle  Garnsey</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Jason  Cordes</span>, <span class="hlFld-ContribAuthor ">Keith  Dlugolenski</span>, <span class="hlFld-ContribAuthor ">Jeremy R.  Edgerton</span>, <span class="hlFld-ContribAuthor ">Anthony R.  Harris</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Stephen  Jenkinson</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Terrence P.  Kenakin</span>, <span class="hlFld-ContribAuthor ">John T.  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Susan M.  Lotarski</span>, <span class="hlFld-ContribAuthor ">Yuxia  Mao</span>, <span class="hlFld-ContribAuthor ">Deane M.  Nason</span>, <span class="hlFld-ContribAuthor ">Carrie  Northcott</span>, <span class="hlFld-ContribAuthor ">Lisa  Nottebaum</span>, <span class="hlFld-ContribAuthor ">Steven V.  O’Neil</span>, <span class="hlFld-ContribAuthor ">Betty  Pettersen</span>, <span class="hlFld-ContribAuthor ">Michael  Popiolek</span>, <span class="hlFld-ContribAuthor ">Veronica  Reinhart</span>, <span class="hlFld-ContribAuthor ">Romelia  Salomon-Ferrer</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Damien  Webb</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, and <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6313-6328. <a href="https://doi.org/10.1021/acs.jmedchem.6b00544" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BPotent%252Band%252BSelective%252BM1%252BPAM-Agonist%252BN-%25255B%2525283R%25252C4S%252529-3-Hydroxytetrahydro-2H-pyran-4-yl%25255D-5-methyl-4-%25255B4-%2525281%25252C3-thiazol-4-yl%252529benzyl%25255Dpyridine-2-carboxamide%252B%252528PF-06767832%252529%25253A%252BEvaluation%252Bof%252BEfficacy%252Band%252BCholinergic%252BSide%252BEffects%26aulast%3DDavoren%26aufirst%3DJennifer%2BE.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11042016%26date%3D01072016%26date%3D14072016%26date%3D08062016%26volume%3D59%26issue%3D13%26spage%3D6313%26epage%3D6328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Sheng  Huang</span>, <span class="hlFld-ContribAuthor ">Shuangying  Liu</span>, <span class="hlFld-ContribAuthor ">Dong  Zou</span>, <span class="hlFld-ContribAuthor ">Mathew  Thomas</span>, <span class="hlFld-ContribAuthor ">Yihan  Wang</span>, <span class="hlFld-ContribAuthor ">Tianjun  Zhou</span>, <span class="hlFld-ContribAuthor ">Jan  Romero</span>, <span class="hlFld-ContribAuthor ">Anna  Kohlmann</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Jiwei  Qi</span>, <span class="hlFld-ContribAuthor ">Lisi  Cai</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Dwight</span>, <span class="hlFld-ContribAuthor ">Yongjin  Xu</span>, <span class="hlFld-ContribAuthor ">Rongsong  Xu</span>, <span class="hlFld-ContribAuthor ">Rory  Dodd</span>, <span class="hlFld-ContribAuthor ">Angela  Toms</span>, <span class="hlFld-ContribAuthor ">Lois  Parillon</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Lu</span>, <span class="hlFld-ContribAuthor ">Rana  Anjum</span>, <span class="hlFld-ContribAuthor ">Sen  Zhang</span>, <span class="hlFld-ContribAuthor ">Frank  Wang</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Keats</span>, <span class="hlFld-ContribAuthor ">Scott D.  Wardwell</span>, <span class="hlFld-ContribAuthor ">Yaoyu  Ning</span>, <span class="hlFld-ContribAuthor ">Qihong  Xu</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Moran</span>, <span class="hlFld-ContribAuthor ">Qurish K.  Mohemmad</span>, <span class="hlFld-ContribAuthor ">Hyun Gyung  Jang</span>, <span class="hlFld-ContribAuthor ">Tim  Clackson</span>, <span class="hlFld-ContribAuthor ">Narayana I.  Narasimhan</span>, <span class="hlFld-ContribAuthor ">Victor M.  Rivera</span>, <span class="hlFld-ContribAuthor ">Xiaotian  Zhu</span>, <span class="hlFld-ContribAuthor ">David  Dalgarno</span>, and <span class="hlFld-ContribAuthor ">William C.  Shakespeare</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4948-4964. <a href="https://doi.org/10.1021/acs.jmedchem.6b00306" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00306%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBrigatinib%252B%252528AP26113%252529%25252C%252Ba%252BPhosphine%252BOxide-Containing%25252C%252BPotent%25252C%252BOrally%252BActive%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%26aulast%3DHuang%26aufirst%3DWei-Sheng%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26022016%26date%3D12052016%26date%3D26052016%26date%3D04052016%26volume%3D59%26issue%3D10%26spage%3D4948%26epage%3D4964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chih-Hsiang  Tu</span>, <span class="hlFld-ContribAuthor ">Wen-Hsing  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Hui  Peng</span>, <span class="hlFld-ContribAuthor ">Tsu  Hsu</span>, <span class="hlFld-ContribAuthor ">Jian-Sung  Wu</span>, <span class="hlFld-ContribAuthor ">Chun-Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Cheng-Tai  Lu</span>, <span class="hlFld-ContribAuthor ">Ping-Chiang  Lyu</span>, <span class="hlFld-ContribAuthor ">Chuan  Shih</span>, <span class="hlFld-ContribAuthor ">Weir-Torn  Jiaang</span>, and <span class="hlFld-ContribAuthor ">Su-Ying  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3906-3919. <a href="https://doi.org/10.1021/acs.jmedchem.6b00106" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00106%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrazolylamine%252BDerivatives%252BReveal%252Bthe%252BConformational%252BSwitching%252Bbetween%252BType%252BI%252Band%252BType%252BII%252BBinding%252BModes%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DTu%26aufirst%3DChih-Hsiang%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D22012016%26date%3D12042016%26date%3D28042016%26date%3D31032016%26volume%3D59%26issue%3D8%26spage%3D3906%26epage%3D3919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saemina  Shin</span>, <span class="hlFld-ContribAuthor ">Shinmee  Mah</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>, and <span class="hlFld-ContribAuthor ">Hwangseo  Park</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Low Micromolar Dual Inhibitors for Wild Type and L1196M Mutant of Anaplastic Lymphoma Kinase through Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (4)
                                     , 802-810. <a href="https://doi.org/10.1021/acs.jcim.6b00026" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00026%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BLow%252BMicromolar%252BDual%252BInhibitors%252Bfor%252BWild%252BType%252Band%252BL1196M%252BMutant%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252Bthrough%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DShin%26aufirst%3DSaemina%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D20012016%26date%3D04042016%26date%3D25042016%26date%3D25032016%26volume%3D56%26issue%3D4%26spage%3D802%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Hatcher</span>, <span class="hlFld-ContribAuthor ">Magda  Bahcall</span>, <span class="hlFld-ContribAuthor ">Hwan Geun  Choi</span>, <span class="hlFld-ContribAuthor ">Yang  Gao</span>, <span class="hlFld-ContribAuthor ">Taebo  Sim</span>, <span class="hlFld-ContribAuthor ">Rani  George</span>, <span class="hlFld-ContribAuthor ">Pasi A.  Jänne</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance Mutation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (23)
                                     , 9296-9308. <a href="https://doi.org/10.1021/acs.jmedchem.5b01136" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01136%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BInhibitors%252BThat%252BOvercome%252Bthe%252BG1202R%252BAnaplastic%252BLymphoma%252BKinase%252BResistance%252BMutation%26aulast%3DHatcher%26aufirst%3DJohn%2BM.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10082015%26date%3D25112015%26date%3D10122015%26date%3D14112015%26volume%3D58%26issue%3D23%26spage%3D9296%26epage%3D9308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinsheng  Xiao</span>, <span class="hlFld-ContribAuthor ">Ying  Xie</span>, <span class="hlFld-ContribAuthor ">Siyi  Bai</span>, <span class="hlFld-ContribAuthor ">Yuanfu  Deng</span>, <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>, and <span class="hlFld-ContribAuthor ">Wei  Zeng</span>  . </span><span class="cited-content_cbyCitation_article-title">Transition-Metal-Free Tandem Chlorocyclization of Amines with Carboxylic Acids: Access to Chloroimidazo[1,2-α]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (16)
                                     , 3998-4001. <a href="https://doi.org/10.1021/acs.orglett.5b01868" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b01868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b01868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b01868%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTransition-Metal-Free%252BTandem%252BChlorocyclization%252Bof%252BAmines%252Bwith%252BCarboxylic%252BAcids%25253A%252BAccess%252Bto%252BChloroimidazo%25255B1%25252C2-%2525CE%2525B1%25255Dpyridines%26aulast%3DXiao%26aufirst%3DXinsheng%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D29062015%26date%3D31072015%26date%3D21082015%26volume%3D17%26issue%3D16%26spage%3D3998%26epage%3D4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>  . </span><span class="cited-content_cbyCitation_article-title">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2584-2608. <a href="https://doi.org/10.1021/jm501535r" title="DOI URL">https://doi.org/10.1021/jm501535r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501535r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCNS%252BDrug%252BDesign%25253A%252BBalancing%252BPhysicochemical%252BProperties%252Bfor%252BOptimal%252BBrain%252BExposure%26aulast%3DRankovic%26aufirst%3DZoran%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05102014%26date%3D06012015%26date%3D26032015%26date%3D11122014%26volume%3D58%26issue%3D6%26spage%3D2584%26epage%3D2608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R.  Butler</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Beck</span>, <span class="hlFld-ContribAuthor ">Gabriela  Barreiro</span>, <span class="hlFld-ContribAuthor ">Charles E.  Nolan</span>, <span class="hlFld-ContribAuthor ">Feng  Pan</span>, <span class="hlFld-ContribAuthor ">Felix  Vajdos</span>, <span class="hlFld-ContribAuthor ">Kevin  Parris</span>, <span class="hlFld-ContribAuthor ">Alison H.  Varghese</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Ricardo  Lira</span>, <span class="hlFld-ContribAuthor ">Shawn D.  Doran</span>, <span class="hlFld-ContribAuthor ">David R.  Riddell</span>, <span class="hlFld-ContribAuthor ">Leanne M.  Buzon</span>, <span class="hlFld-ContribAuthor ">Jason K.  Dutra</span>, <span class="hlFld-ContribAuthor ">Luis A.  Martinez-Alsina</span>, <span class="hlFld-ContribAuthor ">Kevin  Ogilvie</span>, <span class="hlFld-ContribAuthor ">John C.  Murray</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Young</span>, <span class="hlFld-ContribAuthor ">Kevin  Atchison</span>, <span class="hlFld-ContribAuthor ">Ashley  Robshaw</span>, <span class="hlFld-ContribAuthor ">Cathleen  Gonzales</span>, <span class="hlFld-ContribAuthor ">Jinlong  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Zhang</span>, and <span class="hlFld-ContribAuthor ">Brian T.  O’Neill</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2678-2702. <a href="https://doi.org/10.1021/jm501833t" title="DOI URL">https://doi.org/10.1021/jm501833t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501833t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252BEfficient%25252C%252BCentrally%252BEfficacious%252BBACE1%252BInhibitors%252Bthrough%252BStructure-Based%252BDrug%252BDesign%26aulast%3DButler%26aufirst%3DChristopher%2BR.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D26112014%26date%3D09032015%26date%3D26032015%26date%3D19022015%26volume%3D58%26issue%3D6%26spage%3D2678%26epage%3D2702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haoran  Zhang</span>, <span class="hlFld-ContribAuthor ">Lichuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Chenglong  Gao</span>, <span class="hlFld-ContribAuthor ">Rilei  Yu</span>, <span class="hlFld-ContribAuthor ">Congmin  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore screening, molecular docking, ADMET prediction and MD simulations for identification of ALK and MEK potential dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1245 </em>, 131066. <a href="https://doi.org/10.1016/j.molstruc.2021.131066" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131066%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DPharmacophore%252Bscreening%25252C%252Bmolecular%252Bdocking%25252C%252BADMET%252Bprediction%252Band%252BMD%252Bsimulations%252Bfor%252Bidentification%252Bof%252BALK%252Band%252BMEK%252Bpotential%252Bdual%252Binhibitors%26aulast%3DZhang%26aufirst%3DHaoran%26date%3D2021%26volume%3D1245%26spage%3D131066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor T.  Sabe</span>, <span class="hlFld-ContribAuthor ">Thandokuhle  Ntombela</span>, <span class="hlFld-ContribAuthor ">Lindiwe A.  Jhamba</span>, <span class="hlFld-ContribAuthor ">Glenn E.M.  Maguire</span>, <span class="hlFld-ContribAuthor ">Thavendran  Govender</span>, <span class="hlFld-ContribAuthor ">Tricia  Naicker</span>, <span class="hlFld-ContribAuthor ">Hendrik G.  Kruger</span>. </span><span class="cited-content_cbyCitation_article-title">Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113705. <a href="https://doi.org/10.1016/j.ejmech.2021.113705" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113705%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252Btrends%252Bin%252Bcomputer%252Baided%252Bdrug%252Bdesign%252Band%252Ba%252Bhighlight%252Bof%252Bdrugs%252Bdiscovered%252Bvia%252Bcomputational%252Btechniques%25253A%252BA%252Breview%26aulast%3DSabe%26aufirst%3DVictor%2BT.%26date%3D2021%26volume%3D224%26spage%3D113705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Wu</span>, <span class="hlFld-ContribAuthor ">Han  Yao</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Niuniu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangyang  Fan</span>, <span class="hlFld-ContribAuthor ">Albert S.C.  Chan</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing a sulfoxide moiety as anaplastic lymphoma kinase (ALK) inhibition agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>48 </em>, 128253. <a href="https://doi.org/10.1016/j.bmcl.2021.128253" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128253%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252B2%25252C4-diaminopyrimidines%252Bbearing%252Ba%252Bsulfoxide%252Bmoiety%252Bas%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibition%252Bagents%26aulast%3DWu%26aufirst%3DFeng%26date%3D2021%26volume%3D48%26spage%3D128253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Wu</span>, <span class="hlFld-ContribAuthor ">Changliang  He</span>, <span class="hlFld-ContribAuthor ">Lizi  Yin</span>, <span class="hlFld-ContribAuthor ">Funeng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhongqiong  Yin</span>, <span class="hlFld-ContribAuthor ">Guizhou  Yue</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Lixia  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Song</span>, <span class="hlFld-ContribAuthor ">Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Jing</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 105011. <a href="https://doi.org/10.1016/j.bioorg.2021.105011" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bsynthesis%252Breview%252Bof%252Bthe%252Bapproved%252Btyrosine%252Bkinase%252Binhibitors%252Bfor%252Banticancer%252Btherapy%252Bin%252B2015%2525E2%252580%2525932020%26aulast%3DLiang%26aufirst%3DXiaoxia%26date%3D2021%26volume%3D113%26spage%3D105011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Pan  Wu</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>, <span class="hlFld-ContribAuthor ">Yunyu  Xie</span>, <span class="hlFld-ContribAuthor ">Changliang  He</span>, <span class="hlFld-ContribAuthor ">Lizi  Yin</span>, <span class="hlFld-ContribAuthor ">Zhongqiong  Yin</span>, <span class="hlFld-ContribAuthor ">Guizhou  Yue</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Lixia  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Song</span>, <span class="hlFld-ContribAuthor ">Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Jing</span>. </span><span class="cited-content_cbyCitation_article-title">An update of new small-molecule anticancer drugs approved from 2015 to 2020. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113473. <a href="https://doi.org/10.1016/j.ejmech.2021.113473" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113473%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Bupdate%252Bof%252Bnew%252Bsmall-molecule%252Banticancer%252Bdrugs%252Bapproved%252Bfrom%252B2015%252Bto%252B2020%26aulast%3DLiang%26aufirst%3DXiaoxia%26date%3D2021%26volume%3D220%26spage%3D113473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Ando</span>, <span class="hlFld-ContribAuthor ">Ryo  Manabe</span>, <span class="hlFld-ContribAuthor ">Yasunari  Kishino</span>, <span class="hlFld-ContribAuthor ">Sojiro  Kusumoto</span>, <span class="hlFld-ContribAuthor ">Toshimitsu  Yamaoka</span>, <span class="hlFld-ContribAuthor ">Akihiko  Tanaka</span>, <span class="hlFld-ContribAuthor ">Tohru  Ohmori</span>, <span class="hlFld-ContribAuthor ">Hironori  Sagara</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative Efficacy and Safety of Lorlatinib and Alectinib for ALK-Rearrangement Positive Advanced Non-Small Cell Lung Cancer in Asian and Non-Asian Patients: A Systematic Review and Network Meta-Analysis. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (15)
                                     , 3704. <a href="https://doi.org/10.3390/cancers13153704" title="DOI URL">https://doi.org/10.3390/cancers13153704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13153704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13153704%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DComparative%252BEfficacy%252Band%252BSafety%252Bof%252BLorlatinib%252Band%252BAlectinib%252Bfor%252BALK-Rearrangement%252BPositive%252BAdvanced%252BNon-Small%252BCell%252BLung%252BCancer%252Bin%252BAsian%252Band%252BNon-Asian%252BPatients%25253A%252BA%252BSystematic%252BReview%252Band%252BNetwork%252BMeta-Analysis%26aulast%3DAndo%26aufirst%3DKoichi%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D15%26spage%3D3704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Liu</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Merguerian</span>, <span class="hlFld-ContribAuthor ">Steven P.  Rowe</span>, <span class="hlFld-ContribAuthor ">Christine A.  Pratilas</span>, <span class="hlFld-ContribAuthor ">Allen R.  Chen</span>, <span class="hlFld-ContribAuthor ">Brian H.  Ladle</span>. </span><span class="cited-content_cbyCitation_article-title">Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed
              ALK
              F1174L-mutated neuroblastoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Case Studies</span><span> <strong>2021,</strong> <em>7 </em>
                                    (4)
                                     , a006064. <a href="https://doi.org/10.1101/mcs.a006064" title="DOI URL">https://doi.org/10.1101/mcs.a006064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/mcs.a006064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fmcs.a006064%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Case%2520Studies%26atitle%3DExceptional%252Bresponse%252Bto%252Bthe%252BALK%252Band%252BROS1%252Binhibitor%252Blorlatinib%252Band%252Bsubsequent%252Bmechanism%252Bof%252Bresistance%252Bin%252Brelapsed%252BALK%252BF1174L-mutated%252Bneuroblastoma%26aulast%3DLiu%26aufirst%3DTingting%26date%3D2021%26date%3D2021%26volume%3D7%26issue%3D4%26spage%3Da006064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parmida Sadat  Pezeshki</span>, <span class="hlFld-ContribAuthor ">Aysan  Moeinafshar</span>, <span class="hlFld-ContribAuthor ">Faezeh  Ghaemdoust</span>, <span class="hlFld-ContribAuthor ">Sepideh  Razi</span>, <span class="hlFld-ContribAuthor ">Mahsa  Keshavarz-Fathi</span>, <span class="hlFld-ContribAuthor ">Nima  Rezaei</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in pharmacotherapy for neuroblastoma. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2021,</strong> <em>12 </em>, 1-22. <a href="https://doi.org/10.1080/14656566.2021.1953470" title="DOI URL">https://doi.org/10.1080/14656566.2021.1953470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2021.1953470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2021.1953470%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DAdvances%252Bin%252Bpharmacotherapy%252Bfor%252Bneuroblastoma%26aulast%3DPezeshki%26aufirst%3DParmida%2BSadat%26date%3D2021%26date%3D2021%26volume%3D12%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiping  Xu</span>, <span class="hlFld-ContribAuthor ">Melissa T.  O'Gorman</span>, <span class="hlFld-ContribAuthor ">Sunil  Nepal</span>, <span class="hlFld-ContribAuthor ">Lee P.  James</span>, <span class="hlFld-ContribAuthor ">Katherine  Ginman</span>, <span class="hlFld-ContribAuthor ">Yazdi K.  Pithavala</span>. </span><span class="cited-content_cbyCitation_article-title">Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2021,</strong> <em>448 </em><a href="https://doi.org/10.1002/cpdd.1000" title="DOI URL">https://doi.org/10.1002/cpdd.1000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.1000%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DPhase%252B1%252BStudy%252BEvaluating%252Bthe%252BEffects%252Bof%252Bthe%252BProton%252BPump%252BInhibitor%252BRabeprazole%252Band%252BFood%252Bon%252Bthe%252BPharmacokinetics%252Bof%252BLorlatinib%252Bin%252BHealthy%252BParticipants%26aulast%3DXu%26aufirst%3DHuiping%26date%3D2021%26date%3D2021%26volume%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilaria  Attili</span>, <span class="hlFld-ContribAuthor ">Marzia  Del Re</span>, <span class="hlFld-ContribAuthor ">Elena  Guerini-Rocco</span>, <span class="hlFld-ContribAuthor ">Stefania  Crucitta</span>, <span class="hlFld-ContribAuthor ">Pasquale  Pisapia</span>, <span class="hlFld-ContribAuthor ">Francesco  Pepe</span>, <span class="hlFld-ContribAuthor ">Massimo  Barberis</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Troncone</span>, <span class="hlFld-ContribAuthor ">Romano  Danesi</span>, <span class="hlFld-ContribAuthor ">Filippo  de Marinis</span>, <span class="hlFld-ContribAuthor ">Umberto  Malapelle</span>, <span class="hlFld-ContribAuthor ">Antonio  Passaro</span>. </span><span class="cited-content_cbyCitation_article-title">The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Molecular Diagnostics</span><span> <strong>2021,</strong> <em>11 </em>, 1-10. <a href="https://doi.org/10.1080/14737159.2021.1943365" title="DOI URL">https://doi.org/10.1080/14737159.2021.1943365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737159.2021.1943365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737159.2021.1943365%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Molecular%2520Diagnostics%26atitle%3DThe%252Brole%252Bof%252Bmolecular%252Bheterogeneity%252Btargeting%252Bresistance%252Bmechanisms%252Bto%252Blung%252Bcancer%252Btherapies%26aulast%3DAttili%26aufirst%3DIlaria%26date%3D2021%26date%3D2021%26volume%3D11%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elodie  Jouan</span>, <span class="hlFld-ContribAuthor ">Amélie  Moreau</span>, <span class="hlFld-ContribAuthor ">Arnaud  Bruyere</span>, <span class="hlFld-ContribAuthor ">Karima  Alim</span>, <span class="hlFld-ContribAuthor ">Claire  Denizot</span>, <span class="hlFld-ContribAuthor ">Yannick  Parmentier</span>, <span class="hlFld-ContribAuthor ">Olivier  Fardel</span>. </span><span class="cited-content_cbyCitation_article-title">Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Drug Metabolism and Pharmacokinetics</span><span> <strong>2021,</strong> <em>447 </em><a href="https://doi.org/10.1007/s13318-021-00703-2" title="DOI URL">https://doi.org/10.1007/s13318-021-00703-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13318-021-00703-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13318-021-00703-2%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Drug%2520Metabolism%2520and%2520Pharmacokinetics%26atitle%3DDifferential%252BInhibition%252Bof%252BEquilibrative%252BNucleoside%252BTransporter%252B1%252B%252528ENT1%252529%252BActivity%252Bby%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DJouan%26aufirst%3DElodie%26date%3D2021%26date%3D2021%26volume%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip  Cohen</span>, <span class="hlFld-ContribAuthor ">Darren  Cross</span>, <span class="hlFld-ContribAuthor ">Pasi A.  Jänne</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase drug discovery 20 years after imatinib: progress and future directions. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2021,</strong> <em>20 </em>
                                    (7)
                                     , 551-569. <a href="https://doi.org/10.1038/s41573-021-00195-4" title="DOI URL">https://doi.org/10.1038/s41573-021-00195-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-021-00195-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-021-00195-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DKinase%252Bdrug%252Bdiscovery%252B20%252Byears%252Bafter%252Bimatinib%25253A%252Bprogress%252Band%252Bfuture%252Bdirections%26aulast%3DCohen%26aufirst%3DPhilip%26date%3D2021%26date%3D2021%26volume%3D20%26issue%3D7%26spage%3D551%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph  Chen</span>, <span class="hlFld-ContribAuthor ">Ana  Ruiz‐Garcia</span>, <span class="hlFld-ContribAuthor ">Leonard P.  James</span>, <span class="hlFld-ContribAuthor ">Gerson  Peltz</span>, <span class="hlFld-ContribAuthor ">Holger  Thurm</span>, <span class="hlFld-ContribAuthor ">Jill  Clancy</span>, <span class="hlFld-ContribAuthor ">Jennifer  Hibma</span>. </span><span class="cited-content_cbyCitation_article-title">Lorlatinib Exposure‐Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit–Risk Assessment in Non‐Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1002/cpt.2228" title="DOI URL">https://doi.org/10.1002/cpt.2228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpt.2228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpt.2228%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DLorlatinib%252BExposure%2525E2%252580%252590Response%252BAnalyses%252Bfor%252BSafety%252Band%252BEfficacy%252Bin%252Ba%252BPhase%252BI%25252FII%252BTrial%252Bto%252BSupport%252BBenefit%2525E2%252580%252593Risk%252BAssessment%252Bin%252BNon%2525E2%252580%252590Small%252BCell%252BLung%252BCancer%26aulast%3DChen%26aufirst%3DJoseph%26date%3D2021%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoki  Haratake</span>, <span class="hlFld-ContribAuthor ">Gouji  Toyokawa</span>, <span class="hlFld-ContribAuthor ">Takashi  Seto</span>, <span class="hlFld-ContribAuthor ">Tetsuzo  Tagawa</span>, <span class="hlFld-ContribAuthor ">Tasuro  Okamoto</span>, <span class="hlFld-ContribAuthor ">Koji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Sadanori  Takeo</span>, <span class="hlFld-ContribAuthor ">Masaki  Mori</span>. </span><span class="cited-content_cbyCitation_article-title">The mechanisms of resistance to second- and third-generation ALK inhibitors and strategies to overcome such resistance. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2021,</strong> <em>26 </em>, 1-14. <a href="https://doi.org/10.1080/14737140.2021.1940964" title="DOI URL">https://doi.org/10.1080/14737140.2021.1940964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2021.1940964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2021.1940964%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DThe%252Bmechanisms%252Bof%252Bresistance%252Bto%252Bsecond-%252Band%252Bthird-generation%252BALK%252Binhibitors%252Band%252Bstrategies%252Bto%252Bovercome%252Bsuch%252Bresistance%26aulast%3DHaratake%26aufirst%3DNaoki%26date%3D2021%26date%3D2021%26volume%3D26%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debasis  Das</span>, <span class="hlFld-ContribAuthor ">Jingbing  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Next‐Generation Kinase Inhibitors Targeting Specific Biomarkers in Non‐Small Cell Lung Cancer (NSCLC): A Recent Overview. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>71 </em><a href="https://doi.org/10.1002/cmdc.202100166" title="DOI URL">https://doi.org/10.1002/cmdc.202100166</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100166%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNext%2525E2%252580%252590Generation%252BKinase%252BInhibitors%252BTargeting%252BSpecific%252BBiomarkers%252Bin%252BNon%2525E2%252580%252590Small%252BCell%252BLung%252BCancer%252B%252528NSCLC%252529%25253A%252BA%252BRecent%252BOverview%26aulast%3DDas%26aufirst%3DDebasis%26date%3D2021%26date%3D2021%26volume%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serena  Ceddia</span>, <span class="hlFld-ContribAuthor ">Giovanni  Codacci-Pisanelli</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of brain metastases in ALK-positive Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Oncology/Hematology</span><span> <strong>2021,</strong> <em>12 </em>, 103400. <a href="https://doi.org/10.1016/j.critrevonc.2021.103400" title="DOI URL">https://doi.org/10.1016/j.critrevonc.2021.103400</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.critrevonc.2021.103400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.critrevonc.2021.103400%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Oncology%252FHematology%26atitle%3DTreatment%252Bof%252Bbrain%252Bmetastases%252Bin%252BALK-positive%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DCeddia%26aufirst%3DSerena%26date%3D2021%26volume%3D12%26spage%3D103400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerry  Li</span>, <span class="hlFld-ContribAuthor ">Yazdi K.  Pithavala</span>, <span class="hlFld-ContribAuthor ">Jason  Gong</span>, <span class="hlFld-ContribAuthor ">Robert R.  LaBadie</span>, <span class="hlFld-ContribAuthor ">Josué Kunjom  Mfopou</span>, <span class="hlFld-ContribAuthor ">Joseph  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2021,</strong> <em>57 </em><a href="https://doi.org/10.1007/s40262-021-01026-w" title="DOI URL">https://doi.org/10.1007/s40262-021-01026-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-021-01026-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-021-01026-w%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DThe%252BEffect%252Bof%252BModafinil%252Bon%252Bthe%252BSafety%252Band%252BPharmacokinetics%252Bof%252BLorlatinib%25253A%252BA%252BPhase%252BI%252BStudy%252Bin%252BHealthy%252BParticipants%26aulast%3DLi%26aufirst%3DJerry%26date%3D2021%26date%3D2021%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph  Chen</span>, <span class="hlFld-ContribAuthor ">Melissa T.  O’Gorman</span>, <span class="hlFld-ContribAuthor ">Lee P.  James</span>, <span class="hlFld-ContribAuthor ">Karen J.  Klamerus</span>, <span class="hlFld-ContribAuthor ">Ganesh  Mugundu</span>, <span class="hlFld-ContribAuthor ">Yazdi K.  Pithavala</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics of Lorlatinib After Single and Multiple Dosing in Patients with Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer: Results from a Global Phase I/II Study. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2021,</strong> <em>79 </em><a href="https://doi.org/10.1007/s40262-021-01015-z" title="DOI URL">https://doi.org/10.1007/s40262-021-01015-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-021-01015-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-021-01015-z%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DPharmacokinetics%252Bof%252BLorlatinib%252BAfter%252BSingle%252Band%252BMultiple%252BDosing%252Bin%252BPatients%252Bwith%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529-Positive%252BNon-Small%252BCell%252BLung%252BCancer%25253A%252BResults%252Bfrom%252Ba%252BGlobal%252BPhase%252BI%25252FII%252BStudy%26aulast%3DChen%26aufirst%3DJoseph%26date%3D2021%26date%3D2021%26volume%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  Felip</span>, <span class="hlFld-ContribAuthor ">A.T.  Shaw</span>, <span class="hlFld-ContribAuthor ">A.  Bearz</span>, <span class="hlFld-ContribAuthor ">D.R.  Camidge</span>, <span class="hlFld-ContribAuthor ">B.J.  Solomon</span>, <span class="hlFld-ContribAuthor ">J.R.  Bauman</span>, <span class="hlFld-ContribAuthor ">T.M.  Bauer</span>, <span class="hlFld-ContribAuthor ">S.  Peters</span>, <span class="hlFld-ContribAuthor ">F.  Toffalorio</span>, <span class="hlFld-ContribAuthor ">A.  Abbattista</span>, <span class="hlFld-ContribAuthor ">H.  Thurm</span>, <span class="hlFld-ContribAuthor ">G.  Peltz</span>, <span class="hlFld-ContribAuthor ">R.  Wiltshire</span>, <span class="hlFld-ContribAuthor ">B.  Besse</span>. </span><span class="cited-content_cbyCitation_article-title">Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs. </span><span class="cited-content_cbyCitation_journal-name">Annals of Oncology</span><span> <strong>2021,</strong> <em>32 </em>
                                    (5)
                                     , 620-630. <a href="https://doi.org/10.1016/j.annonc.2021.02.012" title="DOI URL">https://doi.org/10.1016/j.annonc.2021.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.annonc.2021.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.annonc.2021.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Oncology%26atitle%3DIntracranial%252Band%252Bextracranial%252Befficacy%252Bof%252Blorlatinib%252Bin%252Bpatients%252Bwith%252BALK-positive%252Bnon-small-cell%252Blung%252Bcancer%252Bpreviously%252Btreated%252Bwith%252Bsecond-generation%252BALK%252BTKIs%26aulast%3DFelip%26aufirst%3DE.%26date%3D2021%26volume%3D32%26issue%3D5%26spage%3D620%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingfeng  Yu</span>, <span class="hlFld-ContribAuthor ">Solomon  Tadesse</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">US FDA‐Approved Small‐Molecule Kinase Inhibitors for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-65. <a href="https://doi.org/10.1002/0471266949.bmc214.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc214.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc214.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc214.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DUS%252BFDA%2525E2%252580%252590Approved%252BSmall%2525E2%252580%252590Molecule%252BKinase%252BInhibitors%252Bfor%252BCancer%252BTherapy%26aulast%3DYu%26aufirst%3DMingfeng%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D65%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Hakamata</span>, <span class="hlFld-ContribAuthor ">Hideo  Nakada</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Muramatsu</span>, <span class="hlFld-ContribAuthor ">Keita  Masuzawa</span>, <span class="hlFld-ContribAuthor ">Hideki  Terai</span>, <span class="hlFld-ContribAuthor ">Shinnosuke  Ikemura</span>, <span class="hlFld-ContribAuthor ">Koichi  Fukunaga</span>, <span class="hlFld-ContribAuthor ">Tohru  Aomori</span>. </span><span class="cited-content_cbyCitation_article-title">Lorlatinib‐induced visual and auditory hallucinations: A case report. </span><span class="cited-content_cbyCitation_journal-name">Clinical Case Reports</span><span> <strong>2021,</strong> <em>14 </em><a href="https://doi.org/10.1002/ccr3.4040" title="DOI URL">https://doi.org/10.1002/ccr3.4040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ccr3.4040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fccr3.4040%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Case%2520Reports%26atitle%3DLorlatinib%2525E2%252580%252590induced%252Bvisual%252Band%252Bauditory%252Bhallucinations%25253A%252BA%252Bcase%252Breport%26aulast%3DHakamata%26aufirst%3DJun%26date%3D2021%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Misako  Nagasaka</span>, <span class="hlFld-ContribAuthor ">Sai-Hong Ignatius  Ou</span>. </span><span class="cited-content_cbyCitation_article-title">Lorlatinib Should Be Considered as the Preferred First-Line Option in Patients With Advanced ALK-Rearranged NSCLC. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thoracic Oncology</span><span> <strong>2021,</strong> <em>16 </em>
                                    (4)
                                     , 532-536. <a href="https://doi.org/10.1016/j.jtho.2020.12.021" title="DOI URL">https://doi.org/10.1016/j.jtho.2020.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtho.2020.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtho.2020.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thoracic%2520Oncology%26atitle%3DLorlatinib%252BShould%252BBe%252BConsidered%252Bas%252Bthe%252BPreferred%252BFirst-Line%252BOption%252Bin%252BPatients%252BWith%252BAdvanced%252BALK-Rearranged%252BNSCLC%26aulast%3DNagasaka%26aufirst%3DMisako%26date%3D2021%26volume%3D16%26issue%3D4%26spage%3D532%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jordi  Remon</span>, <span class="hlFld-ContribAuthor ">Daniele  Pignataro</span>, <span class="hlFld-ContribAuthor ">Silvia  Novello</span>, <span class="hlFld-ContribAuthor ">Francesco  Passiglia</span>. </span><span class="cited-content_cbyCitation_article-title">Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Treatment Reviews</span><span> <strong>2021,</strong> <em>95 </em>, 102178. <a href="https://doi.org/10.1016/j.ctrv.2021.102178" title="DOI URL">https://doi.org/10.1016/j.ctrv.2021.102178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ctrv.2021.102178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ctrv.2021.102178%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Treatment%2520Reviews%26atitle%3DCurrent%252Btreatment%252Band%252Bfuture%252Bchallenges%252Bin%252BROS1-%252Band%252BALK-rearranged%252Badvanced%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DRemon%26aufirst%3DJordi%26date%3D2021%26volume%3D95%26spage%3D102178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoyo  Taketa</span>, <span class="hlFld-ContribAuthor ">Takahito  Nakamura</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy of lorlatinib treatment in
              ALK
              rearrangement lung cancer with severe symptomatic central nervous system metastases and poor performance status. </span><span class="cited-content_cbyCitation_journal-name">Clinical Case Reports</span><span> <strong>2021,</strong> <em>9 </em>
                                    (4)
                                     , 2007-2010. <a href="https://doi.org/10.1002/ccr3.3927" title="DOI URL">https://doi.org/10.1002/ccr3.3927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ccr3.3927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fccr3.3927%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Case%2520Reports%26atitle%3DEfficacy%252Bof%252Blorlatinib%252Btreatment%252Bin%252BALK%252Brearrangement%252Blung%252Bcancer%252Bwith%252Bsevere%252Bsymptomatic%252Bcentral%252Bnervous%252Bsystem%252Bmetastases%252Band%252Bpoor%252Bperformance%252Bstatus%26aulast%3DTaketa%26aufirst%3DTomoyo%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D4%26spage%3D2007%26epage%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shitian  Jiang</span>, <span class="hlFld-ContribAuthor ">Yingxue  Jin</span>, <span class="hlFld-ContribAuthor ">Rui  Yan</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Detailed structural study of cyclic anticancer drug Lorlatinib: spectroscopic and stereostructure investigation (IR, ECD and NMR) using density functional theory approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1225 </em>, 129295. <a href="https://doi.org/10.1016/j.molstruc.2020.129295" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129295%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DDetailed%252Bstructural%252Bstudy%252Bof%252Bcyclic%252Banticancer%252Bdrug%252BLorlatinib%25253A%252Bspectroscopic%252Band%252Bstereostructure%252Binvestigation%252B%252528IR%25252C%252BECD%252Band%252BNMR%252529%252Busing%252Bdensity%252Bfunctional%252Btheory%252Bapproach%26aulast%3DJiang%26aufirst%3DShitian%26date%3D2021%26volume%3D1225%26spage%3D129295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabeth  Smolle</span>, <span class="hlFld-ContribAuthor ">Valentin  Taucher</span>, <span class="hlFld-ContribAuthor ">Joerg  Lindenmann</span>, <span class="hlFld-ContribAuthor ">Philipp J.  Jost</span>, <span class="hlFld-ContribAuthor ">Martin  Pichler</span>. </span><span class="cited-content_cbyCitation_article-title">Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 699. <a href="https://doi.org/10.3390/cancers13040699" title="DOI URL">https://doi.org/10.3390/cancers13040699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13040699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13040699%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCurrent%252BKnowledge%252Babout%252BMechanisms%252Bof%252BDrug%252BResistance%252Bagainst%252BALK%252BInhibitors%252Bin%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DSmolle%26aufirst%3DElisabeth%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  König</span>, <span class="hlFld-ContribAuthor ">Spasenija  Savic Prince</span>, <span class="hlFld-ContribAuthor ">Sacha I.  Rothschild</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 804. <a href="https://doi.org/10.3390/cancers13040804" title="DOI URL">https://doi.org/10.3390/cancers13040804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13040804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13040804%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeted%252BTherapy%252Bin%252BAdvanced%252Band%252BMetastatic%252BNon-Small%252BCell%252BLung%252BCancer.%252BAn%252BUpdate%252Bon%252BTreatment%252Bof%252Bthe%252BMost%252BImportant%252BActionable%252BOncogenic%252BDriver%252BAlterations%26aulast%3DK%25C3%25B6nig%26aufirst%3DDavid%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei  Elsayed</span>, <span class="hlFld-ContribAuthor ">Petros  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Sequencing in ALK+ NSCLC. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (2)
                                     , 80. <a href="https://doi.org/10.3390/ph14020080" title="DOI URL">https://doi.org/10.3390/ph14020080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14020080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14020080%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DTherapeutic%252BSequencing%252Bin%252BALK%25252B%252BNSCLC%26aulast%3DElsayed%26aufirst%3DMei%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D2%26spage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayachandra  Rayadurgam</span>, <span class="hlFld-ContribAuthor ">Sravani  Sana</span>, <span class="hlFld-ContribAuthor ">M.  Sasikumar</span>, <span class="hlFld-ContribAuthor ">Qiong  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium catalyzed C–C and C–N bond forming reactions: an update on the synthesis of pharmaceuticals from 2015–2020. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (2)
                                     , 384-414. <a href="https://doi.org/10.1039/D0QO01146K" title="DOI URL">https://doi.org/10.1039/D0QO01146K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01146K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01146K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DPalladium%252Bcatalyzed%252BC%2525E2%252580%252593C%252Band%252BC%2525E2%252580%252593N%252Bbond%252Bforming%252Breactions%25253A%252Ban%252Bupdate%252Bon%252Bthe%252Bsynthesis%252Bof%252Bpharmaceuticals%252Bfrom%252B2015%2525E2%252580%2525932020%26aulast%3DRayadurgam%26aufirst%3DJayachandra%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D2%26spage%3D384%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Tabbò</span>, <span class="hlFld-ContribAuthor ">Francesco  Passiglia</span>, <span class="hlFld-ContribAuthor ">Silvia  Novello</span>. </span><span class="cited-content_cbyCitation_article-title">Upfront Management of ALK-Rearranged Metastatic Non-small Cell Lung Cancer: One Inhibitor Fits All?. </span><span class="cited-content_cbyCitation_journal-name">Current Oncology Reports</span><span> <strong>2021,</strong> <em>23 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s11912-020-00989-6" title="DOI URL">https://doi.org/10.1007/s11912-020-00989-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11912-020-00989-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11912-020-00989-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Oncology%2520Reports%26atitle%3DUpfront%252BManagement%252Bof%252BALK-Rearranged%252BMetastatic%252BNon-small%252BCell%252BLung%252BCancer%25253A%252BOne%252BInhibitor%252BFits%252BAll%25253F%26aulast%3DTabb%25C3%25B2%26aufirst%3DFabrizio%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gonzalo  Recondo</span>, <span class="hlFld-ContribAuthor ">Luc  Friboulet</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic strategies to overcome ALK resistance in lung cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 123-139. <a href="https://doi.org/10.1016/B978-0-12-821774-0.00004-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-821774-0.00004-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821774-0.00004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821774-0.00004-8%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252Bstrategies%252Bto%252Bovercome%252BALK%252Bresistance%252Bin%252Blung%252Bcancer%26aulast%3DRecondo%26aufirst%3DGonzalo%26date%3D2021%26spage%3D123%26epage%3D139%26pub%3DElsevier%26atitle%3DTherapeutic%252BStrategies%252Bto%252BOvercome%252BALK%252BResistance%252Bin%252BCancer%26date%3D2021%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Collazo-Lorduy</span>, <span class="hlFld-ContribAuthor ">Beatriz  Jiménez</span>, <span class="hlFld-ContribAuthor ">María  Castro-Henriques</span>, <span class="hlFld-ContribAuthor ">Jordi  Remon</span>. </span><span class="cited-content_cbyCitation_article-title">ALK rearranged lung cancer: TKI treatment and outcome. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 31-53. <a href="https://doi.org/10.1016/B978-0-12-821774-0.00013-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-821774-0.00013-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821774-0.00013-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821774-0.00013-9%26sid%3Dliteratum%253Aachs%26atitle%3DALK%252Brearranged%252Blung%252Bcancer%25253A%252BTKI%252Btreatment%252Band%252Boutcome%26aulast%3DCollazo-Lorduy%26aufirst%3DAna%26date%3D2021%26spage%3D31%26epage%3D53%26pub%3DElsevier%26atitle%3DTherapeutic%252BStrategies%252Bto%252BOvercome%252BALK%252BResistance%252Bin%252BCancer%26date%3D2021%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinayak  Palve</span>, <span class="hlFld-ContribAuthor ">Yi  Liao</span>, <span class="hlFld-ContribAuthor ">Lily L.  Remsing Rix</span>, <span class="hlFld-ContribAuthor ">Uwe  Rix</span>. </span><span class="cited-content_cbyCitation_article-title">Turning liabilities into opportunities: Off-target based drug repurposing in cancer. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2021,</strong> <em>68 </em>, 209-229. <a href="https://doi.org/10.1016/j.semcancer.2020.02.003" title="DOI URL">https://doi.org/10.1016/j.semcancer.2020.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2020.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2020.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DTurning%252Bliabilities%252Binto%252Bopportunities%25253A%252BOff-target%252Bbased%252Bdrug%252Brepurposing%252Bin%252Bcancer%26aulast%3DPalve%26aufirst%3DVinayak%26date%3D2021%26volume%3D68%26spage%3D209%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoyuki  Naito</span>, <span class="hlFld-ContribAuthor ">Hideaki  Shiraishi</span>, <span class="hlFld-ContribAuthor ">Yutaka  Fujiwara</span>. </span><span class="cited-content_cbyCitation_article-title">Brigatinib and lorlatinib: their effect on ALK inhibitors in NSCLC focusing on resistant mutations and central nervous system metastases. </span><span class="cited-content_cbyCitation_journal-name">Japanese Journal of Clinical Oncology</span><span> <strong>2021,</strong> <em>51 </em>
                                    (1)
                                     , 37-44. <a href="https://doi.org/10.1093/jjco/hyaa192" title="DOI URL">https://doi.org/10.1093/jjco/hyaa192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jjco/hyaa192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjjco%2Fhyaa192%26sid%3Dliteratum%253Aachs%26jtitle%3DJapanese%2520Journal%2520of%2520Clinical%2520Oncology%26atitle%3DBrigatinib%252Band%252Blorlatinib%25253A%252Btheir%252Beffect%252Bon%252BALK%252Binhibitors%252Bin%252BNSCLC%252Bfocusing%252Bon%252Bresistant%252Bmutations%252Band%252Bcentral%252Bnervous%252Bsystem%252Bmetastases%26aulast%3DNaito%26aufirst%3DTomoyuki%26date%3D2021%26date%3D2020%26volume%3D51%26issue%3D1%26spage%3D37%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Target Validation—Prosecuting the Target. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00014-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00014-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00014-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00014-1%26sid%3Dliteratum%253Aachs%26atitle%3DTarget%252BValidation%2525E2%252580%252594Prosecuting%252Bthe%252BTarget%26aulast%3DJones%26aufirst%3DLyn%2BH.%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah Naomi  Bolz</span>, <span class="hlFld-ContribAuthor ">Sebastian  Salentin</span>, <span class="hlFld-ContribAuthor ">Gary  Jennings</span>, <span class="hlFld-ContribAuthor ">V. Joachim  Haupt</span>, <span class="hlFld-ContribAuthor ">Jared  Sterneckert</span>, <span class="hlFld-ContribAuthor ">Michael  Schroeder</span>. </span><span class="cited-content_cbyCitation_article-title">Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2021,</strong> <em>19 </em>, 3674-3681. <a href="https://doi.org/10.1016/j.csbj.2021.06.013" title="DOI URL">https://doi.org/10.1016/j.csbj.2021.06.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2021.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2021.06.013%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DStructural%252Bbinding%252Bsite%252Bcomparisons%252Breveal%252BCrizotinib%252Bas%252Ba%252Bnovel%252BLRRK2%252Binhibitor%26aulast%3DBolz%26aufirst%3DSarah%2BNaomi%26date%3D2021%26volume%3D19%26spage%3D3674%26epage%3D3681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Haibo  Sun</span>, <span class="hlFld-ContribAuthor ">Laixue  Pang</span>, <span class="hlFld-ContribAuthor ">Baohua  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Mutation-mediated influences on binding of anaplastic lymphoma kinase to crizotinib decoded by multiple replica Gaussian accelerated molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2020,</strong> <em>34 </em>
                                    (12)
                                     , 1289-1305. <a href="https://doi.org/10.1007/s10822-020-00355-5" title="DOI URL">https://doi.org/10.1007/s10822-020-00355-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-020-00355-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-020-00355-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DMutation-mediated%252Binfluences%252Bon%252Bbinding%252Bof%252Banaplastic%252Blymphoma%252Bkinase%252Bto%252Bcrizotinib%252Bdecoded%252Bby%252Bmultiple%252Breplica%252BGaussian%252Baccelerated%252Bmolecular%252Bdynamics%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D12%26spage%3D1289%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice T.  Shaw</span>, <span class="hlFld-ContribAuthor ">Todd M.  Bauer</span>, <span class="hlFld-ContribAuthor ">Filippo  de Marinis</span>, <span class="hlFld-ContribAuthor ">Enriqueta  Felip</span>, <span class="hlFld-ContribAuthor ">Yasushi  Goto</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Liu</span>, <span class="hlFld-ContribAuthor ">Julien  Mazieres</span>, <span class="hlFld-ContribAuthor ">Dong-Wan  Kim</span>, <span class="hlFld-ContribAuthor ">Tony  Mok</span>, <span class="hlFld-ContribAuthor ">Anna  Polli</span>, <span class="hlFld-ContribAuthor ">Holger  Thurm</span>, <span class="hlFld-ContribAuthor ">Anna M.  Calella</span>, <span class="hlFld-ContribAuthor ">Gerson  Peltz</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Solomon</span>. </span><span class="cited-content_cbyCitation_article-title">First-Line Lorlatinib or Crizotinib in Advanced
              ALK
              -Positive Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">New England Journal of Medicine</span><span> <strong>2020,</strong> <em>383 </em>
                                    (21)
                                     , 2018-2029. <a href="https://doi.org/10.1056/NEJMoa2027187" title="DOI URL">https://doi.org/10.1056/NEJMoa2027187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1056/NEJMoa2027187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1056%2FNEJMoa2027187%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520England%2520Journal%2520of%2520Medicine%26atitle%3DFirst-Line%252BLorlatinib%252Bor%252BCrizotinib%252Bin%252BAdvanced%252BALK%252B-Positive%252BLung%252BCancer%26aulast%3DShaw%26aufirst%3DAlice%2BT.%26date%3D2020%26volume%3D383%26issue%3D21%26spage%3D2018%26epage%3D2029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Di</span>, <span class="hlFld-ContribAuthor ">Per  Artursson</span>, <span class="hlFld-ContribAuthor ">Alex  Avdeef</span>, <span class="hlFld-ContribAuthor ">Leslie Z.  Benet</span>, <span class="hlFld-ContribAuthor ">J. Brian  Houston</span>, <span class="hlFld-ContribAuthor ">Manfred  Kansy</span>, <span class="hlFld-ContribAuthor ">Edward H.  Kerns</span>, <span class="hlFld-ContribAuthor ">Hans  Lennernäs</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Smith</span>, <span class="hlFld-ContribAuthor ">Kiyohiko  Sugano</span>. </span><span class="cited-content_cbyCitation_article-title">The Critical Role of Passive Permeability in Designing Successful Drugs. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (20)
                                     , 1862-1874. <a href="https://doi.org/10.1002/cmdc.202000419" title="DOI URL">https://doi.org/10.1002/cmdc.202000419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000419%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BCritical%252BRole%252Bof%252BPassive%252BPermeability%252Bin%252BDesigning%252BSuccessful%252BDrugs%26aulast%3DDi%26aufirst%3DLi%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D20%26spage%3D1862%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takashi  Seto</span>, <span class="hlFld-ContribAuthor ">Hidetoshi  Hayashi</span>, <span class="hlFld-ContribAuthor ">Miyako  Satouchi</span>, <span class="hlFld-ContribAuthor ">Yasushi  Goto</span>, <span class="hlFld-ContribAuthor ">Seiji  Niho</span>, <span class="hlFld-ContribAuthor ">Naoyuki  Nogami</span>, <span class="hlFld-ContribAuthor ">Toyoaki  Hida</span>, <span class="hlFld-ContribAuthor ">Toshiaki  Takahashi</span>, <span class="hlFld-ContribAuthor ">Jun  Sakakibara‐Konishi</span>, <span class="hlFld-ContribAuthor ">Masahiro  Morise</span>, <span class="hlFld-ContribAuthor ">Takashi  Nagasawa</span>, <span class="hlFld-ContribAuthor ">Mie  Suzuki</span>, <span class="hlFld-ContribAuthor ">Masayuki  Ohkura</span>, <span class="hlFld-ContribAuthor ">Kei  Fukuhara</span>, <span class="hlFld-ContribAuthor ">Holger  Thurm</span>, <span class="hlFld-ContribAuthor ">Gerson  Peltz</span>, <span class="hlFld-ContribAuthor ">Makoto  Nishio</span>. </span><span class="cited-content_cbyCitation_article-title">Lorlatinib in previously treated anaplastic lymphoma kinase‐rearranged non–small cell lung cancer: Japanese subgroup analysis of a global study. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2020,</strong> <em>111 </em>
                                    (10)
                                     , 3726-3738. <a href="https://doi.org/10.1111/cas.14576" title="DOI URL">https://doi.org/10.1111/cas.14576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.14576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.14576%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DLorlatinib%252Bin%252Bpreviously%252Btreated%252Banaplastic%252Blymphoma%252Bkinase%2525E2%252580%252590rearranged%252Bnon%2525E2%252580%252593small%252Bcell%252Blung%252Bcancer%25253A%252BJapanese%252Bsubgroup%252Banalysis%252Bof%252Ba%252Bglobal%252Bstudy%26aulast%3DSeto%26aufirst%3DTakashi%26date%3D2020%26date%3D2020%26volume%3D111%26issue%3D10%26spage%3D3726%26epage%3D3738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viola W.  Zhu</span>, <span class="hlFld-ContribAuthor ">Yen-Ting  Lin</span>, <span class="hlFld-ContribAuthor ">Dong-Wan  Kim</span>, <span class="hlFld-ContribAuthor ">Herbert H.  Loong</span>, <span class="hlFld-ContribAuthor ">Misako  Nagasaka</span>, <span class="hlFld-ContribAuthor ">Hao  To</span>, <span class="hlFld-ContribAuthor ">Yvonne Li-En  Ang</span>, <span class="hlFld-ContribAuthor ">Chan-Young  Ock</span>, <span class="hlFld-ContribAuthor ">Nishan  Tchekmedyian</span>, <span class="hlFld-ContribAuthor ">Sai-Hong Ignatius  Ou</span>, <span class="hlFld-ContribAuthor ">Nicholas L.  Syn</span>, <span class="hlFld-ContribAuthor ">Thanyanan  Reungwetwattana</span>, <span class="hlFld-ContribAuthor ">Chia-Chi  Lin</span>, <span class="hlFld-ContribAuthor ">Ross A.  Soo</span>. </span><span class="cited-content_cbyCitation_article-title">An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Positive or ROS1-Positive NSCLC. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thoracic Oncology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (9)
                                     , 1484-1496. <a href="https://doi.org/10.1016/j.jtho.2020.04.019" title="DOI URL">https://doi.org/10.1016/j.jtho.2020.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtho.2020.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtho.2020.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thoracic%2520Oncology%26atitle%3DAn%252BInternational%252BReal-World%252BAnalysis%252Bof%252Bthe%252BEfficacy%252Band%252BSafety%252Bof%252BLorlatinib%252BThrough%252BEarly%252Bor%252BExpanded%252BAccess%252BPrograms%252Bin%252BPatients%252BWith%252BTyrosine%252BKinase%252BInhibitor%2525E2%252580%252593Refractory%252BALK-Positive%252Bor%252BROS1-Positive%252BNSCLC%26aulast%3DZhu%26aufirst%3DViola%2BW.%26date%3D2020%26volume%3D15%26issue%3D9%26spage%3D1484%26epage%3D1496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haidar  El Darsa</span>, <span class="hlFld-ContribAuthor ">Omar  Abdel-Rahman</span>, <span class="hlFld-ContribAuthor ">Randeep  Sangha</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological and clinical properties of lorlatinib in the treatment of
              ALK
              -rearranged advanced non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2020,</strong> <em>21 </em>
                                    (13)
                                     , 1547-1554. <a href="https://doi.org/10.1080/14656566.2020.1774552" title="DOI URL">https://doi.org/10.1080/14656566.2020.1774552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2020.1774552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2020.1774552%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DPharmacological%252Band%252Bclinical%252Bproperties%252Bof%252Blorlatinib%252Bin%252Bthe%252Btreatment%252Bof%252BALK%252B-rearranged%252Badvanced%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DEl%2BDarsa%26aufirst%3DHaidar%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D13%26spage%3D1547%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliana F.  Vilachã</span>, <span class="hlFld-ContribAuthor ">Sarah C.  Mitchel</span>, <span class="hlFld-ContribAuthor ">Muluembet Z.  Akele</span>, <span class="hlFld-ContribAuthor ">Stephen  Evans</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Groves</span>. </span><span class="cited-content_cbyCitation_article-title">Making NSCLC Crystal Clear: How Kinase Structures Revolutionized Lung Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Crystals</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 725. <a href="https://doi.org/10.3390/cryst10090725" title="DOI URL">https://doi.org/10.3390/cryst10090725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cryst10090725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcryst10090725%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystals%26atitle%3DMaking%252BNSCLC%252BCrystal%252BClear%25253A%252BHow%252BKinase%252BStructures%252BRevolutionized%252BLung%252BCancer%252BTreatment%26aulast%3DVilach%25C3%25A3%26aufirst%3DJuliana%2BF.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eunsu  Kang</span>, <span class="hlFld-ContribAuthor ">Hyun Tae  Kim</span>, <span class="hlFld-ContribAuthor ">Jung Min  Joo</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-metal-catalyzed C–H functionalization of pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (32)
                                     , 6192-6210. <a href="https://doi.org/10.1039/D0OB01265C" title="DOI URL">https://doi.org/10.1039/D0OB01265C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01265C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01265C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DTransition-metal-catalyzed%252BC%2525E2%252580%252593H%252Bfunctionalization%252Bof%252Bpyrazoles%26aulast%3DKang%26aufirst%3DEunsu%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D32%26spage%3D6192%26epage%3D6210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Misako  Nagasaka</span>, <span class="hlFld-ContribAuthor ">Yubin  Ge</span>, <span class="hlFld-ContribAuthor ">Ammar  Sukari</span>, <span class="hlFld-ContribAuthor ">Geetika  Kukreja</span>, <span class="hlFld-ContribAuthor ">Sai-Hong Ignatius  Ou</span>. </span><span class="cited-content_cbyCitation_article-title">A user’s guide to lorlatinib. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Oncology/Hematology</span><span> <strong>2020,</strong> <em>151 </em>, 102969. <a href="https://doi.org/10.1016/j.critrevonc.2020.102969" title="DOI URL">https://doi.org/10.1016/j.critrevonc.2020.102969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.critrevonc.2020.102969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.critrevonc.2020.102969%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Oncology%252FHematology%26atitle%3DA%252Buser%2525E2%252580%252599s%252Bguide%252Bto%252Blorlatinib%26aulast%3DNagasaka%26aufirst%3DMisako%26date%3D2020%26volume%3D151%26spage%3D102969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics (
              ADME
              ). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 133-224. <a href="https://doi.org/10.1002/9781119607311.ch3" title="DOI URL">https://doi.org/10.1002/9781119607311.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacokinetics%252B%252528%252BADME%252B%252529%26date%3D2020%26date%3D2020%26spage%3D133%26epage%3D224%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Dujia  Jin</span>, <span class="hlFld-ContribAuthor ">Yafei  Shi</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhang</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhou</span>, <span class="hlFld-ContribAuthor ">Guohui  Li</span>. </span><span class="cited-content_cbyCitation_article-title">The underlying mechanisms of lorlatinib penetration across the blood
              ‐
              brain barrier and the distribution characteristics of lorlatinib in the brain. </span><span class="cited-content_cbyCitation_journal-name">Cancer Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 4350-4359. <a href="https://doi.org/10.1002/cam4.3061" title="DOI URL">https://doi.org/10.1002/cam4.3061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cam4.3061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcam4.3061%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Medicine%26atitle%3DThe%252Bunderlying%252Bmechanisms%252Bof%252Blorlatinib%252Bpenetration%252Bacross%252Bthe%252Bblood%252B%2525E2%252580%252590%252Bbrain%252Bbarrier%252Band%252Bthe%252Bdistribution%252Bcharacteristics%252Bof%252Blorlatinib%252Bin%252Bthe%252Bbrain%26aulast%3DChen%26aufirst%3DWei%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D4350%26epage%3D4359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mollie  Reed</span>, <span class="hlFld-ContribAuthor ">Aimee-Lauren S.  Rosales</span>, <span class="hlFld-ContribAuthor ">Marc D.  Chioda</span>, <span class="hlFld-ContribAuthor ">Lindsey  Parker</span>, <span class="hlFld-ContribAuthor ">Geeta  Devgan</span>, <span class="hlFld-ContribAuthor ">Jacob  Kettle</span>. </span><span class="cited-content_cbyCitation_article-title">Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare Practitioners. </span><span class="cited-content_cbyCitation_journal-name">Advances in Therapy</span><span> <strong>2020,</strong> <em>37 </em>
                                    (6)
                                     , 3019-3030. <a href="https://doi.org/10.1007/s12325-020-01365-3" title="DOI URL">https://doi.org/10.1007/s12325-020-01365-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12325-020-01365-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12325-020-01365-3%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvances%2520in%2520Therapy%26atitle%3DConsensus%252BRecommendations%252Bfor%252BManagement%252Band%252BCounseling%252Bof%252BAdverse%252BEvents%252BAssociated%252BWith%252BLorlatinib%25253A%252BA%252BGuide%252Bfor%252BHealthcare%252BPractitioners%26aulast%3DReed%26aufirst%3DMollie%26date%3D2020%26date%3D2020%26volume%3D37%26issue%3D6%26spage%3D3019%26epage%3D3030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuling  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenjuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Liang  Zeng</span>, <span class="hlFld-ContribAuthor ">Jinye  Mi</span>, <span class="hlFld-ContribAuthor ">Lianxi  Song</span>, <span class="hlFld-ContribAuthor ">Analyn  Lizaso</span>, <span class="hlFld-ContribAuthor ">Xinru  Mao</span>, <span class="hlFld-ContribAuthor ">Nong  Yang</span>, <span class="hlFld-ContribAuthor ">Yongchang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumab. </span><span class="cited-content_cbyCitation_journal-name">Lung Cancer</span><span> <strong>2020,</strong> <em>143 </em>, 55-59. <a href="https://doi.org/10.1016/j.lungcan.2020.03.019" title="DOI URL">https://doi.org/10.1016/j.lungcan.2020.03.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lungcan.2020.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lungcan.2020.03.019%26sid%3Dliteratum%253Aachs%26jtitle%3DLung%2520Cancer%26atitle%3DA%252Bnovel%252BROS1%252BG2032%252BK%252Bmissense%252Bmutation%252Bmediates%252Blorlatinib%252Bresistance%252Bin%252Ba%252Bpatient%252Bwith%252BROS1-rearranged%252Blung%252Badenocarcinoma%252Bbut%252Bresponds%252Bto%252Bnab-paclitaxel%252Bplus%252Bpembrolizumab%26aulast%3DZhou%26aufirst%3DYuling%26date%3D2020%26volume%3D143%26spage%3D55%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John D.  Westbrook</span>, <span class="hlFld-ContribAuthor ">Rose  Soskind</span>, <span class="hlFld-ContribAuthor ">Brian P.  Hudson</span>, <span class="hlFld-ContribAuthor ">Stephen K.  Burley</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of the Protein Data Bank on antineoplastic approvals. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (5)
                                     , 837-850. <a href="https://doi.org/10.1016/j.drudis.2020.02.002" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DImpact%252Bof%252Bthe%252BProtein%252BData%252BBank%252Bon%252Bantineoplastic%252Bapprovals%26aulast%3DWestbrook%26aufirst%3DJohn%2BD.%26date%3D2020%26volume%3D25%26issue%3D5%26spage%3D837%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joan Rou-En  Choo</span>, <span class="hlFld-ContribAuthor ">Ross A  Soo</span>. </span><span class="cited-content_cbyCitation_article-title">Lorlatinib for the treatment of
              ALK
              -positive metastatic non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2020,</strong> <em>20 </em>
                                    (4)
                                     , 233-240. <a href="https://doi.org/10.1080/14737140.2020.1744438" title="DOI URL">https://doi.org/10.1080/14737140.2020.1744438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2020.1744438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2020.1744438%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DLorlatinib%252Bfor%252Bthe%252Btreatment%252Bof%252BALK%252B-positive%252Bmetastatic%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DChoo%26aufirst%3DJoan%2BRou-En%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D4%26spage%3D233%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eiji  Iwama</span>, <span class="hlFld-ContribAuthor ">Yasushi  Goto</span>, <span class="hlFld-ContribAuthor ">Haruyasu  Murakami</span>, <span class="hlFld-ContribAuthor ">Shinsuke  Tsumura</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Sakashita</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Mori</span>, <span class="hlFld-ContribAuthor ">Noriaki  Nakagaki</span>, <span class="hlFld-ContribAuthor ">Yuka  Fujita</span>, <span class="hlFld-ContribAuthor ">Masahiro  Seike</span>, <span class="hlFld-ContribAuthor ">Akihiro  Bessho</span>, <span class="hlFld-ContribAuthor ">Manabu  Ono</span>, <span class="hlFld-ContribAuthor ">Masaru  Nishitsuji</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Akamatsu</span>, <span class="hlFld-ContribAuthor ">Ryotaro  Morinaga</span>, <span class="hlFld-ContribAuthor ">Takanori  Akagi</span>, <span class="hlFld-ContribAuthor ">Takayuki  Shimose</span>, <span class="hlFld-ContribAuthor ">Shoji  Tokunaga</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Yoichi  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Kenji  Sugio</span>, <span class="hlFld-ContribAuthor ">Isamu  Okamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Survival Analysis for Patients with
              ALK
              Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401. </span><span class="cited-content_cbyCitation_journal-name">The Oncologist</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 306. <a href="https://doi.org/10.1634/theoncologist.2019-0728" title="DOI URL">https://doi.org/10.1634/theoncologist.2019-0728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1634/theoncologist.2019-0728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1634%2Ftheoncologist.2019-0728%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Oncologist%26atitle%3DSurvival%252BAnalysis%252Bfor%252BPatients%252Bwith%252BALK%252BRearrangement%2525E2%252580%252590Positive%252BNon%2525E2%252580%252590Small%252BCell%252BLung%252BCancer%252Band%252Ba%252BPoor%252BPerformance%252BStatus%252BTreated%252Bwith%252BAlectinib%25253A%252BUpdated%252BResults%252Bof%252BLung%252BOncology%252BGroup%252Bin%252BKyushu%252B1401%26aulast%3DIwama%26aufirst%3DEiji%26date%3D2020%26date%3D2019%26volume%3D25%26issue%3D4%26spage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saumitra  Sengupta</span>, <span class="hlFld-ContribAuthor ">Goverdhan  Mehta</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclization
              via
              C–H functionalization: a new paradigm in macrocycle synthesis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (10)
                                     , 1851-1876. <a href="https://doi.org/10.1039/C9OB02765C" title="DOI URL">https://doi.org/10.1039/C9OB02765C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB02765C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB02765C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMacrocyclization%252Bvia%252BC%2525E2%252580%252593H%252Bfunctionalization%25253A%252Ba%252Bnew%252Bparadigm%252Bin%252Bmacrocycle%252Bsynthesis%26aulast%3DSengupta%26aufirst%3DSaumitra%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D10%26spage%3D1851%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soumya S.  Rajan</span>, <span class="hlFld-ContribAuthor ">Amit Dipak  Amin</span>, <span class="hlFld-ContribAuthor ">Lingxiao  Li</span>, <span class="hlFld-ContribAuthor ">Delphine C.  Rolland</span>, <span class="hlFld-ContribAuthor ">Haiquan  Li</span>, <span class="hlFld-ContribAuthor ">Deukwoo  Kwon</span>, <span class="hlFld-ContribAuthor ">Mercedes F.  Kweh</span>, <span class="hlFld-ContribAuthor ">Artavazd  Arumov</span>, <span class="hlFld-ContribAuthor ">Evan R.  Roberts</span>, <span class="hlFld-ContribAuthor ">Aimin  Yan</span>, <span class="hlFld-ContribAuthor ">Venkatesha  Basrur</span>, <span class="hlFld-ContribAuthor ">Kojo S. J.  Elenitoba-Johnson</span>, <span class="hlFld-ContribAuthor ">Xi Steven  Chen</span>, <span class="hlFld-ContribAuthor ">Soham D.  Puvvada</span>, <span class="hlFld-ContribAuthor ">Yves A.  Lussier</span>, <span class="hlFld-ContribAuthor ">Daniel  Bilbao</span>, <span class="hlFld-ContribAuthor ">Megan S.  Lim</span>, <span class="hlFld-ContribAuthor ">Jonathan H.  Schatz</span>. </span><span class="cited-content_cbyCitation_article-title">The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2020,</strong> <em>39 </em>
                                    (10)
                                     , 2103-2117. <a href="https://doi.org/10.1038/s41388-019-1136-4" title="DOI URL">https://doi.org/10.1038/s41388-019-1136-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-019-1136-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-019-1136-4%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DThe%252Bmechanism%252Bof%252Bcancer%252Bdrug%252Baddiction%252Bin%252BALK-positive%252BT-Cell%252Blymphoma%26aulast%3DRajan%26aufirst%3DSoumya%2BS.%26date%3D2020%26date%3D2019%26volume%3D39%26issue%3D10%26spage%3D2103%26epage%3D2117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm500261q&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm500261q%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-11&amp;citedByCount=265&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of ALK inhibitors marketed or currently in the clinic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Left panel: compound <b>6b</b> cocrystal structure in the ALK kinase domain (purple, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CNH">4CNH</a>) highlighting the type I U-shaped binding conformation and proximity of the methoxyfluorophenyl headgroup and triazole tail group. Right panel: ALK cocrystal of <b>6h</b> (cyan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMO">4CMO</a>) overlaid with <b>6i</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMT">4CMT</a>) showing the triazole, amide, and G-loop conformations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Left panel: acyclic amide <b>6h</b> cocrystal structure in ALK (cyan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMO">4CMO</a>) overlaid with modeled macrocycle <b>8a</b> (purple) in ALK (see the section “<a class="ref internalNav" href="#sec5_57" aria-label="Modeling Methods">Modeling Methods</a>”). Right panel: <b>8a</b> cocrystal structure in ALK kinase domain (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMU">4CMU</a>) overlaid with the modeled ligand (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Left panel: <b>8a</b>- and ALK-bound structure (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMU">4CMU</a>) and TrkB (purple, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AT3">4AT3</a>) with selectivity residues highlighted. Right panel: ligands from ALK cocrystal structures aligned with TrkB, demonstrating the potential for clash between the ligand and Tyr635 [<b>8a</b> (Me, green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMU">4CMU</a>), <b>8j</b> (cyPr, yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTC">4CTC</a>), <b>8k</b> (CN, cyan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CLI">4CLI</a>), <b>8m</b> (orange, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTB">4CTB</a>)]. Distances shown are between the <b>8a</b> methyl carbon (shown as a ball) and TrkB Tyr635. PDB atom names for the terminal atoms are shown on Tyr635 (OH, CZ, CE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of log <i>D</i>, HBD count, and MW on the MDR BA/AB ratio (blue, <2.5; red, >2.5). The percentage of each sector shown and total count per bin are highlighted in the center of the pie.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Top panel: comparison of acyclic and macrocyclic compound binned MDR ratios (blue, <2.5; red, >2.5) for compounds within the same MW, log <i>D</i>, and HBD count (2) bins. The percentage of each sector shown and total count per bin are highlighted in the center of the pie. Bottom panel: acyclic and macrocyclic compound SASA differences within the same MW, log <i>D</i>, and HBD count (2) bins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Left panel: LipE plot comparing macrocyclic (aqua) and acyclic (light gray) analogues. Right panel: LipE vs HACNT plot with macrocyclic and acyclic analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Ether-Linked Macrocycles <b>7a</b> and <b>7b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (yields for <i>n</i> = 0): (a) 1.1 equiv of ethyl diazoacetate, 100 °C, sealed tube, 18 h, 49%; (b) NH<sub>4</sub>OH, MeOH, 60 °C, 12 h; (c) 4 equiv of TFAA, pyridine, 0 °C, 1 h, 81% over two steps; (d) 0.70 equiv of I<sub>2</sub>, 0.70 equiv of CAN, MeCN, 60 °C, 2 h, 66%; (e) 1.25 equiv of Ph<sub>3</sub>P, 1.25 equiv of DIAD, 1 equiv of Boc-2-amino-3-hydroxy-5-iodopyridine (<b>17</b>), THF, 1 h, 16%; (f) 5 equiv of B<sub>2</sub>pin<sub>2</sub>, 5 equiv of CsF, 6 mol % Pd(amphos)Cl<sub>2</sub>, MeOH, H<sub>2</sub>O, 60 °C, 1 h; (g) 25 equiv of HCl (4 M in dioxane), CH<sub>2</sub>Cl<sub>2</sub>, 12 h, rt, 29% over two steps.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Ether-Linked Macrocycles <b>7c and 7d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (yields for <i>n</i> = 1): (a) 1 equiv of Ph<sub>3</sub>P, 20 mol % CuI, 20 mol % PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, piperidine, 90 °C, 5 h; (b) 10 wt % Pd(OH)<sub>2</sub> (20% on carbon), EtOH, 50 °C, 4 bar of H<sub>2</sub>, 18 h; (c) 15% aq NaOH, EtOH, 85 °C, 12 h, 34% over three steps; (d) 10 equiv of pyridine, 1 equiv of MsCl, cat DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 1 h; (e) 1 equiv of NaH (60 wt %), DMF, 50 °C, 2 h, 37% over two steps.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Ether-Linked Macrocycles <b>7e</b> and <b>7f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (yields for <i>n</i> = 1): (a) 1.1 equiv of ethyl diazoacetate, sealed tube, 100 °C, 18 h, 76%; (b) 1.2 equiv of Me<sub>2</sub>SO<sub>4</sub>, toluene, 80 °C, 12 h, 46%; (c) NH<sub>4</sub>OH, MeOH, 60 °C, 18 h, 74%; (d) 2 equiv of TFAA, 4 equiv of pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h, 94%; (e) 1.1 equiv of NaBH<sub>4</sub>, MeOH, 0 °C, 1 h; (f) 1.1 equiv of MsCl, 1.5 equiv of TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h, 94% over two steps; (g) 1.2 equiv of 2-amino-3-hydroxy-5-bromopyridine, 2 equiv of Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 40 h, 18%; (h) 20 mol % cataCXium A, 20 mol % Pd(OAc)<sub>2</sub>, 5 equiv of KOAc, <i>t</i>-AmOH, 140 °C, 2 h, 24%; (i) chiral SFC, Whelk-O1 (<i>R</i>,<i>R</i>) 30% MeOH at 120 bar, 4 mL/min.</p></p></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyridine Amide Macrocycle <b>8k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 20 mol % CataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 1.24 equiv of <b>45</b>, 1.5 equiv of B<sub>2</sub>pin<sub>2</sub>, 5 equiv of CsF, MeOH, H<sub>2</sub>O, 60 °C, 3 h, 43%; (b) NaOH, MeOH, H<sub>2</sub>O, 40 °C, 3.5 h, 87%; (c) 4 M HCl in dioxane, MeOH, 40 °C, 2.5 h, 87%; (d) for compound <b>8k</b>, 1.4 equiv of HATU, 10 equiv of DIPEA, DMF, 0 °C, 30 min, slow reverse addition, 29%. Macrocycles <b>8a</b>–<b>c</b>, <b>8f</b>, <b>8h</b>, <b>8j</b>, and <b>8l</b> were prepared in an analogous manner.</p></p></figure><figure data-id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Pyrazine Amide Macrocycles <b>8d</b>, <b>8e</b>, <b>8g</b>, <b>8i</b>, and <b>8m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for synthesis of <b>52</b>, 1.25 equiv of 50, 10 mol % Pd(P<sup><i>t</i></sup>Bu<sub>3</sub>)<sub>2</sub>, 5 equiv of DIPEA, toluene, 85 °C, 4 bar of CO, 18 h, 21%; (b) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 5 equiv of B<sub>2</sub>pin<sub>2</sub>, 5 equiv of CsF, MeOH, H<sub>2</sub>O, 90 °C, 6 h, 11%; (c) chiral SFC, Chiralcel OD-H 25% MeOH at 140 bar, 3 mL/min; (d) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 5 equiv of KOAc, 0.25 equiv of PivOH, DMF, 150 °C, 1 h, 8%; (e) 5 mol % Pd(OAc)<sub>2</sub>, 10 mol % DPE-Phos, 5 equiv of DIPEA, MeOH, 50 °C, 4 bar of CO, 3 h, 77%; (f) 5 equiv of NaOH, MeOH/THF/H<sub>2</sub>O (5:2:1), rt, 15 h, 89%; (g) 1.1 equiv of <b>55</b>, 1.5 equiv of EDCI, 1.5 equiv of HOBt, 5 equiv of DIPEA, DMF, −30 °C to rt, 15 h, 46%; (h) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 10 mol % <i>t</i>-AmOH, 5 equiv of KOAc, DMA, 110 °C, 12 h, 12%; (i) 1.1 equiv of <b>57</b>, 1.1 equiv of HATU, 4 equiv of DIPEA, DMF, rt, 12 h, 94%; (j) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 3 equiv of B<sub>2</sub>pin<sub>2</sub>, 5 equiv of K<sub>2</sub>CO<sub>3</sub>, THF, 80 °C, 6 h, 8%.</p></p></figure><figure data-id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/medium/jm-2014-00261q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>8k</b> by Directed Arylation<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500261q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 5 mol % Pd(P<sup><i>t</i></sup>Bu<sub>3</sub>)<sub>2</sub>, 3 equiv of DIPEA, 1.1 equiv of <b>60</b>, toluene, 80 °C, 4 bar of CO, 18 h, 70%; (b) 1.1 equiv of NBS, THF, −10 °C, 2 h, 86%; (c) acetic anhydride, 100 °C, 8 h, quantitative; (d) 20 mol % cataCXium A, 10 mol % Pd(OAc)<sub>2</sub>, 5 equiv of KOAc, <i>t</i>-AmOH, 130 °C, 14 h; (e) 10 equiv of 4 N HCl in dioxane, MeOH, 60 °C, 14 h, 42% over two steps.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i95">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 60 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. P.</span><span> </span><span class="NLM_article-title">ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin’s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">2175</span><span class="NLM_x">–</span> <span class="NLM_lpage">2188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=2175-2188&issue=18&author=S.+W.+Morrisauthor=C.+Naeveauthor=P.+Mathewauthor=P.+L.+Jamesauthor=M.+N.+Kirsteinauthor=X.+Cuiauthor=D.+P.+Witte&title=ALK%2C+the+chromosome+2+gene+locus+altered+by+the+t%282%3B5%29+in+non-Hodgkin%E2%80%99s+lymphoma%2C+encodes+a+novel+neural+receptor+tyrosine+kinase+that+is+highly+related+to+leukocyte+tyrosine+kinase+%28LTK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DNaeve%26aufirst%3DC.%26aulast%3DMathew%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DP.%2BL.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWitte%26aufirst%3DD.%2BP.%26atitle%3DALK%252C%2520the%2520chromosome%25202%2520gene%2520locus%2520altered%2520by%2520the%2520t%25282%253B5%2529%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%252C%2520encodes%2520a%2520novel%2520neural%2520receptor%2520tyrosine%2520kinase%2520that%2520is%2520highly%2520related%2520to%2520leukocyte%2520tyrosine%2520kinase%2520%2528LTK%2529%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26issue%3D18%26spage%3D2175%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bilsland, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeldon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Znamenskiy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnert, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heavens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiting, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Sanjuan, I.</span><span> </span><span class="NLM_article-title">Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=685-700&issue=3&author=J.+G.+Bilslandauthor=A.+Wheeldonauthor=A.+Meadauthor=P.+Znamenskiyauthor=S.+Almondauthor=K.+A.+Watersauthor=M.+Thakurauthor=V.+Beaumontauthor=T.+P.+Bonnertauthor=R.+Heavensauthor=P.+Whitingauthor=G.+McAllisterauthor=I.+Munoz-Sanjuan&title=Behavioral+and+neurochemical+alterations+in+mice+deficient+in+anaplastic+lymphoma+kinase+suggest+therapeutic+potential+for+psychiatric+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilsland%26aufirst%3DJ.%2BG.%26aulast%3DWheeldon%26aufirst%3DA.%26aulast%3DMead%26aufirst%3DA.%26aulast%3DZnamenskiy%26aufirst%3DP.%26aulast%3DAlmond%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DK.%2BA.%26aulast%3DThakur%26aufirst%3DM.%26aulast%3DBeaumont%26aufirst%3DV.%26aulast%3DBonnert%26aufirst%3DT.%2BP.%26aulast%3DHeavens%26aufirst%3DR.%26aulast%3DWhiting%26aufirst%3DP.%26aulast%3DMcAllister%26aufirst%3DG.%26aulast%3DMunoz-Sanjuan%26aufirst%3DI.%26atitle%3DBehavioral%2520and%2520neurochemical%2520alterations%2520in%2520mice%2520deficient%2520in%2520anaplastic%2520lymphoma%2520kinase%2520suggest%2520therapeutic%2520potential%2520for%2520psychiatric%2520indications%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26issue%3D3%26spage%3D685%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Le Beau, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doane, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardiman, J. W.</span><span> </span><span class="NLM_article-title">The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1989&pages=866-870&issue=12&author=M.+M.+Le+Beauauthor=M.+A.+Bitterauthor=R.+A.+Larsonauthor=L.+A.+Doaneauthor=E.+D.+Ellisauthor=W.+A.+Franklinauthor=C.+M.+Rubinauthor=M.+E.+Kadinauthor=J.+W.+Vardiman&title=The+t%282%3B5%29%28p23%3Bq35%29%3A+A+recurring+chromosomal+abnormality+in+Ki-1-positive+anaplastic+large+cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DBitter%26aufirst%3DM.%2BA.%26aulast%3DLarson%26aufirst%3DR.%2BA.%26aulast%3DDoane%26aufirst%3DL.%2BA.%26aulast%3DEllis%26aufirst%3DE.%2BD.%26aulast%3DFranklin%26aufirst%3DW.%2BA.%26aulast%3DRubin%26aufirst%3DC.%2BM.%26aulast%3DKadin%26aufirst%3DM.%2BE.%26aulast%3DVardiman%26aufirst%3DJ.%2BW.%26atitle%3DThe%2520t%25282%253B5%2529%2528p23%253Bq35%2529%253A%2520A%2520recurring%2520chromosomal%2520abnormality%2520in%2520Ki-1-positive%2520anaplastic%2520large%2520cell%2520lymphoma%26jtitle%3DLeukemia%26date%3D1989%26volume%3D3%26issue%3D12%26spage%3D866%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x"> (</span><span class="NLM_issue">5151</span><span class="NLM_x">) </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&issue=5151&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+kinase+gene%2C+ALK%2C+to+a+nucleolar+protein+gene%2C+NPM%2C+in+non-Hodgkin%E2%80%99s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520kinase%2520gene%252C%2520ALK%252C%2520to%2520a%2520nucleolar%2520protein%2520gene%252C%2520NPM%252C%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26issue%3D5151%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, D. R.</span><span> </span><span class="NLM_article-title">ALK-positive large B-cell lymphoma: Report of a case</span> <span class="citation_source-journal">Zhonghua Bing Li Xue Za Zhi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fns1Kiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=561-562&issue=8&author=H.+Yuauthor=J.+X.+Huangauthor=C.+F.+Wangauthor=D.+R.+Shi&title=ALK-positive+large+B-cell+lymphoma%3A+Report+of+a+case"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">ALK-positive large B-cell lymphoma: report of a case</span></div><div class="casAuthors">Yu Hong; Huang Jun-xing; Wang Chao-fu; Shi Da-ren</div><div class="citationInfo"><span class="NLM_cas:title">Zhonghua bing li xue za zhi Chinese journal of pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-2</span>
        ISSN:<span class="NLM_cas:issn">0529-5807</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8MWU7G799eXwOGIfWJ7-GfW6udTcc2ebO3l5AQDdLz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fns1Kiuw%253D%253D&md5=cab1bf32f1eb07c3ea8b4ec0661f8061</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%2BX.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DShi%26aufirst%3DD.%2BR.%26atitle%3DALK-positive%2520large%2520B-cell%2520lymphoma%253A%2520Report%2520of%2520a%2520case%26jtitle%3DZhonghua%2520Bing%2520Li%2520Xue%2520Za%2520Zhi%26date%3D2011%26volume%3D40%26issue%3D8%26spage%3D561%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Griffin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlman, E. J.</span><span> </span><span class="NLM_article-title">Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2776</span><span class="NLM_x">–</span> <span class="NLM_lpage">2780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2776-2780&issue=12&author=C.+A.+Griffinauthor=A.+L.+Hawkinsauthor=C.+Dvorakauthor=C.+Henkleauthor=T.+Ellinghamauthor=E.+J.+Perlman&title=Recurrent+involvement+of+2p23+in+inflammatory+myofibroblastic+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DC.%2BA.%26aulast%3DHawkins%26aufirst%3DA.%2BL.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DHenkle%26aufirst%3DC.%26aulast%3DEllingham%26aufirst%3DT.%26aulast%3DPerlman%26aufirst%3DE.%2BJ.%26atitle%3DRecurrent%2520involvement%2520of%25202p23%2520in%2520inflammatory%2520myofibroblastic%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D12%26spage%3D2776%26epage%3D2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2349</span><span class="NLM_x">–</span> <span class="NLM_lpage">2355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1111%2Fj.1349-7006.2008.00972.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=2349-2355&issue=12&author=H.+Mano&title=Non-solid+oncogenes+in+solid+tumors%3A+EML4-ALK+fusion+genes+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer</span></div><div class="casAuthors">Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2349-2355</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  It is generally accepted that recurrent chromosome translocations play a major role in the mol. pathogenesis of hematol. malignancies but not of solid tumors.  However, chromosome translocations involving the e26 transformation-specific sequence transcription factor loci have been demonstrated recently in many prostate cancer cases.  Furthermore, through a functional screening with retroviral cDNA expression libraries, we have discovered the fusion-type protein tyrosine kinase echinoderm microtubule-assocd. protein like-4 (EML4)-anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) specimens.  A recurrent chromosome translocation, inv(2)(p21p23), in NSCLC generates fused mRNA encoding the amino-terminal half of EML4 ligated to the intracellular region of the receptor-type protein tyrosine kinase ALK.  EML4-ALK oligomerizes constitutively in cells through the coiled coil domain within the EML4 region, and becomes activated to exert a marked oncogenicity both in vitro and in vivo.  Break and fusion points within the EML4 locus may diverge in NSCLC cells to generate various isoforms of EML4-ALK, which may constitute -5% of NSCLC cases, at least in the Asian ethnic group.  In the present review I summarize how detection of EML4-ALK cDNA may become a sensitive diagnostic means for NSCLC cases that are pos. for the fusion gene, and discuss whether suppression of ALK enzymic activity could be an effective treatment strategy against this intractable disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxSS7U51wKbVg90H21EOLACvtfcHk0licX9IIprkenQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D&md5=84386550daedbd29b3a34b11a4774684</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00972.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00972.x%26sid%3Dliteratum%253Aachs%26aulast%3DMano%26aufirst%3DH.%26atitle%3DNon-solid%2520oncogenes%2520in%2520solid%2520tumors%253A%2520EML4-ALK%2520fusion%2520genes%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26issue%3D12%26spage%3D2349%26epage%3D2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span> </span><span class="NLM_article-title">Targeting anaplastic lymphoma kinase in lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1158%2F1078-0432.CCR-10-1591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21288922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2081-2086&issue=8&author=A.+T.+Shawauthor=B.+Solomon&title=Targeting+anaplastic+lymphoma+kinase+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Anaplastic Lymphoma Kinase in Lung Cancer</span></div><div class="casAuthors">Shaw, Alice T.; Solomon, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2081-2086</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Several decades of cancer research have revealed a pivotal role for tyrosine kinases as key regulators of signaling pathways, controlling cell growth and differentiation.  Deregulation of tyrosine kinase-mediated signaling occurs frequently in cancer and is believed to drive the initiation and progression of disease.  Chromosomal rearrangements involving the tyrosine kinase anaplastic lymphoma kinase (ALK) occur in a variety of human malignancies including non-small cell lung cancer (NSCLC), anaplastic large cell lymphomas, and inflammatory myofibroblastic tumors.  The aberrant activation of ALK signaling leads to "oncogene addiction" and marked sensitivity to ALK inhibitors such as crizotinib (PF-02341066).  This review focuses on ALK rearrangements in NSCLC, starting with the discovery of the EML4-ALK fusion oncogene, and culminating in the recent validation of ALK as a therapeutic target in patients with ALK-rearranged NSCLC.  Current efforts seek to expand the role of ALK kinase inhibition in lung and other cancers and to address the mol. basis for the development of resistance.  Clin Cancer Res; 17(8); 2081-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCqEzvXv0qJrVg90H21EOLACvtfcHk0licX9IIprkenQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCgs7k%253D&md5=6d0f5e1174ba934f00c10a877a3b17e1</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-1591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-1591%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DSolomon%26aufirst%3DB.%26atitle%3DTargeting%2520anaplastic%2520lymphoma%2520kinase%2520in%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D8%26spage%3D2081%26epage%3D2086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x"> (</span><span class="NLM_issue">7153</span><span class="NLM_x">) </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1038%2Fnature05945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=17625570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&issue=7153&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+transforming+EML4-ALK+fusion+gene+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span></div><div class="casAuthors">Soda, Manabu; Choi, Young Lim; Enomoto, Munehiro; Takada, Shuji; Yamashita, Yoshihiro; Ishikawa, Shunpei; Fujiwara, Shin-ichiro; Watanabe, Hideki; Kurashina, Kentaro; Hatanaka, Hisashi; Bando, Masashi; Ohno, Shoji; Ishikawa, Yuichi; Aburatani, Hiroyuki; Niki, Toshiro; Sohara, Yasunori; Sugiyama, Yukihiko; Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue">7153</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Improvement in the clin. outcome of lung cancer is likely to be achieved by identification of the mol. events that underlie its pathogenesis.  Here we show that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-assocd. protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells.  Mouse 3T3 fibroblasts forced to express this human fusion tyrosine kinase generated transformed foci in culture and s.c. tumors in nude mice.  The EML4-ALK fusion transcript was detected in 6.7% (5 out of 75) of NSCLC patients examd.; these individuals were distinct from those harboring mutations in the epidermal growth factor receptor gene.  Our data demonstrate that a subset of NSCLC patients may express a transforming fusion kinase that is a promising candidate for a therapeutic target as well as for a diagnostic mol. marker in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomhAXuLtrJ6rVg90H21EOLACvtfcHk0licX9IIprkenQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D&md5=7f567e80814b9ccc87e5bceeebb467a7</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1038%2Fnature05945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05945%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520transforming%2520EML4-ALK%2520fusion%2520gene%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26issue%3D7153%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span> </span><span class="NLM_article-title">Anaplastic lymphoma kinase inhibitors for the treatment of ALK-positive cancers</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2FB978-0-12-396492-2.00019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eju7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=281-293&author=K.+Kinoshitaauthor=N.+Oikawaauthor=T.+Tsukuda&title=Anaplastic+lymphoma+kinase+inhibitors+for+the+treatment+of+ALK-positive+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase inhibitors for the treatment of ALK-positive cancers</span></div><div class="casAuthors">Kinoshita, Kazutomo; Oikawa, Nobuhiro; Tsukuda, Takuo</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">281-293</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review on the development of anaplastic lymphoma kinase (ALK) inhibitors which is the most highly competitive drug targets in oncol. research.  A no. of research groups have identified promising drugs, where Pfizer succeeded in launching a potent ALK inhibitor, crizotinib, for treatment of EML4-ALK-pos. NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX549XOu0aZrVg90H21EOLACvtfcHk0lhKrDEPW_viyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eju7vE&md5=2fb9597a39e7dd478a4ef41be4df7be6</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00019-9%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DOikawa%26aufirst%3DN.%26aulast%3DTsukuda%26aufirst%3DT.%26atitle%3DAnaplastic%2520lymphoma%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520ALK-positive%2520cancers%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D281%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Azarova, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span> </span><span class="NLM_article-title">Emerging importance of ALK in neuroblastoma</span> <span class="citation_source-journal">Semin. Cancer. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2Fj.semcancer.2011.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSktLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=267-275&issue=4&author=A.+M.+Azarovaauthor=G.+Gautamauthor=R.+E.+George&title=Emerging+importance+of+ALK+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging importance of ALK in neuroblastoma</span></div><div class="casAuthors">Azarova, Anna M.; Gautam, Gargi; George, Rani E.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-275</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since the original descriptions of gain-of function mutations in anaplastic lymphoma kinase (ALK), interest in the role of this receptor tyrosine kinase in neuroblastoma development and as a potential therapeutic target has escalated.  As a group, the activating point mutations in full-length ALK, found in approx. 8% of all neuroblastoma tumors, are distributed evenly across different clin. stages.  However, the most frequent somatic mutation, F1174L, is assocd. with amplification of the MYCN oncogene.  This combination of features appears to confer a worse prognosis than MYCN amplification alone, suggesting a cooperative effect on neuroblastoma formation by these two proteins.  Indeed, F1174L has shown more potent transforming activity in vivo than the second most common activating mutation, R1275Q, and is responsible for innate and acquired resistance to crizotinib, a clin. relevant ALK inhibitor that will soon be com. available.  These advances cast ALK as a bona fide oncoprotein in neuroblastoma and emphasize the need to understand ALK-mediated signaling in this tumor.  This review addresses many of the current issues surrounding the role of ALK in normal development and neuroblastoma pathogenesis, and discusses the prospects for clin. effective targeted treatments based on ALK inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpqmFzh9Q3frVg90H21EOLACvtfcHk0lhKrDEPW_viyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSktLzN&md5=e07445aecd9829c465f1f4023124521f</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2011.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2011.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DAzarova%26aufirst%3DA.%2BM.%26aulast%3DGautam%26aufirst%3DG.%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26atitle%3DEmerging%2520importance%2520of%2520ALK%2520in%2520neuroblastoma%26jtitle%3DSemin.%2520Cancer.%2520Biol.%26date%3D2011%26volume%3D21%26issue%3D4%26spage%3D267%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Caren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinsson, T.</span><span> </span><span class="NLM_article-title">High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2008&pages=153-159&issue=2&author=H.+Carenauthor=F.+Abelauthor=P.+Kognerauthor=T.+Martinsson&title=High+incidence+of+DNA+mutations+and+gene+amplifications+of+the+ALK+gene+in+advanced+sporadic+neuroblastoma+tumours"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaren%26aufirst%3DH.%26aulast%3DAbel%26aufirst%3DF.%26aulast%3DKogner%26aufirst%3DP.%26aulast%3DMartinsson%26aufirst%3DT.%26atitle%3DHigh%2520incidence%2520of%2520DNA%2520mutations%2520and%2520gene%2520amplifications%2520of%2520the%2520ALK%2520gene%2520in%2520advanced%2520sporadic%2520neuroblastoma%2520tumours%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D416%26issue%3D2%26spage%3D153%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, S.</span><span> </span><span class="NLM_article-title">Oncogenic mutations of ALK kinase in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7215</span><span class="NLM_x">) </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1038%2Fnature07399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=18923524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GgurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=971-974&issue=7215&author=Y.+Chenauthor=J.+Takitaauthor=Y.+L.+Choiauthor=M.+Katoauthor=M.+Ohiraauthor=M.+Sanadaauthor=L.+Wangauthor=M.+Sodaauthor=A.+Kikuchiauthor=T.+Igarashiauthor=A.+Nakagawaraauthor=Y.+Hayashiauthor=H.+Manoauthor=S.+Ogawa&title=Oncogenic+mutations+of+ALK+kinase+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic mutations of ALK kinase in neuroblastoma</span></div><div class="casAuthors">Chen, Yuyan; Takita, Junko; Choi, Young Lim; Kato, Motohiro; Ohira, Miki; Sanada, Masashi; Wang, Lili; Soda, Manabu; Kikuchi, Akira; Igarashi, Takashi; Nakagawara, Akira; Hayashi, Yasuhide; Mano, Hiroyuki; Ogawa, Seishi</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7215</span>),
    <span class="NLM_cas:pages">971-974</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroblastoma in advanced stages is one of the most intractable pediatric cancers, even with recent therapeutic advances.  Neuroblastoma harbors a variety of genetic changes, including a high frequency of MYCN amplification, loss of heterozygosity at 1p36 and 11q, and gain of genetic material from 17q, all of which have been implicated in the pathogenesis of neuroblastoma.  However, the scarcity of reliable mol. targets has hampered the development of effective therapeutic agents targeting neuroblastoma.  Here we show that the anaplastic lymphoma kinase (ALK), originally identified as a fusion kinase in a subtype of non-Hodgkin's lymphoma (NPM-ALK) and more recently in adenocarcinoma of lung (EML4-ALK), is also a frequent target of genetic alteration in advanced neuroblastoma.  According to our genome-wide scans of genetic lesions in 215 primary neuroblastoma samples using high-d. single-nucleotide polymorphism genotyping microarrays, the ALK locus, centromeric to the MYCN locus, was identified as a recurrent target of copy no. gain and gene amplification.  Furthermore, DNA sequencing of ALK revealed eight novel missense mutations in 13 out of 215 (6.1%) fresh tumors and 8 out of 24 (33%) neuroblastoma-derived cell lines.  All but one mutation in the primary samples (12 out of 13) were found in stages 3-4 of the disease and were harbored in the kinase domain.  The mutated kinases were autophosphorylated and displayed increased kinase activity compared with the wild-type kinase.  They were able to transform NIH3T3 fibroblasts as shown by their colony formation ability in soft agar and their capacity to form tumors in nude mice.  Furthermore, we demonstrate that downregulation of ALK through RNA interference suppresses proliferation of neuroblastoma cells harbouring mutated ALK.  We anticipate that our findings will provide new insights into the pathogenesis of advanced neuroblastoma and that ALK-specific kinase inhibitors might improve its clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot7m1PigjoirVg90H21EOLACvtfcHk0lhKrDEPW_viyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GgurjN&md5=145b8ecbf3e27342d55be53c98ceed24</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1038%2Fnature07399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07399%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTakita%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DOhira%26aufirst%3DM.%26aulast%3DSanada%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DKikuchi%26aufirst%3DA.%26aulast%3DIgarashi%26aufirst%3DT.%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DS.%26atitle%3DOncogenic%2520mutations%2520of%2520ALK%2520kinase%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7215%26spage%3D971%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrady, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Activating mutations in ALK provide a therapeutic target in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7215</span><span class="NLM_x">) </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=975-978&issue=7215&author=R.+E.+Georgeauthor=T.+Sandaauthor=M.+Hannaauthor=S.+Frohlingauthor=W.+Lutherauthor=J.+Zhangauthor=Y.+Ahnauthor=W.+Zhouauthor=W.+B.+Londonauthor=P.+McGradyauthor=L.+Xueauthor=S.+Zozulyaauthor=V.+E.+Gregorauthor=T.+R.+Webbauthor=N.+S.+Grayauthor=D.+G.+Gillilandauthor=L.+Dillerauthor=H.+Greulichauthor=S.+W.+Morrisauthor=M.+Meyersonauthor=A.+T.+Look&title=Activating+mutations+in+ALK+provide+a+therapeutic+target+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DSanda%26aufirst%3DT.%26aulast%3DHanna%26aufirst%3DM.%26aulast%3DFrohling%26aufirst%3DS.%26aulast%3DLuther%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DMcGrady%26aufirst%3DP.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZozulya%26aufirst%3DS.%26aulast%3DGregor%26aufirst%3DV.%2BE.%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DDiller%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DActivating%2520mutations%2520in%2520ALK%2520provide%2520a%2520therapeutic%2520target%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7215%26spage%3D975%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Janoueix-Lerosey, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lequin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugieres, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Pontual, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combaret, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puisieux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleiermacher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valteau-Couanet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frebourg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyonnet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amiel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delattre, O.</span><span> </span><span class="NLM_article-title">Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7215</span><span class="NLM_x">) </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=967-970&issue=7215&author=I.+Janoueix-Leroseyauthor=D.+Lequinauthor=L.+Brugieresauthor=A.+Ribeiroauthor=L.+de+Pontualauthor=V.+Combaretauthor=V.+Raynalauthor=A.+Puisieuxauthor=G.+Schleiermacherauthor=G.+Pierronauthor=D.+Valteau-Couanetauthor=T.+Frebourgauthor=J.+Michonauthor=S.+Lyonnetauthor=J.+Amielauthor=O.+Delattre&title=Somatic+and+germline+activating+mutations+of+the+ALK+kinase+receptor+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanoueix-Lerosey%26aufirst%3DI.%26aulast%3DLequin%26aufirst%3DD.%26aulast%3DBrugieres%26aufirst%3DL.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3Dde%2BPontual%26aufirst%3DL.%26aulast%3DCombaret%26aufirst%3DV.%26aulast%3DRaynal%26aufirst%3DV.%26aulast%3DPuisieux%26aufirst%3DA.%26aulast%3DSchleiermacher%26aufirst%3DG.%26aulast%3DPierron%26aufirst%3DG.%26aulast%3DValteau-Couanet%26aufirst%3DD.%26aulast%3DFrebourg%26aufirst%3DT.%26aulast%3DMichon%26aufirst%3DJ.%26aulast%3DLyonnet%26aufirst%3DS.%26aulast%3DAmiel%26aufirst%3DJ.%26aulast%3DDelattre%26aufirst%3DO.%26atitle%3DSomatic%2520and%2520germline%2520activating%2520mutations%2520of%2520the%2520ALK%2520kinase%2520receptor%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7215%26spage%3D967%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Mosse, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudenslager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquaglia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laureys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speleman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schork, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span> </span><span class="NLM_article-title">Identification of ALK as a major familial neuroblastoma predisposition gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7215</span><span class="NLM_x">) </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=930-935&issue=7215&author=Y.+P.+Mosseauthor=M.+Laudenslagerauthor=L.+Longoauthor=K.+A.+Coleauthor=A.+Woodauthor=E.+F.+Attiyehauthor=M.+J.+Laquagliaauthor=R.+Sennettauthor=J.+E.+Lynchauthor=P.+Perriauthor=G.+Laureysauthor=F.+Spelemanauthor=C.+Kimauthor=C.+Houauthor=H.+Hakonarsonauthor=A.+Torkamaniauthor=N.+J.+Schorkauthor=G.+M.+Brodeurauthor=G.+P.+Toniniauthor=E.+Rappaportauthor=M.+Devotoauthor=J.+M.+Maris&title=Identification+of+ALK+as+a+major+familial+neuroblastoma+predisposition+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMosse%26aufirst%3DY.%2BP.%26aulast%3DLaudenslager%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DLaquaglia%26aufirst%3DM.%2BJ.%26aulast%3DSennett%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BE.%26aulast%3DPerri%26aufirst%3DP.%26aulast%3DLaureys%26aufirst%3DG.%26aulast%3DSpeleman%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DTonini%26aufirst%3DG.%2BP.%26aulast%3DRappaport%26aufirst%3DE.%26aulast%3DDevoto%26aufirst%3DM.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520ALK%2520as%2520a%2520major%2520familial%2520neuroblastoma%2520predisposition%2520gene%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7215%26spage%3D930%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tuma, R. S.</span><span> </span><span class="NLM_article-title">ALK gene amplified in most inflammatory breast cancers</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1093%2Fjnci%2Fdjr553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=22215853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2012&pages=87-88&issue=2&author=R.+S.+Tuma&title=ALK+gene+amplified+in+most+inflammatory+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">ALK Gene Amplified in Most Inflammatory Breast Cancers</span></div><div class="casAuthors">Tuma, Rabiya S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-88</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Inflammatory breast cancer (IBC) is a rare form of the disease that differs substantially from non-inflammatory breast cancer in presentation and response to therapy. Despite those differences, researchers have uncovered few mol. characteristics that distinguish IBC from non-inflammatory breast cancer, and IBC treatment generally relies on std. breast cancer regimens.  Recently, it has been reported that ALK gene amplification is a common feature of IBC tumors and that small-mol. ALK inhibitors are effective in mouse xenograft models.  Current developments on this recent report are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB9yX6fegRi7Vg90H21EOLACvtfcHk0lhItJ-LCd3Ohw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWhsb0%253D&md5=46e7633055aadc3aacfc6bac9b4cb591</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjr553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjr553%26sid%3Dliteratum%253Aachs%26aulast%3DTuma%26aufirst%3DR.%2BS.%26atitle%3DALK%2520gene%2520amplified%2520in%2520most%2520inflammatory%2520breast%2520cancers%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2012%26volume%3D104%26issue%3D2%26spage%3D87%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beausoleil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innocenti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comb, M. J.</span><span> </span><span class="NLM_article-title">Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3312</span><span class="NLM_x">–</span> <span class="NLM_lpage">3323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=3312-3323&issue=13&author=H.+Renauthor=Z.+P.+Tanauthor=X.+Zhuauthor=K.+Crosbyauthor=H.+Haackauthor=J.+M.+Renauthor=S.+Beausoleilauthor=A.+Moritzauthor=G.+Innocentiauthor=J.+Rushauthor=Y.+Zhangauthor=X.+M.+Zhouauthor=T.+L.+Guauthor=Y.+F.+Yangauthor=M.+J.+Comb&title=Identification+of+anaplastic+lymphoma+kinase+as+a+potential+therapeutic+target+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DZ.%2BP.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCrosby%26aufirst%3DK.%26aulast%3DHaack%26aufirst%3DH.%26aulast%3DRen%26aufirst%3DJ.%2BM.%26aulast%3DBeausoleil%26aufirst%3DS.%26aulast%3DMoritz%26aufirst%3DA.%26aulast%3DInnocenti%26aufirst%3DG.%26aulast%3DRush%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%2BM.%26aulast%3DGu%26aufirst%3DT.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BF.%26aulast%3DComb%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%2520anaplastic%2520lymphoma%2520kinase%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26issue%3D13%26spage%3D3312%26epage%3D3323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bergethon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovly, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massion, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siwak-Tapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino-Kenudson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span> </span><span class="NLM_article-title">ROS1 rearrangements define a unique molecular class of lung cancers</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1200%2FJCO.2011.35.6345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC38XntV2lsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=863-870&issue=8&author=K.+Bergethonauthor=A.+T.+Shawauthor=S.+H.+Ouauthor=R.+Katayamaauthor=C.+M.+Lovlyauthor=N.+T.+McDonaldauthor=P.+P.+Massionauthor=C.+Siwak-Tappauthor=A.+Gonzalezauthor=R.+Fangauthor=E.+J.+Markauthor=J.+M.+Battenauthor=H.+Chenauthor=K.+D.+Wilnerauthor=E.+L.+Kwakauthor=J.+W.+Clarkauthor=D.+P.+Carboneauthor=H.+Jiauthor=J.+A.+Engelmanauthor=M.+Mino-Kenudsonauthor=W.+Paoauthor=A.+J.+Iafrate&title=ROS1+rearrangements+define+a+unique+molecular+class+of+lung+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">ROS1 rearrangements define a unique molecular class of lung cancers</span></div><div class="casAuthors">Bergethon, Kristin; Shaw, Alice T.; Ou, Sai-Hong Ignatius; Katayama, Ryohei; Lovly, Christine M.; McDonald, Nerina T.; Massion, Pierre P.; Siwak-Tapp, Christina; Gonzalez, Adriana; Fang, Rong; Mark, Eugene J.; Batten, Julie M.; Chen, Haiquan; Wilner, Keith D.; Kwak, Eunice L.; Clark, Jeffrey W.; Carbone, David P.; Ji, Hongbin; Engelman, Jeffrey A.; Mino-Kenudson, Mari; Pao, William; Iafrate, A. John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">863-870</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Chromosomal rearrangements involving the ROS1 receptor tyrosine kinase gene have recently been described in a subset of non-small-cell lung cancers (NSCLCs).  Because little is known about these tumors, we examd. the clin. characteristics and treatment outcomes of patients with NSCLC with ROS1 rearrangement.  Patients and Methods Using a ROS1 fluorescent in situ hybridization (FISH) assay, we screened 1,073 patients with NSCLC and correlated ROS1 rearrangement status with clin. characteristics, overall survival, and when available, ALK rearrangement status.  In vitro studies assessed the responsiveness of cells with ROS1 rearrangement to the tyrosine kinase inhibitor crizotinib.  The clin. response of one patient with ROS1-rearranged NSCLC to crizotinib was investigated as part of an expanded phase I cohort.  Results Of 1.073 tumors screened, 18 (1.7%) were ROS1 rearranged by FISH, and 31 (2.9%) were ALK rearranged.  Compared with the ROS1-neg. group, patients with ROS1 rearrangements were significantly younger and more likely to be never-smokers (each P < .001).  All of the ROS1-pos. tumors were adenocarcinomas, with a tendency toward higher grade.  ROS1-pos. and -neg. groups showed no difference in overall survival.  The HCC78 ROS1-rearranged NSCLC cell line and 293 cells transfected with CD74-ROS1 showed evidence of sensitivity to crizotinib.  The patient treated with crizotinib showed tumor shrinkage, with a near complete response.  Conclusion ROS1 rearrangement defines a mol. subset of NSCLC with distinct clin. characteristics that are similar to those obsd. in patients with ALK-rearranged NSCLC.  Crizotinib shows in vitro activity and early evidence of clin. activity in ROS1-rearranged NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovHC_E3hvZw7Vg90H21EOLACvtfcHk0lizG6Z1jmMqYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntV2lsbg%253D&md5=2540d37c3135597601ed2c15386b9f13</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.35.6345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.35.6345%26sid%3Dliteratum%253Aachs%26aulast%3DBergethon%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DLovly%26aufirst%3DC.%2BM.%26aulast%3DMcDonald%26aufirst%3DN.%2BT.%26aulast%3DMassion%26aufirst%3DP.%2BP.%26aulast%3DSiwak-Tapp%26aufirst%3DC.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DR.%26aulast%3DMark%26aufirst%3DE.%2BJ.%26aulast%3DBatten%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DCarbone%26aufirst%3DD.%2BP.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DMino-Kenudson%26aufirst%3DM.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26atitle%3DROS1%2520rearrangements%2520define%2520a%2520unique%2520molecular%2520class%2520of%2520lung%2520cancers%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D30%26issue%3D8%26spage%3D863%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gainor, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span> </span><span class="NLM_article-title">Novel targets in non-small cell lung cancer: ROS1 and RET fusions</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=865-875&issue=7&author=J.+F.+Gainorauthor=A.+T.+Shaw&title=Novel+targets+in+non-small+cell+lung+cancer%3A+ROS1+and+RET+fusions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGainor%26aufirst%3DJ.%2BF.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DNovel%2520targets%2520in%2520non-small%2520cell%2520lung%2520cancer%253A%2520ROS1%2520and%2520RET%2520fusions%26jtitle%3DOncologist%26date%3D2013%26volume%3D18%26issue%3D7%26spage%3D865%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&issue=18&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.+P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal-epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Cui, J. Jean; Tran-Dube, Michelle; Shen, Hong; Nambu, Mitchell; Kung, Pei-Pei; Pairish, Mason; Jia, Lei; Meng, Jerry; Funk, Lee; Botrous, Iriny; McTigue, Michele; Grodsky, Neil; Ryan, Kevin; Padrique, Ellen; Alton, Gordon; Timofeevski, Sergei; Yamazaki, Shinji; Li, Qiuhua; Zou, Helen; Christensen, James; Mroczkowski, Barbara; Bender, Steve; Kania, Robert S.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6342-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the crit. roles of aberrant signaling in cancer, both c-MET and ALK receptor tyrosine kinases are attractive oncol. targets for therapeutic intervention.  The cocrystal structure of 3 (PHA-665752), bound to c-MET kinase domain, revealed a novel ATP site environment, which served as the target to guide parallel, multiattribute drug design.  A novel 2-amino-5-aryl-3-benzyloxypyridine series was created to more effectively make the key interactions achieved with 3.  In the novel series, the 2-aminopyridine core allowed a 3-benzyloxy group to reach into the same pocket as the 2,6-dichlorophenyl group of 3 via a more direct vector and thus with a better ligand efficiency (LE).  Further optimization of the lead series generated the clin. candidate crizotinib (PF-02341066), which demonstrated potent in vitro and in vivo c-MET kinase and ALK inhibition, effective tumor growth inhibition, and good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHs_cKJ-U3t7Vg90H21EOLACvtfcHk0lizG6Z1jmMqYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN&md5=dbab4c1b3e7c76180dbad04be2b6a474</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Case history: Xalkori<sup>TM</sup> (Crizotinib), a potent and selective dual inhibitor of mesenchymal epithelial transition (MET) and anaplastic lymphoma kinase (ALK) for cancer treatment</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=421-434&author=J.+J.+Cuiauthor=M.+McTigueauthor=R.+Kaniaauthor=M.+Edwards&title=Case+history%3A+XalkoriTM+%28Crizotinib%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal+epithelial+transition+%28MET%29+and+anaplastic+lymphoma+kinase+%28ALK%29+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DKania%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DCase%2520history%253A%2520XalkoriTM%2520%2528Crizotinib%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal%2520epithelial%2520transition%2520%2528MET%2529%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520for%2520cancer%2520treatment%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D421%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span> </span><span class="NLM_article-title">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">12, Part 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3314</span><span class="NLM_x">–</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1158%2F1535-7163.MCT-07-0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3314-3322&issue=12%2C+Part+1&author=J.+G.+Christensenauthor=H.+Y.+Zouauthor=M.+E.+Arangoauthor=Q.+Liauthor=J.+H.+Leeauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=G.+R.+Altonauthor=B.+Mroczkowskiauthor=G.+Los&title=Cytoreductive+antitumor+activity+of+PF-2341066%2C+a+novel+inhibitor+of+anaplastic+lymphoma+kinase+and+c-Met%2C+in+experimental+models+of+anaplastic+large-cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span></div><div class="casAuthors">Christensen, James G.; Zou, Helen Y.; Arango, Maria E.; Li, Qiuhua; Lee, Joseph H.; McDonnell, Scott R.; Yamazaki, Shinji; Alton, Gordon R.; Mroczkowski, Barbara; Los, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3314-3322</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL).  PF-2341066 was recently identified as a p.o. bioavailable, small-mol. inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK fusion protein.  PF-2341066 also potently inhibited NPM-ALK phosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value, 24 nmol/L).  In biochem. and cellular screens, PF-2341066 was shown to be selective for c-Met and ALK at pharmacol. relevant concns. across a panel of >120 diverse kinases.  PF-2341066 potently inhibited cell proliferation, which was assocd. with G1-S-phase cell cycle arrest and induction of apoptosis in ALK-pos. ALCL cells (IC50 values, ∼30 nmol/L) but not ALK-neg. lymphoma cells.  The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase-mediated nick-end labeling and Annexin V staining (IC50 values, 25-50 nmol/L).  P.o. administration of PF-2341066 to severe combined immunodeficient-Beige mice bearing Karpas299 ALCL tumor xenografts resulted in dose-dependent antitumor efficacy with complete regression of all tumors at the 100 mg/kg/d dose within 15 days of initial compd. administration.  A strong correlation was obsd. between antitumor response and inhibition of NPM-ALK phosphorylation and induction of apoptosis in tumor tissue.  In addn., inhibition of key NPM-ALK signaling mediators, including phospholipase C-γ, signal transducers and activators of transcription 3, extracellular signal-regulated kinases, and Akt by PF-2341066 were obsd. at concns. or dose levels, which correlated with inhibition of NPM-ALK phosphorylation and function.  Collectively, these data illustrate the potential clin. utility of inhibitors of NPM-ALK in treatment of patients with ALK-pos. ALCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptqY0tUwGnurVg90H21EOLACvtfcHk0lg_Z0Cs-5il8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL&md5=04fbbaf43ca527408bde8cabcd38e1fd</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0365%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DLos%26aufirst%3DG.%26atitle%3DCytoreductive%2520antitumor%2520activity%2520of%2520PF-2341066%252C%2520a%2520novel%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520and%2520c-Met%252C%2520in%2520experimental%2520models%2520of%2520anaplastic%2520large-cell%2520lymphoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D12%252C%2520Part%25201%26spage%3D3314%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&issue=9&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.+P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D9%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camidge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezube, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidias, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino-Kenudson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shreeve, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratain, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span> </span><span class="NLM_article-title">Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1056%2FNEJMoa1006448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=20979469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1693-703&issue=18&author=E.+L.+Kwakauthor=Y.+J.+Bangauthor=D.+R.+Camidgeauthor=A.+T.+Shawauthor=B.+Solomonauthor=R.+G.+Makiauthor=S.+H.+Ouauthor=B.+J.+Dezubeauthor=P.+A.+Janneauthor=D.+B.+Costaauthor=M.+Varella-Garciaauthor=W.+H.+Kimauthor=T.+J.+Lynchauthor=P.+Fidiasauthor=H.+Stubbsauthor=J.+A.+Engelmanauthor=L.+V.+Sequistauthor=W.+Tanauthor=L.+Gandhiauthor=M.+Mino-Kenudsonauthor=G.+C.+Weiauthor=S.+M.+Shreeveauthor=M.+J.+Ratainauthor=J.+Settlemanauthor=J.+G.+Christensenauthor=D.+A.+Haberauthor=K.+Wilnerauthor=R.+Salgiaauthor=G.+I.+Shapiroauthor=J.+W.+Clarkauthor=A.+J.+Iafrate&title=Anaplastic+lymphoma+kinase+inhibition+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer</span></div><div class="casAuthors">Kwak, Eunice L.; Bang, Yung-Jue; Camidge, Ross; Shaw, Alice T.; Solomon, Benjamin; Maki, Robert G.; Ou, Sai-Hong I.; Dezube, Bruce J.; Janne, Pasi A.; Costa, Daniel B.; Varella-Garcia, Marileila; Kim, Woo-Ho; Lynch, Thomas J.; Fidias, Panos; Stubbs, Hannah; Engelman, Jeffrey A.; Sequist, Lecia V.; Tan, WeiWei; Gandhi, Leena; Mino-Kenudson, Mari; Wei, Greg C.; Shreeve, Martin; Ratain, Mark J.; Settleman, Jeffrey; Christensen, James G.; Haber, Daniel A.; Wilner, Keith; Salgia, Ravi; Shapiro, Geoffrey I.; Clark, Jeffrey W.; Iafrate, A. John</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1693-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of such tumors.  The authors explored the therapeutic efficacy of inhibiting ALK in such tumors in an early-phase clin. trial of crizotinib (PF-02341066), an orally available small-mol. inhibitor of the ALK tyrosine kinase.  METHODS: After screening tumor samples from approx. 1500 patients with non-small-cell lung cancer for the presence of ALK rearrangements, the authors identified 82 patients with advanced ALK-pos. disease who were eligible for the clin. trial.  Most of the patients had received previous treatment.  These patients were enrolled in an expanded cohort study instituted after phase 1 dose escalation had established a recommended crizotinib dose of 250 mg twice daily in 28-day cycles.  Patients were assessed for adverse events and response to therapy.  RESULTS: Patients with ALK rearrangements tended to be younger than those without the rearrangements, and most of the patients had little or no exposure to tobacco and had adenocarcinomas.  At a mean treatment duration of 6.4 mo, the overall response rate was 57% (47 of 82 patients, with 46 confirmed partial responses and 1 confirmed complete response); 27 patients (33%) had stable disease.  A total of 63 of 82 patients (77%) were continuing to receive crizotinib at the time of data cutoff, and the estd. probability of 6-mo progression-free survival was 72%, with no median for the study reached.  The drug resulted in grade 1 or 2 (mild) gastrointestinal side effects.  CONCLUSIONS: The inhibition of ALK in lung tumors with the ALK rearrangement resulted in tumor shrinkage or stable disease in most patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDt_eL7Lyo7Vg90H21EOLACvtfcHk0ljsGeOGD_tSQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FO&md5=47440b9c944100295cca0f1859138d6b</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1006448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1006448%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DSolomon%26aufirst%3DB.%26aulast%3DMaki%26aufirst%3DR.%2BG.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DDezube%26aufirst%3DB.%2BJ.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DW.%2BH.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DFidias%26aufirst%3DP.%26aulast%3DStubbs%26aufirst%3DH.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DGandhi%26aufirst%3DL.%26aulast%3DMino-Kenudson%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DG.%2BC.%26aulast%3DShreeve%26aufirst%3DS.%2BM.%26aulast%3DRatain%26aufirst%3DM.%2BJ.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DWilner%26aufirst%3DK.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26atitle%3DAnaplastic%2520lymphoma%2520kinase%2520inhibition%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26issue%3D18%26spage%3D1693%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeap, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riely, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butaney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebele, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulig, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selaru, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camidge, D. R.</span><span> </span><span class="NLM_article-title">Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: A retrospective analysis</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2FS1470-2045%2811%2970232-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1KmtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=1004-1012&issue=11&author=A.+T.+Shawauthor=B.+Y.+Yeapauthor=B.+J.+Solomonauthor=G.+J.+Rielyauthor=J.+Gainorauthor=J.+A.+Engelmanauthor=G.+I.+Shapiroauthor=D.+B.+Costaauthor=S.+H.+Ouauthor=M.+Butaneyauthor=R.+Salgiaauthor=R.+G.+Makiauthor=M.+Varella-Garciaauthor=R.+C.+Doebeleauthor=Y.+J.+Bangauthor=K.+Kuligauthor=P.+Selaruauthor=Y.+Tangauthor=K.+D.+Wilnerauthor=E.+L.+Kwakauthor=J.+W.+Clarkauthor=A.+J.+Iafrateauthor=D.+R.+Camidge&title=Effect+of+crizotinib+on+overall+survival+in+patients+with+advanced+non-small-cell+lung+cancer+harbouring+ALK+gene+rearrangement%3A+A+retrospective+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis</span></div><div class="casAuthors">Shaw, Alice T.; Yeap, Beow Y.; Solomon, Benjamin J.; Riely, Gregory J.; Gainor, Justin; Engelman, Jeffrey A.; Shapiro, Geoffrey I.; Costa, Daniel B.; Ou, Sai-Hong I.; Butaney, Mohit; Salgia, Ravi; Maki, Robert G.; Varella-Garcia, Marileila; Doebele, Robert C.; Bang, Yung-Jue; Kulig, Kimary; Selaru, Paulina; Tang, Yiyun; Wilner, Keith D.; Kwak, Eunice L.; Clark, Jeffrey W.; Iafrate, A. John; Camidge, D. Ross</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1004-1012</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">ALK gene rearrangement defines a new mol. subtype of non-small-cell lung cancer (NSCLC).  In a recent phase 1 clin. trial, the ALK tyrosine-kinase inhibitor (TKI) crizotinib showed marked antitumor activity in patients with advanced, ALK-pos. NSCLC.  To assess whether crizotinib affects overall survival in these patients, we did a retrospective study comparing survival outcomes in crizotinib-treated patients in the trial and crizotinib-naive controls screened during the same time period.  We examd. overall survival in patients with advanced, ALK-pos. NSCLC who enrolled in the phase 1 clin. trial of crizotinib, focusing on the cohort of 82 patients who had enrolled through Feb 10, 2010.  For comparators, we identified 36 ALK-pos. patients from trial sites who were not given crizotinib (ALK-pos. controls), 67 patients without ALK rearrangement but pos. for EGFR mutation, and 253 wild-type patients lacking either ALK rearrangement or EGFR mutation.  To assess differences in overall survival, we assessed subsets of clin. comparable ALK-pos. and ALK-neg. patients.  Among 82 ALK-pos. patients who were given crizotinib, median overall survival from initiation of crizotinib has not been reached (95% CI 17 mo to not reached); 1-yr overall survival was 74% (95% CI 63-82), and 2-yr overall survival was 54% (40-66).  Overall survival did not differ based on age, sex, smoking history, or ethnic origin.  Survival in 30 ALK-pos. patients who were given crizotinib in the second-line or third-line setting was significantly longer than in 23 ALK-pos. controls given any second-line therapy (median overall survival not reached [95% CI 14 mo to not reached] vs 6 mo [4-17], 1-yr overall survival 70% [95% CI 50-83] vs 44% [23-64], and 2-yr overall survival 55% [33-72] vs 12% [2-30]; hazard ratio 0.36, 95% CI 0.17-0.75; p = 0.004).  Survival in 56 crizotinib-treated, ALK-pos. patients was similar to that in 63 ALK-neg., EGFR-pos. patients given EGFR TKI therapy (median overall survival not reached [95% CI 17 mo to not reached] vs 24 mo [15-34], 1-yr overall survival 71% [95% CI 58-81] vs 74% [61-83], and 2-yr overall survival 57% [40-71] vs 52% [38-65]; p = 0.786), whereas survival in 36 crizotinib-naive, ALK-pos. controls was similar to that in 253 wild-type controls (median overall survival 20 mo [95% CI 13-26] vs 15 mo [13-17]; p = 0.244).  In patients with advanced, ALK-pos. NSCLC, crizotinib therapy is assocd. with improved survival compared with that of crizotinib-naive controls.  ALK rearrangement is not a favorable prognostic factor in advanced NSCLC.  Funding: Pfizer Inc, V Foundation for Cancer Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMS7fRYJSyrrVg90H21EOLACvtfcHk0ljsGeOGD_tSQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1KmtrzL&md5=5482da97726293764c9fe42419d187cb</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2811%2970232-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252811%252970232-7%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DYeap%26aufirst%3DB.%2BY.%26aulast%3DSolomon%26aufirst%3DB.%2BJ.%26aulast%3DRiely%26aufirst%3DG.%2BJ.%26aulast%3DGainor%26aufirst%3DJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DButaney%26aufirst%3DM.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DMaki%26aufirst%3DR.%2BG.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26aulast%3DKulig%26aufirst%3DK.%26aulast%3DSelaru%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26atitle%3DEffect%2520of%2520crizotinib%2520on%2520overall%2520survival%2520in%2520patients%2520with%2520advanced%2520non-small-cell%2520lung%2520cancer%2520harbouring%2520ALK%2520gene%2520rearrangement%253A%2520A%2520retrospective%2520analysis%26jtitle%3DLancet%2520Oncol.%26date%3D2011%26volume%3D12%26issue%3D11%26spage%3D1004%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielecki, J.</span><span> </span><span class="NLM_article-title">Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1038%2Fnrc2947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWlsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=760-774&issue=11&author=W.+Paoauthor=J.+Chmielecki&title=Rational%2C+biologically+based+treatment+of+EGFR-mutant+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer</span></div><div class="casAuthors">Pao, William; Chmielecki, Juliann</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">760-774</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) was first recognized in 2004 as a distinct, clin. relevant mol. subset of lung cancer.  The disease has been the subject of intensive research at both the basic scientific and clin. levels, becoming a paradigm for how to understand and treat oncogene-driven carcinomas.  Although patients with EGFR-mutant tumors have increased sensitivity to tyrosine kinase inhibitors (TKIs), primary and acquired resistance to these agents remains a major clin. problem.  This Review summarizes recent developments aimed at treating and ultimately curing the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_b4ITVJ2ZnrVg90H21EOLACvtfcHk0ljDXCnQvpnF_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWlsrrN&md5=448b40d66a0a5f171106baa1dc709c29</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc2947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2947%26sid%3Dliteratum%253Aachs%26aulast%3DPao%26aufirst%3DW.%26aulast%3DChmielecki%26aufirst%3DJ.%26atitle%3DRational%252C%2520biologically%2520based%2520treatment%2520of%2520EGFR-mutant%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26issue%3D11%26spage%3D760%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandya, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span> </span><span class="NLM_article-title">CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">e443</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=e443-445&issue=15&author=D.+B.+Costaauthor=S.+Kobayashiauthor=S.+S.+Pandyaauthor=W.+L.+Yeoauthor=Z.+Shenauthor=W.+Tanauthor=K.+D.+Wilner&title=CSF+concentration+of+the+anaplastic+lymphoma+kinase+inhibitor+crizotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DPandya%26aufirst%3DS.%2BS.%26aulast%3DYeo%26aufirst%3DW.%2BL.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26atitle%3DCSF%2520concentration%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520inhibitor%2520crizotinib%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26issue%3D15%26spage%3De443%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camphausen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span> </span><span class="NLM_article-title">Brain metastases as preventive and therapeutic targets</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1038%2Fnrc3053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21472002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVCrtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=352-363&issue=5&author=P.+S.+Steegauthor=K.+A.+Camphausenauthor=Q.+R.+Smith&title=Brain+metastases+as+preventive+and+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Brain metastases as preventive and therapeutic targets</span></div><div class="casAuthors">Steeg, Patricia S.; Camphausen, Kevin A.; Smith, Quentin R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">352-363</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The incidence of metastasis to the brain is apparently rising in cancer patients and threatens to limit the gains that have been made by new systemic treatments.  The brain is considered a 'sanctuary site' as the blood-tumor barrier limits the ability of drugs to enter and kill tumor cells.  Translational research examg. metastasis to the brain needs to be multi-disciplinary, marrying advanced chem., blood-brain barrier pharmacokinetics, neurocognitive testing and radiation biol. with metastasis biol., to develop and implement new clin. trial designs.  Advances in the chemoprevention of brain metastases, the validation of tumor radiation sensitizers and the amelioration of cognitive deficits caused by whole-brain radiation therapy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM3sRu7fNrQrVg90H21EOLACvtfcHk0ljDXCnQvpnF_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVCrtro%253D&md5=b45316ddf5f3ce9a04076157365831b7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrc3053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3053%26sid%3Dliteratum%253Aachs%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DCamphausen%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26atitle%3DBrain%2520metastases%2520as%2520preventive%2520and%2520therapeutic%2520targets%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D5%26spage%3D352%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Yamanaka, R.</span><span> </span><span class="NLM_article-title">Management of refractory or relapsed primary central nervous system lymphoma (review)</span> <span class="citation_source-journal">Mol. Med. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.3892%2Fmmr_00000186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12qsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=879-885&issue=6&author=R.+Yamanaka&title=Management+of+refractory+or+relapsed+primary+central+nervous+system+lymphoma+%28review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Management of refractory or relapsed primary central nervous system lymphoma (review)</span></div><div class="casAuthors">Yamanaka, Ryuya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">879-885</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Primary central nervous system lymphoma (PCNSL) is a non-Hodgkin's lymphoma arising in the central nervous system.  Combined methotrexate-based chemoradiotherapy is the std. treatment for PCNSL, resulting in a median overall survival of 25-51 mo.  Failure of first-line treatment has been reported in most patients with PCNSL.  Salvage therapy improves outcome; however, since many different treatments have been applied, conclusions cannot be drawn regarding an optimal treatment schedule.  This review analyzes the efficacy of different salvage therapies that have been reported in the literature.  These well-designed, randomized trials may help elucidate issues such as the best chemotherapy regimen for second-line treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC3vHGX62hWrVg90H21EOLACvtfcHk0ljDXCnQvpnF_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12qsr%252FE&md5=44fc965a86a713a7b52028195b1c8dab</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3892%2Fmmr_00000186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr_00000186%26sid%3Dliteratum%253Aachs%26aulast%3DYamanaka%26aufirst%3DR.%26atitle%3DManagement%2520of%2520refractory%2520or%2520relapsed%2520primary%2520central%2520nervous%2520system%2520lymphoma%2520%2528review%2529%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2009%26volume%3D2%26issue%3D6%26spage%3D879%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Nguyen, T. D.; DeAngelis, L. M.</span><span> </span><span class="NLM_article-title">Brain metastases</span>.  <span class="citation_source-journal">Neurol. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span>),  <span class="NLM_fpage">x</span><span class="NLM_x">–</span> <span class="NLM_lpage">xi</span>,  <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1192</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=x+1173-xi+1192&issue=4&author=T.+D.+Nguyen&author=L.+M.+DeAngelis&title=Brain+metastases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BD.%26atitle%3DBrain%2520metastases%26jtitle%3DNeurol.%2520Clin.%26date%3D2007%26volume%3D25%26issue%3D4%26spage%3Dx%26epage%3Dxi%26spage%3D1173%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Katayama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifshits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span> </span><span class="NLM_article-title">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7535-7540&issue=18&author=R.+Katayamaauthor=T.+M.+Khanauthor=C.+Benesauthor=E.+Lifshitsauthor=H.+Ebiauthor=V.+M.+Riveraauthor=W.+C.+Shakespeareauthor=A.+J.+Iafrateauthor=J.+A.+Engelmanauthor=A.+T.+Shaw&title=Therapeutic+strategies+to+overcome+crizotinib+resistance+in+non-small+cell+lung+cancers+harboring+the+fusion+oncogene+EML4-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DEbi%26aufirst%3DH.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520strategies%2520to%2520overcome%2520crizotinib%2520resistance%2520in%2520non-small%2520cell%2520lung%2520cancers%2520harboring%2520the%2520fusion%2520oncogene%2520EML4-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26issue%3D18%26spage%3D7535%26epage%3D7540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohwada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span> </span><span class="NLM_article-title">9-substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles as highly selective and potent anaplastic lymphoma kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6286</span><span class="NLM_x">–</span> <span class="NLM_lpage">6294</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200652u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6286-6294&issue=18&author=K.+Kinoshitaauthor=T.+Kobayashiauthor=K.+Asohauthor=N.+Furuichiauthor=T.+Itoauthor=H.+Kawadaauthor=S.+Haraauthor=J.+Ohwadaauthor=K.+Hattoriauthor=T.+Miyagiauthor=W.+S.+Hongauthor=M.+J.+Parkauthor=K.+Takanashiauthor=T.+Tsukaguchiauthor=H.+Sakamotoauthor=T.+Tsukudaauthor=N.+Oikawa&title=9-substituted+6%2C6-dimethyl-11-oxo-6%2C11-dihydro-5H-benzo%5Bb%5Dcarbazoles+as+highly+selective+and+potent+anaplastic+lymphoma+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm200652u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200652u%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DOhwada%26aufirst%3DJ.%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DW.%2BS.%26aulast%3DPark%26aufirst%3DM.%2BJ.%26aulast%3DTakanashi%26aufirst%3DK.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DOikawa%26aufirst%3DN.%26atitle%3D9-substituted%25206%252C6-dimethyl-11-oxo-6%252C11-dihydro-5H-benzo%255Bb%255Dcarbazoles%2520as%2520highly%2520selective%2520and%2520potent%2520anaplastic%2520lymphoma%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6286%26epage%3D6294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span> </span><span class="NLM_article-title">Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3788</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3788-93&issue=12&author=K.+Kinoshitaauthor=Y.+Onoauthor=T.+Emuraauthor=K.+Asohauthor=N.+Furuichiauthor=T.+Itoauthor=H.+Kawadaauthor=S.+Tanakaauthor=K.+Morikamiauthor=T.+Tsukaguchiauthor=H.+Sakamotoauthor=T.+Tsukudaauthor=N.+Oikawa&title=Discovery+of+novel+tetracyclic+compounds+as+anaplastic+lymphoma+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DEmura%26aufirst%3DT.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DOikawa%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520novel%2520tetracyclic%2520compounds%2520as%2520anaplastic%2520lymphoma%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D12%26spage%3D3788%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span> </span><span class="NLM_article-title">CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=679-690&issue=5&author=H.+Sakamotoauthor=T.+Tsukaguchiauthor=S.+Hiroshimaauthor=T.+Kodamaauthor=T.+Kobayashiauthor=T.+A.+Fukamiauthor=N.+Oikawaauthor=T.+Tsukudaauthor=N.+Ishiiauthor=Y.+Aoki&title=CH5424802%2C+a+selective+ALK+inhibitor+capable+of+blocking+the+resistant+gatekeeper+mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DHiroshima%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%2BA.%26aulast%3DOikawa%26aufirst%3DN.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DY.%26atitle%3DCH5424802%252C%2520a%2520selective%2520ALK%2520inhibitor%2520capable%2520of%2520blocking%2520the%2520resistant%2520gatekeeper%2520mutant%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26issue%3D5%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kuromitsu, S.; Mori, M.; Shimada, I.; Kondoh, Y.; Shindoh, N.; Soga, T.; Furutani, T.; Konagai, S.; Sakagami, H.; Nakata, M.; Ueno, Y.; Saito, R.; Sasamata, M.; Kudou, M.</span><span> </span><span class="NLM_article-title">Anti-tumor activity of ASP3026. A novel and selective ALK inhibitor of anaplastic lymphoma kinase (ALK)</span>.  <span class="citation_source-book">Annual Meeting of the American Assocation for Cancer Research (AACR)</span>, Orlando, FL, April 2–6, 2011; <span class="NLM_publisher-name">AACR</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Kuromitsu&author=M.+Mori&author=I.+Shimada&author=Y.+Kondoh&author=N.+Shindoh&author=T.+Soga&author=T.+Furutani&author=S.+Konagai&author=H.+Sakagami&author=M.+Nakata&author=Y.+Ueno&author=R.+Saito&author=M.+Sasamata&author=M.+Kudou&title=Annual+Meeting+of+the+American+Assocation+for+Cancer+Research+%28AACR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKuromitsu%26aufirst%3DS.%26atitle%3DAnti-tumor%2520activity%2520of%2520ASP3026.%2520A%2520novel%2520and%2520selective%2520ALK%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26btitle%3DAnnual%2520Meeting%2520of%2520the%2520American%2520Assocation%2520for%2520Cancer%2520Research%2520%2528AACR%2529%26pub%3DAACR%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&issue=1&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26issue%3D1%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Marsilje, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkisova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pferdekamper, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groessl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phimister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aycinena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursulaya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanewsky, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michellys, P. Y.</span><span> </span><span class="NLM_article-title">Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">5675</span><span class="NLM_x">–</span> <span class="NLM_lpage">5690</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400402q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5675-5690&issue=14&author=T.+H.+Marsiljeauthor=W.+Peiauthor=B.+Chenauthor=W.+Luauthor=T.+Unoauthor=Y.+Jinauthor=T.+Jiangauthor=S.+Kimauthor=N.+Liauthor=M.+Warmuthauthor=Y.+Sarkisovaauthor=F.+Sunauthor=A.+Steffyauthor=A.+C.+Pferdekamperauthor=A.+G.+Liauthor=S.+B.+Josephauthor=Y.+Kimauthor=B.+Liuauthor=T.+Tuntlandauthor=X.+Cuiauthor=N.+S.+Grayauthor=R.+Steensmaauthor=Y.+Wanauthor=J.+Jiangauthor=G.+Chopiukauthor=J.+Liauthor=W.+P.+Gordonauthor=W.+Richmondauthor=K.+Johnsonauthor=J.+Changauthor=T.+Groesslauthor=Y.+Q.+Heauthor=A.+Phimisterauthor=A.+Aycinenaauthor=C.+C.+Leeauthor=B.+Bursulayaauthor=D.+S.+Karanewskyauthor=H.+M.+Seidelauthor=J.+L.+Harrisauthor=P.+Y.+Michellys&title=Synthesis%2C+structure-activity+relationships%2C+and+in+vivo+efficacy+of+the+novel+potent+and+selective+anaplastic+lymphoma+kinase+%28ALK%29+inhibitor+5-chloro-N2-%282-isopropoxy-5-methyl-4-%28piperidin-4-yl%29phenyl%29-N4-%282-%28isopropylsulfonyl%29phenyl%29pyrimidine-2%2C4-diamine+%28LDK378%29+currently+in+phase+1+and+phase+2+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm400402q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400402q%26sid%3Dliteratum%253Aachs%26aulast%3DMarsilje%26aufirst%3DT.%2BH.%26aulast%3DPei%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DUno%26aufirst%3DT.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DSarkisova%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DPferdekamper%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DA.%2BG.%26aulast%3DJoseph%26aufirst%3DS.%2BB.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DW.%2BP.%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DHe%26aufirst%3DY.%2BQ.%26aulast%3DPhimister%26aufirst%3DA.%26aulast%3DAycinena%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DMichellys%26aufirst%3DP.%2BY.%26atitle%3DSynthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520in%2520vivo%2520efficacy%2520of%2520the%2520novel%2520potent%2520and%2520selective%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520inhibitor%25205-chloro-N2-%25282-isopropoxy-5-methyl-4-%2528piperidin-4-yl%2529phenyl%2529-N4-%25282-%2528isopropylsulfonyl%2529phenyl%2529pyrimidine-2%252C4-diamine%2520%2528LDK378%2529%2520currently%2520in%2520phase%25201%2520and%2520phase%25202%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D14%26spage%3D5675%26epage%3D5690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunker, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dack, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsaparikos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1170</span><span class="NLM_x">–</span> <span class="NLM_lpage">1187</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401805h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1170-1187&issue=4&author=Q.+Huangauthor=T.+W.+Johnsonauthor=S.+Baileyauthor=A.+Broounauthor=K.+D.+Bunkerauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=A.+S.+Cookauthor=J.+J.+Cuiauthor=K.+D.+Dackauthor=J.+G.+Dealauthor=Y.-L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=P.+S.+Johnsonauthor=R.+S.+Kaniaauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=Q.+Liauthor=L.+Lingardoauthor=W.+Liuauthor=M.+W.+Luauthor=M.+McTigueauthor=C.+L.+Palmerauthor=P.+F.+Richardsonauthor=N.+W.+Sachauthor=H.+Shenauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=K.+Tsaparikosauthor=H.+Wangauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Design+of+potent+and+selective+inhibitors+to+overcome+clinical+anaplastic+lymphoma+kinase+mutations+resistant+to+crizotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm401805h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401805h%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBunker%26aufirst%3DK.%2BD.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDack%26aufirst%3DK.%2BD.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DJohnson%26aufirst%3DP.%2BS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DM.%2BW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DTsaparikos%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDesign%2520of%2520potent%2520and%2520selective%2520inhibitors%2520to%2520overcome%2520clinical%2520anaplastic%2520lymphoma%2520kinase%2520mutations%2520resistant%2520to%2520crizotinib%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D4%26spage%3D1170%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Johnson, T. W.; Bailey, S.; Burke, B. J.; Collins, M. R.; Cui, J. J.; Deal, J.; Deng, Y.; Edwards, M. P.; He, M.; Hoffman, J.; Hoffman, R. L.; Huang, Q.; Kania, R. S.; Le, P.; McTigue, M.; Palmer, C. L.; Richardson, P. F.; Sach, N. W.; Smith, G. L.; Engstrom, L.; Hu, W.; Lam, H.; Lam, J. L.; Smeal, S.; Zou, H. Y.</span><span> </span><span class="NLM_article-title">Is CNS availability for oncology a no-brainer? Discovery of PF-06463922, a novel small molecule inhibitor of ALK/ROS1 with preclinical brain availability and broad spectrum potency against ALK-resistant mutations</span>.  <span class="citation_source-journal">Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics</span>, Boston, MA, Oct 19–23, 2013; <span class="NLM_publisher-name">American Association for Cancer Research (AACR)</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, 2013;  <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">11, Suppl.</span>), Abstract PR10.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&issue=11%2C+Suppl.&author=T.+W.+Johnson&author=S.+Bailey&author=B.+J.+Burke&author=M.+R.+Collins&author=J.+J.+Cui&author=J.+Deal&author=Y.+Deng&author=M.+P.+Edwards&author=M.+He&author=J.+Hoffman&author=R.+L.+Hoffman&author=Q.+Huang&author=R.+S.+Kania&author=P.+Le&author=M.+McTigue&author=C.+L.+Palmer&author=P.+F.+Richardson&author=N.+W.+Sach&author=G.+L.+Smith&author=L.+Engstrom&author=W.+Hu&author=H.+Lam&author=J.+L.+Lam&author=S.+Smeal&author=H.+Y.+Zou&title=Is+CNS+availability+for+oncology+a+no-brainer%3F+Discovery+of+PF-06463922%2C+a+novel+small+molecule+inhibitor+of+ALK%2FROS1+with+preclinical+brain+availability+and+broad+spectrum+potency+against+ALK-resistant+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26atitle%3DIs%2520CNS%2520availability%2520for%2520oncology%2520a%2520no-brainer%253F%2520Discovery%2520of%2520PF-06463922%252C%2520a%2520novel%2520small%2520molecule%2520inhibitor%2520of%2520ALK%252FROS1%2520with%2520preclinical%2520brain%2520availability%2520and%2520broad%2520spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DProceedings%2520of%2520the%2520AACR-NCI-EORTC%2520International%2520Conference%253A%2520Molecular%2520Targets%2520and%2520Cancer%2520Therapeutics%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%2520%2528AACR%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26issue%3D11%252C%2520Suppl" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zou, H. Y.; Engstrom, L. R.; Li, Q.; West-Lu, M.; Tang, R. W.; Wang, H.; Tsaparikos, K.; Timofeevski, S.; Lam, J.; Yamazaki, S.; Hu, W.; Gukasyan, H.; Lee, N.; Johnson, T. W.; Fantin, V.; Smeal, T.</span><span> </span><span class="NLM_article-title">PF-06463922, a novel ROS1/ALK inhibitor, demonstrates sub-nanomolar potency against oncogenic ROS1 fusions and capable of blocking the resistant ROS1-G2032R mutant in preclinical tumor models</span>.  <span class="citation_source-journal">Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics</span>, Boston, MA, Oct 19–23, 2013; <span class="NLM_publisher-name">American Association for Cancer Research (AACR)</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, 2013;  <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">11, Suppl.</span>), Abstract A277.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&issue=11%2C+Suppl.&author=H.+Y.+Zou&author=L.+R.+Engstrom&author=Q.+Li&author=M.+West-Lu&author=R.+W.+Tang&author=H.+Wang&author=K.+Tsaparikos&author=S.+Timofeevski&author=J.+Lam&author=S.+Yamazaki&author=W.+Hu&author=H.+Gukasyan&author=N.+Lee&author=T.+W.+Johnson&author=V.+Fantin&author=T.+Smeal&title=PF-06463922%2C+a+novel+ROS1%2FALK+inhibitor%2C+demonstrates+sub-nanomolar+potency+against+oncogenic+ROS1+fusions+and+capable+of+blocking+the+resistant+ROS1-G2032R+mutant+in+preclinical+tumor+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26atitle%3DPF-06463922%252C%2520a%2520novel%2520ROS1%252FALK%2520inhibitor%252C%2520demonstrates%2520sub-nanomolar%2520potency%2520against%2520oncogenic%2520ROS1%2520fusions%2520and%2520capable%2520of%2520blocking%2520the%2520resistant%2520ROS1-G2032R%2520mutant%2520in%2520preclinical%2520tumor%2520models%26jtitle%3DProceedings%2520of%2520the%2520AACR-NCI-EORTC%2520International%2520Conference%253A%2520Molecular%2520Targets%2520and%2520Cancer%2520Therapeutics%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%2520%2528AACR%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26issue%3D11%252C%2520Suppl" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zou, H. Y.; Engstrom, L. R.; Li, Q.; Lu, M. W.; Tang, R. W.; Wang, H.; Tsaparikos, K.; Wang, J.; Timofeevski, S.; Dinh, D. M.; Lam, H.; Lam, J.; Yamazaki, S.; Hu, W.; Affolter, T.; Lappin, P. B.; Gukasyan, H.; Lee, N.; Tursi, J. M.; Johnson, T. W.; Fantin, V.; Smeal, T.</span><span> </span><span class="NLM_article-title">PF-06463922, a novel brain-penetrating small molecule inhibitor of ALK/ROS1 with potent activity against a broad spectrum of ALK resistant mutations in preclinical models in vitro and in vivo</span>.  <span class="citation_source-journal">Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics</span>; Boston, MA, Oct 19–23, 2013; <span class="NLM_publisher-name">American Association for Cancer Research (AACR)</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, 2013;  <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">11, Suppl.</span>), Abstract C253.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&issue=11%2C+Suppl.&author=H.+Y.+Zou&author=L.+R.+Engstrom&author=Q.+Li&author=M.+W.+Lu&author=R.+W.+Tang&author=H.+Wang&author=K.+Tsaparikos&author=J.+Wang&author=S.+Timofeevski&author=D.+M.+Dinh&author=H.+Lam&author=J.+Lam&author=S.+Yamazaki&author=W.+Hu&author=T.+Affolter&author=P.+B.+Lappin&author=H.+Gukasyan&author=N.+Lee&author=J.+M.+Tursi&author=T.+W.+Johnson&author=V.+Fantin&author=T.+Smeal&title=PF-06463922%2C+a+novel+brain-penetrating+small+molecule+inhibitor+of+ALK%2FROS1+with+potent+activity+against+a+broad+spectrum+of+ALK+resistant+mutations+in+preclinical+models+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26atitle%3DPF-06463922%252C%2520a%2520novel%2520brain-penetrating%2520small%2520molecule%2520inhibitor%2520of%2520ALK%252FROS1%2520with%2520potent%2520activity%2520against%2520a%2520broad%2520spectrum%2520of%2520ALK%2520resistant%2520mutations%2520in%2520preclinical%2520models%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DProceedings%2520of%2520the%2520AACR-NCI-EORTC%2520International%2520Conference%253A%2520Molecular%2520Targets%2520and%2520Cancer%2520Therapeutics%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%2520%2528AACR%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26issue%3D11%252C%2520Suppl" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span> </span><span class="NLM_article-title">Role of physicochemical properties and lipophilic ligand efficiency (LipE or LLE) in addressing drug safety risks</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=381-391&author=M.+P.+Edwardsauthor=D.+A.+Price&title=Role+of+physicochemical+properties+and+lipophilic+ligand+efficiency+%28LipE+or+LLE%29+in+addressing+drug+safety+risks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520physicochemical%2520properties%2520and%2520lipophilic%2520ligand%2520efficiency%2520%2528LipE%2520or%2520LLE%2529%2520in%2520addressing%2520drug%2520safety%2520risks%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D381%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Freeman-Cook, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span> </span><span class="NLM_article-title">Lipophilic efficiency: The most important efficiency metric in medicinal chemistry</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.4155%2Ffmc.12.208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=23360135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=113-115&issue=2&author=K.+D.+Freeman-Cookauthor=R.+L.+Hoffmanauthor=T.+W.+Johnson&title=Lipophilic+efficiency%3A+The+most+important+efficiency+metric+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span></div><div class="casAuthors">Freeman-Cook, Kevin D.; Hoffman, Robert L.; Johnson, Ted W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-115</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review is given on the crit. role of lipophilicity in drug discovery and optimization of general absorption, distribution, metab. and excretion properties, toxicol. profiles and ultimately pharmacol. response.  Math. equations are presented concerning the impact of lipophilicity on the dose and the calcn. of the lipophilic ligand efficiency (LipE).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhEHH7Hf1qbVg90H21EOLACvtfcHk0lhn9ymCwvndRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D&md5=36170decfa1f1e3ef09ecf772322a210</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.208%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26atitle%3DLipophilic%2520efficiency%253A%2520The%2520most%2520important%2520efficiency%2520metric%2520in%2520medicinal%2520chemistry%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26issue%3D2%26spage%3D113%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&issue=15&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0linlQq7R9exNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D15%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the golden triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&issue=19&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+golden+triangle+to+optimize+clearance+and+oral+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520golden%2520triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5560%26epage%3D5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">Dose is proportional to (<i>C</i><sub>eff</sub>Cl<sub>u</sub>)/<i>F</i>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&issue=4&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0linlQq7R9exNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Bunnage, M. E.; Cook, A. S.; Cui, J. J.; Dack, K. N.; Deal, J. G.; Gu, D.; He, M.; Johnson, P. S.; Johnson, T. W.; Le, P. T.; Palmer, C. L.; Shen, H.</span><span> </span><span class="NLM_article-title">Heterocyclic derivatives for the treatment of diseases</span>. WO 2011/138751 A2,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+E.+Bunnage&author=A.+S.+Cook&author=J.+J.+Cui&author=K.+N.+Dack&author=J.+G.+Deal&author=D.+Gu&author=M.+He&author=P.+S.+Johnson&author=T.+W.+Johnson&author=P.+T.+Le&author=C.+L.+Palmer&author=H.+Shen&title=Heterocyclic+derivatives+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26atitle%3DHeterocyclic%2520derivatives%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&issue=2&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lhgpgdvJ_iKRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26issue%3D2%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">Macrocycles in drug discovery have been defined as a ring system consisting of 12 or more atoms.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrett, N. K.</span><span> </span><span class="NLM_article-title">The exploration of macrocycles for drug discovery--an underexploited structural class</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=608-624&issue=7&author=E.+M.+Driggersauthor=S.+P.+Haleauthor=J.+Leeauthor=N.+K.+Terrett&title=The+exploration+of+macrocycles+for+drug+discovery%2D%2Dan+underexploited+structural+class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DHale%26aufirst%3DS.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26atitle%3DThe%2520exploration%2520of%2520macrocycles%2520for%2520drug%2520discovery--an%2520underexploited%2520structural%2520class%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26issue%3D7%26spage%3D608%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Giordanetto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlberg, J.</span><span> </span><span class="NLM_article-title">Macrocyclic drugs and clinical candidates: What can medicinal chemists learn from their properties?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400887j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=278-295&issue=2&author=F.+Giordanettoauthor=J.+Kihlberg&title=Macrocyclic+drugs+and+clinical+candidates%3A+What+can+medicinal+chemists+learn+from+their+properties%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fjm400887j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400887j%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520drugs%2520and%2520clinical%2520candidates%253A%2520What%2520can%2520medicinal%2520chemists%2520learn%2520from%2520their%2520properties%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D2%26spage%3D278%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Marsault, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span> </span><span class="NLM_article-title">Macrocycles are great cycles: Applications, opportunities, and challenges of synthetic macrocycles in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&issue=7&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+are+great+cycles%3A+Applications%2C+opportunities%2C+and+challenges+of+synthetic+macrocycles+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0lgtvkQ-O0EhSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520are%2520great%2520cycles%253A%2520Applications%252C%2520opportunities%252C%2520and%2520challenges%2520of%2520synthetic%2520macrocycles%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D7%26spage%3D1961%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span> </span><span class="NLM_article-title">Synthetic macrocycles in small-molecule drug discovery</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1016%2FB978-0-12-417150-3.00023-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=371-386&author=S.+Vendevilleauthor=M.+D.+Cummings&title=Synthetic+macrocycles+in+small-molecule+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33dR"><div class="casContent"><span class="casTitleNuber">33d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic macrocycles in small-molecule drug discovery</span></div><div class="casAuthors">Vendeville, Sandrine; Cummings, Maxwell D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">371-386</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Macrocycles, mols. contg. 12-membered or larger rings, are receiving increased attention in small-mol. drug discovery.  In this review the authors briefly describe a few representative examples of recent studies in which macrocyclization has had significant impact on pharmacokinetics and pharmacodynamics and/or potency and/or target selectivity.  The authors conclude with a few relevant issues and several studies aimed at broader understanding in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpY7yB6XMf4rVg90H21EOLACvtfcHk0lgtvkQ-O0EhSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu7%252FL&md5=a47d81142ee71f98d34c9ebeaa9868b0</span></div><a href="/servlet/linkout?suffix=cit33d&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417150-3.00023-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-417150-3.00023-5%26sid%3Dliteratum%253Aachs%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26atitle%3DSynthetic%2520macrocycles%2520in%2520small-molecule%2520drug%2520discovery%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D371%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Breslin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoshe, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knecht, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">Design, synthesis, and anaplastic lymphoma kinase (ALK) inhibitory activity for a novel series of 2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=449-464&issue=1&author=H.+J.+Breslinauthor=B.+M.+Laneauthor=G.+R.+Ottauthor=A.+K.+Ghosheauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=M.+Chengauthor=W.+Wanauthor=R.+C.+Haltiwangerauthor=K.+J.+Wells-Knechtauthor=B.+D.+Dorsey&title=Design%2C+synthesis%2C+and+anaplastic+lymphoma+kinase+%28ALK%29+inhibitory+activity+for+a+novel+series+of+2%2C4%2C8%2C22-tetraazatetracyclo%5B14.3.1.13%2C7.19%2C13%5Ddocosa-1%2820%29%2C3%2822%29%2C4%2C6%2C9%2821%29%2C10%2C12%2C16%2C18-nonaene+macrocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreslin%26aufirst%3DH.%2BJ.%26aulast%3DLane%26aufirst%3DB.%2BM.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DGhoshe%26aufirst%3DA.%2BK.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DWells-Knecht%26aufirst%3DK.%2BJ.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520inhibitory%2520activity%2520for%2520a%2520novel%2520series%2520of%25202%252C4%252C8%252C22-tetraazatetracyclo%255B14.3.1.13%252C7.19%252C13%255Ddocosa-1%252820%2529%252C3%252822%2529%252C4%252C6%252C9%252821%2529%252C10%252C12%252C16%252C18-nonaene%2520macrocycles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D55%26issue%3D1%26spage%3D449%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladysheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crenne, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span> </span><span class="NLM_article-title">The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2012&pages=439-453&issue=3&author=T.+Bertrandauthor=M.+Kotheauthor=J.+Liuauthor=A.+Dupuyauthor=A.+Rakauthor=P.+F.+Berneauthor=S.+Davisauthor=T.+Gladyshevaauthor=C.+Valtreauthor=J.+Y.+Crenneauthor=M.+Mathieu&title=The+crystal+structures+of+TrkA+and+TrkB+suggest+key+regions+for+achieving+selective+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDupuy%26aufirst%3DA.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DBerne%26aufirst%3DP.%2BF.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DGladysheva%26aufirst%3DT.%26aulast%3DValtre%26aufirst%3DC.%26aulast%3DCrenne%26aufirst%3DJ.%2BY.%26aulast%3DMathieu%26aufirst%3DM.%26atitle%3DThe%2520crystal%2520structures%2520of%2520TrkA%2520and%2520TrkB%2520suggest%2520key%2520regions%2520for%2520achieving%2520selective%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D423%26issue%3D3%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleasby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span> </span><span class="NLM_article-title">Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=687-693&issue=9&author=H.+Heauthor=K.+A.+Lyonsauthor=X.+Shenauthor=Z.+Yaoauthor=K.+Bleasbyauthor=G.+Chanauthor=M.+Hafeyauthor=X.+Liauthor=S.+Xuauthor=G.+M.+Salituroauthor=L.+H.+Cohenauthor=W.+Tang&title=Utility+of+unbound+plasma+drug+levels+and+P-glycoprotein+transport+data+in+prediction+of+central+nervous+system+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DBleasby%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DHafey%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DCohen%26aufirst%3DL.%2BH.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DUtility%2520of%2520unbound%2520plasma%2520drug%2520levels%2520and%2520P-glycoprotein%2520transport%2520data%2520in%2520prediction%2520of%2520central%2520nervous%2520system%2520exposure%26jtitle%3DXenobiotica%26date%3D2009%26volume%3D39%26issue%3D9%26spage%3D687%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kodaira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusuhara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushiki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuse, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1124%2Fjpet.111.180398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21934030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=935-944&issue=3&author=H.+Kodairaauthor=H.+Kusuharaauthor=T.+Fujitaauthor=J.+Ushikiauthor=E.+Fuseauthor=Y.+Sugiyama&title=Quantitative+evaluation+of+the+impact+of+active+efflux+by+p-glycoprotein+and+breast+cancer+resistance+protein+at+the+blood-brain+barrier+on+the+predictability+of+the+unbound+concentrations+of+drugs+in+the+brain+using+cerebrospinal+fluid+concentration+as+a+surrogate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of the impact of active efflux by P-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate</span></div><div class="casAuthors">Kodaira, Hiroshi; Kusuhara, Hiroyuki; Fujita, Takuya; Ushiki, Junko; Fuse, Eiichi; Sugiyama, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">935-944</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study investigated the impact of the active efflux mediated by P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp) at the blood-brain barrier (BBB) on the predictability of the unbound brain concn. (Cu,brain) by the concn. in the cerebrospinal fluid (CSF) (Cu,CSF) in rats.  Cu,brain is obtained as the product of the total brain concn. and unbound fraction in the brain (fu,brain) detd. in vitro in brain slices.  Twenty-five compds., including P-gp and/or Bcrp substrates, were given a const. i.v. infusion, and their plasma, brain, and CSF concns. were detd.  P-gp and/or Bcrp substrates, such as verapamil, loperamide, flavopiridol, genistein, quinidine, dantrolene, daidzein, cimetidine, and pefloxacin, showed a higher CSF-to-brain unbound concn. ratio (Kp,uu,CSF/brain) compared with non-P-gp and non-Bcrp substrates.  Kp,uu,CSF/brain values of P-gp-specific (quinidine and verapamil) and Bcrp-specific (daidzein and genistein) substrates were significantly decreased in Mdr1a/1b(-/-) and Bcrp(-/-) mice, resp.  Furthermore, consistent with the contribution of P-gp and Bcrp to the net efflux at the BBB, Kp,uu,CSF/brain values of the common substrates (flavopiridol and erlotinib) were markedly decreased in Mdr1a/1b(-/-)/Bcrp(-/-) mice, but only moderately or weakly in Mdr1a/1b(-/-) mice and negligibly in Bcrp(-/-) mice.  In conclusion, predictability of Cu,brain by Cu,CSF decreases along with the net transport activities by P-gp and Bcrp at the BBB.  Cu,CSF of non-P-gp and non-Bcrp substrates can be a reliable surrogate of Cu,brain for lipophilic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6e2OeGRsyrVg90H21EOLACvtfcHk0lhi4G-Uht8vsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSksbo%253D&md5=36a778b164943b101534146120fc6cdf</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.180398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.180398%26sid%3Dliteratum%253Aachs%26aulast%3DKodaira%26aufirst%3DH.%26aulast%3DKusuhara%26aufirst%3DH.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DUshiki%26aufirst%3DJ.%26aulast%3DFuse%26aufirst%3DE.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DQuantitative%2520evaluation%2520of%2520the%2520impact%2520of%2520active%2520efflux%2520by%2520p-glycoprotein%2520and%2520breast%2520cancer%2520resistance%2520protein%2520at%2520the%2520blood-brain%2520barrier%2520on%2520the%2520predictability%2520of%2520the%2520unbound%2520concentrations%2520of%2520drugs%2520in%2520the%2520brain%2520using%2520cerebrospinal%2520fluid%2520concentration%2520as%2520a%2520surrogate%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26issue%3D3%26spage%3D935%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ohe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanatani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, Y.</span><span> </span><span class="NLM_article-title">Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid/plasma concentration ratio</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1251-1254&issue=10&author=T.+Oheauthor=M.+Satoauthor=S.+Tanakaauthor=N.+Fujinoauthor=M.+Hataauthor=Y.+Shibataauthor=A.+Kanataniauthor=T.+Fukamiauthor=M.+Yamazakiauthor=M.+Chibaauthor=Y.+Ishii&title=Effect+of+P-glycoprotein-mediated+efflux+on+cerebrospinal+fluid%2Fplasma+concentration+ratio"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DFujino%26aufirst%3DN.%26aulast%3DHata%26aufirst%3DM.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DKanatani%26aufirst%3DA.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DY.%26atitle%3DEffect%2520of%2520P-glycoprotein-mediated%2520efflux%2520on%2520cerebrospinal%2520fluid%252Fplasma%2520concentration%2520ratio%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26issue%3D10%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Redzic, Z.</span><span> </span><span class="NLM_article-title">Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: Similarities and differences</span> <span class="citation_source-journal">Fluids Barriers CNS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35d&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1186%2F2045-8118-8-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35d&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21349151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35d&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A280%3ADC%252BC3M3itFSktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=3&issue=1&author=Z.+Redzic&title=Molecular+biology+of+the+blood-brain+and+the+blood-cerebrospinal+fluid+barriers%3A+Similarities+and+differences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35dR"><div class="casContent"><span class="casTitleNuber">35d</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences</span></div><div class="casAuthors">Redzic Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Fluids and barriers of the CNS</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Efficient processing of information by the central nervous system (CNS) represents an important evolutionary advantage.  Thus, homeostatic mechanisms have developed that provide appropriate circumstances for neuronal signaling, including a highly controlled and stable microenvironment.  To provide such a milieu for neurons, extracellular fluids of the CNS are separated from the changeable environment of blood at three major interfaces: at the brain capillaries by the blood-brain barrier (BBB), which is localized at the level of the endothelial cells and separates brain interstitial fluid (ISF) from blood; at the epithelial layer of four choroid plexuses, the blood-cerebrospinal fluid (CSF) barrier (BCSFB), which separates CSF from the CP ISF, and at the arachnoid barrier.  The two barriers that represent the largest interface between blood and brain extracellular fluids, the BBB and the BCSFB, prevent the free paracellular diffusion of polar molecules by complex morphological features, including tight junctions (TJs) that interconnect the endothelial and epithelial cells, respectively.  The first part of this review focuses on the molecular biology of TJs and adherens junctions in the brain capillary endothelial cells and in the CP epithelial cells.  However, normal function of the CNS depends on a constant supply of essential molecules, like glucose and amino acids from the blood, exchange of electrolytes between brain extracellular fluids and blood, as well as on efficient removal of metabolic waste products and excess neurotransmitters from the brain ISF.  Therefore, a number of specific transport proteins are expressed in brain capillary endothelial cells and CP epithelial cells that provide transport of nutrients and ions into the CNS and removal of waste products and ions from the CSF.  The second part of this review concentrates on the molecular biology of various solute carrier (SLC) transport proteins at those two barriers and underlines differences in their expression between the two barriers.  Also, many blood-borne molecules and xenobiotics can diffuse into brain ISF and then into neuronal membranes due to their physicochemical properties.  Entry of these compounds could be detrimental for neural transmission and signalling.  Thus, BBB and BCSFB express transport proteins that actively restrict entry of lipophilic and amphipathic substances from blood and/or remove those molecules from the brain extracellular fluids.  The third part of this review concentrates on the molecular biology of ATP-binding cassette (ABC)-transporters and those SLC transporters that are involved in efflux transport of xenobiotics, their expression at the BBB and BCSFB and differences in expression in the two major blood-brain interfaces.  In addition, transport and diffusion of ions by the BBB and CP epithelium are involved in the formation of fluid, the ISF and CSF, respectively, so the last part of this review discusses molecular biology of ion transporters/exchangers and ion channels in the brain endothelial and CP epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuad1QAAjeCTDnmmyUf5qOfW6udTcc2ea_djSKNMCmFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3itFSktw%253D%253D&md5=4385fc4ed4dec5b9bc4eb50b07d06121</span></div><a href="/servlet/linkout?suffix=cit35d&amp;dbid=16384&amp;doi=10.1186%2F2045-8118-8-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2045-8118-8-3%26sid%3Dliteratum%253Aachs%26aulast%3DRedzic%26aufirst%3DZ.%26atitle%3DMolecular%2520biology%2520of%2520the%2520blood-brain%2520and%2520the%2520blood-cerebrospinal%2520fluid%2520barriers%253A%2520Similarities%2520and%2520differences%26jtitle%3DFluids%2520Barriers%2520CNS%26date%3D2011%26volume%3D8%26issue%3D1%26spage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="note"><p class="first last">Compounds with low intrinsic permeability (MDR BA < 2.5) were removed from the data set to eliminate low MDR BA/AB false positives.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&issue=6&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lghOaXUZuh4yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26issue%3D6%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&issue=6&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D6%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">Solvent-accessible surface area values were calculated using the Pipeline Pilot 8.5 “3D Coords” and “Surface Area and Volume 3D” protocols.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span> </span><span class="NLM_article-title">Species independence in brain tissue binding using brain homogenates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&issue=7&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+independence+in+brain+tissue+binding+using+brain+homogenates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0lgKhrbraa_wUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520independence%2520in%2520brain%2520tissue%2520binding%2520using%2520brain%2520homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26issue%3D7%26spage%3D1270%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Illuminati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandolini, L.</span><span> </span><span class="NLM_article-title">Ring closure reactions of bifunctional chain molecules</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar00064a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1981&pages=95-102&issue=4&author=G.+Illuminatiauthor=L.+Mandolini&title=Ring+closure+reactions+of+bifunctional+chain+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1021%2Far00064a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far00064a001%26sid%3Dliteratum%253Aachs%26aulast%3DIlluminati%26aufirst%3DG.%26aulast%3DMandolini%26aufirst%3DL.%26atitle%3DRing%2520closure%2520reactions%2520of%2520bifunctional%2520chain%2520molecules%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1981%26volume%3D14%26issue%3D4%26spage%3D95%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wessjohann, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruitjer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Rivera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, W.</span><span> </span><span class="NLM_article-title">What can a chemist learn from nature’s macrocycles?—A brief, conceptual view</span> <span class="citation_source-journal">Mol. Divers.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=171-186&author=L.+A.+Wessjohannauthor=E.+Ruitjerauthor=D.+Garcia-Riveraauthor=W.+Brandt&title=What+can+a+chemist+learn+from+nature%E2%80%99s+macrocycles%3F%E2%80%94A+brief%2C+conceptual+view"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWessjohann%26aufirst%3DL.%2BA.%26aulast%3DRuitjer%26aufirst%3DE.%26aulast%3DGarcia-Rivera%26aufirst%3DD.%26aulast%3DBrandt%26aufirst%3DW.%26atitle%3DWhat%2520can%2520a%2520chemist%2520learn%2520from%2520nature%25E2%2580%2599s%2520macrocycles%253F%25E2%2580%2594A%2520brief%252C%2520conceptual%2520view%26jtitle%3DMol.%2520Divers.%26date%3D2005%26volume%3D9%26spage%3D171%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Blankenstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span> </span><span class="NLM_article-title">Conformation-directed macrocyclization reactions</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1949</span><span class="NLM_x">–</span> <span class="NLM_lpage">1964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1002%2Fejoc.200400751" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1949-1964&author=J.+Blankensteinauthor=J.+Zhu&title=Conformation-directed+macrocyclization+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200400751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200400751%26sid%3Dliteratum%253Aachs%26aulast%3DBlankenstein%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DConformation-directed%2520macrocyclization%2520reactions%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2005%26volume%3D10%26spage%3D1949%26epage%3D1964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Cheung, K. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynisson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span> </span><span class="NLM_article-title">A facile synthesis of pyrazoles with multi-point structural diversity by 1,3-dipolar cycloaddition</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">5915</span><span class="NLM_x">–</span> <span class="NLM_lpage">5918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=5915-5918&issue=45&author=K.+M.+J.+Cheungauthor=J.+Reynissonauthor=E.+McDonald&title=A+facile+synthesis+of+pyrazoles+with+multi-point+structural+diversity+by+1%2C3-dipolar+cycloaddition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DK.%2BM.%2BJ.%26aulast%3DReynisson%26aufirst%3DJ.%26aulast%3DMcDonald%26aufirst%3DE.%26atitle%3DA%2520facile%2520synthesis%2520of%2520pyrazoles%2520with%2520multi-point%2520structural%2520diversity%2520by%25201%252C3-dipolar%2520cycloaddition%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26issue%3D45%26spage%3D5915%26epage%3D5918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casini, G.</span><span> </span><span class="NLM_article-title">A convenient synthesis of nitriles from primary amides under mild conditions</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">1813</span><span class="NLM_x">–</span> <span class="NLM_lpage">1815</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1977&pages=1813-1815&issue=21&author=F.+Campagnaauthor=A.+Carottiauthor=G.+Casini&title=A+convenient+synthesis+of+nitriles+from+primary+amides+under+mild+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DCasini%26aufirst%3DG.%26atitle%3DA%2520convenient%2520synthesis%2520of%2520nitriles%2520from%2520primary%2520amides%2520under%2520mild%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D1977%26volume%3D18%26issue%3D21%26spage%3D1813%26epage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Swamy, K. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, N. N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaraman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, K. V. P. P.</span><span> </span><span class="NLM_article-title">Mitsunobu and related reactions: Advances and applications</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2651</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr800278z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2551-2651&issue=6&author=K.+C.+K.+Swamyauthor=N.+N.+B.+Kumarauthor=E.+Balaramanauthor=K.+V.+P.+P.+Kumar&title=Mitsunobu+and+related+reactions%3A+Advances+and+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fcr800278z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr800278z%26sid%3Dliteratum%253Aachs%26aulast%3DSwamy%26aufirst%3DK.%2BC.%2BK.%26aulast%3DKumar%26aufirst%3DN.%2BN.%2BB.%26aulast%3DBalaraman%26aufirst%3DE.%26aulast%3DKumar%26aufirst%3DK.%2BV.%2BP.%2BP.%26atitle%3DMitsunobu%2520and%2520related%2520reactions%253A%2520Advances%2520and%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26issue%3D6%26spage%3D2551%26epage%3D2651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Merkul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, T. J. J.</span><span> </span><span class="NLM_article-title">Rapid synthesis of bis(hetero)aryls by one-pot Masuda borylation-Suzuki coupling sequence, and its application to concise total syntheses of meridianins A and G</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3139</span><span class="NLM_x">–</span> <span class="NLM_lpage">3141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=3139-3141&author=E.+Merkulauthor=E.+Sch%C3%A4ferauthor=T.+J.+J.+M%C3%BCller&title=Rapid+synthesis+of+bis%28hetero%29aryls+by+one-pot+Masuda+borylation-Suzuki+coupling+sequence%2C+and+its+application+to+concise+total+syntheses+of+meridianins+A+and+G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerkul%26aufirst%3DE.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BJ.%2BJ.%26atitle%3DRapid%2520synthesis%2520of%2520bis%2528hetero%2529aryls%2520by%2520one-pot%2520Masuda%2520borylation-Suzuki%2520coupling%2520sequence%252C%2520and%2520its%2520application%2520to%2520concise%2520total%2520syntheses%2520of%2520meridianins%2520A%2520and%2520G%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D3139%26epage%3D3141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Han, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group using HCl/dioxane (4M)</span> <span class="citation_source-journal">J. Pept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm500261q&amp;key=10.1034%2Fj.1399-3011.2001.00935.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm500261q&amp;key=11606219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFSgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=338-341&issue=4&author=G.+Hanauthor=M.+Tamakiauthor=V.+J.+Hruby&title=Fast%2C+efficient+and+selective+deprotection+of+the+tert-butoxycarbonyl+%28Boc%29+group+using+HCl%2Fdioxane+%284M%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group using HCl/dioxane (4 M)</span></div><div class="casAuthors">Han, G.; Tamaki, M.; Hruby, V. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">338-341</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group of various amino acids and peptides was achieved by using hydrogen chloride (4 M) in anhyd. dioxane soln. for 30 min at room temp.  In the cases studied by the authors, this protocol provided superior selectivity to deprotect Nα-Boc groups in the presence of tert-Bu esters and tert-Bu ethers, including thio-tert-Bu ethers, but not phenolic tert-Bu ethers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyRVdQlr-XZLVg90H21EOLACvtfcHk0li8QGsMvPQ07Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFSgtr4%253D&md5=0b64fab0273836aa86c15009fe795326</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-3011.2001.00935.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-3011.2001.00935.x%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DG.%26aulast%3DTamaki%26aufirst%3DM.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DFast%252C%2520efficient%2520and%2520selective%2520deprotection%2520of%2520the%2520tert-butoxycarbonyl%2520%2528Boc%2529%2520group%2520using%2520HCl%252Fdioxane%2520%25284M%2529%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2001%26volume%3D58%26issue%3D4%26spage%3D338%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Chinchilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, C.</span><span> </span><span class="NLM_article-title">Recent advances in Sonagashira reactions</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">5084</span><span class="NLM_x">–</span> <span class="NLM_lpage">5121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=5084-5121&author=R.+Chinchillaauthor=C.+N%C3%A1jera&title=Recent+advances+in+Sonagashira+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DR.%26aulast%3DN%25C3%25A1jera%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520Sonagashira%2520reactions%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D5084%26epage%3D5121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cripps, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. C.</span><span> </span><span class="NLM_article-title">Synthesis of aryl ethers via a sulfonyl transfer reaction</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">3886</span><span class="NLM_x">–</span> <span class="NLM_lpage">3889</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol301615z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=3886-3889&issue=15&author=N.+W.+Sachauthor=D.+T.+Richterauthor=S.+Crippsauthor=M.+Tran-Dubeauthor=H.+Zhuauthor=B.+Huangauthor=J.+Cuiauthor=S.+C.+Sutton&title=Synthesis+of+aryl+ethers+via+a+sulfonyl+transfer+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol301615z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol301615z%26sid%3Dliteratum%253Aachs%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DRichter%26aufirst%3DD.%2BT.%26aulast%3DCripps%26aufirst%3DS.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%2BC.%26atitle%3DSynthesis%2520of%2520aryl%2520ethers%2520via%2520a%2520sulfonyl%2520transfer%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26issue%3D15%26spage%3D3886%26epage%3D3889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Ackermann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapdi, A. R.</span><span> </span><span class="NLM_article-title">Transition metal-catalyzed direct arylation of (hetero)arenes by C-H bond cleavage</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">52</span><span class="NLM_x">) </span> <span class="NLM_fpage">9792</span><span class="NLM_x">–</span> <span class="NLM_lpage">9826</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=9792-9826&issue=52&author=L.+Ackermannauthor=R.+Vicenteauthor=A.+R.+Kapdi&title=Transition+metal-catalyzed+direct+arylation+of+%28hetero%29arenes+by+C-H+bond+cleavage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAckermann%26aufirst%3DL.%26aulast%3DVicente%26aufirst%3DR.%26aulast%3DKapdi%26aufirst%3DA.%2BR.%26atitle%3DTransition%2520metal-catalyzed%2520direct%2520arylation%2520of%2520%2528hetero%2529arenes%2520by%2520C-H%2520bond%2520cleavage%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D52%26spage%3D9792%26epage%3D9826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Kaur, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heapy, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brimble, M. A.</span><span> </span><span class="NLM_article-title">Synthesis of the all-L cyclopentapeptides versicoloritides A, B, and C</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2284</span><span class="NLM_x">–</span> <span class="NLM_lpage">2288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=2284-2288&author=H.+Kaurauthor=A.+M.+Heapyauthor=M.+A.+Brimble&title=Synthesis+of+the+all-L+cyclopentapeptides+versicoloritides+A%2C+B%2C+and+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DH.%26aulast%3DHeapy%26aufirst%3DA.%2BM.%26aulast%3DBrimble%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%2520of%2520the%2520all-L%2520cyclopentapeptides%2520versicoloritides%2520A%252C%2520B%252C%2520and%2520C%26jtitle%3DSynlett%26date%3D2012%26volume%3D23%26spage%3D2284%26epage%3D2288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Hoffmann, R. W.</span><span> </span><span class="NLM_article-title">Allylic 1,3-strain as a controlling factor in stereoselective transformations</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1860</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00098a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1989&pages=1841-1860&issue=8&author=R.+W.+Hoffmann&title=Allylic+1%2C3-strain+as+a+controlling+factor+in+stereoselective+transformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fcr00098a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00098a009%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DR.%2BW.%26atitle%3DAllylic%25201%252C3-strain%2520as%2520a%2520controlling%2520factor%2520in%2520stereoselective%2520transformations%26jtitle%3DChem.%2520Rev.%26date%3D1989%26volume%3D89%26issue%3D8%26spage%3D1841%26epage%3D1860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fader, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span> </span><span class="NLM_article-title">Revealing atropisomer axial chirality in drug discovery</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=505-513&issue=3&author=S.+R.+LaPlanteauthor=P.+J.+Edwardsauthor=L.+D.+Faderauthor=A.+Jakalianauthor=O.+Hucke&title=Revealing+atropisomer+axial+chirality+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DHucke%26aufirst%3DO.%26atitle%3DRevealing%2520atropisomer%2520axial%2520chirality%2520in%2520drug%2520discovery%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26issue%3D3%26spage%3D505%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit53b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Clayden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span> </span><span class="NLM_article-title">The challenge of atropisomerism in drug discovery</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">6398</span><span class="NLM_x">–</span> <span class="NLM_lpage">6401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6398-6401&issue=35&author=J.+Claydenauthor=W.+J.+Moranauthor=P.+J.+Edwardsauthor=S.+R.+LaPlante&title=The+challenge+of+atropisomerism+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26aulast%3DMoran%26aufirst%3DW.%2BJ.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26atitle%3DThe%2520challenge%2520of%2520atropisomerism%2520in%2520drug%2520discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D35%26spage%3D6398%26epage%3D6401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit53c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Van den Berge, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pospíšil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieu-Van, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robiette, R.</span><span> </span><span class="NLM_article-title">Planar chirality of imidazole-containing macrocycles—Understanding and tuning atropisomerism</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">6649</span><span class="NLM_x">–</span> <span class="NLM_lpage">6655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2011&pages=6649-6655&author=E.+Van+den+Bergeauthor=J.+Posp%C3%AD%C5%A1ilauthor=T.+Trieu-Vanauthor=L.+Collardauthor=R.+Robiette&title=Planar+chirality+of+imidazole-containing+macrocycles%E2%80%94Understanding+and+tuning+atropisomerism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bden%2BBerge%26aufirst%3DE.%26aulast%3DPosp%25C3%25AD%25C5%25A1il%26aufirst%3DJ.%26aulast%3DTrieu-Van%26aufirst%3DT.%26aulast%3DCollard%26aufirst%3DL.%26aulast%3DRobiette%26aufirst%3DR.%26atitle%3DPlanar%2520chirality%2520of%2520imidazole-containing%2520macrocycles%25E2%2580%2594Understanding%2520and%2520tuning%2520atropisomerism%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2011%26volume%3D33%26spage%3D6649%26epage%3D6655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Carbonelle, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span> </span><span class="NLM_article-title">A novel synthesis of biaryl-containing macrocycles by a domino Miyaura arylboronate formation: Intramolecular Suzuki reaction</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">3377</span><span class="NLM_x">–</span> <span class="NLM_lpage">3380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3377-3380&issue=22&author=A.-C.+Carbonelleauthor=J.+Zhu&title=A+novel+synthesis+of+biaryl-containing+macrocycles+by+a+domino+Miyaura+arylboronate+formation%3A+Intramolecular+Suzuki+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarbonelle%26aufirst%3DA.-C.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DA%2520novel%2520synthesis%2520of%2520biaryl-containing%2520macrocycles%2520by%2520a%2520domino%2520Miyaura%2520arylboronate%2520formation%253A%2520Intramolecular%2520Suzuki%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26issue%3D22%26spage%3D3377%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Brennführer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beller, M.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed carbonylation reactions of aryl halides and related compounds</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4114</span><span class="NLM_x">–</span> <span class="NLM_lpage">4133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=4114-4133&issue=23&author=A.+Brennf%C3%BChrerauthor=H.+Neumannauthor=M.+Beller&title=Palladium-catalyzed+carbonylation+reactions+of+aryl+halides+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrennf%25C3%25BChrer%26aufirst%3DA.%26aulast%3DNeumann%26aufirst%3DH.%26aulast%3DBeller%26aufirst%3DM.%26atitle%3DPalladium-catalyzed%2520carbonylation%2520reactions%2520of%2520aryl%2520halides%2520and%2520related%2520compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D23%26spage%3D4114%26epage%3D4133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Bensaid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laidaoui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Abed, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kacimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doucet, H.</span><span> </span><span class="NLM_article-title">Palladium-catalysed direct arylations of heteroaromatics using more eco-compatible solvents pentan-1-ol or 3-methylbutan-1-ol</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1383-1387&issue=12&author=S.+Bensaidauthor=N.+Laidaouiauthor=D.+El+Abedauthor=S.+Kacimiauthor=H.+Doucet&title=Palladium-catalysed+direct+arylations+of+heteroaromatics+using+more+eco-compatible+solvents+pentan-1-ol+or+3-methylbutan-1-ol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBensaid%26aufirst%3DS.%26aulast%3DLaidaoui%26aufirst%3DN.%26aulast%3DEl%2BAbed%26aufirst%3DD.%26aulast%3DKacimi%26aufirst%3DS.%26aulast%3DDoucet%26aufirst%3DH.%26atitle%3DPalladium-catalysed%2520direct%2520arylations%2520of%2520heteroaromatics%2520using%2520more%2520eco-compatible%2520solvents%2520pentan-1-ol%2520or%25203-methylbutan-1-ol%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26issue%3D12%26spage%3D1383%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Du, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed highly selective <i>ortho</i>-halogenation (I, Br, Cl) of arylnitriles via sp<sup>2</sup> C–H bond activation using cyano as directing group</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2786</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo302765g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=2786-2791&issue=6&author=B.+Duauthor=X.+Jiangauthor=P.+Sun&title=Palladium-catalyzed+highly+selective+ortho-halogenation+%28I%2C+Br%2C+Cl%29+of+arylnitriles+via+sp2+C%E2%80%93H+bond+activation+using+cyano+as+directing+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57a&amp;dbid=16384&amp;doi=10.1021%2Fjo302765g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo302765g%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DP.%26atitle%3DPalladium-catalyzed%2520highly%2520selective%2520ortho-halogenation%2520%2528I%252C%2520Br%252C%2520Cl%2529%2520of%2520arylnitriles%2520via%2520sp2%2520C%25E2%2580%2593H%2520bond%2520activation%2520using%2520cyano%2520as%2520directing%2520group%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26issue%3D6%26spage%3D2786%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit57b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span> </span><span class="NLM_article-title">Synthesis of biphenyl-2-carbonitrile derivatives via a palladium-catalyzed sp<sup>2</sup> C–H bond activation using cyano as a directing group</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol103075n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1286-1289&issue=6&author=W.+Liauthor=Z.+Xuauthor=P.+Sunauthor=X.+Jiangauthor=M.+Fang&title=Synthesis+of+biphenyl-2-carbonitrile+derivatives+via+a+palladium-catalyzed+sp2+C%E2%80%93H+bond+activation+using+cyano+as+a+directing+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57b&amp;dbid=16384&amp;doi=10.1021%2Fol103075n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol103075n%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520biphenyl-2-carbonitrile%2520derivatives%2520via%2520a%2520palladium-catalyzed%2520sp2%2520C%25E2%2580%2593H%2520bond%2520activation%2520using%2520cyano%2520as%2520a%2520directing%2520group%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26issue%3D6%26spage%3D1286%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lafrance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagnou, K.</span><span> </span><span class="NLM_article-title">Mild and efficient palladium-catalyzed intramolecular direct arylation reactions</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6015</span><span class="NLM_x">–</span> <span class="NLM_lpage">6020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=6015-6020&issue=26&author=M.+Lafranceauthor=D.+Lapointeauthor=K.+Fagnou&title=Mild+and+efficient+palladium-catalyzed+intramolecular+direct+arylation+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLafrance%26aufirst%3DM.%26aulast%3DLapointe%26aufirst%3DD.%26aulast%3DFagnou%26aufirst%3DK.%26atitle%3DMild%2520and%2520efficient%2520palladium-catalyzed%2520intramolecular%2520direct%2520arylation%2520reactions%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26issue%3D26%26spage%3D6015%26epage%3D6020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit58b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lafrance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagnou, K.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed benzene arylation: Incorporation of catalytic pivalic acid as a proton shuttle and a key element in catalyst design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x"> (</span><span class="NLM_issue">51</span><span class="NLM_x">) </span> <span class="NLM_fpage">16496</span><span class="NLM_x">–</span> <span class="NLM_lpage">16497</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja067144j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=16496-16497&issue=51&author=M.+Lafranceauthor=K.+Fagnou&title=Palladium-catalyzed+benzene+arylation%3A+Incorporation+of+catalytic+pivalic+acid+as+a+proton+shuttle+and+a+key+element+in+catalyst+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58b&amp;dbid=16384&amp;doi=10.1021%2Fja067144j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja067144j%26sid%3Dliteratum%253Aachs%26aulast%3DLafrance%26aufirst%3DM.%26aulast%3DFagnou%26aufirst%3DK.%26atitle%3DPalladium-catalyzed%2520benzene%2520arylation%253A%2520Incorporation%2520of%2520catalytic%2520pivalic%2520acid%2520as%2520a%2520proton%2520shuttle%2520and%2520a%2520key%2520element%2520in%2520catalyst%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26issue%3D51%26spage%3D16496%26epage%3D16497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kaminski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span> </span><span class="NLM_article-title">Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6474</span><span class="NLM_x">–</span> <span class="NLM_lpage">6487</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp003919d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm500261q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=6474-6487&author=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Evaluation+and+reparametrization+of+the+OPLS-AA+force+field+for+proteins+via+comparison+with+accurate+quantum+chemical+calculations+on+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides</span></div><div class="casAuthors">Kaminski, George A.; Friesner, Richard A.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6474-6487</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present results of improving the OPLS-AA force field for peptides by means of refitting the key Fourier torsional coeffs.  The fitting technique combines using accurate ab initio data as the target, choosing an efficient fitting subspace of the whole potential-energy surface, and detg. wts. for each of the fitting points based on magnitudes of the potential-energy gradient.  The av. energy RMS deviation from the LMP2/cc-pVTZ(-f)//HF/6-31G** data is reduced by ∼40% from 0.81 to 0.47 kcal/mol as a result of the fitting for the electrostatically uncharged dipeptides.  Transferability of the parameters is demonstrated by using the same alanine dipeptide-fitted backbone torsional parameters for all of the other dipeptides (with the appropriate side-chain refitting) and the alanine tetrapeptide.  Parameters of nonbonded interactions have also been refitted for the sulfur-contg. dipeptides (cysteine and methionine), and the validity of the new Coulombic charges and the van der Waals σ's and ε's is proved through reproducing gas-phase energies of complex formation heats of vaporization and densities of pure model liqs.  Moreover, a novel approach to fitting torsional parameters for electrostatically charged mol. systems has been presented and successfully tested on five dipeptides with charged side chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSHwmffIQePbVg90H21EOLACvtfcHk0lglEie_062apg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D&md5=3ff059626977ee7f6342466f5820f5b7</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjp003919d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp003919d%26sid%3Dliteratum%253Aachs%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DEvaluation%2520and%2520reparametrization%2520of%2520the%2520OPLS-AA%2520force%2520field%2520for%2520proteins%2520via%2520comparison%2520with%2520accurate%2520quantum%2520chemical%2520calculations%2520on%2520peptides%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2001%26volume%3D105%26spage%3D6474%26epage%3D6487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Mohamadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, N. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caufield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Still, W. C.</span><span> </span><span class="NLM_article-title">MacroModel—An integrated software system for modeling organic and bioorganic molecules using molecular mechanics</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=440-467&author=F.+Mohamadiauthor=N.+G.+J.+Richardsauthor=W.+C.+Guidaauthor=R.+Liskampauthor=M.+Liptonauthor=C.+Caufieldauthor=G.+Changauthor=T.+Hendricksonauthor=W.+C.+Still&title=MacroModel%E2%80%94An+integrated+software+system+for+modeling+organic+and+bioorganic+molecules+using+molecular+mechanics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohamadi%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DN.%2BG.%2BJ.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLiskamp%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DM.%26aulast%3DCaufield%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHendrickson%26aufirst%3DT.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DMacroModel%25E2%2580%2594An%2520integrated%2520software%2520system%2520for%2520modeling%2520organic%2520and%2520bioorganic%2520molecules%2520using%2520molecular%2520mechanics%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1990%26volume%3D11%26spage%3D440%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CNH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CNH','PDB','4CNH'); return false;">PDB: 4CNH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMO','PDB','4CMO'); return false;">PDB: 4CMO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMT','PDB','4CMT'); return false;">PDB: 4CMT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CMU','PDB','4CMU'); return false;">PDB: 4CMU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AT3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AT3','PDB','4AT3'); return false;">PDB: 4AT3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTC','PDB','4CTC'); return false;">PDB: 4CTC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CLI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CLI','PDB','4CLI'); return false;">PDB: 4CLI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CTB','PDB','4CTB'); return false;">PDB: 4CTB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CLJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CLJ','PDB','4CLJ'); return false;">PDB: 4CLJ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i91"><a href="/doi/suppl/10.1021/jm500261q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_76585"></div></div></div></div></div><hr /></hr><p class="last">X-ray data and 207-member panel kinase selectivity data for compound <b>8k</b> and experimental data for compounds <b>6e</b>, <b>6f</b>, <b>6h</b>, <b>9</b>, <b>10</b>, <b>17</b>, <b>20</b>, <b>21</b>, <b>30</b>, <b>31</b>, <b>44</b>, <b>45</b>, <b>49</b>–<b>51</b>, <b>55</b>, <b>57</b>, <b>59</b>, <b>60</b>, and <b>69</b>–<b>75</b> not explicitly shown in the schemes. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500261q/suppl_file/jm500261q_si_001.pdf">jm500261q_si_001.pdf (800.32 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500261q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm500261q%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500261q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799780ae8d13cca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
